,experiment_alias,Hakan,Yue,study_id,fin_cell_line,Can,id,study_id.y,matched_experiment_id,study_name,organism,cell_line,new_cell_line_liaoyi,updated_cell_line_liaoyi,source_name,cell_info
2918,GSM2667787,hESC,hESC,318,hESC,NA,5770,318,5772,GSE100007,Homo sapiens,hESC,hesc,hESC,Human embryonic stem cells (hESC),cell type: Human embryonic stem cells (hESC) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2919,GSM2667788,hESC,hESC,318,hESC,NA,5771,318,5773,GSE100007,Homo sapiens,hESC,hesc,hESC,Human embryonic stem cells (hESC),cell type: Human embryonic stem cells (hESC) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2920,GSM2667789,hESC,hESC,318,hESC,NA,5772,318,5770,GSE100007,Homo sapiens,hESC,hesc,hESC,Human embryonic stem cells (hESC),cell type: Human embryonic stem cells (hESC) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2921,GSM2667790,hESC,hESC,318,hESC,NA,5773,318,5771,GSE100007,Homo sapiens,hESC,hesc,hESC,Human embryonic stem cells (hESC),cell type: Human embryonic stem cells (hESC) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2922,GSM2667791,NPC,NPC,318,NPC,NA,5774,318,5776,GSE100007,Homo sapiens,NPC,npc,NPC,Neural progenitor cells (NPC),cell type: Neural progenitor cells (NPC) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2923,GSM2667792,NPC,NPC,318,NPC,NA,5775,318,5777,GSE100007,Homo sapiens,NPC,npc,NPC,Neural progenitor cells (NPC),cell type: Neural progenitor cells (NPC) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2924,GSM2667793,NPC,NPC,318,NPC,NA,5776,318,5774,GSE100007,Homo sapiens,NPC,npc,NPC,Neural progenitor cells (NPC),cell type: Neural progenitor cells (NPC) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2925,GSM2667794,NPC,NPC,318,NPC,NA,5777,318,5775,GSE100007,Homo sapiens,NPC,npc,NPC,Neural progenitor cells (NPC),cell type: Neural progenitor cells (NPC) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2926,GSM2667795,neu14,neu14,318,neu14,NA,5778,318,5780,GSE100007,Homo sapiens,neu14,neu14,neu14,Neural cultures (14 days),cell type: Neural cultures (14 days) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2927,GSM2667796,neu14,neu14,318,neu14,NA,5779,318,5781,GSE100007,Homo sapiens,neu14,neu14,neu14,Neural cultures (14 days),cell type: Neural cultures (14 days) | fraction: Ribosome protected footprints | molecule: Ribosome protected footprints
2928,GSM2667797,neu14,neu14,318,neu14,NA,5780,318,5778,GSE100007,Homo sapiens,neu14,neu14,neu14,Neural cultures (14 days),cell type: Neural cultures (14 days) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2929,GSM2667798,neu14,neu14,318,neu14,NA,5781,318,5779,GSE100007,Homo sapiens,neu14,neu14,neu14,Neural cultures (14 days),cell type: Neural cultures (14 days) | fraction: Cytoplasm | molecule: Cytoplasmic RNA
2930,GSM2676351,HepG2,HepG2,319,HepG2,NA,5782,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,S1_control_PARSseq,cell line: HepG2 | sirna: scrambled | nuclease: S1
2931,GSM2676352,HepG2,HepG2,319,HepG2,NA,5783,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,S1_KD_PARSseq,cell line: HepG2 | sirna: siADAR1 | nuclease: S1
2932,GSM2676353,HepG2,HepG2,319,HepG2,NA,5784,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,S1_control_PARSseq,cell line: HepG2 | sirna: scrambled | nuclease: S1
2933,GSM2676354,HepG2,HepG2,319,HepG2,NA,5785,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,S1_KD_PARSseq,cell line: HepG2 | sirna: siADAR1 | nuclease: S1
2934,GSM2676355,HepG2,HepG2,319,HepG2,NA,5786,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,V1_control_PARSseq,cell line: HepG2 | sirna: scrambled | nuclease: RNase V1
2935,GSM2676356,HepG2,HepG2,319,HepG2,NA,5787,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,V1_KD_PARSseq,cell line: HepG2 | sirna: siADAR1 | nuclease: RNase V1
2936,GSM2676357,HepG2,HepG2,319,HepG2,NA,5788,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,V1_control_PARSseq,cell line: HepG2 | sirna: scrambled | nuclease: RNase V1
2937,GSM2676358,HepG2,HepG2,319,HepG2,NA,5789,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,V1_KD_PARSseq,cell line: HepG2 | sirna: siADAR1 | nuclease: RNase V1
2938,GSM2676359,HepG2,HepG2,319,HepG2,NA,5790,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,control_RNAseq,cell line: HepG2 | sirna: scrambled
2939,GSM2676360,HepG2,HepG2,319,HepG2,NA,5791,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,KD_RNAseq,cell line: HepG2 | sirna: siADAR1
2940,GSM2676361,HepG2,HepG2,319,HepG2,NA,5792,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,control_Riboseq,cell line: HepG2 | sirna: scrambled
2941,GSM2676362,HepG2,HepG2,319,HepG2,NA,5793,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,KD_Riboseq,cell line: HepG2 | sirna: siADAR1
2942,GSM2676363,HepG2,HepG2,319,HepG2,NA,5794,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,control_Riboseq,cell line: HepG2 | sirna: scrambled
2943,GSM2676364,HepG2,HepG2,319,HepG2,NA,5795,319,NA,GSE100210,Homo sapiens,HepG2,hepg2,HepG2,KD_Riboseq,cell line: HepG2 | sirna: siADAR1
3010,GSM2714725,A549 cells,A549,326,A549,NA,6160,326,6164,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: control | cell type: A549 cells | molecule: RPF
3011,GSM2714726,A549 cells,A549,326,A549,NA,6161,326,6165,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8[delta]NS1 | cell type: A549 cells | molecule: RPF
3012,GSM2714727,A549 cells,A549,326,A549,NA,6162,326,6166,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: mock | cell type: A549 cells | molecule: RPF
3013,GSM2714728,A549 cells,A549,326,A549,NA,6163,326,6167,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8 | cell type: A549 cells | molecule: RPF
3014,GSM2714729,A549 cells,A549,326,A549,NA,6164,326,6160,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: control | cell type: A549 cells | molecule: total RNA
3015,GSM2714730,A549 cells,A549,326,A549,NA,6165,326,6161,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8[delta]NS1 | cell type: A549 cells | molecule: total RNA
3016,GSM2714731,A549 cells,A549,326,A549,NA,6166,326,6162,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: mock | cell type: A549 cells | molecule: total RNA
3017,GSM2714732,A549 cells,A549,326,A549,NA,6167,326,6163,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8 | cell type: A549 cells | molecule: total RNA
3018,GSM2714733,A549 cells,A549,326,A549,NA,6168,326,6172,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8[delta]NS1 | cell type: A549 cells | molecule: total RNA
3019,GSM2714734,A549 cells,A549,326,A549,NA,6169,326,6173,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: none | cell type: A549 cells | molecule: total RNA
3020,GSM2714735,A549 cells,A549,326,A549,NA,6170,326,6174,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8 | cell type: A549 cells | molecule: total RNA
3021,GSM2714736,A549 cells,A549,326,A549,NA,6171,326,6175,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: mock | cell type: A549 cells | molecule: total RNA
3022,GSM2714737,A549 cells,A549,326,A549,NA,6172,326,6168,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8[delta]NS1 | cell type: A549 cells | molecule: RPF
3023,GSM2714738,A549 cells,A549,326,A549,NA,6173,326,6169,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: control | cell type: A549 cells | molecule: RPF
3024,GSM2714739,A549 cells,A549,326,A549,NA,6174,326,6170,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: H1N1 PR8 | cell type: A549 cells | molecule: RPF
3025,GSM2714740,A549 cells,A549,326,A549,NA,6175,326,6171,GSE101760,Homo sapiens,A549,a549,A549,A549 epithelial cells,infection: mock | cell type: A549 cells | molecule: RPF
3044,GSM2722300,HEK293T,HEK293T,328,HEK293T,NA,6216,328,6217,GSE102040,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_HEK293T_RNA-seq,cell line: HEK293T | cell type: human embryonic kindey cells | enrichment: None | further treatment: None | reverse transcription condition: SS III; pH 8.3; 3mM MgCl2 | molecule subtype: rRNA depleted fraction
3045,GSM2722301,HEK293T,HEK293T,328,HEK293T,NA,6217,328,6216,GSE102040,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_HEK293T_Ribo-seq,cell line: HEK293T | cell type: human embryonic kindey cells | enrichment: None | further treatment: None | reverse transcription condition: SS III; pH 8.3; 3mM MgCl2 | molecule subtype: Ribosome protected RNA
3046,GSM2724023,HeLa,HeLa,329,HeLa,NA,6224,329,6235,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: NAT10-/-
3047,GSM2724024,HeLa,HeLa,329,HeLa,NA,6225,329,6236,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: NAT10-/-
3048,GSM2724025,HeLa,HeLa,329,HeLa,NA,6226,329,6233,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: WT
3049,GSM2724026,HeLa,HeLa,329,HeLa,NA,6227,329,6234,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: WT
3050,GSM2724032,HeLa,HeLa,329,HeLa,NA,6233,329,6226,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: WT
3051,GSM2724033,HeLa,HeLa,329,HeLa,NA,6234,329,6227,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: WT
3052,GSM2724034,HeLa,HeLa,329,HeLa,NA,6235,329,6224,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: NAT10-/-
3053,GSM2724035,HeLa,HeLa,329,HeLa,NA,6236,329,6225,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, total RNA",tissue: HeLa cells | genotype: NAT10-/-
3054,GSM2724036,HeLa,HeLa,329,HeLa,NA,6237,329,NA,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, Ribosome Protected RNA",tissue: HeLa cells | genotype: WT
3055,GSM2724037,HeLa,HeLa,329,HeLa,NA,6238,329,NA,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, Ribosome Protected RNA",tissue: HeLa cells | genotype: WT
3056,GSM2724038,HeLa,HeLa,329,HeLa,NA,6239,329,NA,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, Ribosome Protected RNA",tissue: HeLa cells | genotype: NAT10-/-
3057,GSM2724039,HeLa,HeLa,329,HeLa,NA,6240,329,NA,GSE102113,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, Ribosome Protected RNA",tissue: HeLa cells | genotype: NAT10-/-
3058,GSM2734576,HeLa,HeLa,332,HeLa,NA,6271,332,6281,GSE102315,Homo sapiens,HeLa,hela,HeLa,fS,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum
3059,GSM2734577,HeLa,HeLa,332,HeLa,NA,6272,332,6282,GSE102315,Homo sapiens,HeLa,hela,HeLa,fS,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum
3060,GSM2734578,HeLa,HeLa,332,HeLa,NA,6273,332,6283,GSE102315,Homo sapiens,HeLa,hela,HeLa,fS+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum +20nM queuine
3061,GSM2734579,HeLa,HeLa,332,HeLa,NA,6274,332,6284,GSE102315,Homo sapiens,HeLa,hela,HeLa,fS+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum +20nM queuine
3062,GSM2734580,HeLa,HeLa,332,HeLa,NA,6275,332,6285,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free
3063,GSM2734581,HeLa,HeLa,332,HeLa,NA,6276,332,6286,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free
3064,GSM2734582,HeLa,HeLa,332,HeLa,NA,6277,332,6287,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF+qR,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free 30 days+20nm queuine 15 days
3065,GSM2734583,HeLa,HeLa,332,HeLa,NA,6278,332,6288,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF+qR,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free 30 days+20nm queuine 15 days
3066,GSM2734584,HeLa,HeLa,332,HeLa,NA,6279,332,6289,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free+20nm queuine 45 days
3067,GSM2734585,HeLa,HeLa,332,HeLa,NA,6280,332,6290,GSE102315,Homo sapiens,HeLa,hela,HeLa,fSF+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free+20nm queuine 45 days
3068,GSM2734586,HeLa,HeLa,332,HeLa,NA,6281,332,6271,GSE102315,Homo sapiens,HeLa,hela,HeLa,rS,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum
3069,GSM2734587,HeLa,HeLa,332,HeLa,NA,6282,332,6272,GSE102315,Homo sapiens,HeLa,hela,HeLa,rS,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum
3070,GSM2734588,HeLa,HeLa,332,HeLa,NA,6283,332,6273,GSE102315,Homo sapiens,HeLa,hela,HeLa,rS+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum +20nM queuine
3071,GSM2734589,HeLa,HeLa,332,HeLa,NA,6284,332,6274,GSE102315,Homo sapiens,HeLa,hela,HeLa,rS+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum +20nM queuine
3072,GSM2734590,HeLa,HeLa,332,HeLa,NA,6285,332,6275,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free
3073,GSM2734591,HeLa,HeLa,332,HeLa,NA,6286,332,6276,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free
3074,GSM2734592,HeLa,HeLa,332,HeLa,NA,6287,332,6277,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF+qR,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free 30 days+20nm queuine 15 days
3075,GSM2734593,HeLa,HeLa,332,HeLa,NA,6288,332,6278,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF+qR,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free 30 days+20nm queuine 15 days
3076,GSM2734594,HeLa,HeLa,332,HeLa,NA,6289,332,6279,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free+20nm queuine 45 days
3077,GSM2734595,HeLa,HeLa,332,HeLa,NA,6290,332,6280,GSE102315,Homo sapiens,HeLa,hela,HeLa,rSF+q,cell line: cervix adenocarcinoma cell line HeLa | treatment: Serum free+20nm queuine 45 days
3102,GSM2743733,HEK293T,HEK293T,335,HEK293T,NA,6322,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: control DMSO treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3103,GSM2743734,HEK293T,HEK293T,335,HEK293T,NA,6323,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: control DMSO treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3104,GSM2743735,HEK293T,HEK293T,335,HEK293T,NA,6324,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: RocA treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3105,GSM2743736,HEK293T,HEK293T,335,HEK293T,NA,6325,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: control DMSO treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3106,GSM2743737,HEK293T,HEK293T,335,HEK293T,NA,6326,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: control DMSO treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3107,GSM2743738,HEK293T,HEK293T,335,HEK293T,NA,6327,335,NA,GSE102720,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T-REx,"treatment: RocA treatment | cell line: HEK293T-REx | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
3108,GSM2746367,HEK293,HEK293,746,HEK293,NA,14639,746,NA,GSE102786,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | transfection: empty vector
3109,GSM2746368,HEK293,HEK293,746,HEK293,NA,14640,746,NA,GSE102786,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | transfection: eIF5
3110,GSM2746369,HEK293,HEK293,746,HEK293,NA,14641,746,NA,GSE102786,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | transfection: 5MP
3111,GSM2746370,HEK293,HEK293,746,HEK293,NA,14642,746,NA,GSE102786,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | transfection: eIF5&amp;5MP
3136,GSM2760246,RD,RD,368,RD,NA,6955,368,6956,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 1.75 h
3137,GSM2760247,RD,RD,368,RD,NA,6956,368,6955,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 1.75 h
3138,GSM2760248,RD,RD,368,RD,NA,6957,368,6958,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 1.75 h
3139,GSM2760249,RD,RD,368,RD,NA,6958,368,6957,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 1.75 h
3140,GSM2760250,RD,RD,368,RD,NA,6959,368,6960,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 3.5 h
3141,GSM2760251,RD,RD,368,RD,NA,6960,368,6959,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 3.5 h
3142,GSM2760252,RD,RD,368,RD,NA,6961,368,6962,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 3.5 h
3143,GSM2760253,RD,RD,368,RD,NA,6962,368,6961,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 3.5 h
3144,GSM2760254,RD,RD,368,RD,NA,6963,368,6964,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 6.25 h
3145,GSM2760255,RD,RD,368,RD,NA,6964,368,6963,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 6.25 h
3146,GSM2760256,RD,RD,368,RD,NA,6965,368,6966,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 6.25 h
3147,GSM2760257,RD,RD,368,RD,NA,6966,368,6965,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 6.25 h
3148,GSM2760258,RD,RD,368,RD,NA,6967,368,6968,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 3.5 h
3149,GSM2760259,RD,RD,368,RD,NA,6968,368,6967,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 3.5 h
3150,GSM2760260,RD,RD,368,RD,NA,6969,368,6970,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 3.5 h
3151,GSM2760261,RD,RD,368,RD,NA,6970,368,6969,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 3.5 h
3152,GSM2760262,RD,RD,368,RD,NA,6971,368,6972,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 6.25 h
3153,GSM2760263,RD,RD,368,RD,NA,6972,368,6971,GSE103308,Homo sapiens,RD,rd,RD,muscle,cell type: RD | infection: mock | virus strain: not applicable | time: 6.25 h
3154,GSM2760264,RD,RD,368,RD,NA,6973,368,6974,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 6.25 h
3155,GSM2760265,RD,RD,368,RD,NA,6974,368,6973,GSE103308,Homo sapiens,RD,rd,RD,muscle and virus,cell type: RD | infection: Enterovirus 71 | virus strain: SK-EV006/Malaysia/97 | time: 6.25 h
3164,GSM2779661,HEK293,HEK293,341,HEK293,NA,6431,341,6439,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3165,GSM2779662,HEK293,HEK293,341,HEK293,NA,6432,341,6440,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3166,GSM2779663,HEK293,HEK293,341,HEK293,NA,6433,341,6441,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3167,GSM2779664,HEK293,HEK293,341,HEK293,NA,6434,341,6442,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3168,GSM2779665,HEK293,HEK293,341,HEK293,NA,6435,341,6443,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3169,GSM2779666,HEK293,HEK293,341,HEK293,NA,6436,341,6444,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3170,GSM2779667,HEK293,HEK293,341,HEK293,NA,6437,341,6445,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3171,GSM2779668,HEK293,HEK293,341,HEK293,NA,6438,341,6446,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3172,GSM2779669,HEK293,HEK293,341,HEK293,NA,6439,341,6431,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3173,GSM2779670,HEK293,HEK293,341,HEK293,NA,6440,341,6432,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3174,GSM2779671,HEK293,HEK293,341,HEK293,NA,6441,341,6433,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3175,GSM2779672,HEK293,HEK293,341,HEK293,NA,6442,341,6434,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: DMSO for 2h | sirna transfection: none
3176,GSM2779673,HEK293,HEK293,341,HEK293,NA,6443,341,6435,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3177,GSM2779674,HEK293,HEK293,341,HEK293,NA,6444,341,6436,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3178,GSM2779675,HEK293,HEK293,341,HEK293,NA,6445,341,6437,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3179,GSM2779676,HEK293,HEK293,341,HEK293,NA,6446,341,6438,GSE103719,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: Fetus derived cell line from female human embryonic kidney | passages: 10-20 | drug treatment: THAP (2Ã‚ÂµM) for 2h | sirna transfection: none
3180,GSM2788001,HAP-1,HAP-1,343,HAP-1,NA,6459,343,6462,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3181,GSM2788002,HAP-1,HAP-1,343,HAP-1,NA,6460,343,6463,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3182,GSM2788003,HAP-1,HAP-1,343,HAP-1,NA,6461,343,6464,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3183,GSM2788004,HAP-1,HAP-1,343,HAP-1,NA,6462,343,6459,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3184,GSM2788005,HAP-1,HAP-1,343,HAP-1,NA,6463,343,6460,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3185,GSM2788006,HAP-1,HAP-1,343,HAP-1,NA,6464,343,6461,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: METTL13-KO | tissue: HAP-1 cells
3186,GSM2788007,HAP-1,HAP-1,343,HAP-1,NA,6465,343,6467,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: wild type | tissue: HAP-1 cells
3187,GSM2788008,HAP-1,HAP-1,343,HAP-1,NA,6466,343,6468,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: wild type | tissue: HAP-1 cells
3188,GSM2788009,HAP-1,HAP-1,343,HAP-1,NA,6467,343,6465,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: wild type | tissue: HAP-1 cells
3189,GSM2788010,HAP-1,HAP-1,343,HAP-1,NA,6468,343,6466,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: wild type | tissue: HAP-1 cells
3190,GSM2788011,HAP-1,HAP-1,343,HAP-1,NA,6469,343,6469,GSE104033,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1,genotype: wild type | tissue: HAP-1 cells
3219,GSM2817679,HeLa,HeLa,346,HeLa,NA,6501,346,6512,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: untreated
3220,GSM2817680,HeLa,HeLa,346,HeLa,NA,6502,346,6513,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: untreated
3221,GSM2817681,HeLa,HeLa,346,HeLa,NA,6503,346,6514,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3222,GSM2817682,HeLa,HeLa,346,HeLa,NA,6504,346,6515,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3223,GSM2817683,HeLa,HeLa,346,HeLa,NA,6505,346,6516,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3224,GSM2817684,HeLa,HeLa,346,HeLa,NA,6506,346,6517,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3225,GSM2817685,HeLa,HeLa,346,HeLa,NA,6507,346,6518,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3226,GSM2817686,HeLa,HeLa,346,HeLa,NA,6508,346,6519,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3227,GSM2817687,HeLa,HeLa,346,HeLa,NA,6509,346,6520,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3228,GSM2817688,HeLa,HeLa,346,HeLa,NA,6510,346,6521,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3229,GSM2817689,HeLa,HeLa,346,HeLa,NA,6511,346,6522,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3230,GSM2817690,HeLa,HeLa,346,HeLa,NA,6512,346,6501,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: untreated
3231,GSM2817691,HeLa,HeLa,346,HeLa,NA,6513,346,6502,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: untreated
3232,GSM2817692,HeLa,HeLa,346,HeLa,NA,6514,346,6503,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3233,GSM2817693,HeLa,HeLa,346,HeLa,NA,6515,346,6504,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3234,GSM2817694,HeLa,HeLa,346,HeLa,NA,6516,346,6505,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: scramble siRNA
3235,GSM2817695,HeLa,HeLa,346,HeLa,NA,6517,346,6506,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3236,GSM2817696,HeLa,HeLa,346,HeLa,NA,6518,346,6507,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3237,GSM2817697,HeLa,HeLa,346,HeLa,NA,6519,346,6508,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX36 siRNA
3238,GSM2817698,HeLa,HeLa,346,HeLa,NA,6520,346,6509,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3239,GSM2817699,HeLa,HeLa,346,HeLa,NA,6521,346,6510,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3240,GSM2817700,HeLa,HeLa,346,HeLa,NA,6522,346,6511,GSE105082,Homo sapiens,HeLa,hela,HeLa,ATCC Cell Lines,cell type: HeLa | treatment: DHX9 siRNA
3255,GSM2824204,HEK293,HEK293,715,HEK293,NA,13999,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3256,GSM2824205,HEK293,HEK293,715,HEK293,NA,14000,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3257,GSM2824206,HEK293,HEK293,715,HEK293,NA,14001,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3258,GSM2824207,HEK293,HEK293,715,HEK293,NA,14002,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3259,GSM2824208,HEK293,HEK293,715,HEK293,NA,14003,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3260,GSM2824209,HEK293,HEK293,715,HEK293,NA,14004,715,NA,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 2 Ã‚ÂµM carboxyPyridostatin (cPDS)
3261,GSM2824214,HEK293,HEK293,715,HEK293,NA,14009,715,14015,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3262,GSM2824215,HEK293,HEK293,715,HEK293,NA,14010,715,14016,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3263,GSM2824216,HEK293,HEK293,715,HEK293,NA,14011,715,14017,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3264,GSM2824217,HEK293,HEK293,715,HEK293,NA,14012,715,14018,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3265,GSM2824218,HEK293,HEK293,715,HEK293,NA,14013,715,14019,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3266,GSM2824219,HEK293,HEK293,715,HEK293,NA,14014,715,14020,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout | passages: 15 - 20 | treated with: 100 Ã‚Âµg/ml cyclohexamide
3267,GSM2824220,HEK293,HEK293,715,HEK293,NA,14015,715,14009,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type
3268,GSM2824221,HEK293,HEK293,715,HEK293,NA,14016,715,14010,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type
3269,GSM2824222,HEK293,HEK293,715,HEK293,NA,14017,715,14011,GSE105175,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293 | genotype/variation: wild type
3270,GSM2824223,HEK293,HEK293,715,HEK293,NA,14018,715,14012,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout
3271,GSM2824224,HEK293,HEK293,715,HEK293,NA,14019,715,14013,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout
3272,GSM2824225,HEK293,HEK293,715,HEK293,NA,14020,715,14014,GSE105175,Homo sapiens,HEK293,hek293,HEK293,DHX36-KO-HEK293,cell line: HEK293 | genotype/variation: CRISPR/Cas9-mediated DHX36 Knockout
3273,GSM2825122,HeLa,HeLa,348,HeLa,NA,6537,348,6543,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3274,GSM2825123,HeLa,HeLa,348,HeLa,NA,6538,348,6544,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3275,GSM2825124,HeLa,HeLa,348,HeLa,NA,6539,348,6545,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3276,GSM2825125,HeLa,HeLa,348,HeLa,NA,6540,348,6546,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3277,GSM2825126,HeLa,HeLa,348,HeLa,NA,6541,348,6547,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3278,GSM2825127,HeLa,HeLa,348,HeLa,NA,6542,348,6548,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3279,GSM2825128,HeLa,HeLa,348,HeLa,NA,6543,348,6537,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3280,GSM2825129,HeLa,HeLa,348,HeLa,NA,6544,348,6538,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3281,GSM2825130,HeLa,HeLa,348,HeLa,NA,6545,348,6539,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3282,GSM2825131,HeLa,HeLa,348,HeLa,NA,6546,348,6540,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3283,GSM2825132,HeLa,HeLa,348,HeLa,NA,6547,348,6541,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: - doxycycline
3284,GSM2825133,HeLa,HeLa,348,HeLa,NA,6548,348,6542,GSE105248,Homo sapiens,HeLa,hela,HeLa,HELA cells (sh FBL integrated),cell line: HeLa (sh FBL integrated) | antibiotic treatment: + doxycycline
3302,GSM2838830,Huh7,Huh7,352,Huh7,NA,6686,352,6687,GSE106483,Homo sapiens,Huh7,huh7,Huh7,Dengue 1 infected Huh7 cells,assembly: EU081230.1 | cell type: Huh7 cells | agent: Dengue 1
3303,GSM2838831,Huh7,Huh7,352,Huh7,NA,6687,352,6686,GSE106483,Homo sapiens,Huh7,huh7,Huh7,Dengue 1 infected Huh7 cells,assembly: EU081230.1 | cell type: Huh7 cells | agent: Dengue 1
3304,GSM2838832,Huh7,Huh7,352,Huh7,NA,6688,352,6689,GSE106483,Homo sapiens,Huh7,huh7,Huh7,Dengue 1 infected Huh7 cells,assembly: EU081230.1 | cell type: Huh7 cells | agent: Dengue 1
3305,GSM2838833,Huh7,Huh7,352,Huh7,NA,6689,352,6688,GSE106483,Homo sapiens,Huh7,huh7,Huh7,Dengue 1 infected Huh7 cells,assembly: EU081230.1 | cell type: Huh7 cells | agent: Dengue 1
3332,GSM2856121,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13096,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: none
3333,GSM2856122,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13097,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: none
3334,GSM2856123,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13098,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: none
3335,GSM2856124,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13099,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: none
3336,GSM2856125,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13100,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: none
3337,GSM2856126,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13101,667,NA,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: none
3363,GSM2883304,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13102,667,13106,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3364,GSM2883305,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13103,667,13107,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3365,GSM2883306,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13104,667,13108,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3366,GSM2883307,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13105,667,13109,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3367,GSM2883308,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13106,667,13102,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3368,GSM2883309,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13107,667,13103,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3369,GSM2883310,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13108,667,13104,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3370,GSM2883311,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13109,667,13105,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3371,GSM2883312,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13110,667,13114,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3372,GSM2883313,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13111,667,13115,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3373,GSM2883314,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13112,667,13116,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3374,GSM2883315,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13113,667,13117,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3375,GSM2883316,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13114,667,13110,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3376,GSM2883317,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13115,667,13111,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3377,GSM2883318,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13116,667,13112,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3378,GSM2883319,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13117,667,13113,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3379,GSM2883320,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13118,667,13122,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3380,GSM2883321,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13119,667,13123,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3381,GSM2883322,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13120,667,13124,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3382,GSM2883323,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13121,667,13125,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3383,GSM2883324,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13122,667,13118,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shCTR
3384,GSM2883325,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13123,667,13119,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: EtOH | shRNA: shEIF2B5
3385,GSM2883326,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13124,667,13120,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shCTR
3386,GSM2883327,SW480TetOnAPC,SW480TetOnAPC,667,SW480TetOnAPC,NA,13125,667,13121,GSE106858,Homo sapiens,SW480TetOnAPC,sw480tetonapc,SW480TetOnAPC,SW480TetOnAPC cells,tissue: human colorectal cancer cell line | cell line: SW480TetOnAPC | treatment: Dox | shRNA: shEIF2B5
3338,GSM2862007,HepG2,HepG2,355,HepG2,NA,6703,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cell
3339,GSM2862008,HepG2,HepG2,355,HepG2,NA,6704,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cell
3340,GSM2862009,HepG2,HepG2,355,HepG2,NA,6705,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: nucleus
3341,GSM2862010,HepG2,HepG2,355,HepG2,NA,6706,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: nucleus
3342,GSM2862011,HepG2,HepG2,355,HepG2,NA,6707,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cytoplasm
3343,GSM2862012,HepG2,HepG2,355,HepG2,NA,6708,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cytoplasm
3344,GSM2862013,HepG2,HepG2,355,HepG2,NA,6709,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: ribosome
3345,GSM2862014,HepG2,HepG2,355,HepG2,NA,6710,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: ribosome
3346,GSM2862015,HepG2,HepG2,355,HepG2,NA,6711,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cytosol
3347,GSM2862016,HepG2,HepG2,355,HepG2,NA,6712,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: cytosol
3348,GSM2862017,HepG2,HepG2,355,HepG2,NA,6713,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: exosome
3349,GSM2862018,HepG2,HepG2,355,HepG2,NA,6714,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: exosome
3350,GSM2862019,HepG2,HepG2,355,HepG2,NA,6715,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: mitochondria
3351,GSM2862020,HepG2,HepG2,355,HepG2,NA,6716,355,NA,GSE107169,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | fractions: mitochondria
3353,GSM2871726,HEK293T,HEK293T,696,HEK293T,NA,13767,696,NA,GSE107588,Homo sapiens,HEK293T,hek293t,HEK293T,Transgenic cells,cell type: Embryonic kidney cells | passages: 10
3354,GSM2871727,HEK293T,HEK293T,696,HEK293T,NA,13768,696,NA,GSE107588,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell type: Embryonic kidney cells | passages: 10
4427,GSM3450419,HepG2,HepG2,727,HepG2,NA,8357,727,8351,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: Non specific control | fraction: 80S monosome
4428,GSM3450420,HepG2,HepG2,727,HepG2,NA,8358,727,8352,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: Non specific control | fraction: 80S monosome
4429,GSM3450421,HepG2,HepG2,727,HepG2,NA,8359,727,8353,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTL14 | fraction: 80S monosome
4430,GSM3450422,HepG2,HepG2,727,HepG2,NA,8360,727,8354,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTL14 | fraction: 80S monosome
4431,GSM3450423,HepG2,HepG2,727,HepG2,NA,8361,727,8355,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | fraction: 80S monosome
4432,GSM3450424,HepG2,HepG2,727,HepG2,NA,8362,727,8356,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | fraction: 80S monosome
3461,GSM3020061,iPSC,iPSC,372,iPSC,NA,7021,372,7025,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: isWT1.Bld2 | cardiomyocyte type: ventricular | maturity: d90
3462,GSM3020062,iPSC,iPSC,372,iPSC,NA,7022,372,7026,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iWT.D2.1o | cardiomyocyte type: ventricular | maturity: d90
3463,GSM3020063,iPSC,iPSC,372,iPSC,NA,7023,372,7027,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iWT.D2.1o | cardiomyocyte type: ventricular | maturity: d90
3464,GSM3020064,iPSC,iPSC,372,iPSC,NA,7024,372,7028,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iBM76.3 | cardiomyocyte type: ventricular | maturity: d90
3465,GSM3020065,iPSC,iPSC,372,iPSC,NA,7025,372,7021,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: isWT1.Bld2 | cardiomyocyte type: atrial | maturity: d90
3466,GSM3020066,iPSC,iPSC,372,iPSC,NA,7026,372,7022,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iWT.D2.1o | cardiomyocyte type: atrial | maturity: d90
3467,GSM3020067,iPSC,iPSC,372,iPSC,NA,7027,372,7023,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iWT.D2.1o | cardiomyocyte type: atrial | maturity: d90
3468,GSM3020068,iPSC,iPSC,372,iPSC,NA,7028,372,7024,GSE111007,Homo sapiens,iPSC,ipsc,iPSC,cardiomyocytes,cell type: iPSC-derived cardiomyocytes | cell line: iBM76.3 | cardiomyocyte type: atrial | maturity: d90
3497,GSM3042964,MCF-7,MCF7,378,MCF7,NA,7146,378,7147,GSE111866,Homo sapiens,MCF7,mcf7,MCF7,"MCF-7 cells, ribosome profiling (RIBO_seq)",cell line: MCF-7 | rna fraction: cytoplasmic RNA
3498,GSM3042965,MCF-7,MCF7,378,MCF7,NA,7147,378,7146,GSE111866,Homo sapiens,MCF7,mcf7,MCF7,"MCF-7 cells, transcriptome profiling (RNA_seq)",cell line: MCF-7 | rna fraction: cytoplasmic RNA
3511,GSM3057200,H9 Cells,H9,381,H9,NA,7162,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3512,GSM3057201,H9 Cells,H9,381,H9,NA,7163,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3513,GSM3057202,H9 Cells,H9,381,H9,NA,7164,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3514,GSM3057203,H9 Cells,H9,381,H9,NA,7165,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3515,GSM3057204,H9 Cells,H9,381,H9,NA,7166,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3516,GSM3057205,H9 Cells,H9,381,H9,NA,7167,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3517,GSM3057206,H9 Cells,H9,381,H9,NA,7168,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3518,GSM3057207,H9 Cells,H9,381,H9,NA,7169,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3519,GSM3057208,H9 Cells,H9,381,H9,NA,7170,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3520,GSM3057209,H9 Cells,H9,381,H9,NA,7171,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3521,GSM3057210,H9 Cells,H9,381,H9,NA,7172,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3522,GSM3057211,H9 Cells,H9,381,H9,NA,7173,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3523,GSM3057212,H9 Cells,H9,381,H9,NA,7174,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3524,GSM3057213,H9 Cells,H9,381,H9,NA,7175,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3525,GSM3057214,H9 Cells,H9,381,H9,NA,7176,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3526,GSM3057215,H9 Cells,H9,381,H9,NA,7177,381,NA,GSE112085,Homo sapiens,H9,h9,H9,H9 cells,cell type: human embryonic stem cells
3672,GSM3069548,HeLa,HeLa,722,HeLa,NA,14078,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3673,GSM3069549,HeLa,HeLa,722,HeLa,NA,14079,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3674,GSM3069550,HeLa,HeLa,722,HeLa,NA,14080,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3675,GSM3069551,HeLa,HeLa,722,HeLa,NA,14081,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3676,GSM3069552,HeLa,HeLa,722,HeLa,NA,14082,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3677,GSM3069553,HeLa,HeLa,722,HeLa,NA,14083,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3678,GSM3069554,HeLa,HeLa,722,HeLa,NA,14084,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3679,GSM3069555,HeLa,HeLa,722,HeLa,NA,14085,722,NA,GSE112276,Homo sapiens,HeLa,hela,HeLa,cell,sample type: cell culture
3668,GSM3068264,HEK-293,HEK293,388,HEK293,NA,7340,388,NA,GSE112353,Homo sapiens,HEK293,hek293,HEK293,"HEK-293 cells, active ribosome profiling with RiboLace, biological replicate 1",cells: HEK-293 | rna fraction: RiboLace-RIBOseq | replicate: #1
3669,GSM3068265,HEK-293,HEK293,388,HEK293,NA,7341,388,NA,GSE112353,Homo sapiens,HEK293,hek293,HEK293,"HEK-293 cells, active ribosome profiling with RiboLace, biological replicate 2",cells: HEK-293 | rna fraction: RiboLace-RIBOseq | replicate: #2
3670,GSM3068266,HEK-293,HEK293,388,HEK293,NA,7342,388,NA,GSE112353,Homo sapiens,HEK293,hek293,HEK293,"HEK-293 cells, standard ribosome profiling, biological replicate 1",cells: HEK-293 | rna fraction: standard-RIBOseq | replicate: #1
3671,GSM3068267,HEK-293,HEK293,388,HEK293,NA,7343,388,NA,GSE112353,Homo sapiens,HEK293,hek293,HEK293,"HEK-293 cells, standard ribosome profiling, biological replicate 2",cells: HEK-293 | rna fraction: standard-RIBOseq | replicate: #2
3716,GSM3081736,LC001 normal,LC_normal,393,LC_normal,NA,7505,393,7506,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC001 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3717,GSM3081737,LC001 normal,LC_normal,393,LC_normal,NA,7506,393,7505,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC001 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3718,GSM3081738,LC001 tumor,tumor,393,tumor,NA,7507,393,7508,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC001 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3719,GSM3081739,LC001 tumor,tumor,393,tumor,NA,7508,393,7507,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC001 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3720,GSM3081740,LC033 normal,LC_normal,393,LC_normal,NA,7509,393,7510,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC033 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3721,GSM3081741,LC033 normal,LC_normal,393,LC_normal,NA,7510,393,7509,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC033 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3722,GSM3081742,LC033 tumor,tumor,393,tumor,NA,7511,393,7512,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC033 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3723,GSM3081743,LC033 tumor,tumor,393,tumor,NA,7512,393,7511,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC033 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3724,GSM3081744,LC034 normal,LC_normal,393,LC_normal,NA,7513,393,7514,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC034 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3725,GSM3081745,LC034 normal,LC_normal,393,LC_normal,NA,7514,393,7513,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC034 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3726,GSM3081746,LC034 tumor,tumor,393,tumor,NA,7515,393,7516,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC034 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3727,GSM3081747,LC034 tumor,tumor,393,tumor,NA,7516,393,7515,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC034 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3728,GSM3081748,LC501 normal,LC_normal,393,LC_normal,NA,7517,393,7518,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC501 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3729,GSM3081749,LC501 normal,LC_normal,393,LC_normal,NA,7518,393,7517,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC501 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3730,GSM3081750,LC501 tumor,tumor,393,tumor,NA,7519,393,7520,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC501 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3731,GSM3081751,LC501 tumor,tumor,393,tumor,NA,7520,393,7519,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC501 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3732,GSM3081752,LC502 normal,LC_normal,393,LC_normal,NA,7521,393,7522,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC502 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3733,GSM3081753,LC502 normal,LC_normal,393,LC_normal,NA,7522,393,7521,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC502 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3734,GSM3081754,LC502 tumor,tumor,393,tumor,NA,7523,393,7524,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC502 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3735,GSM3081755,LC502 tumor,tumor,393,tumor,NA,7524,393,7523,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC502 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3736,GSM3081756,LC505 normal,LC_normal,393,LC_normal,NA,7525,393,7526,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC505 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3737,GSM3081757,LC505 normal,LC_normal,393,LC_normal,NA,7526,393,7525,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC505 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3738,GSM3081758,LC505 tumor,tumor,393,tumor,NA,7527,393,7528,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC505 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3739,GSM3081759,LC505 tumor,tumor,393,tumor,NA,7528,393,7527,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC505 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3740,GSM3081760,LC506 normal,LC_normal,393,LC_normal,NA,7529,393,7530,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC506 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3741,GSM3081761,LC506 normal,LC_normal,393,LC_normal,NA,7530,393,7529,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC506 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3742,GSM3081762,LC506 tumor,tumor,393,tumor,NA,7531,393,7532,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC506 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3743,GSM3081763,LC506 tumor,tumor,393,tumor,NA,7532,393,7531,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC506 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3744,GSM3081764,LC507 normal,LC_normal,393,LC_normal,NA,7533,393,7534,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC507 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3745,GSM3081765,LC507 normal,LC_normal,393,LC_normal,NA,7534,393,7533,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC507 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3746,GSM3081766,LC507 tumor,tumor,393,tumor,NA,7535,393,7536,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC507 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3747,GSM3081767,LC507 tumor,tumor,393,tumor,NA,7536,393,7535,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC507 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3748,GSM3081768,LC508 normal,LC_normal,393,LC_normal,NA,7537,393,7538,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC508 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3749,GSM3081769,LC508 normal,LC_normal,393,LC_normal,NA,7538,393,7537,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC508 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3750,GSM3081770,LC508 tumor,tumor,393,tumor,NA,7539,393,7540,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC508 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3751,GSM3081771,LC508 tumor,tumor,393,tumor,NA,7540,393,7539,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC508 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3752,GSM3081772,LC509 normal,LC_normal,393,LC_normal,NA,7541,393,7542,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_RPF,subject status: HCC patient | subject id: LC509 | tissue type: adjacent normal liver tissue | molecule subtype: ribosome-protected mRNA fragment (RPF)
3753,GSM3081773,LC509 normal,LC_normal,393,LC_normal,NA,7542,393,7541,GSE112705,Homo sapiens,LC_normal,lc_normal,LC_normal,normal_totalRNA,"subject status: HCC patient | subject id: LC509 | tissue type: adjacent normal liver tissue | molecule subtype: rRNA-depleted, fragmented total RNA"
3754,GSM3081774,LC509 tumor,tumor,393,tumor,NA,7543,393,7544,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_RPF,subject status: HCC patient | subject id: LC509 | tissue type: liver tumor | molecule subtype: ribosome-protected mRNA fragment (RPF)
3755,GSM3081775,LC509 tumor,tumor,393,tumor,NA,7544,393,7543,GSE112705,Homo sapiens,tumor,tumor,tumor,tumor_totalRNA,"subject status: HCC patient | subject id: LC509 | tissue type: liver tumor | molecule subtype: rRNA-depleted, fragmented total RNA"
3768,GSM3090510,HeLa,HeLa,737,HeLa,NA,14539,737,NA,GSE112891,Homo sapiens,HeLa,hela,HeLa,HeLa,strain/cell line: HeLa | genotype: n/a | lentivirally transduced transgenes: dCas9-BFP-KRAB
3769,GSM3090511,HeLa,HeLa,737,HeLa,NA,14540,737,NA,GSE112891,Homo sapiens,HeLa,hela,HeLa,HeLa,strain/cell line: HeLa | genotype: n/a | lentivirally transduced transgenes: dCas9-BFP-KRAB; sgEmc2 Puro-T2A-BFP
3770,GSM3090512,HeLa,HeLa,737,HeLa,NA,14541,737,NA,GSE112891,Homo sapiens,HeLa,hela,HeLa,HeLa,strain/cell line: HeLa | genotype: n/a | lentivirally transduced transgenes: dCas9-BFP-KRAB; sgGal4 Puro-T2A-BFP
3771,GSM3098446,HeLa,HeLa,733,HeLa,NA,14441,733,14453,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3772,GSM3098447,HeLa,HeLa,733,HeLa,NA,14442,733,14454,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3773,GSM3098448,HeLa,HeLa,733,HeLa,NA,14443,733,14455,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3774,GSM3098449,HeLa,HeLa,733,HeLa,NA,14444,733,14456,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3775,GSM3098450,HeLa,HeLa,733,HeLa,NA,14445,733,14457,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3776,GSM3098451,HeLa,HeLa,733,HeLa,NA,14446,733,14458,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3777,GSM3098452,HeLa,HeLa,733,HeLa,NA,14447,733,14459,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3778,GSM3098453,HeLa,HeLa,733,HeLa,NA,14448,733,14460,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3779,GSM3098454,HeLa,HeLa,733,HeLa,NA,14449,733,14461,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3780,GSM3098455,HeLa,HeLa,733,HeLa,NA,14450,733,14462,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3781,GSM3098456,HeLa,HeLa,733,HeLa,NA,14451,733,14463,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3782,GSM3098457,HeLa,HeLa,733,HeLa,NA,14452,733,14464,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3783,GSM3098458,HeLa,HeLa,733,HeLa,NA,14453,733,14441,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3784,GSM3098459,HeLa,HeLa,733,HeLa,NA,14454,733,14442,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3785,GSM3098460,HeLa,HeLa,733,HeLa,NA,14455,733,14443,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3786,GSM3098461,HeLa,HeLa,733,HeLa,NA,14456,733,14444,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3787,GSM3098462,HeLa,HeLa,733,HeLa,NA,14457,733,14445,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3788,GSM3098463,HeLa,HeLa,733,HeLa,NA,14458,733,14446,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3789,GSM3098464,HeLa,HeLa,733,HeLa,NA,14459,733,14447,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3790,GSM3098465,HeLa,HeLa,733,HeLa,NA,14460,733,14448,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3791,GSM3098466,HeLa,HeLa,733,HeLa,NA,14461,733,14449,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Tunicamycin(Tm) | cell line: HeLa
3792,GSM3098467,HeLa,HeLa,733,HeLa,NA,14462,733,14450,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 1Hr | cell line: HeLa
3793,GSM3098468,HeLa,HeLa,733,HeLa,NA,14463,733,14451,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 4Hr | cell line: HeLa
3794,GSM3098469,HeLa,HeLa,733,HeLa,NA,14464,733,14452,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Tunicamycin(Tm) 8Hr | cell line: HeLa
3795,GSM3098482,HeLa,HeLa,733,HeLa,NA,14477,733,14489,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3796,GSM3098483,HeLa,HeLa,733,HeLa,NA,14478,733,14490,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3797,GSM3098484,HeLa,HeLa,733,HeLa,NA,14479,733,14491,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3798,GSM3098485,HeLa,HeLa,733,HeLa,NA,14480,733,14492,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3799,GSM3098486,HeLa,HeLa,733,HeLa,NA,14481,733,14493,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3800,GSM3098487,HeLa,HeLa,733,HeLa,NA,14482,733,14494,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3801,GSM3098488,HeLa,HeLa,733,HeLa,NA,14483,733,14495,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3802,GSM3098489,HeLa,HeLa,733,HeLa,NA,14484,733,14496,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3803,GSM3098490,HeLa,HeLa,733,HeLa,NA,14485,733,14497,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3804,GSM3098491,HeLa,HeLa,733,HeLa,NA,14486,733,14498,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3805,GSM3098492,HeLa,HeLa,733,HeLa,NA,14487,733,14499,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3806,GSM3098493,HeLa,HeLa,733,HeLa,NA,14488,733,14500,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3807,GSM3098494,HeLa,HeLa,733,HeLa,NA,14489,733,14477,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3808,GSM3098495,HeLa,HeLa,733,HeLa,NA,14490,733,14478,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3809,GSM3098496,HeLa,HeLa,733,HeLa,NA,14491,733,14479,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3810,GSM3098497,HeLa,HeLa,733,HeLa,NA,14492,733,14480,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3811,GSM3098498,HeLa,HeLa,733,HeLa,NA,14493,733,14481,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3812,GSM3098499,HeLa,HeLa,733,HeLa,NA,14494,733,14482,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3813,GSM3098500,HeLa,HeLa,733,HeLa,NA,14495,733,14483,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3814,GSM3098501,HeLa,HeLa,733,HeLa,NA,14496,733,14484,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3815,GSM3098502,HeLa,HeLa,733,HeLa,NA,14497,733,14485,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: No Hydrogen peroxide | cell line: HeLa
3816,GSM3098503,HeLa,HeLa,733,HeLa,NA,14498,733,14486,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 1Hr | cell line: HeLa
3817,GSM3098504,HeLa,HeLa,733,HeLa,NA,14499,733,14487,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 4Hr | cell line: HeLa
3818,GSM3098505,HeLa,HeLa,733,HeLa,NA,14500,733,14488,GSE113171,Homo sapiens,HeLa,hela,HeLa,cervical cancer cells,treatment: Hydrogen peroxide 8Hr | cell line: HeLa
3819,GSM3112181,C643,C643,395,C643,NA,7557,395,7569,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: WT-splice | cell line: C643
3820,GSM3112182,C643,C643,395,C643,NA,7558,395,7570,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: WT-splice | cell line: C643
3821,GSM3112183,C643,C643,395,C643,NA,7559,395,7571,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: WT-splice | cell line: C643
3822,GSM3112184,C643,C643,395,C643,NA,7560,395,7572,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: Splice Reversed | cell line: C643
3823,GSM3112185,C643,C643,395,C643,NA,7561,395,7573,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: Splice Reversed | cell line: C643
3824,GSM3112186,C643,C643,395,C643,NA,7562,395,7574,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: mRNA | splice status: Splice Reversed | cell line: C643
3825,GSM3112187,CAL62,CAL62,395,CAL62,NA,7563,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: WT no splice | cell line: CAL62
3826,GSM3112188,CAL62,CAL62,395,CAL62,NA,7564,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: WT no splice | cell line: CAL62
3827,GSM3112189,CAL62,CAL62,395,CAL62,NA,7565,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: WT no splice | cell line: CAL62
3828,GSM3112190,CAL62,CAL62,395,CAL62,NA,7566,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: Splice Induced | cell line: CAL62
3829,GSM3112191,CAL62,CAL62,395,CAL62,NA,7567,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: Splice Induced | cell line: CAL62
3830,GSM3112192,CAL62,CAL62,395,CAL62,NA,7568,395,NA,GSE113695,Homo sapiens,CAL62,cal62,CAL62,CAL62,mrna type: mRNA | splice status: Splice Induced | cell line: CAL62
3831,GSM3112193,C643,C643,395,C643,NA,7569,395,7557,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: WT-splice | cell line: C643
3832,GSM3112194,C643,C643,395,C643,NA,7570,395,7558,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: WT-splice | cell line: C643
3833,GSM3112195,C643,C643,395,C643,NA,7571,395,7559,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: WT-splice | cell line: C643
3834,GSM3112196,C643,C643,395,C643,NA,7572,395,7560,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: Splice Reversed | cell line: C643
3835,GSM3112197,C643,C643,395,C643,NA,7573,395,7561,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: Splice Reversed | cell line: C643
3836,GSM3112198,C643,C643,395,C643,NA,7574,395,7562,GSE113695,Homo sapiens,C643,c643,C643,C643,mrna type: ribosome protected mRNA | splice status: Splice Reversed | cell line: C643
3837,GSM3118928,HEK293T,HEK293T,396,HEK293T,NA,7575,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: October 2017
3838,GSM3118929,HEK293T,HEK293T,396,HEK293T,NA,7576,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Arginine | treatment length: 6 hours | genotype: wild type | date experiment was sequenced: October 2017
3839,GSM3118930,HEK293T,HEK293T,396,HEK293T,NA,7577,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: October 2017
3840,GSM3118931,HEK293T,HEK293T,396,HEK293T,NA,7578,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: October 2017
3841,GSM3118932,HCT116,HCT116,396,HCT116,NA,7579,396,NA,GSE113751,Homo sapiens,HCT116,hct116,HCT116,"HCT116 cells, NCI-60 panel",cell line: HCT116 | tissue lineage: colorectal carcinoma | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: March 2017
3842,GSM3118933,HCT116,HCT116,396,HCT116,NA,7580,396,NA,GSE113751,Homo sapiens,HCT116,hct116,HCT116,"HCT116 cells, NCI-60 panel",cell line: HCT116 | tissue lineage: colorectal carcinoma | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: March 2017
3843,GSM3118934,HCT116,HCT116,396,HCT116,NA,7581,396,NA,GSE113751,Homo sapiens,HCT116,hct116,HCT116,"HCT116 cells, NCI-60 panel",cell line: HCT116 | tissue lineage: colorectal carcinoma | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: March 2017
3844,GSM3118935,HeLa,HeLa,396,HeLa,NA,7582,396,NA,GSE113751,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, ATCC CCL-2",cell line: HeLa | tissue lineage: cervical adenocarcinoma | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: August 2013
3845,GSM3118936,HeLa,HeLa,396,HeLa,NA,7583,396,NA,GSE113751,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, ATCC CCL-2",cell line: HeLa | tissue lineage: cervical adenocarcinoma | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: August 2013
3846,GSM3118937,HeLa,HeLa,396,HeLa,NA,7584,396,NA,GSE113751,Homo sapiens,HeLa,hela,HeLa,"HeLa cells, ATCC CCL-2",cell line: HeLa | tissue lineage: cervical adenocarcinoma | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: wild type | date experiment was sequenced: August 2013
3847,GSM3118938,HEK293T,HEK293T,396,HEK293T,NA,7585,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3848,GSM3118939,HEK293T,HEK293T,396,HEK293T,NA,7586,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine + 250 nM Torin1 | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3849,GSM3118940,HEK293T,HEK293T,396,HEK293T,NA,7587,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3850,GSM3118941,HEK293T,HEK293T,396,HEK293T,NA,7588,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine + 250 nM Torin1 | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3851,GSM3118942,HEK293T,HEK293T,396,HEK293T,NA,7589,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3852,GSM3118943,HEK293T,HEK293T,396,HEK293T,NA,7590,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS + 250 nM Torin1 | treatment length: 3 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2016
3853,GSM3118944,HEK293T,HEK293T,396,HEK293T,NA,7591,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-WT",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-WT | date experiment was sequenced: March 2016
3854,GSM3118945,HEK293T,HEK293T,396,HEK293T,NA,7592,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-WT",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-WT | date experiment was sequenced: March 2016
3855,GSM3118946,HEK293T,HEK293T,396,HEK293T,NA,7593,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-WT",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-WT | date experiment was sequenced: March 2016
3856,GSM3118947,HEK293T,HEK293T,396,HEK293T,NA,7594,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2016
3857,GSM3118948,HEK293T,HEK293T,396,HEK293T,NA,7595,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2016
3858,GSM3118949,HEK293T,HEK293T,396,HEK293T,NA,7596,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 3 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2016
3859,GSM3118950,HEK293T,HEK293T,396,HEK293T,NA,7597,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 6 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2017
3860,GSM3118951,HEK293T,HEK293T,396,HEK293T,NA,7598,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 6 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2017
3861,GSM3118952,HEK293T,HEK293T,396,HEK293T,NA,7599,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:hrGFP",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 6 hours | genotype: AAVS1-iCAG:hrGFP | date experiment was sequenced: March 2017
3862,GSM3118953,HEK293T,HEK293T,396,HEK293T,NA,7600,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 6 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2017
3863,GSM3118954,HEK293T,HEK293T,396,HEK293T,NA,7601,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 6 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2017
3864,GSM3118955,HEK293T,HEK293T,396,HEK293T,NA,7602,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216 + AAVS1:Flag-RagB-Q99L",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 6 hours | genotype: AAVS1-iCAG:Flag-RagB-Q99L | date experiment was sequenced: March 2017
3865,GSM3118956,HEK293T,HEK293T,396,HEK293T,NA,7603,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216, GCN2 KO",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 6 hours | genotype: complete GCN2 knockout | date experiment was sequenced: March 2017
3866,GSM3118957,HEK293T,HEK293T,396,HEK293T,NA,7604,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216, GCN2 KO",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 6 hours | genotype: complete GCN2 knockout | date experiment was sequenced: March 2017
3867,GSM3118958,HEK293T,HEK293T,396,HEK293T,NA,7605,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216, GCN2 KO",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 6 hours | genotype: complete GCN2 knockout | date experiment was sequenced: March 2017
3868,GSM3118959,HEK293T,HEK293T,396,HEK293T,NA,7606,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS  Ã¢ÂˆÂ’Arginine | treatment length: 6 hours | genotype: wild type | date experiment was sequenced: March 2017
3869,GSM3118960,HEK293T,HEK293T,396,HEK293T,NA,7607,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS Ã¢ÂˆÂ’Leucine | treatment length: 6 hours | genotype: wild type | date experiment was sequenced: March 2017
3870,GSM3118961,HEK293T,HEK293T,396,HEK293T,NA,7608,396,NA,GSE113751,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK293T cells, ATCC CRL-3216",cell line: HEK293T | tissue lineage: embryonic kidney | treatment medium: DMEM + 10% dialyzed FBS | treatment length: 6 hours | genotype: wild type | date experiment was sequenced: March 2017
3922,GSM3138101,GBM,GBM,479,Glioblastoma,,8962,479,8963,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Polysome-associated RNA | fraction: Polysome-associated RNA
3923,GSM3138102,GBM,GBM,479,Glioblastoma,,8963,479,8962,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Total RNA
3924,GSM3138103,GBM,GBM,479,Glioblastoma,,8964,479,8965,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Polysome-associated RNA | fraction: Polysome-associated RNA
3925,GSM3138104,GBM,GBM,479,Glioblastoma,,8965,479,8964,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Total RNA
3926,GSM3138105,GBM,GBM,479,Glioblastoma,,8966,479,8967,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Polysome-associated RNA | fraction: Polysome-associated RNA
3927,GSM3138106,GBM,GBM,479,Glioblastoma,,8967,479,8966,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Stem Total RNA
3928,GSM3138107,GBM,GBM,479,Glioblastoma,,8968,479,8969,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Polysome-associated RNA | fraction: Polysome-associated RNA
3929,GSM3138108,GBM,GBM,479,Glioblastoma,,8969,479,8968,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Total RNA
3930,GSM3138109,GBM,GBM,479,Glioblastoma,,8970,479,8971,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Polysome-associated RNA | fraction: Polysome-associated RNA
3931,GSM3138110,GBM,GBM,479,Glioblastoma,,8971,479,8970,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Total RNA
3932,GSM3138111,GBM,GBM,479,Glioblastoma,,8972,479,8973,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Polysome-associated RNA | fraction: Polysome-associated RNA
3933,GSM3138112,GBM,GBM,479,Glioblastoma,,8973,479,8972,GSE114222,Homo sapiens,GBM,Glioblastoma,Glioblastoma,Glioblastoma,tissue: brain | treatment: Differentiated Total RNA
3934,GSM3146275,A549,A549,401,A549,NA,7674,401,7682,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells
3935,GSM3146276,A549,A549,401,A549,NA,7675,401,7683,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | treatment: IFN-b (20 U/ml)
3936,GSM3146277,A549,A549,401,A549,NA,7676,401,7684,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,"cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus mixture of low and high CTG NP (reassortant A/PeurtoRico/1934 (PA, PB1, PB2) and A/WSN/1933 (M, NS, HA, NA) and either low or high CTG PR8 NP)"
3937,GSM3146278,A549,A549,401,A549,NA,7677,401,7685,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,"cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus mixture of low and high CTG NP (reassortant A/PeurtoRico/1934 (PA, PB1, PB2) and A/WSN/1933 (M, NS, HA, NA) and either low or high CTG PR8 NP) | treatment: IFN-b (20 U/ml)"
3938,GSM3146279,A549,A549,401,A549,NA,7678,401,NA,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells
3939,GSM3146280,A549,A549,401,A549,NA,7679,401,NA,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | treatment: IFN-b (20 U/ml)
3940,GSM3146281,A549,A549,401,A549,NA,7680,401,NA,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,"cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus mixture of low and high CTG NP (reassortant A/PeurtoRico/1934 (PA, PB1, PB2) and A/WSN/1933 (M, NS, HA, NA) and either low or high CTG PR8 NP)"
3941,GSM3146282,A549,A549,401,A549,NA,7681,401,NA,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,"cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus mixture of low and high CTG NP (reassortant A/PeurtoRico/1934 (PA, PB1, PB2) and A/WSN/1933 (M, NS, HA, NA) and either low or high CTG PR8 NP) | treatment: IFN-b (20 U/ml)"
3942,GSM3146283,A549,A549,401,A549,NA,7682,401,7674,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells
3943,GSM3146284,A549,A549,401,A549,NA,7683,401,7675,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | treatment: IFN-b (20 U/ml)
3944,GSM3146285,A549,A549,401,A549,NA,7684,401,7676,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus (reassortant A/PeurtoRico/1934 and A/WSN/1933)
3945,GSM3146286,A549,A549,401,A549,NA,7685,401,7677,GSE114636,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: influenza virus (reassortant A/PeurtoRico/1934 and A/WSN/1933) | treatment: IFN-b (20 U/ml)
3946,GSM3150265,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7686,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3947,GSM3150266,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7687,402,7718,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3948,GSM3150267,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7688,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3949,GSM3150268,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7689,402,7719,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3950,GSM3150269,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7690,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3951,GSM3150270,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7691,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3952,GSM3150271,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7692,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3953,GSM3150272,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7693,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3954,GSM3150273,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7694,402,7720,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3955,GSM3150274,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7695,402,7721,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3956,GSM3150275,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7696,402,NA,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3957,GSM3150276,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7697,402,7722,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3958,GSM3150277,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7698,402,7723,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3959,GSM3150278,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7699,402,7724,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3960,GSM3150279,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7700,402,7725,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3961,GSM3150280,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7701,402,7726,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3962,GSM3150281,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7702,402,7727,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3963,GSM3150282,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7703,402,7728,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3964,GSM3150283,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7704,402,7729,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3965,GSM3150284,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7705,402,7730,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3966,GSM3150285,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7706,402,7731,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3967,GSM3150286,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7707,402,7732,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3968,GSM3150287,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7708,402,7733,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3969,GSM3150288,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7709,402,7734,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3970,GSM3150289,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7710,402,7735,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3971,GSM3150290,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7711,402,7737,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3972,GSM3150291,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7712,402,7736,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3973,GSM3150292,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7713,402,7738,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3974,GSM3150293,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7714,402,7739,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3975,GSM3150294,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7715,402,7741,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3976,GSM3150295,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7716,402,7740,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3977,GSM3150296,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7717,402,7742,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3978,GSM3150297,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7718,402,7687,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3979,GSM3150298,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7719,402,7689,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3980,GSM3150299,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7720,402,7694,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3981,GSM3150300,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7721,402,7695,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3982,GSM3150301,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7722,402,7697,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3983,GSM3150302,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7723,402,7698,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3984,GSM3150303,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7724,402,7699,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3985,GSM3150304,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7725,402,7700,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3986,GSM3150305,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7726,402,7701,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3987,GSM3150306,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7727,402,7702,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3988,GSM3150307,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7728,402,7703,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3989,GSM3150308,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7729,402,7704,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3990,GSM3150309,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7730,402,7705,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3991,GSM3150310,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7731,402,7706,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3992,GSM3150311,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7732,402,7707,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3993,GSM3150312,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7733,402,7708,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3994,GSM3150313,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7734,402,7709,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
3995,GSM3150314,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7735,402,7710,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3996,GSM3150315,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7736,402,7712,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3997,GSM3150316,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7737,402,7711,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3998,GSM3150317,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7738,402,7713,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Ethanol
3999,GSM3150318,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7739,402,7714,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
4000,GSM3150319,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7740,402,7716,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
4001,GSM3150320,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7741,402,7715,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
4002,GSM3150321,MCF10A-ER-Src,MCF10A-ER-Src,402,MCF10A-ER-Src,NA,7742,402,7717,GSE114794,Homo sapiens,MCF10A-ER-Src,mcf10a-er-src,MCF10A-ER-Src,Breast epithelial cell,cell type: MCF10A-ER-Src | passages: 04-10 | strain: ER-Src expressing | treatment: Tamoxifen
4029,GSM3168228,HeLa,HeLa,404,HeLa,NA,7779,404,7783,GSE115146,Homo sapiens,HeLa,hela,HeLa,WT RNAseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: WT
4030,GSM3168229,HeLa,HeLa,404,HeLa,NA,7780,404,7784,GSE115146,Homo sapiens,HeLa,hela,HeLa,WT RNAseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: WT
4031,GSM3168230,HeLa,HeLa,404,HeLa,NA,7781,404,7786,GSE115146,Homo sapiens,HeLa,hela,HeLa,OE RNAseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: miR17/20a OE
4032,GSM3168231,HeLa,HeLa,404,HeLa,NA,7782,404,7787,GSE115146,Homo sapiens,HeLa,hela,HeLa,OE RNAseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: miR17/20a OE
4033,GSM3168232,HeLa,HeLa,404,HeLa,NA,7783,404,7779,GSE115146,Homo sapiens,HeLa,hela,HeLa,WT Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: WT
4034,GSM3168233,HeLa,HeLa,404,HeLa,NA,7784,404,7780,GSE115146,Homo sapiens,HeLa,hela,HeLa,WT Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: WT
4035,GSM3168234,HeLa,HeLa,404,HeLa,NA,7785,404,NA,GSE115146,Homo sapiens,HeLa,hela,HeLa,WT Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: WT
4036,GSM3168235,HeLa,HeLa,404,HeLa,NA,7786,404,7781,GSE115146,Homo sapiens,HeLa,hela,HeLa,OE Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: miR17/20a OE
4037,GSM3168236,HeLa,HeLa,404,HeLa,NA,7787,404,7782,GSE115146,Homo sapiens,HeLa,hela,HeLa,OE Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: miR17/20a OE
4038,GSM3168237,HeLa,HeLa,404,HeLa,NA,7788,404,NA,GSE115146,Homo sapiens,HeLa,hela,HeLa,OE Riboseq,cell line: HeLa | cell type: cervical adenocarcinoma cells | genotype/variation: miR17/20a OE
4039,GSM3168387,MDA-MB-231,MDA-MB-231,408,MDA-MB-231,NA,7817,408,NA,GSE115161,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,MDA-MB-231 ribosome profiling,cell line: MDA-MB-231 | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4040,GSM3168389,HeLa,HeLa,408,HeLa,NA,7819,408,NA,GSE115161,Homo sapiens,HeLa,hela,HeLa,HeLa ribosome profiling,cell line: HeLa | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4041,GSM3168390,HeLa,HeLa,408,HeLa,NA,7820,408,NA,GSE115161,Homo sapiens,HeLa,hela,HeLa,HeLa ribosome profiling,cell line: HeLa | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4042,GSM3168391,HeLa,HeLa,408,HeLa,NA,7821,408,NA,GSE115161,Homo sapiens,HeLa,hela,HeLa,HeLa Gln starvation 6hr,cell line: HeLa | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4043,GSM3168392,HeLa,HeLa,408,HeLa,NA,7822,408,NA,GSE115161,Homo sapiens,HeLa,hela,HeLa,HeLa Gln starvation 6hr CHXTIG,cell line: HeLa | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4044,GSM3168393,HeLa,HeLa,408,HeLa,NA,7823,408,NA,GSE115161,Homo sapiens,HeLa,hela,HeLa,HeLa Gln starvation 9hr,cell line: HeLa | plasmid(s): None | molecule subtype: Ribosome Protected mRNA (15-34 nt)
4302,GSM3396990,iPSC,iPSC,417,iPSC,NA,7978,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 6.6742 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4303,GSM3396991,iPSC,iPSC,417,iPSC,NA,7979,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 4.5942 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4304,GSM3396992,iPSC,iPSC,417,iPSC,NA,7980,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 5.1298 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4305,GSM3396993,iPSC,iPSC,417,iPSC,NA,7981,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 5.1246 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4306,GSM3396994,iPSC,iPSC,417,iPSC,NA,7982,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 15.2542 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4307,GSM3396995,iPSC,iPSC,417,iPSC,NA,7983,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 12.4956 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4308,GSM3396996,iPSC,iPSC,417,iPSC,NA,7984,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 14.625 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4309,GSM3396997,iPSC,iPSC,417,iPSC,NA,7985,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 11.3672 | rnase concentration: 20ng RNase A + 12U RNase T1/A260
4310,GSM3396998,iPSC,iPSC,417,iPSC,NA,7986,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 1.4768 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4311,GSM3396999,iPSC,iPSC,417,iPSC,NA,7987,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 8.151 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4312,GSM3397000,iPSC,iPSC,417,iPSC,NA,7988,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 9.4198 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4313,GSM3397001,iPSC,iPSC,417,iPSC,NA,7989,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 0.9854 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4314,GSM3397002,iPSC,iPSC,417,iPSC,NA,7990,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 2.5584 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4315,GSM3397003,iPSC,iPSC,417,iPSC,NA,7991,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 1 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 2.3062 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4316,GSM3397004,iPSC,iPSC,417,iPSC,NA,7992,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 0.4992 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4317,GSM3397005,iPSC,iPSC,417,iPSC,NA,7993,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 22.126 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4318,GSM3397006,iPSC,iPSC,417,iPSC,NA,7994,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: Fragile X Syndrome | extract_protocol: Ribosome profiling | monosome rna yield (ug): 27.585 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4319,GSM3397007,iPSC,iPSC,417,iPSC,NA,7995,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 0.3172 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4320,GSM3397008,iPSC,iPSC,417,iPSC,NA,7996,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 1.0712 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4321,GSM3397009,iPSC,iPSC,417,iPSC,NA,7997,417,NA,GSE116233,Homo sapiens,iPSC,ipsc,iPSC,iPSC-derived neurons,strain: Patient 2 | genotype: CRISPR-rescued | extract_protocol: Ribosome profiling | monosome rna yield (ug): 8.7334 | rnase concentration: 100ng RNaseA + 60U RNase T1/A260
4111,GSM3290679,HeLa,HeLa,422,HeLa,NA,8080,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4112,GSM3290680,HeLa,HeLa,422,HeLa,NA,8081,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4113,GSM3290681,HeLa,HeLa,422,HeLa,NA,8082,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4114,GSM3290682,HeLa,HeLa,422,HeLa,NA,8083,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4115,GSM3290683,HeLa,HeLa,422,HeLa,NA,8084,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4116,GSM3290684,HeLa,HeLa,422,HeLa,NA,8085,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4117,GSM3290685,HeLa,HeLa,422,HeLa,NA,8086,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4118,GSM3290686,HeLa,HeLa,422,HeLa,NA,8087,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4119,GSM3290687,HeLa,HeLa,422,HeLa,NA,8088,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4120,GSM3290688,HeLa,HeLa,422,HeLa,NA,8089,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4121,GSM3290689,HeLa,HeLa,422,HeLa,NA,8090,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4122,GSM3290690,HeLa,HeLa,422,HeLa,NA,8091,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4123,GSM3290691,HeLa,HeLa,422,HeLa,NA,8092,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4124,GSM3290692,HeLa,HeLa,422,HeLa,NA,8093,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4125,GSM3290693,HeLa,HeLa,422,HeLa,NA,8094,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4126,GSM3290694,HeLa,HeLa,422,HeLa,NA,8095,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4127,GSM3290695,HeLa,HeLa,422,HeLa,NA,8096,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4128,GSM3290696,HeLa,HeLa,422,HeLa,NA,8097,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4129,GSM3290697,HeLa,HeLa,422,HeLa,NA,8098,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4130,GSM3290698,HeLa,HeLa,422,HeLa,NA,8099,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4131,GSM3290699,HeLa,HeLa,422,HeLa,NA,8100,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4132,GSM3290700,HeLa,HeLa,422,HeLa,NA,8101,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4133,GSM3290701,HeLa,HeLa,422,HeLa,NA,8102,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4134,GSM3290702,HeLa,HeLa,422,HeLa,NA,8103,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4135,GSM3290703,HeLa,HeLa,422,HeLa,NA,8104,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4136,GSM3290704,HeLa,HeLa,422,HeLa,NA,8105,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4137,GSM3290705,HeLa,HeLa,422,HeLa,NA,8106,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4138,GSM3290706,HeLa,HeLa,422,HeLa,NA,8107,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4139,GSM3290707,HeLa,HeLa,422,HeLa,NA,8108,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4140,GSM3290708,HeLa,HeLa,422,HeLa,NA,8109,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4141,GSM3290709,HeLa,HeLa,422,HeLa,NA,8110,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4142,GSM3290710,HeLa,HeLa,422,HeLa,NA,8111,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 0h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4143,GSM3290711,HeLa,HeLa,422,HeLa,NA,8112,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4144,GSM3290712,HeLa,HeLa,422,HeLa,NA,8113,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4145,GSM3290713,HeLa,HeLa,422,HeLa,NA,8114,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4146,GSM3290714,HeLa,HeLa,422,HeLa,NA,8115,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 2h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4147,GSM3290715,HeLa,HeLa,422,HeLa,NA,8116,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4148,GSM3290716,HeLa,HeLa,422,HeLa,NA,8117,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4149,GSM3290717,HeLa,HeLa,422,HeLa,NA,8118,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4150,GSM3290718,HeLa,HeLa,422,HeLa,NA,8119,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 4h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4151,GSM3290719,HeLa,HeLa,422,HeLa,NA,8120,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: control | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa parental cells
4152,GSM3290720,HeLa,HeLa,422,HeLa,NA,8121,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShGFP | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShGFP control
4153,GSM3290721,HeLa,HeLa,422,HeLa,NA,8122,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShML3-2 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-2
4154,GSM3290722,HeLa,HeLa,422,HeLa,NA,8123,422,NA,GSE117299,Homo sapiens,HeLa,hela,HeLa,HeLa cells,actd treatment: 6h | shRNA knockdown: ShML3-3 | cell line: HeLa | cell type: cervical cancer cells | experiment: HeLa ShMETTL3 shRNA-3
4155,GSM3316956,HeLa,HeLa,424,HeLa,NA,8142,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: eGFP under Tet repressor | rna type: Ribosome protected fragments
4156,GSM3316957,HeLa,HeLa,424,HeLa,NA,8143,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: eGFP under Tet repressor | rna type: Ribosome protected fragments
4157,GSM3316958,HeLa,HeLa,424,HeLa,NA,8144,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: eGFP under Tet repressor | rna type: Ribosome protected fragments
4158,GSM3316959,HeLa,HeLa,424,HeLa,NA,8145,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: SDOS-eGFP under Tet repressor | rna type: Ribosome protected fragments
4159,GSM3316960,HeLa,HeLa,424,HeLa,NA,8146,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: SDOS-eGFP under Tet repressor | rna type: Ribosome protected fragments
4160,GSM3316961,HeLa,HeLa,424,HeLa,NA,8147,424,NA,GSE117998,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell type: T-REx-HeLa Cell Line | genotype: SDOS-eGFP under Tet repressor | rna type: Ribosome protected fragments
4161,GSM3323389,HEK293T,HEK293T,425,HEK293T,NA,8148,425,8150,GSE118239,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | passages: 15-18 | lentivirus 1: anti-EIF3A shRNA | lentivirus 2: Control (CT) EIF3A
4162,GSM3323390,HEK293T,HEK293T,425,HEK293T,NA,8149,425,8151,GSE118239,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | passages: 15-18 | lentivirus 1: anti-EIF3A shRNA | lentivirus 2: HLH mutant EIF3A
4163,GSM3323391,HEK293T,HEK293T,425,HEK293T,NA,8150,425,8148,GSE118239,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | passages: 15-18 | lentivirus 1: anti-EIF3A shRNA | lentivirus 2: Control (CT) EIF3A
4164,GSM3323392,HEK293T,HEK293T,425,HEK293T,NA,8151,425,8149,GSE118239,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | passages: 15-18 | lentivirus 1: anti-EIF3A shRNA | lentivirus 2: HLH mutant EIF3A
4229,GSM3378855,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8219,432,8221,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: Non-differentiated SH-SY5Y cells | days treatment: 0
4230,GSM3378856,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8220,432,8225,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: RA-differentiated SH-SY5Y cells | days treatment: 6
4231,GSM3378857,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8221,432,8219,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: Non-differentiated SH-SY5Y cells | days treatment: 0
4232,GSM3378858,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8222,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: Non-differentiated SH-SY5Y cells | days treatment: 0
4233,GSM3378859,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8223,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: Non-differentiated SH-SY5Y cells | days treatment: 0
4234,GSM3378860,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8224,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: Non-differentiated SH-SY5Y cells | days treatment: 0
4235,GSM3378861,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8225,432,8220,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: RA-differentiated SH-SY5Y cells | days treatment: 6
4236,GSM3378862,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8226,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: RA-differentiated SH-SY5Y cells | days treatment: 6
4237,GSM3378863,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8227,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: RA-differentiated SH-SY5Y cells | days treatment: 6
4238,GSM3378864,SH-SY5Y,SH-SY5Y,432,SH-SY5Y,NA,8228,432,NA,GSE119615,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,SH-SY5Y cells,cell type: RA-differentiated SH-SY5Y cells | days treatment: 6
4259,GSM3395010,PANC1,PANC1,833,PANC1,NA,15871,833,15877,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: Ribosome protected RNA
4260,GSM3395011,PANC1,PANC1,833,PANC1,NA,15872,833,15878,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: Ribosome protected RNA
4261,GSM3395012,PANC1,PANC1,833,PANC1,NA,15873,833,15879,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: Ribosome protected RNA
4262,GSM3395013,PANC1,PANC1,833,PANC1,NA,15874,833,15880,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: Ribosome protected RNA
4263,GSM3395014,PANC1,PANC1,833,PANC1,NA,15875,833,15881,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: Ribosome protected RNA
4264,GSM3395015,PANC1,PANC1,833,PANC1,NA,15876,833,15882,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: Ribosome protected RNA
4265,GSM3395016,PANC1,PANC1,833,PANC1,NA,15877,833,15871,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: RNA
4266,GSM3395017,PANC1,PANC1,833,PANC1,NA,15878,833,15872,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: RNA
4267,GSM3395018,PANC1,PANC1,833,PANC1,NA,15879,833,15873,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: control | molecule: RNA
4268,GSM3395019,PANC1,PANC1,833,PANC1,NA,15880,833,15874,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: RNA
4269,GSM3395020,PANC1,PANC1,833,PANC1,NA,15881,833,15875,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: RNA
4270,GSM3395021,PANC1,PANC1,833,PANC1,NA,15882,833,15876,GSE120159,Homo sapiens,PANC1,panc1,PANC1,PANC1 cell line,sample type: CR31B treated | molecule: RNA
4381,GSM3434466,U2OS Cells,U2OS,440,U2OS,NA,8343,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: CDK12 | library: ribosome footprinting | replicate: A
4382,GSM3434467,U2OS Cells,U2OS,440,U2OS,NA,8344,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: CDK12 | library: total RNA control | replicate: A
4383,GSM3434468,U2OS Cells,U2OS,440,U2OS,NA,8345,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: CDK12 | library: ribosome footprinting | replicate: B
4384,GSM3434469,U2OS Cells,U2OS,440,U2OS,NA,8346,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: CDK12 | library: total RNA control | replicate: B
4385,GSM3434470,U2OS Cells,U2OS,440,U2OS,NA,8347,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: control | library: ribosome footprinting | replicate: A
4386,GSM3434471,U2OS Cells,U2OS,440,U2OS,NA,8348,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: control | library: total RNA control | replicate: A
4387,GSM3434472,U2OS Cells,U2OS,440,U2OS,NA,8349,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: control | library: ribosome footprinting | replicate: B
4388,GSM3434473,U2OS Cells,U2OS,440,U2OS,NA,8350,440,NA,GSE121391,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,knockdown: control | library: total RNA control | replicate: B
4433,GSM3452610,Huh7,Huh7,443,Huh7,NA,8381,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-067446846for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4434,GSM3452611,Huh7,Huh7,443,Huh7,NA,8382,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-067446846for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4435,GSM3452612,Huh7,Huh7,443,Huh7,NA,8383,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-067446846for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4436,GSM3452613,Huh7,Huh7,443,Huh7,NA,8384,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-06378503for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-06378503for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4437,GSM3452614,Huh7,Huh7,443,Huh7,NA,8385,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-06378503for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-06378503for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4438,GSM3452615,Huh7,Huh7,443,Huh7,NA,8386,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-06378503for 1 hr,"cell line: Huh7 | treatment: 1.5 Ã‚ÂµM PF-06378503for 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4439,GSM3452616,Huh7,Huh7,443,Huh7,NA,8387,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.5% DMSOfor 1 hr,"cell line: Huh7 | treatment: 0.5% DMSOfor 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4440,GSM3452617,Huh7,Huh7,443,Huh7,NA,8388,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.5% DMSOfor 1 hr,"cell line: Huh7 | treatment: 0.5% DMSOfor 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4441,GSM3452618,Huh7,Huh7,443,Huh7,NA,8389,443,NA,GSE121981,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.5% DMSOfor 1 hr,"cell line: Huh7 | treatment: 0.5% DMSOfor 1 hr | molecule subtype: mRNA, ribosome protected fragments"
4442,GSM3454274,HEK293T,HEK293T,445,HEK293T,NA,8408,445,8413,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,ribo WT,genetic background: WT | cell line: HEK293T | extracted molecule: total RNA
4443,GSM3454275,HEK293T,HEK293T,445,HEK293T,NA,8409,445,8415,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,ribo KO1,genetic background: CSAM-KO#1 | cell line: HEK293T | extracted molecule: total RNA
4444,GSM3454276,HEK293T,HEK293T,445,HEK293T,NA,8410,445,8416,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,ribo KO1,genetic background: CSAM-KO#1 | cell line: HEK293T | extracted molecule: total RNA
4445,GSM3454277,HEK293T,HEK293T,445,HEK293T,NA,8411,445,8417,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,ribo KO2,genetic background: CSAM-KO#2 | cell line: HEK293T | extracted molecule: total RNA
4446,GSM3454278,HEK293T,HEK293T,445,HEK293T,NA,8412,445,8418,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,ribo KO2,genetic background: CSAM-KO#2 | cell line: HEK293T | extracted molecule: total RNA
4447,GSM3454279,HEK293T,HEK293T,445,HEK293T,NA,8413,445,8408,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna WT,genetic background: WT#1 | cell line: HEK293T | extracted molecule: total RNA
4448,GSM3454280,HEK293T,HEK293T,445,HEK293T,NA,8414,445,NA,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna WT,genetic background: WT#2 | cell line: HEK293T | extracted molecule: total RNA
4449,GSM3454281,HEK293T,HEK293T,445,HEK293T,NA,8415,445,8409,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna KO1,genetic background: CSAM-KO#1 | cell line: HEK293T | extracted molecule: total RNA
4450,GSM3454282,HEK293T,HEK293T,445,HEK293T,NA,8416,445,8410,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna KO1,genetic background: CSAM-KO#1 | cell line: HEK293T | extracted molecule: total RNA
4451,GSM3454283,HEK293T,HEK293T,445,HEK293T,NA,8417,445,8411,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna KO2,genetic background: CSAM-KO#2 | cell line: HEK293T | extracted molecule: total RNA
4452,GSM3454284,HEK293T,HEK293T,445,HEK293T,NA,8418,445,8412,GSE122071,Homo sapiens,HEK293T,hek293t,HEK293T,rna KO2,genetic background: CSAM-KO#2 | cell line: HEK293T | extracted molecule: total RNA
4455,GSM3476285,HEK293,HEK293,807,HEK293,NA,15366,807,15375,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 36 hours
4456,GSM3476286,HEK293,HEK293,807,HEK293,NA,15367,807,NA,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 36 hours
4457,GSM3476287,HEK293,HEK293,807,HEK293,NA,15368,807,15376,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 36 hours
4458,GSM3476288,HEK293,HEK293,807,HEK293,NA,15369,807,15377,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 36 hours
4459,GSM3476289,HEK293,HEK293,807,HEK293,NA,15370,807,15378,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 36 hours
4460,GSM3476290,HEK293,HEK293,807,HEK293,NA,15371,807,15381,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 72 hours
4461,GSM3476291,HEK293,HEK293,807,HEK293,NA,15372,807,15382,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 72 hours
4462,GSM3476292,HEK293,HEK293,807,HEK293,NA,15373,807,15379,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 72 hours
4463,GSM3476293,HEK293,HEK293,807,HEK293,NA,15374,807,15380,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 72 hours
4464,GSM3476294,HEK293,HEK293,807,HEK293,NA,15375,807,15366,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 36 hours
4465,GSM3476296,HEK293,HEK293,807,HEK293,NA,15376,807,15368,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 36 hours
4466,GSM3476297,HEK293,HEK293,807,HEK293,NA,15377,807,15369,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 36 hours
4467,GSM3476298,HEK293,HEK293,807,HEK293,NA,15378,807,15370,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 36 hours
4468,GSM3476299,HEK293,HEK293,807,HEK293,NA,15379,807,15373,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 72 hours
4469,GSM3476300,HEK293,HEK293,807,HEK293,NA,15380,807,15374,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: dCas9 RNP nucleofection | timepoint: 72 hours
4470,GSM3476301,HEK293,HEK293,807,HEK293,NA,15381,807,15371,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 72 hours
4471,GSM3476302,HEK293,HEK293,807,HEK293,NA,15382,807,15372,GSE122615,Homo sapiens,HEK293,hek293,HEK293,HEK293 cell line,tissue: HEK293 cell line | treatment: Cas9 RNP nucleofection | timepoint: 72 hours
4472,GSM3483766,PBMC,PBMC,447,PBMC,NA,8425,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: subacute ischemic stroke
4473,GSM3483767,PBMC,PBMC,447,PBMC,NA,8426,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: subacute ischemic stroke
4474,GSM3483768,PBMC,PBMC,447,PBMC,NA,8427,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: subacute ischemic stroke
4475,GSM3483769,PBMC,PBMC,447,PBMC,NA,8428,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: subacute ischemic stroke
4476,GSM3483770,PBMC,PBMC,447,PBMC,NA,8429,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: subacute ischemic stroke
4477,GSM3483771,PBMC,PBMC,447,PBMC,NA,8430,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: acute ischemic stroke
4478,GSM3483772,PBMC,PBMC,447,PBMC,NA,8431,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: acute ischemic stroke
4479,GSM3483773,PBMC,PBMC,447,PBMC,NA,8432,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: acute ischemic stroke
4480,GSM3483774,PBMC,PBMC,447,PBMC,NA,8433,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: acute ischemic stroke
4481,GSM3483775,PBMC,PBMC,447,PBMC,NA,8434,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: acute ischemic stroke
4482,GSM3483776,PBMC,PBMC,447,PBMC,NA,8435,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: healthy control
4483,GSM3483777,PBMC,PBMC,447,PBMC,NA,8436,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: healthy control
4484,GSM3483778,PBMC,PBMC,447,PBMC,NA,8437,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: healthy control
4485,GSM3483779,PBMC,PBMC,447,PBMC,NA,8438,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: healthy control
4486,GSM3483780,PBMC,PBMC,447,PBMC,NA,8439,447,NA,GSE122709,Homo sapiens,PBMC,pbmc,PBMC,peripheral blood mononuclear cells,tissue: blood | condition: healthy control
4487,GSM3485526,,,448,Normal tissue adjacent to gastric cancer,,8443,448,NA,GSE122796,Homo sapiens,,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,tissue: Normal tissue adjacent to gastric cancer
4488,GSM3485527,,,448,Gastric cancer,,8444,448,NA,GSE122796,Homo sapiens,,Gastric cancer,Gastric cancer,Gastric cancer,tissue: Gastric cancer
4489,GSM3485528,,,448,Normal tissue adjacent to gastric cancer,,8445,448,NA,GSE122796,Homo sapiens,,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,tissue: Normal tissue adjacent to gastric cancer
4490,GSM3485529,,,448,Gastric cancer,,8440,448,NA,GSE122796,Homo sapiens,,Gastric cancer,Gastric cancer,Gastric cancer,tissue: Gastric cancer
4491,GSM3485530,,,448,Normal tissue adjacent to gastric cancer,,8441,448,NA,GSE122796,Homo sapiens,,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,Normal tissue adjacent to gastric cancer,tissue: Normal tissue adjacent to gastric cancer
4492,GSM3485531,,,448,Gastric cancer,,8442,448,NA,GSE122796,Homo sapiens,,Gastric cancer,Gastric cancer,Gastric cancer,tissue: Gastric cancer
4493,GSM3489023,HEK293T,HEK293T,711,HEK293T,NA,13932,711,13937,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4494,GSM3489024,HEK293T,HEK293T,711,HEK293T,NA,13933,711,13938,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4495,GSM3489025,HEK293T,HEK293T,711,HEK293T,NA,13934,711,13939,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4496,GSM3489026,HEK293T,HEK293T,711,HEK293T,NA,13935,711,13940,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: WT
4497,GSM3489027,HEK293T,HEK293T,711,HEK293T,NA,13936,711,13941,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: WT
4498,GSM3489028,HEK293T,HEK293T,711,HEK293T,NA,13937,711,13932,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4499,GSM3489029,HEK293T,HEK293T,711,HEK293T,NA,13938,711,13933,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4500,GSM3489030,HEK293T,HEK293T,711,HEK293T,NA,13939,711,13934,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: PCIF1 KO
4501,GSM3489031,HEK293T,HEK293T,711,HEK293T,NA,13940,711,13935,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: WT
4502,GSM3489032,HEK293T,HEK293T,711,HEK293T,NA,13941,711,13936,GSE122948,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: WT
4543,GSM3506277,HEK,HEK293,449,HEK293,NA,8446,449,8458,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: membrane
4544,GSM3506278,HEK,HEK293,449,HEK293,NA,8447,449,8459,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: membrane
4545,GSM3506279,HEK,HEK293,449,HEK293,NA,8448,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: cytosolic
4546,GSM3506280,HEK,HEK293,449,HEK293,NA,8449,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: cytosolic
4547,GSM3506281,HEK,HEK293,449,HEK293,NA,8450,449,8460,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: membrane
4548,GSM3506282,HEK,HEK293,449,HEK293,NA,8451,449,8461,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: membrane
4549,GSM3506283,HEK,HEK293,449,HEK293,NA,8452,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: cytosolic
4550,GSM3506284,HEK,HEK293,449,HEK293,NA,8453,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: cytosolic
4551,GSM3506285,HEK,HEK293,449,HEK293,NA,8454,449,8462,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from HEK293 cells,cell line: HEK 293 | fraction: membrane
4552,GSM3506286,HEK,HEK293,449,HEK293,NA,8455,449,8463,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Membrane fraction from HEK293 cells,cell line: HEK 293 | fraction: membrane
4553,GSM3506287,HEK,HEK293,449,HEK293,NA,8456,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from HEK293 cells,cell line: HEK 293 | fraction: cytosolic
4554,GSM3506288,HEK,HEK293,449,HEK293,NA,8457,449,NA,GSE123539,Homo sapiens,HEK293,hek293,HEK293,Cytosolic fraction from HEK293 cells,cell line: HEK 293 | fraction: cytosolic
4555,GSM3506289,HEK,HEK293,449,HEK293,NA,8458,449,8446,GSE123539,Homo sapiens,HEK293,hek293,HEK293,UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: whole cell lysate
4556,GSM3506290,HEK,HEK293,449,HEK293,NA,8459,449,8447,GSE123539,Homo sapiens,HEK293,hek293,HEK293,UFM1-KO HEK293 cells,cell line: Clonal UFM1-KO HEK293 cells generated with Cas9 | fraction: whole cell lysate
4557,GSM3506291,HEK,HEK293,449,HEK293,NA,8460,449,8450,GSE123539,Homo sapiens,HEK293,hek293,HEK293,UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: whole cell lysate
4558,GSM3506292,HEK,HEK293,449,HEK293,NA,8461,449,8451,GSE123539,Homo sapiens,HEK293,hek293,HEK293,UFSP2-KO HEK293 cells,cell line: Clonal UFSP2-KO HEK293 cells generated with Cas9 | fraction: whole cell lysate
4559,GSM3506293,HEK,HEK293,449,HEK293,NA,8462,449,8454,GSE123539,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK 293 | fraction: whole cell lysate
4560,GSM3506294,HEK,HEK293,449,HEK293,NA,8463,449,8455,GSE123539,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK 293 | fraction: whole cell lysate
4561,GSM3507209,LCL,LCL,450,LCL,NA,8464,450,8478,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: polyA enriched mRNA-seq
4562,GSM3507210,LCL,LCL,450,LCL,NA,8465,450,8479,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: polyA enriched mRNA-seq
4563,GSM3507211,LCL,LCL,450,LCL,NA,8466,450,8480,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: polyA enriched mRNA-seq
4564,GSM3507212,LCL,LCL,450,LCL,NA,8467,450,8483,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: polyA enriched mRNA-seq
4565,GSM3507213,LCL,LCL,450,LCL,NA,8468,450,8484,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: polyA enriched mRNA-seq
4566,GSM3507214,LCL,LCL,450,LCL,NA,8469,450,8485,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: polyA enriched mRNA-seq
4567,GSM3507215,LCL,LCL,450,LCL,NA,8470,450,NA,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 9 | rna type: polyA enriched mRNA-seq
4568,GSM3507216,LCL,LCL,450,LCL,NA,8471,450,8476,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 9 | rna type: polyA enriched mRNA-seq
4569,GSM3507217,LCL,LCL,450,LCL,NA,8472,450,8477,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 9 | rna type: polyA enriched mRNA-seq
4570,GSM3507218,LCL,LCL,450,LCL,NA,8473,450,NA,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 5 | rna type: polyA enriched mRNA-seq
4571,GSM3507219,LCL,LCL,450,LCL,NA,8474,450,8481,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 5 | rna type: polyA enriched mRNA-seq
4572,GSM3507220,LCL,LCL,450,LCL,NA,8475,450,8482,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 5 | rna type: polyA enriched mRNA-seq
4573,GSM3507221,LCL,LCL,450,LCL,NA,8476,450,8471,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 9 | rna type: Ribosomal profiling
4574,GSM3507222,LCL,LCL,450,LCL,NA,8477,450,8472,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 9 | rna type: Ribosomal profiling
4575,GSM3507223,LCL,LCL,450,LCL,NA,8478,450,8464,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: Ribosomal profiling
4576,GSM3507224,LCL,LCL,450,LCL,NA,8479,450,8465,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: Ribosomal profiling
4577,GSM3507225,LCL,LCL,450,LCL,NA,8480,450,8466,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 6 | rna type: Ribosomal profiling
4578,GSM3507226,LCL,LCL,450,LCL,NA,8481,450,8474,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 5 | rna type: Ribosomal profiling
4579,GSM3507227,LCL,LCL,450,LCL,NA,8482,450,8475,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 5 | rna type: Ribosomal profiling
4580,GSM3507228,LCL,LCL,450,LCL,NA,8483,450,8467,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: Ribosomal profiling
4581,GSM3507229,LCL,LCL,450,LCL,NA,8484,450,8468,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: Ribosomal profiling
4582,GSM3507230,LCL,LCL,450,LCL,NA,8485,450,8469,GSE123564,Homo sapiens,LCL,lcl,LCL,Skin fibroblasts,passage: 7 | rna type: Ribosomal profiling
4679,GSM3537582,WI38,WI38,489,WI38,NA,9145,489,9153,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Control | replicate: 1
4680,GSM3537583,WI38,WI38,489,WI38,NA,9146,489,9154,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Control | replicate: 2
4681,GSM3537584,WI38,WI38,489,WI38,NA,9147,489,9155,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Heat shock | replicate: 1
4682,GSM3537585,WI38,WI38,489,WI38,NA,9148,489,9156,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Heat shock | replicate: 2
4683,GSM3537586,WI38,WI38,489,WI38,NA,9149,489,9157,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Control | replicate: 1
4684,GSM3537587,WI38,WI38,489,WI38,NA,9150,489,9158,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Control | replicate: 2
4685,GSM3537588,WI38,WI38,489,WI38,NA,9151,489,9159,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Heat shock | replicate: 1
4686,GSM3537589,WI38,WI38,489,WI38,NA,9152,489,9160,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Heat shock | replicate: 2
4687,GSM3537590,WI38,WI38,489,WI38,NA,9153,489,9145,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Control | replicate: 1
4688,GSM3537591,WI38,WI38,489,WI38,NA,9154,489,9146,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Control | replicate: 2
4689,GSM3537592,WI38,WI38,489,WI38,NA,9155,489,9147,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Heat shock | replicate: 1
4690,GSM3537593,WI38,WI38,489,WI38,NA,9156,489,9148,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 24 | phenotype: young | treatment: Heat shock | replicate: 2
4691,GSM3537594,WI38,WI38,489,WI38,NA,9157,489,9149,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Control | replicate: 1
4692,GSM3537595,WI38,WI38,489,WI38,NA,9158,489,9150,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Control | replicate: 2
4693,GSM3537596,WI38,WI38,489,WI38,NA,9159,489,9151,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Heat shock | replicate: 1
4694,GSM3537597,WI38,WI38,489,WI38,NA,9160,489,9152,GSE124609,Homo sapiens,WI38,wi38,WI38,WI38 cells,cell line: WI38 | cell type: human lung fibroblasts | passage: 36 | phenotype: senescent | treatment: Heat shock | replicate: 2
4783,GSM3562582,HeLa,HeLa,459,HeLa,NA,8633,459,8639,GSE125086,Homo sapiens,HeLa,hela,HeLa,"Vehicle-treated, HeLa cells",cell line: HeLa | treatment: control
4784,GSM3562583,HeLa,HeLa,459,HeLa,NA,8634,459,8640,GSE125086,Homo sapiens,HeLa,hela,HeLa,"Vehicle-treated, HeLa cells",cell line: HeLa | treatment: control
4785,GSM3562584,HeLa,HeLa,459,HeLa,NA,8635,459,8641,GSE125086,Homo sapiens,HeLa,hela,HeLa,"15 min-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 15 min
4786,GSM3562585,HeLa,HeLa,459,HeLa,NA,8636,459,8642,GSE125086,Homo sapiens,HeLa,hela,HeLa,"15 min-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 15 min
4787,GSM3562586,HeLa,HeLa,459,HeLa,NA,8637,459,8643,GSE125086,Homo sapiens,HeLa,hela,HeLa,"24 h-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 24 h
4788,GSM3562587,HeLa,HeLa,459,HeLa,NA,8638,459,8644,GSE125086,Homo sapiens,HeLa,hela,HeLa,"24 h-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 24 h
4789,GSM3562588,HeLa,HeLa,459,HeLa,NA,8639,459,8633,GSE125086,Homo sapiens,HeLa,hela,HeLa,"Vehicle-treated, HeLa cells",cell line: HeLa | treatment: control
4790,GSM3562589,HeLa,HeLa,459,HeLa,NA,8640,459,8634,GSE125086,Homo sapiens,HeLa,hela,HeLa,"Vehicle-treated, HeLa cells",cell line: HeLa | treatment: control
4791,GSM3562590,HeLa,HeLa,459,HeLa,NA,8641,459,8635,GSE125086,Homo sapiens,HeLa,hela,HeLa,"15 min-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 15 min
4792,GSM3562591,HeLa,HeLa,459,HeLa,NA,8642,459,8636,GSE125086,Homo sapiens,HeLa,hela,HeLa,"15 min-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 15 min
4793,GSM3562592,HeLa,HeLa,459,HeLa,NA,8643,459,8637,GSE125086,Homo sapiens,HeLa,hela,HeLa,"24 h-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 24 h
4794,GSM3562593,HeLa,HeLa,459,HeLa,NA,8644,459,8638,GSE125086,Homo sapiens,HeLa,hela,HeLa,"24 h-treated, HeLa cells",cell line: HeLa | treatment: CHX | time: 24 h
4795,GSM3563707,HEK293,HEK293,460,HEK293,NA,8645,460,8649,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: ctrl siRNA pool | rna isolation: total RNA | adapter sequence: GATCGGAAGAGCACACGT
4796,GSM3563708,HEK293,HEK293,460,HEK293,NA,8646,460,8650,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: ctrl siRNA pool | rna isolation: total RNA | adapter sequence: GATCGGAAGAGCACACGT
4797,GSM3563709,HEK293,HEK293,460,HEK293,NA,8647,460,8651,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: DDX3 siRNA pool | rna isolation: total RNA | adapter sequence: GATCGGAAGAGCACACGT
4798,GSM3563710,HEK293,HEK293,460,HEK293,NA,8648,460,8652,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: DDX3 siRNA pool | rna isolation: total RNA | adapter sequence: GATCGGAAGAGCACACGT
4799,GSM3563711,HEK293,HEK293,460,HEK293,NA,8649,460,8645,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: ctrl siRNA pool | rna isolation: Ribosome Profiling | adapter sequence: TGGAATTCTCGGGTGCCA
4800,GSM3563712,HEK293,HEK293,460,HEK293,NA,8650,460,8646,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: ctrl siRNA pool | rna isolation: Ribosome Profiling | adapter sequence: TGGAATTCTCGGGTGCCA
4801,GSM3563713,HEK293,HEK293,460,HEK293,NA,8651,460,8647,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: DDX3 siRNA pool | rna isolation: Ribosome Profiling | adapter sequence: TGGAATTCTCGGGTGCCA
4802,GSM3563714,HEK293,HEK293,460,HEK293,NA,8652,460,8648,GSE125114,Homo sapiens,HEK293,hek293,HEK293,HEK 293 FlpIn Trex,RNAi treatment: DDX3 siRNA pool | rna isolation: Ribosome Profiling | adapter sequence: TGGAATTCTCGGGTGCCA
4803,GSM3566397,HEK293T,HEK293T,710,HEK293T,NA,13894,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney
4804,GSM3566398,HEK293T,HEK293T,710,HEK293T,NA,13895,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney
4805,GSM3566399,HEK293T,HEK293T,710,HEK293T,NA,13896,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney
4806,GSM3566400,HEK293T,HEK293T,710,HEK293T,NA,13897,710,13919,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: DMSO
4807,GSM3566401,HEK293T,HEK293T,710,HEK293T,NA,13898,710,13920,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: DMSO
4808,GSM3566402,HEK293T,HEK293T,710,HEK293T,NA,13899,710,13921,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Tunicamycin
4809,GSM3566403,HEK293T,HEK293T,710,HEK293T,NA,13900,710,13922,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Tunicamycin
4810,GSM3566404,HEK293T,HEK293T,710,HEK293T,NA,13901,710,13923,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Thapsigargin
4811,GSM3566405,HEK293T,HEK293T,710,HEK293T,NA,13902,710,13924,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Thapsigargin
4812,GSM3566406,HeLa-S3,HeLa S3,710,HeLa S3,NA,13903,710,13925,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma
4813,GSM3566407,HeLa-S3,HeLa S3,710,HeLa S3,NA,13904,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma
4814,GSM3566408,HeLa-S3,HeLa S3,710,HeLa S3,NA,13905,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma
4815,GSM3566409,HeLa-S3,HeLa S3,710,HeLa S3,NA,13906,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma
4816,GSM3566410,K562,K562,710,K562,NA,13907,710,13926,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia
4817,GSM3566411,K562,K562,710,K562,NA,13908,710,NA,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia
4818,GSM3566412,K562,K562,710,K562,NA,13909,710,NA,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia
4819,GSM3566413,HEK293T,HEK293T,710,HEK293T,NA,13910,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Harringtonine
4820,GSM3566414,HEK293T,HEK293T,710,HEK293T,NA,13911,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Lactimidomycin
4821,GSM3566415,HEK293T,HEK293T,710,HEK293T,NA,13912,710,NA,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Lactimidomycin
4822,GSM3566416,HeLa-S3,HeLa S3,710,HeLa S3,NA,13913,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma | treatment: Harringtonine
4823,GSM3566417,HeLa-S3,HeLa S3,710,HeLa S3,NA,13914,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma | treatment: Harringtonine
4824,GSM3566418,HeLa-S3,HeLa S3,710,HeLa S3,NA,13915,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma | treatment: Lactimidomycin
4825,GSM3566419,HeLa-S3,HeLa S3,710,HeLa S3,NA,13916,710,NA,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma | treatment: Lactimidomycin
4826,GSM3566420,K562,K562,710,K562,NA,13917,710,NA,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia | treatment: Harringtonine
4827,GSM3566421,K562,K562,710,K562,NA,13918,710,NA,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia | treatment: Harringtonine
4828,GSM3566422,HEK293T,HEK293T,710,HEK293T,NA,13919,710,13897,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: DMSO
4829,GSM3566423,HEK293T,HEK293T,710,HEK293T,NA,13920,710,13898,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: DMSO
4830,GSM3566424,HEK293T,HEK293T,710,HEK293T,NA,13921,710,13899,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Tunicamycin
4831,GSM3566425,HEK293T,HEK293T,710,HEK293T,NA,13922,710,13900,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Tunicamycin
4832,GSM3566426,HEK293T,HEK293T,710,HEK293T,NA,13923,710,13901,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Thapsigargin
4833,GSM3566427,HEK293T,HEK293T,710,HEK293T,NA,13924,710,13902,GSE125218,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T (Human Embryonic Kidney),cell line: HEK293T | cell type: Human Embryonic Kidney | treatment: Thapsigargin
4834,GSM3566428,HeLa-S3,HeLa S3,710,HeLa S3,NA,13925,710,13903,GSE125218,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa-S3 (Human Cervix Adenocarcinoma),cell line: HeLa-S3 | cell type: Human Cervix Adenocarcinoma
4835,GSM3566429,K562,K562,710,K562,NA,13926,710,13907,GSE125218,Homo sapiens,K562,k562,K562,K562 (Human Chronic Myelogenous Leukemia),cell line: K562 | cell type: Human Chronic Myelogenous Leukemia
4836,GSM3580276,,,462,CD3-CD56+ NK cells,,8711,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4837,GSM3580277,,,462,CD3-CD56+ NK cells,,8712,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4838,GSM3580278,,,462,CD3-CD56+ NK cells,,8713,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4839,GSM3580279,,,462,CD3-CD56+ NK cells,,8714,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4840,GSM3580280,,,462,CD3-CD56+ NK cells,,8715,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4841,GSM3580281,,,462,CD3-CD56+ NK cells,,8716,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4842,GSM3580282,,,462,CD3-CD56+ NK cells,,8717,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4843,GSM3580283,,,462,CD3-CD56+ NK cells,,8718,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: HBeAg- Hepatitis
4844,GSM3580284,,,462,CD3-CD56+ NK cells,,8719,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4845,GSM3580285,,,462,CD3-CD56+ NK cells,,8720,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4846,GSM3580286,,,462,CD3-CD56+ NK cells,,8721,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4847,GSM3580287,,,462,CD3-CD56+ NK cells,,8722,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4848,GSM3580288,,,462,CD3-CD56+ NK cells,,8723,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4849,GSM3580289,,,462,CD3-CD56+ NK cells,,8724,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4850,GSM3580290,,,462,CD3-CD56+ NK cells,,8725,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4851,GSM3580291,,,462,CD3-CD56+ NK cells,,8726,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HCV | hbv clinical phase: HCV
4852,GSM3580292,,,462,CD3-CD56+ NK cells,,8727,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4853,GSM3580293,,,462,CD3-CD56+ NK cells,,8728,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4854,GSM3580294,,,462,CD3-CD56+ NK cells,,8729,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4855,GSM3580295,,,462,CD3-CD56+ NK cells,,8730,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4856,GSM3580296,,,462,CD3-CD56+ NK cells,,8731,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4857,GSM3580297,,,462,CD3-CD56+ NK cells,,8732,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4858,GSM3580298,,,462,CD3-CD56+ NK cells,,8733,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4859,GSM3580299,,,462,CD3-CD56+ NK cells,,8734,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4860,GSM3580300,,,462,CD3-CD56+ NK cells,,8735,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4861,GSM3580301,,,462,CD3-CD56+ NK cells,,8736,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4862,GSM3580302,,,462,CD3-CD56+ NK cells,,8737,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4863,GSM3580303,,,462,CD3-CD56+ NK cells,,8738,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Healthy | hbv clinical phase: Healthy
4864,GSM3580304,,,462,CD3-CD56+ NK cells,,8739,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Healthy | hbv clinical phase: Healthy
4865,GSM3580305,,,462,CD3-CD56+ NK cells,,8740,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Healthy | hbv clinical phase: Healthy
4866,GSM3580306,,,462,CD3-CD56+ NK cells,,8741,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Healthy | hbv clinical phase: Healthy
4867,GSM3580307,,,462,CD3-CD56+ NK cells,,8742,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Healthy | hbv clinical phase: Healthy
4868,GSM3580308,,,462,CD3-CD56+ NK cells,,8743,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4869,GSM3580309,,,462,CD3-CD56+ NK cells,,8744,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4870,GSM3580310,,,462,CD3-CD56+ NK cells,,8745,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4871,GSM3580311,,,462,CD3-CD56+ NK cells,,8746,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4872,GSM3580312,,,462,CD3-CD56+ NK cells,,8747,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4873,GSM3580313,,,462,CD3-CD56+ NK cells,,8748,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: HIV | hbv clinical phase: HIV-1
4874,GSM3580314,,,462,CD3-CD56+ NK cells,,8749,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4875,GSM3580315,,,462,CD3-CD56+ NK cells,,8750,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4876,GSM3580316,,,462,CD3-CD56+ NK cells,,8751,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4877,GSM3580317,,,462,CD3-CD56+ NK cells,,8752,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4878,GSM3580318,,,462,CD3-CD56+ NK cells,,8753,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4879,GSM3580319,,,462,CD3-CD56+ NK cells,,8754,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4880,GSM3580320,,,462,CD3-CD56+ NK cells,,8755,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4881,GSM3580321,,,462,CD3-CD56+ NK cells,,8756,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Active
4882,GSM3580322,,,462,CD3-CD56+ NK cells,,8757,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4883,GSM3580323,,,462,CD3-CD56+ NK cells,,8758,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4884,GSM3580324,,,462,CD3-CD56+ NK cells,,8759,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4885,GSM3580325,,,462,CD3-CD56+ NK cells,,8760,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4886,GSM3580326,,,462,CD3-CD56+ NK cells,,8761,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4887,GSM3580327,,,462,CD3-CD56+ NK cells,,8762,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4888,GSM3580328,,,462,CD3-CD56+ NK cells,,8763,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4889,GSM3580329,,,462,CD3-CD56+ NK cells,,8764,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Control
4890,GSM3580330,,,462,CD3-CD56+ NK cells,,8765,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4891,GSM3580331,,,462,CD3-CD56+ NK cells,,8766,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4892,GSM3580332,,,462,CD3-CD56+ NK cells,,8767,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4893,GSM3580333,,,462,CD3-CD56+ NK cells,,8768,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4894,GSM3580334,,,462,CD3-CD56+ NK cells,,8769,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4895,GSM3580335,,,462,CD3-CD56+ NK cells,,8770,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Male | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4896,GSM3580336,,,462,CD3-CD56+ NK cells,,8771,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4897,GSM3580337,,,462,CD3-CD56+ NK cells,,8772,462,NA,GSE125686,Homo sapiens,,CD3-CD56+ NK cells,CD3-CD56+ NK cells,PBMC,cell type: CD3-CD56+ NK cells | gender: Female | diagnosis: Chronic HBV | hbv clinical phase: Immune Tolerant
4946,GSM3581510,HepG2,HepG2,552,HepG2,NA,10784,552,NA,GSE125757,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: wild type | treatment: 500 ng/mL ADR for 24 h
4947,GSM3581511,HepG2,HepG2,552,HepG2,NA,10785,552,NA,GSE125757,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: wild type | treatment: 500 ng/mL ADR for 24 h
4948,GSM3582924,WM902B,WM902B,793,WM902B,NA,15240,793,15218,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR | molecule subtype: ribosome protected RNA fragments (RPF)
4949,GSM3582925,WM902B,WM902B,793,WM902B,NA,15241,793,15219,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR | molecule subtype: ribosome protected RNA fragments (RPF)
4950,GSM3582926,WM902B,WM902B,793,WM902B,NA,15242,793,15220,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR | molecule subtype: ribosome protected RNA fragments (RPF)
4951,GSM3582927,WM902B,WM902B,793,WM902B,NA,15243,793,15221,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR | molecule subtype: ribosome protected RNA fragments (RPF)
4952,GSM3582928,WM902B,WM902B,793,WM902B,NA,15244,793,NA,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR | molecule subtype: polyA RNA
4953,GSM3582929,WM902B,WM902B,793,WM902B,NA,15245,793,NA,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR | molecule subtype: polyA RNA
4954,GSM3582930,WM902B,WM902B,793,WM902B,NA,15246,793,NA,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR | molecule subtype: polyA RNA
4955,GSM3582931,WM902B,WM902B,793,WM902B,NA,15247,793,NA,GSE125835,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell line: WM902B | cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR | molecule subtype: polyA RNA
4956,GSM3595796,HEK293T,HEK293T,672,HEK293T,NA,13174,672,13178,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
4957,GSM3595797,HEK293T,HEK293T,672,HEK293T,NA,13175,672,13179,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
4958,GSM3595798,HEK293T,HEK293T,672,HEK293T,NA,13176,672,13180,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: EIF4A2KO | cell line: HEK293T
4959,GSM3595799,HEK293T,HEK293T,672,HEK293T,NA,13177,672,13181,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: EIF4A2KO | cell line: HEK293T
4960,GSM3595800,HEK293T,HEK293T,672,HEK293T,NA,13178,672,13174,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
4961,GSM3595801,HEK293T,HEK293T,672,HEK293T,NA,13179,672,13175,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
4962,GSM3595802,HEK293T,HEK293T,672,HEK293T,NA,13180,672,13176,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: EIF4A2KO | cell line: HEK293T
4963,GSM3595803,HEK293T,HEK293T,672,HEK293T,NA,13181,672,13177,GSE126298,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: EIF4A2KO | cell line: HEK293T
4975,GSM3597562,HCT-116,HCT-116,671,HCT-116,NA,13162,671,13168,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4976,GSM3597563,HCT-116,HCT-116,671,HCT-116,NA,13163,671,13169,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4977,GSM3597564,HCT-116,HCT-116,671,HCT-116,NA,13164,671,13170,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4978,GSM3597565,HCT-116,HCT-116,671,HCT-116,NA,13165,671,13171,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4979,GSM3597566,HCT-116,HCT-116,671,HCT-116,NA,13166,671,13172,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4980,GSM3597567,HCT-116,HCT-116,671,HCT-116,NA,13167,671,13173,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4981,GSM3597568,HCT-116,HCT-116,671,HCT-116,NA,13168,671,13162,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4982,GSM3597569,HCT-116,HCT-116,671,HCT-116,NA,13169,671,13163,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4983,GSM3597570,HCT-116,HCT-116,671,HCT-116,NA,13170,671,13164,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4984,GSM3597571,HCT-116,HCT-116,671,HCT-116,NA,13171,671,13165,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4985,GSM3597572,HCT-116,HCT-116,671,HCT-116,NA,13172,671,13166,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
4986,GSM3597573,HCT-116,HCT-116,671,HCT-116,NA,13173,671,13167,GSE126385,Homo sapiens,HCT-116,hct-116,HCT-116,colon cancer cell line,tissue: human colon cancer cell line | cell type: HCT116 (ATCC CCL-247)
5005,GSM3611926,HMECs,HMECs,651,HMECs,NA,12596,651,12599,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease | molecule subtype: ribosome protected fragments
5006,GSM3611927,HMECs,HMECs,651,HMECs,NA,12597,651,12600,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease | molecule subtype: ribosome protected fragments
5007,GSM3611928,HMECs,HMECs,651,HMECs,NA,12598,651,12601,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease | molecule subtype: ribosome protected fragments
5008,GSM3611929,HMECs,HMECs,651,HMECs,NA,12599,651,12596,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease
5009,GSM3611930,HMECs,HMECs,651,HMECs,NA,12600,651,12597,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease
5010,GSM3611931,HMECs,HMECs,651,HMECs,NA,12601,651,12598,GSE126736,Homo sapiens,HMECs,hmecs,HMECs,adult human female breast,cell line/type: Human mammary epithelial cells (HMECs) | tissue source: breast | developmental stage: adult | tumor stage: no apparent disease
5011,GSM3611932,MCF10A,MCF10A,651,MCF10A,NA,12602,651,12604,GSE126736,Homo sapiens,MCF10A,mcf10a,MCF10A,"adult human female breast, fibrocystic disease",cell line/type: MCF10A | tissue source: breast | developmental stage: adult | tumor stage: fibrocystic disease | molecule subtype: ribosome protected fragments
5012,GSM3611933,MCF10A,MCF10A,651,MCF10A,NA,12603,651,12605,GSE126736,Homo sapiens,MCF10A,mcf10a,MCF10A,"adult human female breast, fibrocystic disease",cell line/type: MCF10A | tissue source: breast | developmental stage: adult | tumor stage: fibrocystic disease | molecule subtype: ribosome protected fragments
5013,GSM3611934,MCF10A,MCF10A,651,MCF10A,NA,12604,651,12602,GSE126736,Homo sapiens,MCF10A,mcf10a,MCF10A,"adult human female breast, fibrocystic disease",cell line/type: MCF10A | tissue source: breast | developmental stage: adult | tumor stage: fibrocystic disease
5014,GSM3611935,MCF10A,MCF10A,651,MCF10A,NA,12605,651,12603,GSE126736,Homo sapiens,MCF10A,mcf10a,MCF10A,"adult human female breast, fibrocystic disease",cell line/type: MCF10A | tissue source: breast | developmental stage: adult | tumor stage: fibrocystic disease
5015,GSM3611936,T47D,T47D,651,T47D,NA,12606,651,12608,GSE126736,Homo sapiens,T47D,t47d,T47D,Human ER(+) breast cancer,cell line/type: T47D | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5016,GSM3611937,T47D,T47D,651,T47D,NA,12607,651,12609,GSE126736,Homo sapiens,T47D,t47d,T47D,Human ER(+) breast cancer,cell line/type: T47D | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5017,GSM3611938,T47D,T47D,651,T47D,NA,12608,651,12606,GSE126736,Homo sapiens,T47D,t47d,T47D,Human ER(+) breast cancer,cell line/type: T47D | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5018,GSM3611939,T47D,T47D,651,T47D,NA,12609,651,12607,GSE126736,Homo sapiens,T47D,t47d,T47D,Human ER(+) breast cancer,cell line/type: T47D | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5019,GSM3611940,ZR75-1,ZR75-1,651,ZR75-1,NA,12610,651,12612,GSE126736,Homo sapiens,ZR75-1,zr75-1,ZR75-1,Human ER(+) breast cancer,cell line/type: ZR75-1 | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5020,GSM3611941,ZR75-1,ZR75-1,651,ZR75-1,NA,12611,651,12613,GSE126736,Homo sapiens,ZR75-1,zr75-1,ZR75-1,Human ER(+) breast cancer,cell line/type: ZR75-1 | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5021,GSM3611942,ZR75-1,ZR75-1,651,ZR75-1,NA,12612,651,12610,GSE126736,Homo sapiens,ZR75-1,zr75-1,ZR75-1,Human ER(+) breast cancer,cell line/type: ZR75-1 | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5022,GSM3611943,ZR75-1,ZR75-1,651,ZR75-1,NA,12613,651,12611,GSE126736,Homo sapiens,ZR75-1,zr75-1,ZR75-1,Human ER(+) breast cancer,cell line/type: ZR75-1 | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5023,GSM3611944,SUM159PT,SUM159PT,651,SUM159PT,NA,12614,651,12618,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor | molecule subtype: ribosome protected fragments
5024,GSM3611945,SUM159PT,SUM159PT,651,SUM159PT,NA,12615,651,12619,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor | molecule subtype: ribosome protected fragments
5025,GSM3611946,SUM159PT,SUM159PT,651,SUM159PT,NA,12616,651,12620,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor | molecule subtype: ribosome protected fragments
5026,GSM3611947,SUM159PT,SUM159PT,651,SUM159PT,NA,12617,651,12621,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor | molecule subtype: ribosome protected fragments
5027,GSM3611948,SUM159PT,SUM159PT,651,SUM159PT,NA,12618,651,12614,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor
5028,GSM3611949,SUM159PT,SUM159PT,651,SUM159PT,NA,12619,651,12615,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor
5029,GSM3611950,SUM159PT,SUM159PT,651,SUM159PT,NA,12620,651,12616,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor
5030,GSM3611951,SUM159PT,SUM159PT,651,SUM159PT,NA,12621,651,12617,GSE126736,Homo sapiens,SUM159PT,sum159pt,SUM159PT,Human triple negative breast cancer,cell line/type: SUM159PT | tissue source: breast | developmental stage: adult | tumor stage: primary tumor
5031,GSM3611952,MDA-MB-231,MDA-MB-231,651,MDA-MB-231,NA,12622,651,12624,GSE126736,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Human triple negative breast cancer,cell line/type: MDA-MB-231 | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5032,GSM3611953,MDA-MB-231,MDA-MB-231,651,MDA-MB-231,NA,12623,651,12625,GSE126736,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Human triple negative breast cancer,cell line/type: MDA-MB-231 | tissue source: breast | developmental stage: adult | tumor stage: metastatic | molecule subtype: ribosome protected fragments
5033,GSM3611954,MDA-MB-231,MDA-MB-231,651,MDA-MB-231,NA,12624,651,12622,GSE126736,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Human triple negative breast cancer,cell line/type: MDA-MB-231 | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5034,GSM3611955,MDA-MB-231,MDA-MB-231,651,MDA-MB-231,NA,12625,651,12623,GSE126736,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Human triple negative breast cancer,cell line/type: MDA-MB-231 | tissue source: breast | developmental stage: adult | tumor stage: metastatic
5035,GSM3637564,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8788,465,8791,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Ribo protected RNA
5036,GSM3637565,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8789,465,8792,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Ribo protected RNA
5037,GSM3637566,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8790,465,8793,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Ribo protected RNA
5038,GSM3637567,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8791,465,8788,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Total RNA
5039,GSM3637568,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8792,465,8789,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Total RNA
5040,GSM3637569,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8793,465,8790,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post HCV transfection | molecule: Total RNA
5041,GSM3637570,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8794,465,8797,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Ribo protected RNA
5042,GSM3637571,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8795,465,8798,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Ribo protected RNA
5043,GSM3637572,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8796,465,8799,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Ribo protected RNA
5044,GSM3637573,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8797,465,8794,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Total RNA
5045,GSM3637574,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8798,465,8795,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Total RNA
5046,GSM3637575,Huh-7.5,Huh-7.5,465,Huh-7.5,NA,8799,465,8796,GSE127713,Homo sapiens,Huh-7.5,huh-7.5,Huh-7.5,heptoma cells,cell line: Huh-7.5 | time: 6 days post mock transfection | molecule: Total RNA
5207,GSM3723750,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8836,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5208,GSM3723751,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8837,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5209,GSM3723752,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8838,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5210,GSM3723753,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8839,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5211,GSM3723754,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8840,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5212,GSM3723755,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8841,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5213,GSM3723756,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8842,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5214,GSM3723757,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8843,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5215,GSM3723758,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8844,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5216,GSM3723759,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8845,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5217,GSM3723760,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8846,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5218,GSM3723761,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8847,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: confluent
5219,GSM3723762,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8848,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5220,GSM3723763,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8849,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5221,GSM3723764,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8850,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5222,GSM3723765,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8851,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5223,GSM3723766,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8852,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5224,GSM3723767,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8853,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5225,GSM3723768,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8854,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5226,GSM3723769,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8855,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5227,GSM3723770,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8856,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5228,GSM3723771,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8857,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5229,GSM3723772,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8858,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
5230,GSM3723773,human foreskin fibroblasts,human foreskin fibroblasts,468,foreskin fibroblasts,,8859,468,NA,GSE129869,Homo sapiens,human foreskin fibroblasts,foreskin fibroblasts,foreskin fibroblasts,Human Foreskin Fibroblasts and RH Toxoplasma,host cell type: human foreskin fibroblasts | parasite: Toxoplasma gondii RH | host growth: subconfluent
4503,GSM3490775,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13206,676,13226,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4504,GSM3490776,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13207,676,13227,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4505,GSM3490777,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13208,676,13228,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4506,GSM3490778,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13209,676,13229,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4507,GSM3490779,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13210,676,13230,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4508,GSM3490780,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13211,676,13231,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4509,GSM3490781,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13212,676,13232,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4510,GSM3490782,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13213,676,13233,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4511,GSM3490783,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13214,676,13234,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4512,GSM3490784,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13215,676,13235,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4513,GSM3490785,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13216,676,13236,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4514,GSM3490786,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13217,676,13237,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4515,GSM3490787,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13218,676,13238,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4516,GSM3490788,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13219,676,13239,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4517,GSM3490789,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13220,676,13240,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4518,GSM3490790,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13221,676,13241,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4519,GSM3490791,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13222,676,13242,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4520,GSM3490792,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13223,676,13243,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4521,GSM3490793,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13224,676,13244,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4522,GSM3490794,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13225,676,13245,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: Ribo-seq
4523,GSM3490795,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13226,676,13206,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4524,GSM3490796,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13227,676,13207,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4525,GSM3490797,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13228,676,13208,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4526,GSM3490798,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13229,676,13209,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4527,GSM3490799,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13230,676,13210,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 1,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4528,GSM3490800,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13231,676,13211,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4529,GSM3490801,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13232,676,13212,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4530,GSM3490802,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13233,676,13213,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4531,GSM3490803,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13234,676,13214,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4532,GSM3490804,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13235,676,13215,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 2,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4533,GSM3490805,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13236,676,13216,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4534,GSM3490806,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13237,676,13217,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4535,GSM3490807,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13238,676,13218,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4536,GSM3490808,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13239,676,13219,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4537,GSM3490809,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13240,676,13220,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 3,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4538,GSM3490810,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13241,676,13221,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4539,GSM3490811,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13242,676,13222,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4540,GSM3490812,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13243,676,13223,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4541,GSM3490813,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13244,676,13224,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: RNA-seq
4542,GSM3490814,cardiac fibroblasts,cardiac fibroblasts,676,cardiac fibroblasts,NA,13245,676,13225,GSE131112,Homo sapiens,cardiac fibroblasts,cardiac fibroblasts,cardiac fibroblasts,Patient 4,cell type: Cardiac fibroblasts | sequencing: RNA-seq
8145,GSM546921,HeLa cells,HeLa,3,HeLa,NA,11,3,10,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: mock | time: 32hr
8146,GSM546922,HeLa cells,HeLa,3,HeLa,NA,12,3,13,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-155 duplex | time: 32hr
8147,GSM546923,HeLa cells,HeLa,3,HeLa,NA,13,3,12,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-155 duplex | time: 32hr
8148,GSM546924,HeLa cells,HeLa,3,HeLa,NA,14,3,15,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-1 duplex | time: 32hr
8149,GSM546925,HeLa cells,HeLa,3,HeLa,NA,15,3,14,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-1 duplex | time: 32hr
8150,GSM546926,HeLa cells,HeLa,3,HeLa,NA,16,3,17,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: mock | time: 12hr
8151,GSM546927,HeLa cells,HeLa,3,HeLa,NA,17,3,16,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: mock | time: 12hr
8152,GSM546928,HeLa cells,HeLa,3,HeLa,NA,18,3,19,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-155 duplex | time: 12hr
8153,GSM546929,HeLa cells,HeLa,3,HeLa,NA,19,3,18,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-155 duplex | time: 12hr
8154,GSM546930,HeLa cells,HeLa,3,HeLa,NA,20,3,21,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-1 duplex | time: 12hr
8155,GSM546931,HeLa cells,HeLa,3,HeLa,NA,21,3,20,GSE21992,Homo sapiens,HeLa,hela,HeLa,HeLa,transfection: miR-1 duplex | time: 12hr
8406,GSM782785,HEK293,HEK293,7,HEK293,NA,62,7,63,GSE31539,Homo sapiens,HEK293,hek293,HEK293,HEK293_ER_mRNA,cell line: HEK293 | sample fraction: Purified endoplasmic reticulum
8409,GSM782788,HEK293,HEK293,7,HEK293,NA,65,7,64,GSE31539,Homo sapiens,HEK293,hek293,HEK293,HEK293_Cyt_footprints,cell line: HEK293 | sample fraction: Purified cytoplasm
61,GSM1063575,293T cells,HEK293T,27,HEK293T,NA,308,27,NA,GSE32060,Homo sapiens,HEK293T,hek293t,HEK293T,293T cells,cell line: 293T cells | transfected with: 3XFLAG-GFP | assay type: Riboseq
62,GSM1063576,293T cells,HEK293T,27,HEK293T,NA,309,27,NA,GSE32060,Homo sapiens,HEK293T,hek293t,HEK293T,293T cells,cell line: 293T cells | transfected with: 3XFLAG-GFP | treatment: severe heat shock (44C 2 hours) | assay type: Riboseq
63,GSM1063577,293T cells,HEK293T,27,HEK293T,NA,310,27,NA,GSE32060,Homo sapiens,HEK293T,hek293t,HEK293T,293T cells,cell line: 293T cells | transfected with: 3XFLAG-Hspa1a | assay type: Riboseq
64,GSM1063578,293T cells,HEK293T,27,HEK293T,NA,311,27,NA,GSE32060,Homo sapiens,HEK293T,hek293t,HEK293T,293T cells,cell line: 293T cells | transfected with: 3XFLAG-Hspa1a | treatment: severe heat shock (44C 2 hours) | assay type: Riboseq
8420,GSM869036,PC3,PC3,13,PC3,NA,179,13,180,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: vehicle
8421,GSM869037,PC3,PC3,13,PC3,NA,180,13,179,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: vehicle
8422,GSM869038,PC3,PC3,13,PC3,NA,181,13,182,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: rapamycin
8423,GSM869039,PC3,PC3,13,PC3,NA,182,13,181,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: rapamycin
8424,GSM869040,PC3,PC3,13,PC3,NA,183,13,184,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: PP242
8425,GSM869041,PC3,PC3,13,PC3,NA,184,13,183,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: PP242
8426,GSM869042,PC3,PC3,13,PC3,NA,185,13,186,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: vehicle
8427,GSM869043,PC3,PC3,13,PC3,NA,186,13,185,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: vehicle
8428,GSM869044,PC3,PC3,13,PC3,NA,187,13,188,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: rapamycin
8429,GSM869045,PC3,PC3,13,PC3,NA,188,13,187,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: rapamycin
8430,GSM869046,PC3,PC3,13,PC3,NA,189,13,190,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: polyA RNA | treatment: PP242
8431,GSM869047,PC3,PC3,13,PC3,NA,190,13,189,GSE35469,Homo sapiens,PC3,pc3,PC3,PC3 human prostate cancer cells,cell line: PC3 | sample type: ribosome protected RNA | treatment: PP242
8437,GSM926674,HEK293,HEK293,17,HEK293,NA,207,17,NA,GSE37744,Homo sapiens,HEK293,hek293,HEK293,HEK293 low,cell line: HEK293 | cell type: human embryonic kidney
8438,GSM926675,HEK293,HEK293,17,HEK293,NA,208,17,NA,GSE37744,Homo sapiens,HEK293,hek293,HEK293,HEK293 medium,cell line: HEK293 | cell type: human embryonic kidney
8439,GSM926676,HEK293,HEK293,17,HEK293,NA,209,17,NA,GSE37744,Homo sapiens,HEK293,hek293,HEK293,HEK293 high,cell line: HEK293 | cell type: human embryonic kidney
5,GSM1020234,Hs27,Hs27,21,Hs27,NA,241,21,235,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, cycloheximide, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: cycloheximide | infection duration: 5hr
6,GSM1020235,Hs27,Hs27,21,Hs27,NA,226,21,236,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, cycloheximide, 24hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: cycloheximide | infection duration: 24hr
7,GSM1020236,Hs27,Hs27,21,Hs27,NA,227,21,237,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, cycloheximide, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: cycloheximide | infection duration: 72hr
8,GSM1020237,Hs27,Hs27,21,Hs27,NA,228,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, cycloheximide, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: cycloheximide | infection duration: 72hr
9,GSM1020238,Hs27,Hs27,21,Hs27,NA,229,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, Harringtonine, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: Harringtonine | infection duration: 5hr
10,GSM1020239,Hs27,Hs27,21,Hs27,NA,230,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, Harringtonine, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: Harringtonine | infection duration: 72hr
11,GSM1020240,Hs27,Hs27,21,Hs27,NA,231,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, LTM, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: lactimidomycin (LTM) | infection duration: 5hr
12,GSM1020241,Hs27,Hs27,21,Hs27,NA,232,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, LTM, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: lactimidomycin (LTM) | infection duration: 72hr
13,GSM1020242,Hs27,Hs27,21,Hs27,NA,233,21,238,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, none, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: none | infection duration: 5hr
14,GSM1020243,Hs27,Hs27,21,Hs27,NA,234,21,240,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, none, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | drug pre-treatment: none | infection duration: 72hr
15,GSM1020244,Hs27,Hs27,21,Hs27,NA,235,21,241,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 5hr
16,GSM1020245,Hs27,Hs27,21,Hs27,NA,236,21,226,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 24hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 24hr
17,GSM1020246,Hs27,Hs27,21,Hs27,NA,237,21,227,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 72hr
18,GSM1020247,Hs27,Hs27,21,Hs27,NA,238,21,233,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 5hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 5hr
19,GSM1020248,Hs27,Hs27,21,Hs27,NA,239,21,NA,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 24hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 24hr
20,GSM1020249,Hs27,Hs27,21,Hs27,NA,240,21,234,GSE41605,Homo sapiens,Hs27,hs27,Hs27,"Human fibroblasts infected with HCMV, 72hr",strain: Merlin | cell type: HCMV-infected human foreskin fibroblasts | infection duration: 72hr
34,GSM1041191,BJ cells,BJ,24,BJ,NA,275,24,284,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
35,GSM1041192,BJ cells,BJ,24,BJ,NA,276,24,285,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
36,GSM1041193,BJ cells,BJ,24,BJ,NA,277,24,286,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Quiescence induced by serum depletion
37,GSM1041194,BJ cells,BJ,24,BJ,NA,278,24,287,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Quiescence induced by serum depletion
38,GSM1041195,BJ cells,BJ,24,BJ,NA,279,24,288,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: pre-senescence; 5 dys after RASG12V induction | protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 5 days
39,GSM1041196,BJ cells,BJ,24,BJ,NA,280,24,NA,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: pre-senescence; 5 dys after RASG12V induction | protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 5 days
40,GSM1041197,BJ cells,BJ,24,BJ,NA,281,24,290,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
41,GSM1041198,BJ cells,BJ,24,BJ,NA,282,24,289,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Senescence; 14 dys after RASG12V induction | protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 14 days
42,GSM1041199,BJ cells,BJ,24,BJ,NA,283,24,291,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Transformed cells (induced by RASG12V in the background of stable p53 and p16INK4A kds) | protocol: BJ cells expressing hTERT, p16INK4A-KD, p53-KD and SV40 small T were retrovirally transduced with pBabe-puro-RASG12V"
43,GSM1047584,BJ cells,BJ,24,BJ,NA,284,24,275,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
44,GSM1047585,BJ cells,BJ,24,BJ,NA,285,24,276,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
45,GSM1047586,BJ cells,BJ,24,BJ,NA,286,24,277,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Quiescence induced by serum depletion
46,GSM1047587,BJ cells,BJ,24,BJ,NA,287,24,278,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Quiescence induced by serum depletion
47,GSM1047588,BJ cells,BJ,24,BJ,NA,288,24,279,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: pre-senescence; 5 dys after RASG12V induction | protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 5 days
48,GSM1047589,BJ cells,BJ,24,BJ,NA,289,24,282,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Proliferation, normal conditions"
49,GSM1047590,BJ cells,BJ,24,BJ,NA,290,24,281,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Senescence; 14 dys after RASG12V induction | protocol: BJ cells expressing hTERT and tamoxifen-inducible RASG12V were cultured in the presence of 10-7M 4-OHT-Tamoxifen for 14 days
50,GSM1047591,BJ cells,BJ,24,BJ,NA,291,24,283,GSE42509,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Transformed cells (induced by RASG12V in the background of stable p53 and p16INK4A kds) | protocol: BJ cells expressing hTERT, p16INK4A-KD, p53-KD and SV40 small T were retrovirally transduced with pBabe-puro-RASG12V"
51,GSM1060352,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,298,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: supplemented with 1:1 ratio of MSC
52,GSM1060353,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,299,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: supplemented with 1:1 ratio of MSC
53,GSM1060354,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,300,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: supplemented with 1:1 ratio of MSC
54,GSM1060355,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,301,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: supplemented with 1:1 ratio of MSC
55,GSM1060356,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,302,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: supplemented with 1:1 ratio of MSC
56,GSM1060357,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,303,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: without MSC supplementation
57,GSM1060358,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,304,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: without MSC supplementation
58,GSM1060359,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,305,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: without MSC supplementation
59,GSM1060360,EGFP-10a+ MDA-MB-231,EGFP-10a+ MDA-MB-231,26,EGFP-10a+ MDA-MB-231,NA,306,26,NA,GSE43306,Homo sapiens,EGFP-10a+ MDA-MB-231,egfp-10a+ mda-mb-231,EGFP-10a+ MDA-MB-231,mammary tumor xenograft,cell line: EGFP-10a+ MDA-MB-231 | protocol: without MSC supplementation
65,GSM1115083,BJ cells,BJ,30,BJ,NA,353,30,358,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Control sample
66,GSM1115084,BJ cells,BJ,30,BJ,NA,354,30,359,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 2h"
67,GSM1115085,BJ cells,BJ,30,BJ,NA,355,30,360,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 4h"
68,GSM1115086,BJ cells,BJ,30,BJ,NA,356,30,361,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 6h"
69,GSM1115087,BJ cells,BJ,30,BJ,NA,357,30,362,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 19h"
70,GSM1115204,BJ cells,BJ,30,BJ,NA,358,30,353,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,cell line: BJ cells | condition: Control sample
71,GSM1115207,BJ cells,BJ,30,BJ,NA,359,30,354,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 2h"
72,GSM1115210,BJ cells,BJ,30,BJ,NA,360,30,355,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 4h"
73,GSM1115213,BJ cells,BJ,30,BJ,NA,361,30,356,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 6h"
74,GSM1115216,BJ cells,BJ,30,BJ,NA,362,30,357,GSE45785,Homo sapiens,BJ,bj,BJ,Immortalized primary fibroblasts,"cell line: BJ cells | condition: Nutlin-3a, 19h"
87,GSM1133259,HeLa,HeLa,33,HeLa,NA,399,33,NA,GSE46613,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa
88,GSM1133261,HeLa,HeLa,33,HeLa,NA,401,33,NA,GSE46613,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa
253,GSM1321438,HBE,HBE,33,HBE,NA,402,33,NA,GSE46613,Homo sapiens,HBE,hbe,HBE,HBE cells,cell type: HBE
254,GSM1321439,A549,A549,33,A549,NA,403,33,NA,GSE46613,Homo sapiens,A549,a549,A549,A549 cells,cell line: A549
255,GSM1321440,H1299,H1299,33,H1299,NA,404,33,NA,GSE46613,Homo sapiens,H1299,h1299,H1299,H1299 cells,cell line: H1299
408,GSM1436481,HeLa,HeLa,33,HeLa,NA,405,33,NA,GSE46613,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa
89,GSM1184591,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,513,38,514,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 0h (untreated) | sample type: poly(A) mRNA
90,GSM1184592,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,514,38,513,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 0h (untreated) | sample type: ribosome footprint
91,GSM1184593,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,515,38,516,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 1.5h | sample type: poly(A) mRNA
92,GSM1184594,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,516,38,515,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 1.5h | sample type: ribosome footprint
93,GSM1184595,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,517,38,518,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 3h | sample type: poly(A) mRNA
94,GSM1184596,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,518,38,517,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 3h | sample type: ribosome footprint
95,GSM1184597,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,519,38,520,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 6h | sample type: poly(A) mRNA
96,GSM1184598,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,520,38,519,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 6h | sample type: ribosome footprint
97,GSM1184599,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,521,38,522,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 9h | sample type: poly(A) mRNA
98,GSM1184600,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,522,38,521,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 9h | sample type: ribosome footprint
99,GSM1184601,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,523,38,524,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: none | time point: 12h | sample type: poly(A) mRNA
100,GSM1184602,MM1.S myeloma cell line,MM1.S,38,MM1.S,NA,524,38,523,GSE48785,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S myeloma cell line,cycloheximide: 0.1 mg/mL cycloheximide | time point: 12h | sample type: ribosome footprint
101,GSM1187134,BJ Cells,BJ,39,BJ,NA,525,39,527,GSE48933,Homo sapiens,BJ,bj,BJ,Foreskin fibroblast,cell type: Foreskin fibroblast | cell line: BJ | sample type: other
102,GSM1187135,BJ Cells,BJ,39,BJ,NA,526,39,528,GSE48933,Homo sapiens,BJ,bj,BJ,Foreskin fibroblast,cell type: Foreskin fibroblast | cell line: BJ | sample type: other
103,GSM1187136,BJ Cells,BJ,39,BJ,NA,527,39,525,GSE48933,Homo sapiens,BJ,bj,BJ,Foreskin fibroblast,cell type: Foreskin fibroblast | cell line: BJ | sample type: polyA RNA
104,GSM1187137,BJ Cells,BJ,39,BJ,NA,528,39,526,GSE48933,Homo sapiens,BJ,bj,BJ,Foreskin fibroblast,cell type: Foreskin fibroblast | cell line: BJ | sample type: polyA RNA
105,GSM1187138,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,529,39,533,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: control | sample type: other
106,GSM1187139,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,530,39,NA,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: control | sample type: other
107,GSM1187140,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,531,39,534,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: 5556GA | sample type: other
108,GSM1187141,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,532,39,NA,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: 5556GA | sample type: other
109,GSM1187142,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,533,39,529,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: control | sample type: polyA RNA
110,GSM1187143,Cybrid Cells,Cybrid Cells,39,Cybrid Cells,NA,534,39,531,GSE48933,Homo sapiens,Cybrid Cells,cybrid cells,Cybrid Cells,Osteosarcoma,cell type: Cybrid | mtdna genotype: 5556GA | sample type: polyA RNA
111,GSM1197612,HeLa,HeLa,42,HeLa,NA,650,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
112,GSM1197613,HeLa,HeLa,42,HeLa,NA,651,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
113,GSM1197614,HeLa,HeLa,42,HeLa,NA,652,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
114,GSM1197615,HeLa,HeLa,42,HeLa,NA,653,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
115,GSM1197616,HeLa,HeLa,42,HeLa,NA,654,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
116,GSM1197617,HeLa,HeLa,42,HeLa,NA,655,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
117,GSM1197618,HeLa,HeLa,42,HeLa,NA,656,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
118,GSM1197619,HeLa,HeLa,42,HeLa,NA,657,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
119,GSM1197620,HeLa,HeLa,42,HeLa,NA,658,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
120,GSM1197621,HeLa,HeLa,42,HeLa,NA,659,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | treatment: 40nM siRNA knock-down for 48h
121,GSM1197622,HeLa,HeLa,42,HeLa,NA,660,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 0h"
122,GSM1197623,HeLa,HeLa,42,HeLa,NA,661,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 3h"
123,GSM1197624,HeLa,HeLa,42,HeLa,NA,662,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 6h"
124,GSM1197625,HeLa,HeLa,42,HeLa,NA,663,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 0h"
125,GSM1197626,HeLa,HeLa,42,HeLa,NA,664,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 3h"
126,GSM1197627,HeLa,HeLa,42,HeLa,NA,665,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 6h"
127,GSM1197628,HeLa,HeLa,42,HeLa,NA,666,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 0h"
128,GSM1197629,HeLa,HeLa,42,HeLa,NA,667,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 3h"
129,GSM1197630,HeLa,HeLa,42,HeLa,NA,668,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 6h"
130,GSM1197631,HeLa,HeLa,42,HeLa,NA,669,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 0h"
131,GSM1197632,HeLa,HeLa,42,HeLa,NA,670,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 3h"
132,GSM1197633,HeLa,HeLa,42,HeLa,NA,671,42,NA,GSE49339,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | treatment: 40nM siRNA knock-down for 48h, then add actinomycin for 6h"
133,GSM1206278,SW13,SW13,43,SW13,NA,672,43,673,GSE49716,Homo sapiens,SW13,sw13,SW13,RNA_sequencing,procedure: RNA_sequencing | cell line: SW13 | cell type: human adrenal adenocarcinoma cells | genotype/variation: Overexpression of murine non-coding RNAs
134,GSM1206279,SW13,SW13,43,SW13,NA,673,43,672,GSE49716,Homo sapiens,SW13,sw13,SW13,Ribosome_profiling,procedure: Ribosome_profiling | cell line: SW13 | cell type: human adrenal adenocarcinoma cells | genotype/variation: Overexpression of murine non-coding RNAs
571,GSM1495244,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,730,49,735,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
572,GSM1495245,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,731,49,736,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
573,GSM1495246,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,732,49,737,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
574,GSM1495247,tumor,tumor,49,tumor,NA,733,49,738,GSE51424,Homo sapiens,tumor,tumor,tumor,Tumor resection,tissue origin: Tumor
575,GSM1495248,tumor,tumor,49,tumor,NA,734,49,739,GSE51424,Homo sapiens,tumor,tumor,tumor,Tumor resection,tissue origin: Tumor
576,GSM1495249,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,735,49,730,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
577,GSM1495250,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,736,49,731,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
578,GSM1495251,normal brain tissue,normal brain tissue,49,normal brain tissue,NA,737,49,732,GSE51424,Homo sapiens,normal brain tissue,normal brain tissue,normal brain tissue,normal brain,tissue origin: normal brain
579,GSM1495252,tumor,tumor,49,tumor,NA,738,49,733,GSE51424,Homo sapiens,tumor,tumor,tumor,Tumor resection,tissue origin: Tumor
580,GSM1495253,tumor,tumor,49,tumor,NA,739,49,734,GSE51424,Homo sapiens,tumor,tumor,tumor,Tumor resection,tissue origin: Tumor
158,GSM1248728,U2OS cells,U2OS,50,U2OS,NA,740,50,741,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-1 duplex | time: 32 hours
159,GSM1248729,U2OS cells,U2OS,50,U2OS,NA,741,50,740,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-1 duplex | time: 32 hours
160,GSM1248730,U2OS cells,U2OS,50,U2OS,NA,742,50,NA,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-1 duplex | time: 32 hours
161,GSM1248731,U2OS cells,U2OS,50,U2OS,NA,743,50,744,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-155 duplex | time: 32 hours
162,GSM1248732,U2OS cells,U2OS,50,U2OS,NA,744,50,743,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-155 duplex | time: 32 hours
163,GSM1248733,U2OS cells,U2OS,50,U2OS,NA,745,50,NA,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: miR-155 duplex | time: 32 hours
164,GSM1248734,U2OS cells,U2OS,50,U2OS,NA,746,50,747,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: mock | time: 32 hours
165,GSM1248735,U2OS cells,U2OS,50,U2OS,NA,747,50,746,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: mock | time: 32 hours
166,GSM1248736,U2OS cells,U2OS,50,U2OS,NA,748,50,NA,GSE51584,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,transfection: mock | time: 32 hours
173,GSM1267846,HEK293,HEK293,784,HEK293,NA,15134,784,15140,GSE52447,Homo sapiens,HEK293,hek293,HEK293,HEK293_Control_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Cytoplasmic Poly(A) RNA
174,GSM1267847,HEK293,HEK293,784,HEK293,NA,15135,784,15141,GSE52447,Homo sapiens,HEK293,hek293,HEK293,HEK293_Control_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Cytoplasmic Poly(A) RNA
175,GSM1267848,HEK293,HEK293,784,HEK293,NA,15136,784,15142,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_KnockDown_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Cytoplasmic Poly(A) RNA
176,GSM1267849,HEK293,HEK293,784,HEK293,NA,15137,784,15143,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_KnockDown_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Cytoplasmic Poly(A) RNA
177,GSM1267850,HEK293,HEK293,784,HEK293,NA,15138,784,15144,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_Overexpression_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: Flag-Stau1-WT (65KDa Isoform) | molecule subtype: Cytoplasmic Poly(A) RNA
178,GSM1267851,HEK293,HEK293,784,HEK293,NA,15139,784,15145,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_Overexpression_RNASeq_BiolReplica,cell line: HEK293 | protein expressed: Flag-Stau1-WT (65KDa Isoform) | molecule subtype: Cytoplasmic Poly(A) RNA
179,GSM1267852,HEK293,HEK293,784,HEK293,NA,15140,784,15134,GSE52447,Homo sapiens,HEK293,hek293,HEK293,HEK293_Control_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Ribosome footprint mRNA
180,GSM1267853,HEK293,HEK293,784,HEK293,NA,15141,784,15135,GSE52447,Homo sapiens,HEK293,hek293,HEK293,HEK293_Control_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Ribosome footprint mRNA
181,GSM1267854,HEK293,HEK293,784,HEK293,NA,15142,784,15136,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_KnockDown_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Ribosome footprint mRNA
182,GSM1267855,HEK293,HEK293,784,HEK293,NA,15143,784,15137,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_KnockDown_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: N/A | molecule subtype: Ribosome footprint mRNA
183,GSM1267856,HEK293,HEK293,784,HEK293,NA,15144,784,15138,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_Overexpression_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: Flag-Stau1-WT (65KDa Isoform) | molecule subtype: Ribosome footprint mRNA
184,GSM1267857,HEK293,HEK293,784,HEK293,NA,15145,784,15139,GSE52447,Homo sapiens,HEK293,hek293,HEK293,Stau1_Overexpression_RibosomeFootprinting_BiolReplica,cell line: HEK293 | protein expressed: Flag-Stau1-WT (65KDa Isoform) | molecule subtype: Ribosome footprint mRNA
185,GSM1279683,HEK293,HEK293,773,HEK293,NA,14928,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: Control siRNA
186,GSM1279684,HEK293,HEK293,773,HEK293,NA,14929,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: AUF1 siRNA
187,GSM1279685,HEK293,HEK293,773,HEK293,NA,14930,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: Empty Vector
188,GSM1279686,HEK293,HEK293,773,HEK293,NA,14931,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: p37 overexpresion
189,GSM1279687,HEK293,HEK293,773,HEK293,NA,14932,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: p40 overexpresion
190,GSM1279688,HEK293,HEK293,773,HEK293,NA,14933,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: p42 overexpresion
191,GSM1279689,HEK293,HEK293,773,HEK293,NA,14934,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: p45 overexpresion
192,GSM1279690,HEK293,HEK293,773,HEK293,NA,14935,773,NA,GSE52973,Homo sapiens,HEK293,hek293,HEK293,HEK293,"rna type: HEK293 Total RNA | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HEK293 | treatment: p37, p40, p42, p45 overexpresion"
193,GSM1279702,WI-38,WI-38,773,WI-38,NA,14936,773,NA,GSE52975,Homo sapiens,WI-38,wi-38,WI-38,WI-38,rna type: WI-38 Total RNA | passages: PDL15 | crosslinking: not applied | ip protein: not applied | cell line: WI-38
194,GSM1279703,WI-38,WI-38,773,WI-38,NA,14937,773,NA,GSE52975,Homo sapiens,WI-38,wi-38,WI-38,WI-38,rna type: WI-38 Total RNA | passages: PDL55 | crosslinking: not applied | ip protein: not applied | cell line: WI-38
195,GSM1279704,WI-38,WI-38,773,WI-38,NA,14938,773,NA,GSE52975,Homo sapiens,WI-38,wi-38,WI-38,WI-38,rna type: WI-38 Total RNA | passages: PDL15 | crosslinking: not applied | ip protein: not applied | cell line: WI-38 | treatment: PDL 15 Contro siRNA
196,GSM1279705,WI-38,WI-38,773,WI-38,NA,14939,773,NA,GSE52975,Homo sapiens,WI-38,wi-38,WI-38,WI-38,rna type: WI-38 Total RNA | passages: PDL15 | crosslinking: not applied | ip protein: not applied | cell line: WI-38 | treatment: PDL 15 AUF1 siRNA
197,GSM1279706,WI-38,WI-38,773,WI-38,NA,14940,773,NA,GSE52975,Homo sapiens,WI-38,wi-38,WI-38,WI-38,rna type: WI-38 Total RNA | passages: PDL15 | crosslinking: not applied | ip protein: not applied | cell line: WI-38 | treatment: PDL 15 HuR siRNA
198,GSM1279707,HeLa,HeLa,59,HeLa,NA,996,59,NA,GSE52976,Homo sapiens,HeLa,hela,HeLa,HeLa,rna type: HeLa RNA from mono ribosome | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HeLa | treatment: Control siRNA
199,GSM1279708,HeLa,HeLa,59,HeLa,NA,997,59,NA,GSE52976,Homo sapiens,HeLa,hela,HeLa,HeLa,rna type: HeLa RNA from mono ribosome | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HeLa | treatment: AUF1 siRNA
200,GSM1279709,HeLa,HeLa,59,HeLa,NA,998,59,NA,GSE52976,Homo sapiens,HeLa,hela,HeLa,HeLa,rna type: HeLa RNA from mono ribosome | passages: unknown | crosslinking: not applied | ip protein: not applied | cell line: HeLa | treatment: HuR siRNA
256,GSM1331342,Hek293T,HEK293T,65,HEK293T,NA,1091,65,1092,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: vehicle | rna type: ribosome protected fragment | cell line: Hek293T
257,GSM1331343,Hek293T,HEK293T,65,HEK293T,NA,1092,65,1091,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: vehicle | rna type: Ã¢Â€ÂœnakedÃ¢Â€Â mRNAseq | cell line: Hek293T
258,GSM1331344,Hek293T,HEK293T,65,HEK293T,NA,1093,65,1094,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: 0.5 hour arsenite | rna type: ribosome protected fragment | cell line: Hek293T
259,GSM1331345,Hek293T,HEK293T,65,HEK293T,NA,1094,65,1093,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: 0.5 hour arsenite | rna type: Ã¢Â€ÂœnakedÃ¢Â€Â mRNAseq | cell line: Hek293T
260,GSM1331346,Hek293T,HEK293T,65,HEK293T,NA,1095,65,1096,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: vehicle | rna type: ribosome protected fragment | cell line: Hek293T
261,GSM1331347,Hek293T,HEK293T,65,HEK293T,NA,1096,65,1095,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: vehicle | rna type: Ã¢Â€ÂœnakedÃ¢Â€Â mRNAseq | cell line: Hek293T
262,GSM1331348,Hek293T,HEK293T,65,HEK293T,NA,1097,65,1098,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: 0.5 hour arsenite | rna type: ribosome protected fragment | cell line: Hek293T
263,GSM1331349,Hek293T,HEK293T,65,HEK293T,NA,1098,65,1097,GSE55195,Homo sapiens,HEK293T,hek293t,HEK293T,Hek293T,treatment: 0.5 hour arsenite | rna type: Ã¢Â€ÂœnakedÃ¢Â€Â mRNAseq | cell line: Hek293T
264,GSM1356674,Skeletal muscle tissue,Skeletal muscle tissue,66,Skeletal muscle tissue,NA,1099,66,1101,GSE56148,Homo sapiens,Skeletal muscle tissue,skeletal muscle tissue,Skeletal muscle tissue,skeletal muscle,tissue: skeletal muscle | genotype/variation: c.40_41delGA dystrophin mutation
265,GSM1356675,Skeletal muscle tissue,Skeletal muscle tissue,66,Skeletal muscle tissue,NA,1100,66,1102,GSE56148,Homo sapiens,Skeletal muscle tissue,skeletal muscle tissue,Skeletal muscle tissue,skeletal muscle,tissue: skeletal muscle | genotype/variation: normal control
266,GSM1356676,Skeletal muscle tissue,Skeletal muscle tissue,66,Skeletal muscle tissue,NA,1101,66,1099,GSE56148,Homo sapiens,Skeletal muscle tissue,skeletal muscle tissue,Skeletal muscle tissue,skeletal muscle,tissue: skeletal muscle | genotype/variation: c.40_41delGA dystrophin mutation
267,GSM1356677,Skeletal muscle tissue,Skeletal muscle tissue,66,Skeletal muscle tissue,NA,1102,66,1100,GSE56148,Homo sapiens,Skeletal muscle tissue,skeletal muscle tissue,Skeletal muscle tissue,skeletal muscle,tissue: skeletal muscle | genotype/variation: normal control
268,GSM1371395,U2-OS,U2OS,71,U2OS,NA,1161,71,1185,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
269,GSM1371396,U2-OS,U2OS,71,U2OS,NA,1162,71,1186,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
270,GSM1371397,U2-OS,U2OS,71,U2OS,NA,1163,71,1187,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
271,GSM1371398,U2-OS,U2OS,71,U2OS,NA,1164,71,1188,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
272,GSM1371399,U2-OS,U2OS,71,U2OS,NA,1165,71,1189,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
273,GSM1371400,U2-OS,U2OS,71,U2OS,NA,1166,71,1190,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
274,GSM1371401,U2-OS,U2OS,71,U2OS,NA,1167,71,1191,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
275,GSM1371402,U2-OS,U2OS,71,U2OS,NA,1168,71,1192,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
276,GSM1371403,U2-OS,U2OS,71,U2OS,NA,1169,71,1193,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
277,GSM1371404,U2-OS,U2OS,71,U2OS,NA,1170,71,1195,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
278,GSM1371405,U2-OS,U2OS,71,U2OS,NA,1171,71,1196,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
279,GSM1371406,U2-OS,U2OS,71,U2OS,NA,1172,71,1197,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
280,GSM1371407,U2-OS,U2OS,71,U2OS,NA,1173,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
281,GSM1371408,U2-OS,U2OS,71,U2OS,NA,1174,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
282,GSM1371409,U2-OS,U2OS,71,U2OS,NA,1175,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
283,GSM1371410,U2-OS,U2OS,71,U2OS,NA,1176,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
284,GSM1371411,U2-OS,U2OS,71,U2OS,NA,1177,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
285,GSM1371412,U2-OS,U2OS,71,U2OS,NA,1178,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
286,GSM1371413,U2-OS,U2OS,71,U2OS,NA,1179,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
287,GSM1371414,U2-OS,U2OS,71,U2OS,NA,1180,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
288,GSM1371415,U2-OS,U2OS,71,U2OS,NA,1181,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
289,GSM1371416,U2-OS,U2OS,71,U2OS,NA,1182,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
290,GSM1371417,U2-OS,U2OS,71,U2OS,NA,1183,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
291,GSM1371418,U2-OS,U2OS,71,U2OS,NA,1184,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
292,GSM1371419,U2-OS,U2OS,71,U2OS,NA,1185,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
293,GSM1371420,U2-OS,U2OS,71,U2OS,NA,1186,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
294,GSM1371421,U2-OS,U2OS,71,U2OS,NA,1187,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
295,GSM1371422,U2-OS,U2OS,71,U2OS,NA,1188,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
296,GSM1371423,U2-OS,U2OS,71,U2OS,NA,1189,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
297,GSM1371424,U2-OS,U2OS,71,U2OS,NA,1190,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
298,GSM1371425,U2-OS,U2OS,71,U2OS,NA,1191,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
299,GSM1371426,U2-OS,U2OS,71,U2OS,NA,1192,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
300,GSM1371427,U2-OS,U2OS,71,U2OS,NA,1193,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
301,GSM1371428,U2-OS,U2OS,71,U2OS,NA,1194,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
302,GSM1371429,U2-OS,U2OS,71,U2OS,NA,1195,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
303,GSM1371430,U2-OS,U2OS,71,U2OS,NA,1196,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
304,GSM1371431,U2-OS,U2OS,71,U2OS,NA,1197,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
305,GSM1371432,U2-OS,U2OS,71,U2OS,NA,1198,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
306,GSM1371433,U2-OS,U2OS,71,U2OS,NA,1199,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
307,GSM1371434,U2-OS,U2OS,71,U2OS,NA,1200,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
308,GSM1371435,U2-OS,U2OS,71,U2OS,NA,1201,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
309,GSM1371436,U2-OS,U2OS,71,U2OS,NA,1202,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
310,GSM1371437,U2-OS,U2OS,71,U2OS,NA,1203,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
311,GSM1371438,U2-OS,U2OS,71,U2OS,NA,1204,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
312,GSM1371439,U2-OS,U2OS,71,U2OS,NA,1205,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
313,GSM1371440,U2-OS,U2OS,71,U2OS,NA,1206,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
314,GSM1371441,U2-OS,U2OS,71,U2OS,NA,1207,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
315,GSM1371442,U2-OS,U2OS,71,U2OS,NA,1208,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
316,GSM1371443,U2-OS,U2OS,71,U2OS,NA,1209,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
317,GSM1371444,U2-OS,U2OS,71,U2OS,NA,1210,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
318,GSM1371445,U2-OS,U2OS,71,U2OS,NA,1211,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
319,GSM1371446,U2-OS,U2OS,71,U2OS,NA,1212,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
320,GSM1371447,U2-OS,U2OS,71,U2OS,NA,1213,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
321,GSM1371448,U2-OS,U2OS,71,U2OS,NA,1214,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
322,GSM1371449,U2-OS,U2OS,71,U2OS,NA,1215,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
323,GSM1371450,U2-OS,U2OS,71,U2OS,NA,1216,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
324,GSM1371451,U2-OS,U2OS,71,U2OS,NA,1217,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
325,GSM1371452,U2-OS,U2OS,71,U2OS,NA,1218,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
326,GSM1371453,U2-OS,U2OS,71,U2OS,NA,1219,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
327,GSM1371454,U2-OS,U2OS,71,U2OS,NA,1220,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: None
328,GSM1371455,U2-OS,U2OS,71,U2OS,NA,1221,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
329,GSM1371456,U2-OS,U2OS,71,U2OS,NA,1222,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
330,GSM1371457,U2-OS,U2OS,71,U2OS,NA,1223,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
331,GSM1371458,U2-OS,U2OS,71,U2OS,NA,1224,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
332,GSM1371459,U2-OS,U2OS,71,U2OS,NA,1225,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
333,GSM1371460,U2-OS,U2OS,71,U2OS,NA,1226,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
334,GSM1371461,U2-OS,U2OS,71,U2OS,NA,1227,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
335,GSM1371462,U2-OS,U2OS,71,U2OS,NA,1228,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
336,GSM1371463,U2-OS,U2OS,71,U2OS,NA,1229,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
337,GSM1371464,U2-OS,U2OS,71,U2OS,NA,1230,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
338,GSM1371465,U2-OS,U2OS,71,U2OS,NA,1231,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
339,GSM1371466,U2-OS,U2OS,71,U2OS,NA,1232,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: None
340,GSM1371467,U2-OS,U2OS,71,U2OS,NA,1233,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
341,GSM1371468,U2-OS,U2OS,71,U2OS,NA,1234,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
342,GSM1371469,U2-OS,U2OS,71,U2OS,NA,1235,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
343,GSM1371470,U2-OS,U2OS,71,U2OS,NA,1236,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
344,GSM1371471,U2-OS,U2OS,71,U2OS,NA,1237,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
345,GSM1371472,U2-OS,U2OS,71,U2OS,NA,1238,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
346,GSM1371473,U2-OS,U2OS,71,U2OS,NA,1239,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
347,GSM1371474,U2-OS,U2OS,71,U2OS,NA,1240,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
348,GSM1371475,U2-OS,U2OS,71,U2OS,NA,1241,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
349,GSM1371476,U2-OS,U2OS,71,U2OS,NA,1242,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
350,GSM1371477,U2-OS,U2OS,71,U2OS,NA,1243,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
351,GSM1371478,U2-OS,U2OS,71,U2OS,NA,1244,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 1 | sirna treatment: Bmal1 siRNA
352,GSM1371479,U2-OS,U2OS,71,U2OS,NA,1245,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
353,GSM1371480,U2-OS,U2OS,71,U2OS,NA,1246,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
354,GSM1371481,U2-OS,U2OS,71,U2OS,NA,1247,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
355,GSM1371482,U2-OS,U2OS,71,U2OS,NA,1248,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
356,GSM1371483,U2-OS,U2OS,71,U2OS,NA,1249,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
357,GSM1371484,U2-OS,U2OS,71,U2OS,NA,1250,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
358,GSM1371485,U2-OS,U2OS,71,U2OS,NA,1251,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
359,GSM1371486,U2-OS,U2OS,71,U2OS,NA,1252,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
360,GSM1371487,U2-OS,U2OS,71,U2OS,NA,1253,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
361,GSM1371488,U2-OS,U2OS,71,U2OS,NA,1254,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
362,GSM1371489,U2-OS,U2OS,71,U2OS,NA,1255,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
363,GSM1371490,U2-OS,U2OS,71,U2OS,NA,1256,71,NA,GSE56924,Homo sapiens,U2OS,u2os,U2OS,U2-OS Cells,cell type: osteosarcoma | cell line: U2-OS | replicate: 2 | sirna treatment: Bmal1 siRNA
364,GSM1403307,Colorectal carcinoma derived cell line,Colorectal carcinoma derived cell line,75,Colorectal carcinoma derived cell line,NA,1317,75,NA,GSE58207,Homo sapiens,Colorectal carcinoma derived cell line,colorectal carcinoma derived cell line,Colorectal carcinoma derived cell line,Colorectal carcinoma cell line,cell type: HCT116 | cell type: Colorectal carcinoma derived cell line | treated with: 100 Ã‚Âµg/ml cycloheximide for 30 min at 37Ã‚Â°C | molecule subtype: Ribosome protected fragments
365,GSM1403308,Colorectal carcinoma derived cell line,Colorectal carcinoma derived cell line,75,Colorectal carcinoma derived cell line,NA,1318,75,NA,GSE58207,Homo sapiens,Colorectal carcinoma derived cell line,colorectal carcinoma derived cell line,Colorectal carcinoma derived cell line,Colorectal carcinoma cell line,cell type: HCT116 | cell type: Colorectal carcinoma derived cell line | treated with: 50 Ã‚ÂµM lactimidomycin for 30 min at 37Ã‚Â°C | molecule subtype: Ribosome protected fragments
388,GSM1427351,HEK293T,HEK293T,470,HEK293T,NA,1375,470,1386,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with GFP expressing plasmid | sorting parameter: sorted by flow cytometry for GFP+ population | over-expression product: GFP
389,GSM1427352,HEK293T,HEK293T,470,HEK293T,NA,1376,470,1387,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with GFP WT DDX3X expressing plasmid | sorting parameter: sorted by flow cytometry for GFP+ population | over-expression product: GFP-WT DDX3X
390,GSM1427353,HEK293T,HEK293T,470,HEK293T,NA,1377,470,NA,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with GFP DDX3X T275M expressing plasmid | sorting parameter: sorted by flow cytometry for GFP+ population | over-expression product: GFP-DDX3X T275M
391,GSM1427354,HEK293T,HEK293T,470,HEK293T,NA,1378,470,NA,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with GFP DDX3X G302V expressing plasmid | sorting parameter: sorted by flow cytometry for GFP+ population | over-expression product: GFP-DDX3X G302V
392,GSM1427355,HEK293T,HEK293T,470,HEK293T,NA,1379,470,NA,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transfected with control siRNA for 48 hr
393,GSM1427356,HEK293T,HEK293T,470,HEK293T,NA,1380,470,NA,GSE59093,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transfected with DDX3X siRNA for 48 hr
394,GSM1427362,HEK293T,HEK293T,470,HEK293T,NA,1386,470,1375,GSE59095,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with empty pCDNA3.1 vector | over-expression product: none (control)
395,GSM1427363,HEK293T,HEK293T,470,HEK293T,NA,1387,470,1376,GSE59095,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with WT DDX3X expressing vector | over-expression product: FLAG-tagged WT DDX3X
396,GSM1427364,HEK293T,HEK293T,470,HEK293T,NA,1388,470,NA,GSE59095,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | cell type: Neuronal | transfection construct: cells transiently transfected with DDX3X-G325E expressing vector | over-expression product: FLAG-tagged DDX3X G325E
435,GSM1446832,SUM1315,SUM1315,86,SUM1315,NA,1464,86,NA,GSE59815,Homo sapiens,SUM1315,sum1315,SUM1315,SUM1315 control RP,cell line: SUM1315
436,GSM1446833,SUM1315,SUM1315,86,SUM1315,NA,1465,86,NA,GSE59815,Homo sapiens,SUM1315,sum1315,SUM1315,SUM1315 harringtonine RP,cell line: SUM1315
437,GSM1446834,MCF10A,MCF10A,87,MCF10A,NA,1467,87,NA,GSE59816,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control RP,cell line: MCF10A
438,GSM1446838,MCF10A,MCF10A,87,MCF10A,NA,1468,87,NA,GSE59816,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A torin RP,cell line: MCF10A
1737,GSM1922007,MCF10A,MCF10A,87,MCF10A,NA,1466,87,NA,GSE59816,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: MCF10A
439,GSM1446846,MCF10A,MCF10A,88,MCF10A,NA,1469,88,1471,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control 1 batch1 RP,cell line: MCF10A
440,GSM1446847,MCF10A,MCF10A,88,MCF10A,NA,1470,88,1472,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A TGFb 1 batch1 RP,cell line: MCF10A
441,GSM1446848,MCF10A,MCF10A,88,MCF10A,NA,1471,88,1469,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control 1 batch1 RNAseq,cell line: MCF10A
442,GSM1446849,MCF10A,MCF10A,88,MCF10A,NA,1472,88,1470,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A TGFb 1 batch1 RNAseq,cell line: MCF10A
443,GSM1446850,MCF10A,MCF10A,88,MCF10A,NA,1473,88,NA,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control 2 batch1 RP,cell line: MCF10A
444,GSM1446851,MCF10A,MCF10A,88,MCF10A,NA,1474,88,NA,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A TGFb 2 batch1 RP,cell line: MCF10A
445,GSM1446852,MCF10A,MCF10A,88,MCF10A,NA,1475,88,NA,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control 1 batch2 RP,cell line: MCF10A
446,GSM1446853,MCF10A,MCF10A,88,MCF10A,NA,1476,88,NA,GSE59817,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A TGFb 1 batch2 RP,cell line: MCF10A
447,GSM1446854,MCF10A,MCF10A,89,MCF10A,NA,1477,89,1481,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siCtrl batch4 RP,cell line: MCF10A
448,GSM1446855,MCF10A,MCF10A,89,MCF10A,NA,1478,89,1482,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siCtrl TGFb batch4 RP,cell line: MCF10A
449,GSM1446856,MCF10A,MCF10A,89,MCF10A,NA,1479,89,1483,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siSLC3A2 batch4 RP,cell line: MCF10A
450,GSM1446857,MCF10A,MCF10A,89,MCF10A,NA,1480,89,1484,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siSLC3A2 TGFb batch4 RP,cell line: MCF10A
451,GSM1446858,MCF10A,MCF10A,89,MCF10A,NA,1481,89,1477,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siCtrl batch4 RNAseq,cell line: MCF10A
452,GSM1446859,MCF10A,MCF10A,89,MCF10A,NA,1482,89,1478,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siCtrl TGFb batch4 RNAseq,cell line: MCF10A
453,GSM1446860,MCF10A,MCF10A,89,MCF10A,NA,1483,89,1479,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siSLC3A2 batch4 RNAseq,cell line: MCF10A
454,GSM1446861,MCF10A,MCF10A,89,MCF10A,NA,1484,89,1480,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A siSLC3A2 TGFb batch4 RNAseq,cell line: MCF10A
455,GSM1446862,MCF10A,MCF10A,89,MCF10A,NA,1485,89,NA,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A control batch5 RP,cell line: MCF10A
456,GSM1446863,MCF10A,MCF10A,89,MCF10A,NA,1486,89,NA,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A TGFb batch5 RP,cell line: MCF10A
457,GSM1446864,MCF10A,MCF10A,89,MCF10A,NA,1487,89,NA,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A SLC3A2 OE batch5 RP,cell line: MCF10A
458,GSM1446865,MCF10A,MCF10A,89,MCF10A,NA,1488,89,NA,GSE59818,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A SLC3A2 OE TGFb batch5 RP,cell line: MCF10A
459,GSM1446866,U2OS,U2OS,90,U2OS,NA,1489,90,1491,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS control batch6 RP,cell line: U2OS
460,GSM1446867,U2OS,U2OS,90,U2OS,NA,1490,90,1492,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS myc batch6 RP,cell line: U2OS
461,GSM1446868,U2OS,U2OS,90,U2OS,NA,1491,90,1489,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS control batch6 RNAseq,cell line: U2OS
462,GSM1446869,U2OS,U2OS,90,U2OS,NA,1492,90,1490,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS myc batch6 RNAseq,cell line: U2OS
463,GSM1446870,U2OS,U2OS,90,U2OS,NA,1493,90,1495,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS control batch7 RP,cell line: U2OS
464,GSM1446871,U2OS,U2OS,90,U2OS,NA,1494,90,1496,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS myc batch7 RP,cell line: U2OS
465,GSM1446872,U2OS,U2OS,90,U2OS,NA,1495,90,1493,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS control batch7 RNAseq,cell line: U2OS
466,GSM1446873,U2OS,U2OS,90,U2OS,NA,1496,90,1494,GSE59819,Homo sapiens,U2OS,u2os,U2OS,U2OS myc batch7 RNAseq,cell line: U2OS
467,GSM1446874,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1513,91,1497,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney normal tissue 1 RP,tissue: Kidney
468,GSM1446875,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1514,91,1498,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney normal tissue 2 RP,tissue: Kidney
469,GSM1446876,ccRCC,ccRCC,91,ccRCC,NA,1515,91,1499,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tumor tissue 1 RP,tissue: Kidney
470,GSM1446877,ccRCC,ccRCC,91,ccRCC,NA,1516,91,1500,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tumor tissue 2 RP,tissue: Kidney
471,GSM1446878,ccRCC,ccRCC,91,ccRCC,NA,1517,91,1501,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tumor tissue 3 RP,tissue: Kidney
472,GSM1446879,ccRCC,ccRCC,91,ccRCC,NA,1518,91,1502,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tumor tissue 4 RP,tissue: Kidney
1365,GSM1712825,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1497,91,1513,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,tissue: kidney
1366,GSM1712826,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1498,91,1514,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,tissue: kidney
1367,GSM1712827,ccRCC,ccRCC,91,ccRCC,NA,1499,91,1515,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1368,GSM1712828,ccRCC,ccRCC,91,ccRCC,NA,1500,91,1516,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1369,GSM1712829,ccRCC,ccRCC,91,ccRCC,NA,1501,91,1517,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1370,GSM1712830,ccRCC,ccRCC,91,ccRCC,NA,1502,91,1518,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1371,GSM1712831,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1503,91,NA,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,tissue: kidney
1372,GSM1712832,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1504,91,NA,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,tissue: kidney
1373,GSM1712833,ccRCC,ccRCC,91,ccRCC,NA,1505,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1374,GSM1712834,ccRCC,ccRCC,91,ccRCC,NA,1506,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1375,GSM1712835,ccRCC,ccRCC,91,ccRCC,NA,1507,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1376,GSM1712836,ccRCC,ccRCC,91,ccRCC,NA,1508,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,tissue: kidney
1738,GSM1922046,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1509,91,NA,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | tissue: normal
1739,GSM1922047,ccRCC,ccRCC,91,ccRCC,NA,1510,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | tissue: tumor
1740,GSM1922048,Kidney normal tissue,Kidney normal tissue,91,Kidney normal tissue,NA,1511,91,NA,GSE59820,Homo sapiens,Kidney normal tissue,kidney normal tissue,Kidney normal tissue,Kidney tissue,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | tissue: normal
1741,GSM1922049,ccRCC,ccRCC,91,ccRCC,NA,1512,91,NA,GSE59820,Homo sapiens,ccRCC,ccrcc,ccRCC,Kidney tissue,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | tissue: tumor
473,GSM1464095,HFF,HFF,92,foreskin fibroblasts,,1519,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,cell type: human foreskin fibroblasts | time post infection: mock | infection with: mock | barcode: NNNTTGTNN
474,GSM1464096,HFF,HFF,92,foreskin fibroblasts,,1520,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 1 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCAATNN"
475,GSM1464097,HFF,HFF,92,foreskin fibroblasts,,1521,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 2 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNGGCGNN"
476,GSM1464098,HFF,HFF,92,foreskin fibroblasts,,1522,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 4 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCCGGNN"
477,GSM1464099,HFF,HFF,92,foreskin fibroblasts,,1523,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 6 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNTGGCNN"
478,GSM1464100,HFF,HFF,92,foreskin fibroblasts,,1524,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCCACNN"
479,GSM1464101,HFF,HFF,92,foreskin fibroblasts,,1525,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,cell type: human foreskin fibroblasts | time post infection: mock | infection with: mock | barcode: NNNTTGTNN
480,GSM1464102,HFF,HFF,92,foreskin fibroblasts,,1526,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 1 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCAATNN"
481,GSM1464103,HFF,HFF,92,foreskin fibroblasts,,1527,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 2 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNGGCGNN"
482,GSM1464104,HFF,HFF,92,foreskin fibroblasts,,1528,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 4 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCCGGNN"
483,GSM1464105,HFF,HFF,92,foreskin fibroblasts,,1529,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 6 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNTGGCNN"
484,GSM1464106,HFF,HFF,92,foreskin fibroblasts,,1530,92,NA,GSE60040,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCCACNN"
487,GSM1464903,HEK,HEK293,93,HEK293,NA,1533,93,NA,GSE60095,Homo sapiens,HEK293,hek293,HEK293,HEK cell,treatment: DMEM + 10% FBS | cell line: HEK
488,GSM1464904,HEK,HEK293,93,HEK293,NA,1534,93,NA,GSE60095,Homo sapiens,HEK293,hek293,HEK293,HEK cell,treatment: DMEM + 10% FBS | cell line: HEK
505,GSM1479585,U2OS,U2OS,778,U2OS,NA,15002,778,15005,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: mock transfection
506,GSM1479586,U2OS,U2OS,778,U2OS,NA,15003,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: mock transfection
507,GSM1479587,U2OS,U2OS,778,U2OS,NA,15004,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: mock transfection
508,GSM1479588,U2OS,U2OS,778,U2OS,NA,15005,778,15002,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: mock transfection
509,GSM1479589,U2OS,U2OS,778,U2OS,NA,15006,778,15009,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-1 transfection
510,GSM1479590,U2OS,U2OS,778,U2OS,NA,15007,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-1 transfection
511,GSM1479591,U2OS,U2OS,778,U2OS,NA,15008,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-1 transfection
512,GSM1479592,U2OS,U2OS,778,U2OS,NA,15009,778,15006,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-1 transfection
513,GSM1479593,U2OS,U2OS,778,U2OS,NA,15010,778,15013,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-155 transfection
514,GSM1479594,U2OS,U2OS,778,U2OS,NA,15011,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-155 transfection
515,GSM1479595,U2OS,U2OS,778,U2OS,NA,15012,778,NA,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-155 transfection
516,GSM1479596,U2OS,U2OS,778,U2OS,NA,15013,778,15010,GSE60426,Homo sapiens,U2OS,u2os,U2OS,U2OS cell line,cell line: U2OS cell line | treatment: miR-155 transfection
517,GSM1479597,HEK293T,HEK293T,778,HEK293T,NA,15014,778,15015,GSE60426,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cell line,cell line: HEK293T cell line | treatment: mock transfection
518,GSM1479598,HEK293T,HEK293T,778,HEK293T,NA,15015,778,15014,GSE60426,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cell line,cell line: HEK293T cell line | treatment: mock transfection
519,GSM1479599,HEK293T,HEK293T,778,HEK293T,NA,15016,778,15017,GSE60426,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cell line,cell line: HEK293T cell line | treatment: miR-1 transfection
520,GSM1479600,HEK293T,HEK293T,778,HEK293T,NA,15017,778,15016,GSE60426,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cell line,cell line: HEK293T cell line | treatment: miR-1 transfection
581,GSM1495535,HEK293T,HEK293T,98,HEK293T,NA,1602,98,NA,GSE61012,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: n/a | lentivirally transduced transgenes: pEF1a-ATHmmuRPL10A; pTRE-3xFLAG-BirA-mCherry-Sec61beta | strain: HEK293T
582,GSM1495536,HEK293T,HEK293T,98,HEK293T,NA,1603,98,NA,GSE61012,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: n/a | lentivirally transduced transgenes: pEF1a-ATHmmuRPL10A; pTRE-3xFLAG-BirA-mCherry-Sec61beta | strain: HEK293T
583,GSM1503433,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1604,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: DMSO for 1 hour
584,GSM1503434,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1605,99,1609,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: DMSO for 2 hours
585,GSM1503435,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1606,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: 25 nM Silvestrol for 1 hour
586,GSM1503436,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1607,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: 25 nM Silvestrol for 1 hour
587,GSM1503437,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1608,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: untreated
588,GSM1503438,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1609,99,1605,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: untreated
589,GSM1503439,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1610,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: 25 nM Silvestrol for 2 hours
590,GSM1503440,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1611,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 4 | treatment: DMSO for 2 hours
591,GSM1503441,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1612,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 4 | treatment: 25 nM Silvestrol for 2 hours
592,GSM1503442,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1613,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: DMSO for 2 hours
593,GSM1503443,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1614,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: 200 nM INK128 for 2 hours
594,GSM1503444,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1615,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: DMSO for 2 hours
595,GSM1503445,MDA-MB-231,MDA-MB-231,99,MDA-MB-231,NA,1616,99,NA,GSE61375,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,Breast cancer cells,cell line: MDA-MB-231 | cell type: Ductal breast carcinoma | passage #: 3 | treatment: 200 nM INK128 for 2 hours
596,GSM1513187,LCL,LCL,101,LCL,NA,1620,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18486 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
597,GSM1513188,LCL,LCL,101,LCL,NA,1621,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18498 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
598,GSM1513189,LCL,LCL,101,LCL,NA,1622,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18499 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
599,GSM1513190,LCL,LCL,101,LCL,NA,1623,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18501 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
600,GSM1513191,LCL,LCL,101,LCL,NA,1624,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18502 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
601,GSM1513192,LCL,LCL,101,LCL,NA,1625,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18504 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
602,GSM1513193,LCL,LCL,101,LCL,NA,1626,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18505 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
603,GSM1513194,LCL,LCL,101,LCL,NA,1627,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18507 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
604,GSM1513195,LCL,LCL,101,LCL,NA,1628,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18508 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
605,GSM1513196,LCL,LCL,101,LCL,NA,1629,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18510 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
606,GSM1513197,LCL,LCL,101,LCL,NA,1630,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18511 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
607,GSM1513198,LCL,LCL,101,LCL,NA,1631,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18516 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
608,GSM1513199,LCL,LCL,101,LCL,NA,1632,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18517 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
609,GSM1513200,LCL,LCL,101,LCL,NA,1633,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18519 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
610,GSM1513201,LCL,LCL,101,LCL,NA,1634,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18520 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
611,GSM1513202,LCL,LCL,101,LCL,NA,1635,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18522 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
612,GSM1513203,LCL,LCL,101,LCL,NA,1636,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18523 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
613,GSM1513204,LCL,LCL,101,LCL,NA,1637,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18852 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
614,GSM1513205,LCL,LCL,101,LCL,NA,1638,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18853 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
615,GSM1513206,LCL,LCL,101,LCL,NA,1639,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18855 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
616,GSM1513207,LCL,LCL,101,LCL,NA,1640,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18856 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
617,GSM1513208,LCL,LCL,101,LCL,NA,1641,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18858 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
618,GSM1513209,LCL,LCL,101,LCL,NA,1642,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18861 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
619,GSM1513210,LCL,LCL,101,LCL,NA,1643,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18862 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
620,GSM1513211,LCL,LCL,101,LCL,NA,1644,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18870 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
621,GSM1513212,LCL,LCL,101,LCL,NA,1645,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18907 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
622,GSM1513213,LCL,LCL,101,LCL,NA,1646,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18909 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
623,GSM1513214,LCL,LCL,101,LCL,NA,1647,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18912 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
624,GSM1513215,LCL,LCL,101,LCL,NA,1648,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM18913 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
625,GSM1513216,LCL,LCL,101,LCL,NA,1649,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM18916 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
626,GSM1513217,LCL,LCL,101,LCL,NA,1650,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19092 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
627,GSM1513218,LCL,LCL,101,LCL,NA,1651,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19093 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
628,GSM1513219,LCL,LCL,101,LCL,NA,1652,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19098 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
629,GSM1513220,LCL,LCL,101,LCL,NA,1653,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19099 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
630,GSM1513221,LCL,LCL,101,LCL,NA,1654,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19101 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
631,GSM1513222,LCL,LCL,101,LCL,NA,1655,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19102 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
632,GSM1513223,LCL,LCL,101,LCL,NA,1656,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19108 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
633,GSM1513224,LCL,LCL,101,LCL,NA,1657,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19114 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
634,GSM1513225,LCL,LCL,101,LCL,NA,1658,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19116 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
635,GSM1513226,LCL,LCL,101,LCL,NA,1659,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19119 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
636,GSM1513227,LCL,LCL,101,LCL,NA,1660,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19127 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
637,GSM1513228,LCL,LCL,101,LCL,NA,1661,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19128 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
638,GSM1513229,LCL,LCL,101,LCL,NA,1662,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19130 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
639,GSM1513230,LCL,LCL,101,LCL,NA,1663,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19131 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
640,GSM1513231,LCL,LCL,101,LCL,NA,1664,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19137 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
641,GSM1513232,LCL,LCL,101,LCL,NA,1665,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19138 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
642,GSM1513233,LCL,LCL,101,LCL,NA,1666,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19140 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
643,GSM1513234,LCL,LCL,101,LCL,NA,1667,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19141 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
644,GSM1513235,LCL,LCL,101,LCL,NA,1668,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19143 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
645,GSM1513236,LCL,LCL,101,LCL,NA,1669,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19144 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
646,GSM1513237,LCL,LCL,101,LCL,NA,1670,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19147 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
647,GSM1513238,LCL,LCL,101,LCL,NA,1671,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19152 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
648,GSM1513239,LCL,LCL,101,LCL,NA,1672,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19153 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
649,GSM1513240,LCL,LCL,101,LCL,NA,1673,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19159 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
650,GSM1513241,LCL,LCL,101,LCL,NA,1674,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19160 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
651,GSM1513242,LCL,LCL,101,LCL,NA,1675,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19171 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
652,GSM1513243,LCL,LCL,101,LCL,NA,1676,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19172 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
653,GSM1513244,LCL,LCL,101,LCL,NA,1677,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19190 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
654,GSM1513245,LCL,LCL,101,LCL,NA,1678,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19192 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
655,GSM1513246,LCL,LCL,101,LCL,NA,1679,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19193 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
656,GSM1513247,LCL,LCL,101,LCL,NA,1680,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19200 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
657,GSM1513248,LCL,LCL,101,LCL,NA,1681,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19201 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
658,GSM1513249,LCL,LCL,101,LCL,NA,1682,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19204 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
659,GSM1513250,LCL,LCL,101,LCL,NA,1683,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19207 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
660,GSM1513251,LCL,LCL,101,LCL,NA,1684,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19209 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
661,GSM1513252,LCL,LCL,101,LCL,NA,1685,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19210 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
662,GSM1513253,LCL,LCL,101,LCL,NA,1686,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19222 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
663,GSM1513254,LCL,LCL,101,LCL,NA,1687,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19223 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
664,GSM1513255,LCL,LCL,101,LCL,NA,1688,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19225 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
665,GSM1513256,LCL,LCL,101,LCL,NA,1689,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19238 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
666,GSM1513257,LCL,LCL,101,LCL,NA,1690,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Male | cell line: GM19239 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
667,GSM1513258,LCL,LCL,101,LCL,NA,1691,101,NA,GSE61742,Homo sapiens,LCL,lcl,LCL,lymphoblastoid cell lines derived fromHapMap Yoruba individual,gender: Female | cell line: GM19257 | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | molecule subtype: cytoplasmic RNA
716,GSM1523624,H1,H1,104,H1,NA,1786,104,1802,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
717,GSM1523625,H1,H1,104,H1,NA,1787,104,1803,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 1d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
718,GSM1523626,H1,H1,104,H1,NA,1788,104,1804,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
719,GSM1523627,H1,H1,104,H1,NA,1789,104,1805,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 6d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
720,GSM1523628,H1,H1,104,H1,NA,1790,104,1806,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
721,GSM1523629,H1,H1,104,H1,NA,1791,104,1807,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 1d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
722,GSM1523630,H1,H1,104,H1,NA,1792,104,1808,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
723,GSM1523631,H1,H1,104,H1,NA,1793,104,1809,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 6d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
724,GSM1523632,H1,H1,104,H1,NA,1794,104,1810,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
725,GSM1523633,H1,H1,104,H1,NA,1795,104,1811,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 1d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
726,GSM1523634,H1,H1,104,H1,NA,1796,104,1812,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
727,GSM1523635,H1,H1,104,H1,NA,1797,104,1813,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 6d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
728,GSM1523636,H1,H1,104,H1,NA,1798,104,1814,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
729,GSM1523637,H1,H1,104,H1,NA,1799,104,1815,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 1d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
730,GSM1523638,H1,H1,104,H1,NA,1800,104,1816,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
731,GSM1523639,H1,H1,104,H1,NA,1801,104,1817,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 6d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
732,GSM1523640,H1,H1,104,H1,NA,1802,104,1786,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
733,GSM1523641,H1,H1,104,H1,NA,1803,104,1787,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 1d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
734,GSM1523642,H1,H1,104,H1,NA,1804,104,1788,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
735,GSM1523643,H1,H1,104,H1,NA,1805,104,1789,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 6d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
736,GSM1523644,H1,H1,104,H1,NA,1806,104,1790,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
737,GSM1523645,H1,H1,104,H1,NA,1807,104,1791,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 1d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
738,GSM1523646,H1,H1,104,H1,NA,1808,104,1792,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
739,GSM1523647,H1,H1,104,H1,NA,1809,104,1793,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 6d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
740,GSM1523648,H1,H1,104,H1,NA,1810,104,1794,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
741,GSM1523649,H1,H1,104,H1,NA,1811,104,1795,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 1d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
742,GSM1523650,H1,H1,104,H1,NA,1812,104,1796,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
743,GSM1523651,H1,H1,104,H1,NA,1813,104,1797,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 6d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
744,GSM1523652,H1,H1,104,H1,NA,1814,104,1798,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
745,GSM1523653,H1,H1,104,H1,NA,1815,104,1799,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 1d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
746,GSM1523654,H1,H1,104,H1,NA,1816,104,1800,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
747,GSM1523655,H1,H1,104,H1,NA,1817,104,1801,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 6d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
1422,GSM1782874,H1,H1,104,H1,NA,1772,104,1779,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1423,GSM1782875,H1,H1,104,H1,NA,1773,104,1780,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1424,GSM1782876,H1,H1,104,H1,NA,1774,104,1781,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1425,GSM1782877,H1,H1,104,H1,NA,1775,104,1782,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting TCOF1","treatment: lentiviral infection with sh TCOF1 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1426,GSM1782878,H1,H1,104,H1,NA,1776,104,1783,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d","treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1427,GSM1782879,H1,H1,104,H1,NA,1777,104,1784,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d","treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1428,GSM1782880,H1,H1,104,H1,NA,1778,104,1785,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting TCOF1, ND 3d","treatment: lentiviral infection with sh TCOF1 | cell line: H1 | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
1429,GSM1782881,H1,H1,104,H1,NA,1779,104,1772,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
1430,GSM1782882,H1,H1,104,H1,NA,1780,104,1773,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
1431,GSM1782883,H1,H1,104,H1,NA,1781,104,1774,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
1432,GSM1782884,H1,H1,104,H1,NA,1782,104,1775,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting TCOF1",treatment: lentiviral infection with sh TCOF1 | cell line: H1 | extract_protocol: Standard mRNA-seq
1433,GSM1782885,H1,H1,104,H1,NA,1783,104,1776,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh control, ND 3d",treatment: lentiviral infection with sh control | cell line: H1 | extract_protocol: Standard mRNA-seq
1434,GSM1782886,H1,H1,104,H1,NA,1784,104,1777,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting KBTBD8, ND 3d",treatment: lentiviral infection with sh KBTBD8 | cell line: H1 | extract_protocol: Standard mRNA-seq
1435,GSM1782887,H1,H1,104,H1,NA,1785,104,1778,GSE62247,Homo sapiens,H1,h1,H1,"hES cell, treated with sh targeting TCOF1, ND 3d",treatment: lentiviral infection with sh TCOF1 | cell line: H1 | extract_protocol: Standard mRNA-seq
748,GSM1552807,NCCIT,NCCIT,107,NCCIT,NA,1827,107,1833,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,Rec-OE-NCCIT hECC,"cell type: NCCIT cells, hECC | Sex: male"
749,GSM1552808,NCCIT,NCCIT,107,NCCIT,NA,1828,107,1835,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,NCCIT hECC,"cell type: NCCIT cells, hECC | Sex: male"
802,GSM1592570,NCCIT,NCCIT,107,NCCIT,NA,1833,107,1827,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,Rec-OE-NCCIT hECC,"gender: male | cell type: NCCIT cells, hECC | molecule subtype: total RNA (rRNA depleted)"
803,GSM1592571,NCCIT,NCCIT,107,NCCIT,NA,1834,107,NA,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,Rec-OE-NCCIT hECC,"gender: male | cell type: NCCIT cells, hECC | molecule subtype: total RNA (rRNA depleted)"
804,GSM1592572,NCCIT,NCCIT,107,NCCIT,NA,1835,107,1828,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,NCCIT hECC,"gender: male | cell type: NCCIT cells, hECC | molecule subtype: total RNA (rRNA depleted)"
805,GSM1592573,NCCIT,NCCIT,107,NCCIT,NA,1836,107,NA,GSE63570,Homo sapiens,NCCIT,nccit,NCCIT,NCCIT hECC,"gender: male | cell type: NCCIT cells, hECC | molecule subtype: total RNA (rRNA depleted)"
750,GSM1553248,HeLa,HeLa,108,HeLa,NA,1847,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Isolate from surcrose gradient, recovered by trizol"
751,GSM1553249,HeLa,HeLa,108,HeLa,NA,1848,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Extract by trizol, then rRNA removal"
752,GSM1553250,HeLa,HeLa,108,HeLa,NA,1849,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Isolate from surcrose gradient, recovered by trizol"
753,GSM1553251,HeLa,HeLa,108,HeLa,NA,1850,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Extract by trizol, then rRNA removal"
754,GSM1553252,HeLa,HeLa,108,HeLa,NA,1851,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Isolate from surcrose gradient, recovered by trizol"
755,GSM1553253,HeLa,HeLa,108,HeLa,NA,1852,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Extracy by trizol, then rRNA removal"
756,GSM1553254,HeLa,HeLa,108,HeLa,NA,1853,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Isolate from surcrose gradient, recovered by trizol"
757,GSM1553255,HeLa,HeLa,108,HeLa,NA,1854,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,"cell line: HeLa | cell treatment: 40nM siRNA knock-down for 48h | sample treatment and extract: Extracy by trizol, then rRNA removal"
1403,GSM1717890,HeLa,HeLa,108,HeLa,NA,1837,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | transfection: siControl-RPF | cell treatment: 40nM siRNA knock-down for 48h
1404,GSM1717891,HeLa,HeLa,108,HeLa,NA,1838,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | transfection: siControl | cell treatment: 40nM siRNA knock-down for 48h
1405,GSM1717892,HeLa,HeLa,108,HeLa,NA,1839,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | transfection: SiMETTL3-RPF | cell treatment: 40nM siRNA knock-down for 48h
1406,GSM1717893,HeLa,HeLa,108,HeLa,NA,1840,108,NA,GSE63591,Homo sapiens,HeLa,hela,HeLa,HeLa cell,cell line: HeLa | transfection: SiMETTL3 | cell treatment: 40nM siRNA knock-down for 48h
760,GSM1585204,Human fibroblast,Human fibroblast,113,fibroblast,,1886,113,1892,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: wt | timepoint after treatment: 24 hours | treatment: d-leucine
761,GSM1585205,Human fibroblast,Human fibroblast,113,fibroblast,,1887,113,1893,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: wt | timepoint after treatment: 24 hours | treatment: l-leucine
762,GSM1585206,Human fibroblast,Human fibroblast,113,fibroblast,,1888,113,1894,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
763,GSM1585207,Human fibroblast,Human fibroblast,113,fibroblast,,1889,113,1895,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
764,GSM1585208,Human fibroblast,Human fibroblast,113,fibroblast,,1890,113,NA,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: d-leucine
765,GSM1585209,Human fibroblast,Human fibroblast,113,fibroblast,,1891,113,NA,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: l-leucine
766,GSM1585210,Human fibroblast,Human fibroblast,113,fibroblast,,1892,113,1886,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: wt | timepoint after treatment: 24 hours | treatment: d-leucine
767,GSM1585211,Human fibroblast,Human fibroblast,113,fibroblast,,1893,113,1887,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: wt | timepoint after treatment: 24 hours | treatment: l-leucine
768,GSM1585212,Human fibroblast,Human fibroblast,113,fibroblast,,1894,113,1888,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
769,GSM1585213,Human fibroblast,Human fibroblast,113,fibroblast,,1895,113,1889,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
770,GSM1585214,Human fibroblast,Human fibroblast,113,fibroblast,,1896,113,1904,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
771,GSM1585215,Human fibroblast,Human fibroblast,113,fibroblast,,1897,113,1905,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
772,GSM1585216,Human fibroblast,Human fibroblast,113,fibroblast,,1898,113,1906,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
773,GSM1585217,Human fibroblast,Human fibroblast,113,fibroblast,,1899,113,1907,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
774,GSM1585218,Human fibroblast,Human fibroblast,113,fibroblast,,1900,113,1908,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: d-leucine
775,GSM1585219,Human fibroblast,Human fibroblast,113,fibroblast,,1901,113,1909,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: l-leucine
776,GSM1585220,Human fibroblast,Human fibroblast,113,fibroblast,,1902,113,1910,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: d-leucine
777,GSM1585221,Human fibroblast,Human fibroblast,113,fibroblast,,1903,113,1911,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: l-leucine
778,GSM1585222,Human fibroblast,Human fibroblast,113,fibroblast,,1904,113,1896,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
779,GSM1585223,Human fibroblast,Human fibroblast,113,fibroblast,,1905,113,1897,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
780,GSM1585224,Human fibroblast,Human fibroblast,113,fibroblast,,1906,113,1898,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: d-leucine
781,GSM1585225,Human fibroblast,Human fibroblast,113,fibroblast,,1907,113,1899,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 24 hours | treatment: l-leucine
782,GSM1585226,Human fibroblast,Human fibroblast,113,fibroblast,,1908,113,1900,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: d-leucine
783,GSM1585227,Human fibroblast,Human fibroblast,113,fibroblast,,1909,113,1901,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: l-leucine
784,GSM1585228,Human fibroblast,Human fibroblast,113,fibroblast,,1910,113,1902,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: d-leucine
785,GSM1585229,Human fibroblast,Human fibroblast,113,fibroblast,,1911,113,1903,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 24 hours | treatment: l-leucine
786,GSM1585230,Human fibroblast,Human fibroblast,113,fibroblast,,1912,113,1920,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 3 hours | treatment: d-leucine
787,GSM1585231,Human fibroblast,Human fibroblast,113,fibroblast,,1913,113,1921,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 3 hours | treatment: l-leucine
788,GSM1585232,Human fibroblast,Human fibroblast,113,fibroblast,,1914,113,1922,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 3 hours | treatment: d-leucine
789,GSM1585233,Human fibroblast,Human fibroblast,113,fibroblast,,1915,113,1923,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: corrected | timepoint after treatment: 3 hours | treatment: l-leucine
790,GSM1585234,Human fibroblast,Human fibroblast,113,fibroblast,,1916,113,1924,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: d-leucine
791,GSM1585235,Human fibroblast,Human fibroblast,113,fibroblast,,1917,113,1925,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: l-leucine
792,GSM1585236,Human fibroblast,Human fibroblast,113,fibroblast,,1918,113,1926,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: d-leucine
793,GSM1585237,Human fibroblast,Human fibroblast,113,fibroblast,,1919,113,1927,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: RNA-seq | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: l-leucine
794,GSM1585238,Human fibroblast,Human fibroblast,113,fibroblast,,1920,113,1912,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 3 hours | treatment: d-leucine
795,GSM1585239,Human fibroblast,Human fibroblast,113,fibroblast,,1921,113,1913,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 3 hours | treatment: l-leucine
796,GSM1585240,Human fibroblast,Human fibroblast,113,fibroblast,,1922,113,1914,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 3 hours | treatment: d-leucine
797,GSM1585241,Human fibroblast,Human fibroblast,113,fibroblast,,1923,113,1915,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: corrected | timepoint after treatment: 3 hours | treatment: l-leucine
798,GSM1585242,Human fibroblast,Human fibroblast,113,fibroblast,,1924,113,1916,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: d-leucine
799,GSM1585243,Human fibroblast,Human fibroblast,113,fibroblast,,1925,113,1917,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: l-leucine
800,GSM1585244,Human fibroblast,Human fibroblast,113,fibroblast,,1926,113,1918,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: d-leucine
801,GSM1585245,Human fibroblast,Human fibroblast,113,fibroblast,,1927,113,1919,GSE64962,Homo sapiens,Human fibroblast,fibroblast,fibroblast,Human fibroblast,experiment type: Ribosomal profiling | genotype: esco2 mutant | timepoint after treatment: 3 hours | treatment: l-leucine
806,GSM1606099,HEK293T,HEK293T,115,HEK293T,NA,1932,115,1940,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: untreated
807,GSM1606100,HEK293T,HEK293T,115,HEK293T,NA,1933,115,1941,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: untreated
808,GSM1606101,HEK293T,HEK293T,115,HEK293T,NA,1934,115,1942,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: ISRIB (200 nM) for 1 hour
809,GSM1606102,HEK293T,HEK293T,115,HEK293T,NA,1935,115,1943,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: ISRIB (200 nM) for 1 hour
810,GSM1606103,HEK293T,HEK293T,115,HEK293T,NA,1936,115,1944,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin for 1 hour
811,GSM1606104,HEK293T,HEK293T,115,HEK293T,NA,1937,115,1945,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin for 1 hour
812,GSM1606105,HEK293T,HEK293T,115,HEK293T,NA,1938,115,1946,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin and ISRIB (200 nM) for 1 hour
813,GSM1606106,HEK293T,HEK293T,115,HEK293T,NA,1939,115,1947,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin and ISRIB (200 nM) for 1 hour
814,GSM1606107,HEK293T,HEK293T,115,HEK293T,NA,1940,115,1932,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: untreated
815,GSM1606108,HEK293T,HEK293T,115,HEK293T,NA,1941,115,1933,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: untreated
816,GSM1606109,HEK293T,HEK293T,115,HEK293T,NA,1942,115,1934,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: ISRIB (200 nM) for 1 hour
817,GSM1606110,HEK293T,HEK293T,115,HEK293T,NA,1943,115,1935,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: ISRIB (200 nM) for 1 hour
818,GSM1606111,HEK293T,HEK293T,115,HEK293T,NA,1944,115,1936,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin for 1 hour
819,GSM1606112,HEK293T,HEK293T,115,HEK293T,NA,1945,115,1937,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin for 1 hour
820,GSM1606113,HEK293T,HEK293T,115,HEK293T,NA,1946,115,1938,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin and ISRIB (200 nM) for 1 hour
821,GSM1606114,HEK293T,HEK293T,115,HEK293T,NA,1947,115,1939,GSE65778,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | treatment: 1ÃŽÂ¼g/ml of tunicamycin and ISRIB (200 nM) for 1 hour
822,GSM1608261,MCF-10A,MCF10A,116,MCF10A,NA,1948,116,1963,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
823,GSM1608262,MCF-10A,MCF10A,116,MCF10A,NA,1949,116,1964,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
824,GSM1608263,MCF-10A,MCF10A,116,MCF10A,NA,1950,116,1965,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
825,GSM1608264,MCF-10A,MCF10A,116,MCF10A,NA,1951,116,1955,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
826,GSM1608265,MCF-10A,MCF10A,116,MCF10A,NA,1952,116,1956,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
827,GSM1608266,MCF-10A,MCF10A,116,MCF10A,NA,1953,116,1957,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
828,GSM1608267,MCF-10A,MCF10A,116,MCF10A,NA,1954,116,1958,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Total RNA
829,GSM1608268,MCF-10A,MCF10A,116,MCF10A,NA,1955,116,1951,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
830,GSM1608269,MCF-10A,MCF10A,116,MCF10A,NA,1956,116,1952,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
831,GSM1608270,MCF-10A,MCF10A,116,MCF10A,NA,1957,116,1953,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
832,GSM1608271,MCF-10A,MCF10A,116,MCF10A,NA,1958,116,1954,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
833,GSM1608272,MCF-10A,MCF10A,116,MCF10A,NA,1959,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
834,GSM1608273,MCF-10A,MCF10A,116,MCF10A,NA,1960,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
835,GSM1608274,MCF-10A,MCF10A,116,MCF10A,NA,1961,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
836,GSM1608275,MCF-10A,MCF10A,116,MCF10A,NA,1962,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
837,GSM1608276,MCF-10A,MCF10A,116,MCF10A,NA,1963,116,1948,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
838,GSM1608277,MCF-10A,MCF10A,116,MCF10A,NA,1964,116,1949,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
839,GSM1608278,MCF-10A,MCF10A,116,MCF10A,NA,1965,116,1950,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
840,GSM1608279,MCF-10A,MCF10A,116,MCF10A,NA,1966,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
841,GSM1608280,MCF-10A,MCF10A,116,MCF10A,NA,1967,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
842,GSM1608281,MCF-10A,MCF10A,116,MCF10A,NA,1968,116,NA,GSE65885,Homo sapiens,MCF10A,mcf10a,MCF10A,Breast epithelial cell,cell line: MCF10A-ER-Src | cell type: breast epithelial | rna type: Ribosome protected fragments
843,GSM1608282,BJ,BJ,116,BJ,NA,1969,116,1972,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Total RNA
844,GSM1608283,BJ,BJ,116,BJ,NA,1970,116,1973,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Total RNA
845,GSM1608284,BJ,BJ,116,BJ,NA,1971,116,1974,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Total RNA
846,GSM1608285,BJ,BJ,116,BJ,NA,1972,116,1969,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
847,GSM1608286,BJ,BJ,116,BJ,NA,1973,116,1970,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
848,GSM1608287,BJ,BJ,116,BJ,NA,1974,116,1971,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
849,GSM1608288,BJ,BJ,116,BJ,NA,1975,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
850,GSM1608289,BJ,BJ,116,BJ,NA,1976,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
851,GSM1608290,BJ,BJ,116,BJ,NA,1977,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
852,GSM1608291,BJ,BJ,116,BJ,NA,1978,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
853,GSM1608292,BJ,BJ,116,BJ,NA,1979,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
854,GSM1608293,BJ,BJ,116,BJ,NA,1980,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
855,GSM1608294,BJ,BJ,116,BJ,NA,1981,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
856,GSM1608295,BJ,BJ,116,BJ,NA,1982,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
857,GSM1608296,BJ,BJ,116,BJ,NA,1983,116,NA,GSE65885,Homo sapiens,BJ,bj,BJ,Fibroblast cell,cell line: BJ | cell type: Fibroblast | rna type: Ribosome protected fragments
858,GSM1609377,GM10847,GM_tissue,117,GM_tissue,NA,1984,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM10847 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
859,GSM1609378,GM12878,GM_tissue,117,GM_tissue,NA,1985,117,2034,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12878 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
860,GSM1609379,GM12878,GM_tissue,117,GM_tissue,NA,1986,117,2035,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12878 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
861,GSM1609380,GM12890,GM_tissue,117,GM_tissue,NA,1987,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12890 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
862,GSM1609381,GM12890,GM_tissue,117,GM_tissue,NA,1988,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12890 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
863,GSM1609382,GM12891,GM_tissue,117,GM_tissue,NA,1989,117,2037,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12891 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
864,GSM1609383,GM12891,GM_tissue,117,GM_tissue,NA,1990,117,2038,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12891 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
865,GSM1609384,GM12892,GM_tissue,117,GM_tissue,NA,1991,117,2040,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12892 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
866,GSM1609385,GM12892,GM_tissue,117,GM_tissue,NA,1992,117,2041,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12892 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
867,GSM1609386,GM18489,GM_tissue,117,GM_tissue,NA,1993,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18489 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
868,GSM1609387,GM18499,GM_tissue,117,GM_tissue,NA,1994,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18499 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
869,GSM1609388,GM18499,GM_tissue,117,GM_tissue,NA,1995,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18499 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
870,GSM1609389,GM18501,GM_tissue,117,GM_tissue,NA,1996,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18501 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
871,GSM1609390,GM18501,GM_tissue,117,GM_tissue,NA,1997,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18501 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
872,GSM1609391,GM18502,GM_tissue,117,GM_tissue,NA,1998,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18502 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
873,GSM1609392,GM18504,GM_tissue,117,GM_tissue,NA,1999,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18504 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
874,GSM1609393,GM18504,GM_tissue,117,GM_tissue,NA,2000,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18504 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
875,GSM1609394,GM18505,GM_tissue,117,GM_tissue,NA,2001,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18505 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
876,GSM1609395,GM18511,GM_tissue,117,GM_tissue,NA,2002,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18511 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
877,GSM1609396,GM18519,GM_tissue,117,GM_tissue,NA,2003,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18519 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
878,GSM1609397,GM18522,GM_tissue,117,GM_tissue,NA,2004,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18522 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
879,GSM1609398,GM18522,GM_tissue,117,GM_tissue,NA,2005,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18522 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
880,GSM1609399,GM18523,GM_tissue,117,GM_tissue,NA,2006,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18523 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
881,GSM1609400,GM18523,GM_tissue,117,GM_tissue,NA,2007,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18523 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
882,GSM1609401,GM18526,GM_tissue,117,GM_tissue,NA,2008,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18526 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
883,GSM1609402,GM18870,GM_tissue,117,GM_tissue,NA,2009,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18870 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
884,GSM1609403,GM18951,GM_tissue,117,GM_tissue,NA,2010,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18951 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
885,GSM1609404,GM18951,GM_tissue,117,GM_tissue,NA,2011,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18951 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
886,GSM1609405,GM18951,GM_tissue,117,GM_tissue,NA,2012,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18951 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
887,GSM1609406,GM19098,GM_tissue,117,GM_tissue,NA,2013,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19098 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
888,GSM1609407,GM19098,GM_tissue,117,GM_tissue,NA,2014,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19098 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
889,GSM1609408,GM19099,GM_tissue,117,GM_tissue,NA,2015,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19099 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
890,GSM1609409,GM19137,GM_tissue,117,GM_tissue,NA,2016,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19137 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
891,GSM1609410,GM19137,GM_tissue,117,GM_tissue,NA,2017,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19137 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
892,GSM1609411,GM19138,GM_tissue,117,GM_tissue,NA,2018,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19138 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
893,GSM1609412,GM19138,GM_tissue,117,GM_tissue,NA,2019,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19138 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
894,GSM1609413,GM19139,GM_tissue,117,GM_tissue,NA,2020,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19139 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
895,GSM1609414,GM19193,GM_tissue,117,GM_tissue,NA,2021,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19193 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
896,GSM1609415,GM19200,GM_tissue,117,GM_tissue,NA,2022,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19200 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
897,GSM1609416,GM19201,GM_tissue,117,GM_tissue,NA,2023,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19201 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
898,GSM1609417,GM19238,GM_tissue,117,GM_tissue,NA,2024,117,2043,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19238 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
899,GSM1609418,GM19238,GM_tissue,117,GM_tissue,NA,2025,117,2045,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19238 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
900,GSM1609419,GM19239,GM_tissue,117,GM_tissue,NA,2026,117,2046,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19239 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
901,GSM1609420,GM19239,GM_tissue,117,GM_tissue,NA,2027,117,2047,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19239 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
902,GSM1609421,GM19240,GM_tissue,117,GM_tissue,NA,2028,117,2049,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
903,GSM1609422,GM19240,GM_tissue,117,GM_tissue,NA,2029,117,2050,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
904,GSM1609423,GM19240,GM_tissue,117,GM_tissue,NA,2030,117,2051,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
905,GSM1609424,GM18526,GM_tissue,117,GM_tissue,NA,2031,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18526 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
906,GSM1609425,GM18526,GM_tissue,117,GM_tissue,NA,2032,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18526 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
907,GSM1609426,GM18507,GM_tissue,117,GM_tissue,NA,2033,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM18507 | cell type: EBV-transformed lymphoblastoid | adapter: AGATCGGAAGAGCACACGTCT | rna type: ribosome protected fragment
908,GSM1609427,GM12878,GM_tissue,117,GM_tissue,NA,2034,117,1985,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12878 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
909,GSM1609428,GM12878,GM_tissue,117,GM_tissue,NA,2035,117,1986,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12878 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
910,GSM1609429,GM12878,GM_tissue,117,GM_tissue,NA,2036,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12878 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
911,GSM1609430,GM12891,GM_tissue,117,GM_tissue,NA,2037,117,1989,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12891 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
912,GSM1609431,GM12891,GM_tissue,117,GM_tissue,NA,2038,117,1990,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12891 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
913,GSM1609432,GM12891,GM_tissue,117,GM_tissue,NA,2039,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12891 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
914,GSM1609433,GM12892,GM_tissue,117,GM_tissue,NA,2040,117,1991,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12892 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
915,GSM1609434,GM12892,GM_tissue,117,GM_tissue,NA,2041,117,1992,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12892 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
916,GSM1609435,GM12892,GM_tissue,117,GM_tissue,NA,2042,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM12892 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
917,GSM1609436,GM19238,GM_tissue,117,GM_tissue,NA,2043,117,2024,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19238 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
918,GSM1609437,GM19238,GM_tissue,117,GM_tissue,NA,2044,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19238 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
919,GSM1609438,GM19238,GM_tissue,117,GM_tissue,NA,2045,117,2025,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19238 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
920,GSM1609439,GM19239,GM_tissue,117,GM_tissue,NA,2046,117,2026,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19239 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
921,GSM1609440,GM19239,GM_tissue,117,GM_tissue,NA,2047,117,2027,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19239 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
922,GSM1609441,GM19239,GM_tissue,117,GM_tissue,NA,2048,117,NA,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19239 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
923,GSM1609442,GM19240,GM_tissue,117,GM_tissue,NA,2049,117,2028,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
924,GSM1609443,GM19240,GM_tissue,117,GM_tissue,NA,2050,117,2029,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
925,GSM1609444,GM19240,GM_tissue,117,GM_tissue,NA,2051,117,2030,GSE65912,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,EBV-transformed lymphoblastoid cells,cell line: GM19240 | cell type: EBV-transformed lymphoblastoid | rna type: polyA RNA
938,GSM1612420,HEK293,HEK293,119,HEK293,NA,2060,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: Control (empty vector)
939,GSM1612421,HEK293,HEK293,119,HEK293,NA,2061,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: Control (empty vector)
940,GSM1612422,HEK293,HEK293,119,HEK293,NA,2062,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: Control (empty vector)
941,GSM1612423,HEK293,HEK293,119,HEK293,NA,2063,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 long isoform
942,GSM1612424,HEK293,HEK293,119,HEK293,NA,2064,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 long isoform
943,GSM1612425,HEK293,HEK293,119,HEK293,NA,2065,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 long isoform
944,GSM1612426,HEK293,HEK293,119,HEK293,NA,2066,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 short isoform
945,GSM1612427,HEK293,HEK293,119,HEK293,NA,2067,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 short isoform
946,GSM1612428,HEK293,HEK293,119,HEK293,NA,2068,119,NA,GSE65999,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293 | transfection: ADARB1 short isoform
959,GSM1632189,U2OS,U2OS,472,U2OS,NA,8887,472,2183,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, control",cell type: U2OS | treatment: control
960,GSM1632190,U2OS,U2OS,472,U2OS,NA,8888,472,2184,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation (36 hr)",cell type: U2OS | treatment: Myc activation (36 hr)
961,GSM1632191,U2OS,U2OS,472,U2OS,NA,8889,472,2185,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, control",cell type: U2OS | treatment: control
962,GSM1632192,U2OS,U2OS,472,U2OS,NA,8890,472,2187,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation (36 hr)",cell type: U2OS | treatment: Myc activation (36 hr)
963,GSM1632193,U2OS,U2OS,472,U2OS,NA,8891,472,2189,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Torin-1",cell type: U2OS | treatment: Torin-1
964,GSM1632194,U2OS,U2OS,472,U2OS,NA,8892,472,2191,GSE66789,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation + Torin-1",cell type: U2OS | treatment: Myc activation + Torin-1
965,GSM1632594,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2175,471,2177,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
966,GSM1632595,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2176,471,2178,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
967,GSM1632596,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2177,471,2175,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
968,GSM1632597,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2178,471,2176,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
969,GSM1632598,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2179,471,2181,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
970,GSM1632599,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2180,471,2182,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
971,GSM1632600,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2181,471,2179,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
972,GSM1632601,Human primary macrophages,Human primary macrophages,471,primary macrophages,,2182,471,2180,GSE66809,Homo sapiens,Human primary macrophages,primary macrophages,primary macrophages,human primary macrophages,tlr stimulation: TLR2 stimulated
973,GSM1634443,U2OS,U2OS,472,U2OS,NA,2183,472,8887,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, control",cell type: U2OS | treatment: control
974,GSM1634444,U2OS,U2OS,472,U2OS,NA,2184,472,8888,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation (36 hr)",cell type: U2OS | treatment: Myc activation (36 hr)
975,GSM1634445,U2OS,U2OS,472,U2OS,NA,2185,472,8889,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, control",cell type: U2OS | treatment: control
976,GSM1634446,U2OS,U2OS,472,U2OS,NA,2186,472,NA,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, control",cell type: U2OS | treatment: control
977,GSM1634447,U2OS,U2OS,472,U2OS,NA,2187,472,8890,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation (36 hr)",cell type: U2OS | treatment: Myc activation (36 hr)
978,GSM1634448,U2OS,U2OS,472,U2OS,NA,2188,472,NA,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation (36 hr)",cell type: U2OS | treatment: Myc activation (36 hr)
979,GSM1634449,U2OS,U2OS,472,U2OS,NA,2189,472,8891,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Torin-1",cell type: U2OS | treatment: Torin-1
980,GSM1634450,U2OS,U2OS,472,U2OS,NA,2190,472,NA,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Torin-1",cell type: U2OS | treatment: Torin-1
981,GSM1634451,U2OS,U2OS,472,U2OS,NA,2191,472,8892,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation + Torin-1",cell type: U2OS | treatment: Myc activation + Torin-1
982,GSM1634452,U2OS,U2OS,472,U2OS,NA,2192,472,NA,GSE66927,Homo sapiens,U2OS,u2os,U2OS,"U2OS, Myc activation + Torin-1",cell type: U2OS | treatment: Myc activation + Torin-1
1041,GSM1657720,RPE-1,RPE-1,132,RPE-1,NA,2380,132,2386,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested. | cell cycle timepoint: G1 | drug pre-treatment: cells were pretreated with cycloheximide
1042,GSM1657721,RPE-1,RPE-1,132,RPE-1,NA,2381,132,2387,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested. | cell cycle timepoint: G1 | drug pre-treatment: cells were pretreated with cycloheximide
1043,GSM1657722,RPE-1,RPE-1,132,RPE-1,NA,2382,132,2388,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr and harvested | cell cycle timepoint: G2 | drug pre-treatment: cells were pretreated with cycloheximide
1044,GSM1657723,RPE-1,RPE-1,132,RPE-1,NA,2383,132,2389,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr and harvested | cell cycle timepoint: G2 | drug pre-treatment: cells were pretreated with cycloheximide
1045,GSM1657724,RPE-1,RPE-1,132,RPE-1,NA,2384,132,2390,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were harvested 45 min later through mitotic shake-off | cell cycle timepoint: M | drug pre-treatment: cells were pretreated with cycloheximide
1046,GSM1657725,RPE-1,RPE-1,132,RPE-1,NA,2385,132,2391,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were harvested 45 min later through mitotic shake-off | cell cycle timepoint: M | drug pre-treatment: cells were pretreated with cycloheximide
1047,GSM1657726,RPE-1,RPE-1,132,RPE-1,NA,2386,132,2380,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested. | cell cycle timepoint: G1 | drug pre-treatment: cells were pretreated with cycloheximide
1048,GSM1657727,RPE-1,RPE-1,132,RPE-1,NA,2387,132,2381,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were collected 45 min later through mitotic shake-off and replated to allow normal mitotic exit. 3hr later G1 cells were harvested. | cell cycle timepoint: G1 | drug pre-treatment: cells were pretreated with cycloheximide
1049,GSM1657728,RPE-1,RPE-1,132,RPE-1,NA,2388,132,2382,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr and harvested | cell cycle timepoint: G2 | drug pre-treatment: cells were pretreated with cycloheximide
1050,GSM1657729,RPE-1,RPE-1,132,RPE-1,NA,2389,132,2383,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr and harvested | cell cycle timepoint: G2 | drug pre-treatment: cells were pretreated with cycloheximide
1051,GSM1657730,RPE-1,RPE-1,132,RPE-1,NA,2390,132,2384,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were harvested 45 min later through mitotic shake-off | cell cycle timepoint: M | drug pre-treatment: cells were pretreated with cycloheximide
1052,GSM1657731,RPE-1,RPE-1,132,RPE-1,NA,2391,132,2385,GSE67902,Homo sapiens,RPE-1,rpe-1,RPE-1,Human Retinal pigment epithelial cells immortalized with hTERT,cell type: RPE-1 cells immortalized with hTERT | cell synchronization: Cells were treated with 6 micromolar RO-3306 for 18 hr. RO-3306 was then removed and mitotic cells were harvested 45 min later through mitotic shake-off | cell cycle timepoint: M | drug pre-treatment: cells were pretreated with cycloheximide
1053,GSM1660950,Lymphocytes,Lymphocytes,133,Lymphocytes,NA,2392,133,NA,GSE68008,Homo sapiens,Lymphocytes,lymphocytes,Lymphocytes,Lymphocytes,sample type: No ribosome purification | cell type: Lymphocytes
1054,GSM1660951,Lymphocytes,Lymphocytes,133,Lymphocytes,NA,2393,133,NA,GSE68008,Homo sapiens,Lymphocytes,lymphocytes,Lymphocytes,Lymphocytes,sample type: With ribosome purification | cell type: Lymphocytes
1175,GSM1691196,MM1.S,MM1.S,141,MM1.S,NA,2611,141,2617,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: untreated | cell lline: MM1.S
1176,GSM1691197,MM1.S,MM1.S,141,MM1.S,NA,2612,141,2618,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1177,GSM1691198,MM1.S,MM1.S,141,MM1.S,NA,2613,141,2619,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1178,GSM1691199,MM1.S,MM1.S,141,MM1.S,NA,2614,141,2620,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1179,GSM1691200,MM1.S,MM1.S,141,MM1.S,NA,2615,141,2621,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1180,GSM1691201,MM1.S,MM1.S,141,MM1.S,NA,2616,141,2622,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1181,GSM1691202,MM1.S,MM1.S,141,MM1.S,NA,2617,141,2611,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: untreated | cell lline: MM1.S
1182,GSM1691203,MM1.S,MM1.S,141,MM1.S,NA,2618,141,2612,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1183,GSM1691204,MM1.S,MM1.S,141,MM1.S,NA,2619,141,2613,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1184,GSM1691205,MM1.S,MM1.S,141,MM1.S,NA,2620,141,2614,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1185,GSM1691206,MM1.S,MM1.S,141,MM1.S,NA,2621,141,2615,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1186,GSM1691207,MM1.S,MM1.S,141,MM1.S,NA,2622,141,2616,GSE69047,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1.S cells,drug treatment: 0.5 nM bortezomib | cell lline: MM1.S
1187,GSM1704503,Huh7 cells,Huh7,145,Huh7,NA,2683,145,2731,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1188,GSM1704504,Huh7 cells,Huh7,145,Huh7,NA,2684,145,2732,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1189,GSM1704505,Huh7 cells,Huh7,145,Huh7,NA,2685,145,2733,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1190,GSM1704506,Huh7 cells,Huh7,145,Huh7,NA,2686,145,2734,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1191,GSM1704507,Huh7 cells,Huh7,145,Huh7,NA,2687,145,2735,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1192,GSM1704508,Huh7 cells,Huh7,145,Huh7,NA,2688,145,2736,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1193,GSM1704509,Huh7 cells,Huh7,145,Huh7,NA,2689,145,2737,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1194,GSM1704510,Huh7 cells,Huh7,145,Huh7,NA,2690,145,2738,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1195,GSM1704511,Huh7 cells,Huh7,145,Huh7,NA,2691,145,2739,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1196,GSM1704512,Huh7 cells,Huh7,145,Huh7,NA,2692,145,2740,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: DENV2 (M29095.1)
1197,GSM1704513,Huh7 cells,Huh7,145,Huh7,NA,2693,145,2741,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 1 | strain: none
1198,GSM1704514,Huh7 cells,Huh7,145,Huh7,NA,2694,145,2742,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: ribosome profiling | replicate: Rep 1 | strain: none
1199,GSM1704515,Huh7 cells,Huh7,145,Huh7,NA,2695,145,2743,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1200,GSM1704516,Huh7 cells,Huh7,145,Huh7,NA,2696,145,2744,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1201,GSM1704517,Huh7 cells,Huh7,145,Huh7,NA,2697,145,2745,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1202,GSM1704518,Huh7 cells,Huh7,145,Huh7,NA,2698,145,2746,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1203,GSM1704519,Huh7 cells,Huh7,145,Huh7,NA,2699,145,2747,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1204,GSM1704520,Huh7 cells,Huh7,145,Huh7,NA,2700,145,2748,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1205,GSM1704521,Huh7 cells,Huh7,145,Huh7,NA,2701,145,2749,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1206,GSM1704522,Huh7 cells,Huh7,145,Huh7,NA,2702,145,2750,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1207,GSM1704523,Huh7 cells,Huh7,145,Huh7,NA,2703,145,2751,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1208,GSM1704524,Huh7 cells,Huh7,145,Huh7,NA,2704,145,2752,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: DENV2 (M29095.1)
1209,GSM1704525,Huh7 cells,Huh7,145,Huh7,NA,2705,145,2753,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 2 | strain: none
1210,GSM1704526,Huh7 cells,Huh7,145,Huh7,NA,2706,145,2754,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: ribosome profiling | replicate: Rep 2 | strain: none
1211,GSM1704527,Huh7 cells,Huh7,145,Huh7,NA,2707,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1212,GSM1704528,Huh7 cells,Huh7,145,Huh7,NA,2708,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1213,GSM1704529,Huh7 cells,Huh7,145,Huh7,NA,2709,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1214,GSM1704530,Huh7 cells,Huh7,145,Huh7,NA,2710,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1215,GSM1704531,Huh7 cells,Huh7,145,Huh7,NA,2711,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1216,GSM1704532,Huh7 cells,Huh7,145,Huh7,NA,2712,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1217,GSM1704533,Huh7 cells,Huh7,145,Huh7,NA,2713,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1218,GSM1704534,Huh7 cells,Huh7,145,Huh7,NA,2714,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1219,GSM1704535,Huh7 cells,Huh7,145,Huh7,NA,2715,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1220,GSM1704536,Huh7 cells,Huh7,145,Huh7,NA,2716,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: DENV2 (M29095.1)
1221,GSM1704537,Huh7 cells,Huh7,145,Huh7,NA,2717,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 3 | strain: none
1222,GSM1704538,Huh7 cells,Huh7,145,Huh7,NA,2718,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: ribosome profiling | replicate: Rep 3 | strain: none
1223,GSM1704539,Huh7 cells,Huh7,145,Huh7,NA,2719,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1224,GSM1704540,Huh7 cells,Huh7,145,Huh7,NA,2720,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1225,GSM1704541,Huh7 cells,Huh7,145,Huh7,NA,2721,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1226,GSM1704542,Huh7 cells,Huh7,145,Huh7,NA,2722,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1227,GSM1704543,Huh7 cells,Huh7,145,Huh7,NA,2723,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1228,GSM1704544,Huh7 cells,Huh7,145,Huh7,NA,2724,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1229,GSM1704545,Huh7 cells,Huh7,145,Huh7,NA,2725,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1230,GSM1704546,Huh7 cells,Huh7,145,Huh7,NA,2726,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1231,GSM1704547,Huh7 cells,Huh7,145,Huh7,NA,2727,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1232,GSM1704548,Huh7 cells,Huh7,145,Huh7,NA,2728,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: DENV2 (M29095.1)
1233,GSM1704549,Huh7 cells,Huh7,145,Huh7,NA,2729,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: ribosome profiling | replicate: Rep 4 | strain: none
1234,GSM1704550,Huh7 cells,Huh7,145,Huh7,NA,2730,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: ribosome profiling | replicate: Rep 4 | strain: none
1235,GSM1704551,Huh7 cells,Huh7,145,Huh7,NA,2731,145,2683,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1236,GSM1704552,Huh7 cells,Huh7,145,Huh7,NA,2732,145,2684,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1237,GSM1704553,Huh7 cells,Huh7,145,Huh7,NA,2733,145,2685,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1238,GSM1704554,Huh7 cells,Huh7,145,Huh7,NA,2734,145,2686,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1239,GSM1704555,Huh7 cells,Huh7,145,Huh7,NA,2735,145,2687,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1240,GSM1704556,Huh7 cells,Huh7,145,Huh7,NA,2736,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1241,GSM1704557,Huh7 cells,Huh7,145,Huh7,NA,2737,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1242,GSM1704558,Huh7 cells,Huh7,145,Huh7,NA,2738,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1243,GSM1704559,Huh7 cells,Huh7,145,Huh7,NA,2739,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1244,GSM1704560,Huh7 cells,Huh7,145,Huh7,NA,2740,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: DENV2 (M29095.1)
1245,GSM1704561,Huh7 cells,Huh7,145,Huh7,NA,2741,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 1 | strain: none
1246,GSM1704562,Huh7 cells,Huh7,145,Huh7,NA,2742,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: mRNA-seq | replicate: Rep 1 | strain: none
1247,GSM1704563,Huh7 cells,Huh7,145,Huh7,NA,2743,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1248,GSM1704564,Huh7 cells,Huh7,145,Huh7,NA,2744,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1249,GSM1704565,Huh7 cells,Huh7,145,Huh7,NA,2745,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1250,GSM1704566,Huh7 cells,Huh7,145,Huh7,NA,2746,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1251,GSM1704567,Huh7 cells,Huh7,145,Huh7,NA,2747,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1252,GSM1704568,Huh7 cells,Huh7,145,Huh7,NA,2748,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1253,GSM1704569,Huh7 cells,Huh7,145,Huh7,NA,2749,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1254,GSM1704570,Huh7 cells,Huh7,145,Huh7,NA,2750,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 40 h infection | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1255,GSM1704571,Huh7 cells,Huh7,145,Huh7,NA,2751,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1256,GSM1704572,Huh7 cells,Huh7,145,Huh7,NA,2752,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Interferon treatment | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: DENV2 (M29095.1)
1257,GSM1704573,Huh7 cells,Huh7,145,Huh7,NA,2753,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: cytosol | analysis: mRNA-seq | replicate: Rep 2 | strain: none
1258,GSM1704574,Huh7 cells,Huh7,145,Huh7,NA,2754,145,NA,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: ER | analysis: mRNA-seq | replicate: Rep 2 | strain: none
1259,GSM1704575,Huh7 cells,Huh7,145,Huh7,NA,2755,145,2777,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV1 (EU081230.1)
1260,GSM1704576,Huh7 cells,Huh7,145,Huh7,NA,2756,145,2778,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV1 (EU081230.1)
1261,GSM1704577,Huh7 cells,Huh7,145,Huh7,NA,2757,145,2779,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV1 (EU081230.1)
1262,GSM1704578,Huh7 cells,Huh7,145,Huh7,NA,2758,145,2780,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV1 (EU081230.1)
1263,GSM1704579,Huh7 cells,Huh7,145,Huh7,NA,2759,145,2781,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV1 (EU081230.1)
1264,GSM1704580,Huh7 cells,Huh7,145,Huh7,NA,2760,145,2782,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: none
1265,GSM1704581,Huh7 cells,Huh7,145,Huh7,NA,2761,145,2783,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV1 (EU081230.1)
1266,GSM1704582,Huh7 cells,Huh7,145,Huh7,NA,2762,145,2784,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV1 (EU081230.1)
1267,GSM1704583,Huh7 cells,Huh7,145,Huh7,NA,2763,145,2785,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV1 (EU081230.1)
1268,GSM1704584,Huh7 cells,Huh7,145,Huh7,NA,2764,145,2786,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV1 (EU081230.1)
1269,GSM1704585,Huh7 cells,Huh7,145,Huh7,NA,2765,145,2787,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV1 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV1 (EU081230.1)
1270,GSM1704586,Huh7 cells,Huh7,145,Huh7,NA,2766,145,2788,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: none
1271,GSM1704587,Huh7 cells,Huh7,145,Huh7,NA,2767,145,2789,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV2 (EU081177.1)
1272,GSM1704588,Huh7 cells,Huh7,145,Huh7,NA,2768,145,2790,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV2 (EU081177.1)
1273,GSM1704589,Huh7 cells,Huh7,145,Huh7,NA,2769,145,2791,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV2 (EU081177.1)
1274,GSM1704590,Huh7 cells,Huh7,145,Huh7,NA,2770,145,2792,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV2 (EU081177.1)
1275,GSM1704591,Huh7 cells,Huh7,145,Huh7,NA,2771,145,2793,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 1 | strain: DENV2 (EU081177.1)
1276,GSM1704592,Huh7 cells,Huh7,145,Huh7,NA,2772,145,2794,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV2 (EU081177.1)
1277,GSM1704593,Huh7 cells,Huh7,145,Huh7,NA,2773,145,2795,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV2 (EU081177.1)
1278,GSM1704594,Huh7 cells,Huh7,145,Huh7,NA,2774,145,2796,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV2 (EU081177.1)
1279,GSM1704595,Huh7 cells,Huh7,145,Huh7,NA,2775,145,2797,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV2 (EU081177.1)
1280,GSM1704596,Huh7 cells,Huh7,145,Huh7,NA,2776,145,2798,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV2 infection | compartment: Total cell lysate | analysis: ribosome profiling | replicate: rep 2 | strain: DENV2 (EU081177.1)
1281,GSM1704597,Huh7 cells,Huh7,145,Huh7,NA,2777,145,2755,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV1 (EU081230.1)
1282,GSM1704598,Huh7 cells,Huh7,145,Huh7,NA,2778,145,2756,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV1 (EU081230.1)
1283,GSM1704599,Huh7 cells,Huh7,145,Huh7,NA,2779,145,2757,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV1 (EU081230.1)
1284,GSM1704600,Huh7 cells,Huh7,145,Huh7,NA,2780,145,2758,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV1 (EU081230.1)
1285,GSM1704601,Huh7 cells,Huh7,145,Huh7,NA,2781,145,2759,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV1 (EU081230.1)
1286,GSM1704602,Huh7 cells,Huh7,145,Huh7,NA,2782,145,2760,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: none
1287,GSM1704603,Huh7 cells,Huh7,145,Huh7,NA,2783,145,2761,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV1 (EU081230.1)
1288,GSM1704604,Huh7 cells,Huh7,145,Huh7,NA,2784,145,2762,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV1 (EU081230.1)
1289,GSM1704605,Huh7 cells,Huh7,145,Huh7,NA,2785,145,2763,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV1 (EU081230.1)
1290,GSM1704606,Huh7 cells,Huh7,145,Huh7,NA,2786,145,2764,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV1 (EU081230.1)
1291,GSM1704607,Huh7 cells,Huh7,145,Huh7,NA,2787,145,2765,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV1 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV1 (EU081230.1)
1292,GSM1704608,Huh7 cells,Huh7,145,Huh7,NA,2788,145,2766,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: Uninfected | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: none
1293,GSM1704609,Huh7 cells,Huh7,145,Huh7,NA,2789,145,2767,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV2 (EU081177.1)
1294,GSM1704610,Huh7 cells,Huh7,145,Huh7,NA,2790,145,2768,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV2 (EU081177.1)
1295,GSM1704611,Huh7 cells,Huh7,145,Huh7,NA,2791,145,2769,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV2 (EU081177.1)
1296,GSM1704612,Huh7 cells,Huh7,145,Huh7,NA,2792,145,2770,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV2 (EU081177.1)
1297,GSM1704613,Huh7 cells,Huh7,145,Huh7,NA,2793,145,2771,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 1 | strain: DENV2 (EU081177.1)
1298,GSM1704614,Huh7 cells,Huh7,145,Huh7,NA,2794,145,2772,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 12 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV2 (EU081177.1)
1299,GSM1704615,Huh7 cells,Huh7,145,Huh7,NA,2795,145,2773,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 24 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV2 (EU081177.1)
1300,GSM1704616,Huh7 cells,Huh7,145,Huh7,NA,2796,145,2774,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 48 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV2 (EU081177.1)
1301,GSM1704617,Huh7 cells,Huh7,145,Huh7,NA,2797,145,2775,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 6 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV2 (EU081177.1)
1302,GSM1704618,Huh7 cells,Huh7,145,Huh7,NA,2798,145,2776,GSE69602,Homo sapiens,Huh7,huh7,Huh7,Huh7 cells,cell line: Huh7 cells | protocol: 72 h DENV2 infection | compartment: Total cell lysate | analysis: mRNA-seq | replicate: rep 2 | strain: DENV2 (EU081177.1)
1351,GSM1712271,CRL-1634,CRL-1634,150,CRL-1634,NA,2859,150,2866,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints uninfected fibroblasts,cell type: Primary fibroblasts
1352,GSM1712272,CRL-1634,CRL-1634,150,CRL-1634,NA,2860,150,2867,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints uninfected fibroblasts treated with type 1 interferon,cell type: Primary fibroblasts
1353,GSM1712273,CRL-1634,CRL-1634,150,CRL-1634,NA,2861,150,2868,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints fibroblasts infected with irradiated virus,cell type: Primary fibroblasts
1354,GSM1712274,CRL-1634,CRL-1634,150,CRL-1634,NA,2862,150,2869,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints fibroblasts infected for 5hr,cell type: Primary fibroblasts
1355,GSM1712275,CRL-1634,CRL-1634,150,CRL-1634,NA,2863,150,2870,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints fibroblasts infected for 12hr,cell type: Primary fibroblasts
1356,GSM1712276,CRL-1634,CRL-1634,150,CRL-1634,NA,2864,150,2871,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints fibroblasts infected for 24hr,cell type: Primary fibroblasts
1357,GSM1712277,CRL-1634,CRL-1634,150,CRL-1634,NA,2865,150,2872,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,footprints fibroblasts infected for 72hr,cell type: Primary fibroblasts
1358,GSM1712278,CRL-1634,CRL-1634,150,CRL-1634,NA,2866,150,2859,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA uninfected fibroblasts,cell type: Primary fibroblasts
1359,GSM1712279,CRL-1634,CRL-1634,150,CRL-1634,NA,2867,150,2860,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA uninfected fibroblasts treated with type 1 interferon,cell type: Primary fibroblasts
1360,GSM1712280,CRL-1634,CRL-1634,150,CRL-1634,NA,2868,150,2861,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA fibroblasts infected with irradiated virus,cell type: Primary fibroblasts
1361,GSM1712281,CRL-1634,CRL-1634,150,CRL-1634,NA,2869,150,2862,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA fibroblasts infected for 5hr,cell type: Primary fibroblasts
1362,GSM1712282,CRL-1634,CRL-1634,150,CRL-1634,NA,2870,150,2863,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA fibroblasts infected for 12hr,cell type: Primary fibroblasts
1363,GSM1712283,CRL-1634,CRL-1634,150,CRL-1634,NA,2871,150,2864,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA fibroblasts infected for 24hr,cell type: Primary fibroblasts
1364,GSM1712284,CRL-1634,CRL-1634,150,CRL-1634,NA,2872,150,2865,GSE69906,Homo sapiens,CRL-1634,crl-1634,CRL-1634,mRNA fibroblasts infected for 72hr,cell type: Primary fibroblasts
1377,GSM1712837,SUM159,SUM159,151,SUM159,NA,2873,151,NA,GSE69921,Homo sapiens,SUM159,sum159,SUM159,SUM159 cell line,cell line: SUM159
1378,GSM1712838,SUM159,SUM159,151,SUM159,NA,2874,151,NA,GSE69921,Homo sapiens,SUM159,sum159,SUM159,SUM159 cell line,cell line: SUM159
1379,GSM1712839,SUM159,SUM159,151,SUM159,NA,2875,151,NA,GSE69921,Homo sapiens,SUM159,sum159,SUM159,SUM159 cell line,cell line: SUM159
1380,GSM1712840,MCF10A,MCF10A,152,MCF10A,NA,2876,152,NA,GSE69922,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cell line,cell line: MCF10A
1381,GSM1712841,MCF10A,MCF10A,152,MCF10A,NA,2877,152,NA,GSE69922,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cell line,cell line: MCF10A
1382,GSM1712842,MCF10A,MCF10A,152,MCF10A,NA,2878,152,NA,GSE69922,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cell line,cell line: MCF10A
1383,GSM1712843,MCF7,MCF7,153,MCF7,NA,2879,153,NA,GSE69923,Homo sapiens,MCF7,mcf7,MCF7,MCF7 cell line,cell line: MCF7
1384,GSM1712844,T47D,T47D,153,T47D,NA,2880,153,NA,GSE69923,Homo sapiens,T47D,t47d,T47D,T47D cell line,cell line: T47D
1385,GSM1712845,MDA-MB-231,MDA-MB-231,153,MDA-MB-231,NA,2881,153,NA,GSE69923,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,MDA-MB-231 cell line,cell line: MDA-MB-231
1386,GSM1712846,Hs578t,Hs578t,153,Hs578t,NA,2882,153,NA,GSE69923,Homo sapiens,Hs578t,hs578t,Hs578t,Hs578t cell line,cell line: Hs578t
1387,GSM1712847,MCF7,MCF7,153,MCF7,NA,2883,153,NA,GSE69923,Homo sapiens,MCF7,mcf7,MCF7,MCF7 cell line,cell line: MCF7
1388,GSM1712848,T47D,T47D,153,T47D,NA,2884,153,NA,GSE69923,Homo sapiens,T47D,t47d,T47D,T47D cell line,cell line: T47D
1389,GSM1712849,MDA-MB-231,MDA-MB-231,153,MDA-MB-231,NA,2885,153,NA,GSE69923,Homo sapiens,MDA-MB-231,mda-mb-231,MDA-MB-231,MDA-MB-231 cell line,cell line: MDA-MB-231
1390,GSM1712850,Hs578t,Hs578t,153,Hs578t,NA,2886,153,NA,GSE69923,Homo sapiens,Hs578t,hs578t,Hs578t,Hs578t cell line,cell line: Hs578t
1407,GSM1720803,HEK293,HEK293,156,HEK293,NA,2899,156,2904,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1408,GSM1720804,HEK293,HEK293,156,HEK293,NA,2900,156,2905,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1409,GSM1720805,HEK293,HEK293,156,HEK293,NA,2901,156,2906,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_RocA003,cell line: HEK 293 T-REx cell | treatment: RocA 0.03 uM | molecule: total RNA
1410,GSM1720806,HEK293,HEK293,156,HEK293,NA,2902,156,2907,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_RocA03,cell line: HEK 293 T-REx cell | treatment: RocA 0.3 uM | molecule: total RNA
1411,GSM1720807,HEK293,HEK293,156,HEK293,NA,2903,156,2908,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_RocA3,cell line: HEK 293 T-REx cell | treatment: RocA 3 uM | molecule: total RNA
1412,GSM1720808,HEK293,HEK293,156,HEK293,NA,2904,156,2899,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_rna_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1413,GSM1720809,HEK293,HEK293,156,HEK293,NA,2905,156,2900,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_rna_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1414,GSM1720810,HEK293,HEK293,156,HEK293,NA,2906,156,2901,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_rna_RocA003,cell line: HEK 293 T-REx cell | treatment: RocA 0.03 uM | molecule: total RNA
1415,GSM1720811,HEK293,HEK293,156,HEK293,NA,2907,156,2902,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_rna_RocA03,cell line: HEK 293 T-REx cell | treatment: RocA 0.3 uM | molecule: total RNA
1416,GSM1720812,HEK293,HEK293,156,HEK293,NA,2908,156,2903,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_rna_RocA3,cell line: HEK 293 T-REx cell | treatment: RocA 3 uM | molecule: total RNA
1417,GSM1720813,HEK293,HEK293,156,HEK293,NA,2909,156,NA,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_PP242,cell line: HEK 293 T-REx cell | treatment: PP242 2.5 uM | molecule: total RNA
1418,GSM1720814,HEK293,HEK293,156,HEK293,NA,2910,156,NA,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1419,GSM1720815,HEK293,HEK293,156,HEK293,NA,2911,156,NA,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_DMSO,cell line: HEK 293 T-REx cell | treatment: DMSO | molecule: total RNA
1420,GSM1720816,HEK293,HEK293,156,HEK293,NA,2912,156,NA,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_Hipp001,cell line: HEK 293 T-REx cell | treatment: Hipp 0.01 uM | molecule: total RNA
1421,GSM1720817,HEK293,HEK293,156,HEK293,NA,2913,156,NA,GSE70211,Homo sapiens,HEK293,hek293,HEK293,HEK 293 T-Rex_ribo_Hipp1,cell line: HEK 293 T-REx cell | treatment: Hipp 1 uM | molecule: total RNA
1436,GSM1819217,HEK293,HEK293,763,HEK293,NA,2936,763,2948,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: Rluc control
1437,GSM1819218,HEK293,HEK293,763,HEK293,NA,2937,763,2949,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 WT
1438,GSM1819219,HEK293,HEK293,763,HEK293,NA,2938,763,2950,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 R534H
1439,GSM1819220,HEK293,HEK293,763,HEK293,NA,2939,763,2951,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: Rluc control
1440,GSM1819221,HEK293,HEK293,763,HEK293,NA,2940,763,2952,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 WT
1441,GSM1819222,HEK293,HEK293,763,HEK293,NA,2941,763,2953,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 R534H
1442,GSM1819223,HEK293,HEK293,763,HEK293,NA,2942,763,2954,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: Rluc control
1443,GSM1819224,HEK293,HEK293,763,HEK293,NA,2943,763,2955,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 WT
1444,GSM1819225,HEK293,HEK293,763,HEK293,NA,2944,763,2956,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 R534H
1445,GSM1819226,HEK293,HEK293,763,HEK293,NA,2945,763,2957,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: Rluc control
1446,GSM1819227,HEK293,HEK293,763,HEK293,NA,2946,763,2958,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 WT
1447,GSM1819228,HEK293,HEK293,763,HEK293,NA,2947,763,2959,GSE70802,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 R534H
1448,GSM1819229,HEK293,HEK293,763,HEK293,NA,2948,763,2936,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: Rluc control
1449,GSM1819230,HEK293,HEK293,763,HEK293,NA,2949,763,2937,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 WT
1450,GSM1819231,HEK293,HEK293,763,HEK293,NA,2950,763,2938,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 R534H
1451,GSM1819232,HEK293,HEK293,763,HEK293,NA,2951,763,2939,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: Rluc control
1452,GSM1819233,HEK293,HEK293,763,HEK293,NA,2952,763,2940,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 WT
1453,GSM1819234,HEK293,HEK293,763,HEK293,NA,2953,763,2941,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 R534H
1454,GSM1819235,HEK293,HEK293,763,HEK293,NA,2954,763,2942,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: Rluc control
1455,GSM1819236,HEK293,HEK293,763,HEK293,NA,2955,763,2943,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 WT
1456,GSM1819237,HEK293,HEK293,763,HEK293,NA,2956,763,2944,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: control | expressed protein: DDX3 R534H
1457,GSM1819238,HEK293,HEK293,763,HEK293,NA,2957,763,2945,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: Rluc control
1458,GSM1819239,HEK293,HEK293,763,HEK293,NA,2958,763,2946,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 WT
1459,GSM1819240,HEK293,HEK293,763,HEK293,NA,2959,763,2947,GSE70803,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell type: Embryonic kidney | cell line: HEK293-Flp-In-T-Rex | gender: female | treatment: sodium arsenite | expressed protein: DDX3 R534H
1472,GSM1844755,CHL-1,CHL-1,164,CHL-1,NA,2985,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: CRISPR SNORD50A/B
1473,GSM1844756,CHL-1,CHL-1,164,CHL-1,NA,2986,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: CRISPR SNORD50A/B - rRNA removed
1474,GSM1844757,CHL-1,CHL-1,164,CHL-1,NA,2987,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: CHL-1
1475,GSM1844758,CHL-1,CHL-1,164,CHL-1,NA,2988,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: CHL-1 rRNA removed
1476,GSM1844759,CHL-1,CHL-1,164,CHL-1,NA,2989,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: 10mM AZC + MG132
1477,GSM1844760,CHL-1,CHL-1,164,CHL-1,NA,2990,164,NA,GSE71763,Homo sapiens,CHL-1,chl-1,CHL-1,CHL-1 melanoma cells,cell line: CHL-1 | cell type: melanoma cell line | treatment: 10mM AZC + MG132 - rRNA removed
2822,GSM2601309,LCL,LCL,165,LCL,NA,3001,165,NA,GSE71808,Homo sapiens,LCL,lcl,LCL,HapMap,gender: Female | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | cell line: GM19127
2823,GSM2601310,LCL,LCL,165,LCL,NA,3002,165,NA,GSE71808,Homo sapiens,LCL,lcl,LCL,HapMap,gender: Female | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | cell line: GM19137
2824,GSM2601311,LCL,LCL,165,LCL,NA,3003,165,NA,GSE71808,Homo sapiens,LCL,lcl,LCL,HapMap,gender: Male | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | cell line: GM19144
2825,GSM2601312,LCL,LCL,165,LCL,NA,3004,165,NA,GSE71808,Homo sapiens,LCL,lcl,LCL,HapMap,gender: Female | cell type: Lymphoblastoid Cell Line | enrichment type: ribosome protected fragments | cell line: GM19147
1478,GSM1847235,MCF7,MCF7,166,MCF7,NA,3005,166,NA,GSE71893,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1479,GSM1847236,MCF7,MCF7,166,MCF7,NA,3006,166,NA,GSE71893,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1480,GSM1847237,MCF7,MCF7,166,MCF7,NA,3007,166,NA,GSE71893,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1481,GSM1847238,MCF7,MCF7,166,MCF7,NA,3008,166,NA,GSE71893,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1482,GSM1847239,HCT116,HCT116,166,HCT116,NA,3009,166,NA,GSE71893,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1483,GSM1847240,HCT116,HCT116,166,HCT116,NA,3010,166,NA,GSE71893,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1484,GSM1847241,HCT116,HCT116,166,HCT116,NA,3011,166,NA,GSE71893,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1485,GSM1847242,HCT116,HCT116,166,HCT116,NA,3012,166,NA,GSE71893,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1486,GSM1847243,MCF7,MCF7,167,MCF7,NA,3013,167,NA,GSE71895,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1487,GSM1847244,MCF7,MCF7,167,MCF7,NA,3014,167,NA,GSE71895,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1488,GSM1847245,MCF7,MCF7,167,MCF7,NA,3015,167,NA,GSE71895,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1489,GSM1847246,MCF7,MCF7,167,MCF7,NA,3016,167,NA,GSE71895,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1490,GSM1847247,HCT116,HCT116,167,HCT116,NA,3017,167,NA,GSE71895,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1491,GSM1847248,HCT116,HCT116,167,HCT116,NA,3018,167,NA,GSE71895,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1492,GSM1847249,HCT116,HCT116,167,HCT116,NA,3019,167,NA,GSE71895,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1493,GSM1847250,HCT116,HCT116,167,HCT116,NA,3020,167,NA,GSE71895,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1494,GSM1847259,MCF7,MCF7,169,MCF7,NA,3029,169,NA,GSE71900,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1495,GSM1847260,MCF7,MCF7,169,MCF7,NA,3030,169,NA,GSE71900,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, Akti-1/2 treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 Low
1496,GSM1847261,MCF7,MCF7,169,MCF7,NA,3031,169,NA,GSE71900,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1497,GSM1847262,MCF7,MCF7,169,MCF7,NA,3032,169,NA,GSE71900,Homo sapiens,MCF7,mcf7,MCF7,"MCF7 breast adenocarcinoma cells, DMSO treated",cell line: MCF7 | cell type: breast adenocarcinoma | cell state: AKT1 WT
1498,GSM1847263,HCT116,HCT116,169,HCT116,NA,3033,169,NA,GSE71900,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1499,GSM1847264,HCT116,HCT116,169,HCT116,NA,3034,169,NA,GSE71900,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, Akti-1/2 treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 Low
1500,GSM1847265,HCT116,HCT116,169,HCT116,NA,3035,169,NA,GSE71900,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1501,GSM1847266,HCT116,HCT116,169,HCT116,NA,3036,169,NA,GSE71900,Homo sapiens,HCT116,hct116,HCT116,"HCT116 colon carcinoma cells, DMSO treated",cell line: HCT116 | cell type: colon carcinoma | cell state: AKT1 WT
1550,GSM1887643,HEK293,HEK293,180,HEK293,NA,3138,180,NA,GSE73136,Homo sapiens,HEK293,hek293,HEK293,HEK293,cell line: HEK293
1551,GSM1890535,keratinocyte,keratinocyte,181,keratinocyte,NA,3139,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Undifferentiated normal human keratinocytes,cell type: keratinocyte | treatment: undifferentiated | time: control
1552,GSM1890536,keratinocyte,keratinocyte,181,keratinocyte,NA,3140,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Keratinocytes differentiated in 1.3mM Ca2+ for 24 hours,cell type: keratinocyte | treatment: differentiated in 1.3mM Ca2+ | time: 24 hours
1553,GSM1890537,keratinocyte,keratinocyte,181,keratinocyte,NA,3141,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Keratinocytes differentiated in 1.3mM Ca2+ for 48 hours,cell type: keratinocyte | treatment: differentiated in 1.3mM Ca2+ | time: 48 hours
1554,GSM1890538,keratinocyte,keratinocyte,181,keratinocyte,NA,3142,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Keratinocytes differentiated in 1.3mM Ca2+ for 72 hours,cell type: keratinocyte | treatment: differentiated in 1.3mM Ca2+ | time: 72 hours
1555,GSM1890539,keratinocyte,keratinocyte,181,keratinocyte,NA,3143,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Keratinocytes differentiated in 1.3mM Ca2+ for 96 hours,cell type: keratinocyte | treatment: differentiated in 1.3mM Ca2+ | time: 96 hours
1556,GSM1890540,keratinocyte,keratinocyte,181,keratinocyte,NA,3144,181,NA,GSE73305,Homo sapiens,keratinocyte,keratinocyte,keratinocyte,Keratinocytes differentiated in 1.3mM Ca2+ for 120 hours,cell type: keratinocyte | treatment: differentiated in 1.3mM Ca2+ | time: 120 hours
1661,GSM1898006,HeLa S3,HeLa S3,185,HeLa S3,NA,3261,185,3265,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: Total mRNA (RNA-seq)
1662,GSM1898007,HeLa S3,HeLa S3,185,HeLa S3,NA,3262,185,3266,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: Total mRNA (RNA-seq)
1663,GSM1898008,HeLa S3,HeLa S3,185,HeLa S3,NA,3263,185,3267,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: Total mRNA (RNA-seq)
1664,GSM1898009,HeLa S3,HeLa S3,185,HeLa S3,NA,3264,185,3268,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_RNA-Seq Exp2,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: Total mRNA (RNA-seq)
1665,GSM1898010,HeLa S3,HeLa S3,185,HeLa S3,NA,3265,185,3261,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1666,GSM1898011,HeLa S3,HeLa S3,185,HeLa S3,NA,3266,185,3262,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1667,GSM1898012,HeLa S3,HeLa S3,185,HeLa S3,NA,3267,185,3263,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1668,GSM1898013,HeLa S3,HeLa S3,185,HeLa S3,NA,3268,185,3264,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_M_Ribo-Seq Exp2,cell type: HeLa S3 cells | cell cycle phase: M phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1669,GSM1898014,HeLa S3,HeLa S3,185,HeLa S3,NA,3269,185,3273,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: Total mRNA (RNA-seq)
1670,GSM1898015,HeLa S3,HeLa S3,185,HeLa S3,NA,3270,185,3274,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: Total mRNA (RNA-seq)
1671,GSM1898016,HeLa S3,HeLa S3,185,HeLa S3,NA,3271,185,3275,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_RNA-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: Total mRNA (RNA-seq)
1672,GSM1898017,HeLa S3,HeLa S3,185,HeLa S3,NA,3272,185,3276,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_RNA-Seq Exp2,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: Total mRNA (RNA-seq)
1673,GSM1898018,HeLa S3,HeLa S3,185,HeLa S3,NA,3273,185,3269,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1674,GSM1898019,HeLa S3,HeLa S3,185,HeLa S3,NA,3274,185,3270,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1675,GSM1898020,HeLa S3,HeLa S3,185,HeLa S3,NA,3275,185,3271,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_Ribo-Seq Exp1,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1676,GSM1898021,HeLa S3,HeLa S3,185,HeLa S3,NA,3276,185,3272,GSE73565,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3_G1_Ribo-Seq Exp2,cell type: HeLa S3 cells | cell cycle phase: G1 phase | molecule subtype: ribosome-protected fragments  (Ribo-seq)
1716,GSM1916181,Jurkat T-lymphocytes,Jurkat T-lymphocytes,766,Jurkat T-lymphocytes,NA,14896,766,NA,GSE74279,Homo sapiens,Jurkat T-lymphocytes,jurkat t-lymphocytes,Jurkat T-lymphocytes,cell line,tissue: peripheral bloodÃ‚Â  | cell_line: Jurkat T-lymphocytesÃ‚Â  | phenotype: Lymphoid-like | sample_type: cell culture | biomaterial_provider: ATCC | age: 14 | Sex: maleÃ‚Â  | cell_type: T Cell/ T LymphocyteÃ‚Â 
1717,GSM1916182,Jurkat T-lymphocytes,Jurkat T-lymphocytes,766,Jurkat T-lymphocytes,NA,14897,766,NA,GSE74279,Homo sapiens,Jurkat T-lymphocytes,jurkat t-lymphocytes,Jurkat T-lymphocytes,cell line,tissue: peripheral bloodÃ‚Â  | cell_line: Jurkat T-lymphocytesÃ‚Â  | phenotype: Lymphoid-like | sample_type: cell culture | biomaterial_provider: ATCC | age: 14 | Sex: maleÃ‚Â  | cell_type: T Cell/ T LymphocyteÃ‚Â 
1718,GSM1918965,CFBE,CFBE,187,CFBE,NA,3314,187,NA,GSE74365,Homo sapiens,CFBE,cfbe,CFBE,Homo sapiens,cell type: CFBE | molecule type: Ribosome protected fragments
1719,GSM1918967,CFBE,CFBE,187,CFBE,NA,3315,187,NA,GSE74365,Homo sapiens,CFBE,cfbe,CFBE,Homo sapiens,cell type: CFBE | molecule type: Ribosome protected fragments
1720,GSM1918969,CFBE,CFBE,187,CFBE,NA,3316,187,NA,GSE74365,Homo sapiens,CFBE,cfbe,CFBE,Homo sapiens,cell type: CFBE | molecule type: Ribosome protected fragments
1721,GSM1921989,PC3,PC3,189,PC3,NA,3347,189,NA,GSE74510,Homo sapiens,PC3,pc3,PC3,PC3 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: PC3 | agent: none
1722,GSM1921990,PC3,PC3,189,PC3,NA,3348,189,NA,GSE74510,Homo sapiens,PC3,pc3,PC3,PC3 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: PC3 | agent: L-Asparaginase
1723,GSM1921991,PC3,PC3,189,PC3,NA,3349,189,NA,GSE74510,Homo sapiens,PC3,pc3,PC3,PC3 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: PC3 | agent: none
1724,GSM1921992,PC3,PC3,189,PC3,NA,3350,189,NA,GSE74510,Homo sapiens,PC3,pc3,PC3,PC3 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: PC3 | agent: L-Asparaginase
1725,GSM1921993,PC3,PC3,189,PC3,NA,3351,189,NA,GSE74510,Homo sapiens,PC3,pc3,PC3,PC3 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: PC3 | agent: L-Asparaginase
1726,GSM1921994,MCF7,MCF7,191,MCF7,NA,3360,191,NA,GSE74511,Homo sapiens,MCF7,mcf7,MCF7,MCF7 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: MCF7 | protocol: sucrose gradient
1727,GSM1921995,MCF7,MCF7,191,MCF7,NA,3361,191,NA,GSE74511,Homo sapiens,MCF7,mcf7,MCF7,MCF7 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: MCF7 | protocol: IP50
1728,GSM1921996,MCF7,MCF7,191,MCF7,NA,3362,191,NA,GSE74511,Homo sapiens,MCF7,mcf7,MCF7,MCF7 cell line,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: MCF7 | protocol: IP50
1729,GSM1921997,SUM159PT,SUM159PT,190,SUM159PT,NA,3352,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1730,GSM1921998,SUM159PT,SUM159PT,190,SUM159PT,NA,3353,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1731,GSM1921999,SUM159PT,SUM159PT,190,SUM159PT,NA,3354,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1732,GSM1922000,SUM159PT,SUM159PT,190,SUM159PT,NA,3355,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1733,GSM1922001,SUM159PT,SUM159PT,190,SUM159PT,NA,3356,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1734,GSM1922002,SUM159PT,SUM159PT,190,SUM159PT,NA,3357,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1735,GSM1922003,SUM159PT,SUM159PT,190,SUM159PT,NA,3358,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1736,GSM1922004,SUM159PT,SUM159PT,190,SUM159PT,NA,3359,190,NA,GSE74512,Homo sapiens,SUM159PT,sum159pt,SUM159PT,SUM159PT,adapter sequence (3'): TGGAATTCTCGGGTGCCAAGGAACTCCAGTCACATCACGATCTCGTATGCCGTCTTCTGCTTG | cell line: SUM159PT
1826,GSM1948925,GM19204,GM_tissue,198,GM_tissue,NA,3497,198,NA,GSE75290,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,HapMap Lymphoblastoid Cell Line,gender: Female | cell line: GM19204 | enrichment type: ribosome protected fragments
1827,GSM1948926,GM19238,GM_tissue,198,GM_tissue,NA,3498,198,NA,GSE75290,Homo sapiens,GM_tissue,gm_tissue,GM_tissue,HapMap Lymphoblastoid Cell Line,gender: Female | cell line: GM19238 | enrichment type: ribosome protected fragments
1828,GSM1970518,SH-SY5Y neuroblastoma,SH-SY5Y,200,SH-SY5Y,NA,3502,200,NA,GSE75947,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuroblastoma cells,cell type: SH-SY5Y neuroblastoma cells
1829,GSM2042808,MCF7,MCF7,204,MCF7,NA,3522,204,NA,GSE77033,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7
1854,GSM2082509,hESC.2,hESC.2,474,hESC.2,NA,3586,474,3598,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/+ control generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.2 | assayed molecule: mRNA
1855,GSM2082510,hESC.2,hESC.2,474,hESC.2,NA,3587,474,3599,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/+ control generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.2 | assayed molecule: mRNA
1856,GSM2082511,hESC.2,hESC.2,474,hESC.2,NA,3588,474,3600,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/- cell line generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.2 | assayed molecule: mRNA
1857,GSM2082512,hESC.2,hESC.2,474,hESC.2,NA,3589,474,3601,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/- cell line generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.2 | assayed molecule: mRNA
1858,GSM2082513,hESC.2,hESC.2,474,hESC.2,NA,3590,474,3602,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2-/- cell line generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.2 | assayed molecule: mRNA
1859,GSM2082514,hESC.2,hESC.2,474,hESC.2,NA,3591,474,3603,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2-/- cell line generated from hESC cell line 2, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.2 | assayed molecule: mRNA
1860,GSM2082515,hESC.3,hESC.3,474,hESC.3,NA,3592,474,3604,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/+ control generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.3 | assayed molecule: mRNA
1861,GSM2082516,hESC.3,hESC.3,474,hESC.3,NA,3593,474,3605,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/+ control generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.3 | assayed molecule: mRNA
1862,GSM2082517,hESC.3,hESC.3,474,hESC.3,NA,3594,474,3606,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/- cell line generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.3 | assayed molecule: mRNA
1863,GSM2082518,hESC.3,hESC.3,474,hESC.3,NA,3595,474,3607,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/- cell line generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.3 | assayed molecule: mRNA
1864,GSM2082519,hESC.3,hESC.3,474,hESC.3,NA,3596,474,3608,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2-/- cell line generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.3 | assayed molecule: mRNA
1865,GSM2082520,hESC.3,hESC.3,474,hESC.3,NA,3597,474,3609,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2-/- cell line generated from hESC cell line 3, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.3 | assayed molecule: mRNA
1866,GSM2082521,hESC.2,hESC.2,474,hESC.2,NA,3598,474,3586,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/+ control generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1867,GSM2082522,hESC.2,hESC.2,474,hESC.2,NA,3599,474,3587,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/+ control generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1868,GSM2082523,hESC.2,hESC.2,474,hESC.2,NA,3600,474,3588,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/- cell line generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1869,GSM2082524,hESC.2,hESC.2,474,hESC.2,NA,3601,474,3589,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2+/- cell line generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1870,GSM2082525,hESC.2,hESC.2,474,hESC.2,NA,3602,474,3590,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2-/- cell line generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1871,GSM2082526,hESC.2,hESC.2,474,hESC.2,NA,3603,474,3591,GSE78959,Homo sapiens,hESC.2,hesc.2,hESC.2,"TSC2-/- cell line generated from hESC cell line 2, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.2 | assayed molecule: Ribosome protected fragments
1872,GSM2082527,hESC.3,hESC.3,474,hESC.3,NA,3604,474,3592,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/+ control generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1873,GSM2082528,hESC.3,hESC.3,474,hESC.3,NA,3605,474,3593,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/+ control generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1874,GSM2082529,hESC.3,hESC.3,474,hESC.3,NA,3606,474,3594,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/- cell line generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1875,GSM2082530,hESC.3,hESC.3,474,hESC.3,NA,3607,474,3595,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2+/- cell line generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/- | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1876,GSM2082531,hESC.3,hESC.3,474,hESC.3,NA,3608,474,3596,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2-/- cell line generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1877,GSM2082532,hESC.3,hESC.3,474,hESC.3,NA,3609,474,3597,GSE78959,Homo sapiens,hESC.3,hesc.3,hESC.3,"TSC2-/- cell line generated from hESC cell line 3, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | parental cell line id: hESC.3 | assayed molecule: Ribosome protected fragments
1878,GSM2082533,15,15,474,15,NA,3610,474,3612,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 15 | assayed molecule: Ribosome protected fragments
1879,GSM2082534,15,15,474,15,NA,3611,474,3613,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 15 | assayed molecule: Ribosome protected fragments
1880,GSM2082535,15,15,474,15,NA,3612,474,3610,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 15 | assayed molecule: mRNA
1881,GSM2082536,15,15,474,15,NA,3613,474,3611,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 15 | assayed molecule: mRNA
1882,GSM2082537,15,15,474,15,NA,3614,474,3616,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 15 | assayed molecule: Ribosome protected fragments
1883,GSM2082538,15,15,474,15,NA,3615,474,3617,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 15 | assayed molecule: Ribosome protected fragments
1884,GSM2082539,15,15,474,15,NA,3616,474,3614,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 15 | assayed molecule: mRNA
1885,GSM2082540,15,15,474,15,NA,3617,474,3615,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 15 | assayed molecule: mRNA
1886,GSM2082541,15,15,474,15,NA,3618,474,3620,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 15 | assayed molecule: Ribosome protected fragments
1887,GSM2082542,15,15,474,15,NA,3619,474,3621,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 15 | assayed molecule: Ribosome protected fragments
1888,GSM2082543,15,15,474,15,NA,3620,474,3618,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 15 | assayed molecule: mRNA
1889,GSM2082544,15,15,474,15,NA,3621,474,3619,GSE78960,Homo sapiens,15,15,15,"TSC2+/+ cells (number 15) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 15 | assayed molecule: mRNA
1890,GSM2082545,16,16,474,16,NA,3622,474,3624,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 16 | assayed molecule: Ribosome protected fragments
1891,GSM2082546,16,16,474,16,NA,3623,474,3625,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 16 | assayed molecule: Ribosome protected fragments
1892,GSM2082547,16,16,474,16,NA,3624,474,3622,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 16 | assayed molecule: mRNA
1893,GSM2082548,16,16,474,16,NA,3625,474,3623,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: AZD-8055 | cell line id: 16 | assayed molecule: mRNA
1894,GSM2082549,16,16,474,16,NA,3626,474,3628,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 16 | assayed molecule: Ribosome protected fragments
1895,GSM2082550,16,16,474,16,NA,3627,474,3629,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 16 | assayed molecule: Ribosome protected fragments
1896,GSM2082551,16,16,474,16,NA,3628,474,3626,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 16 | assayed molecule: mRNA
1897,GSM2082552,16,16,474,16,NA,3629,474,3627,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: DMSO | cell line id: 16 | assayed molecule: mRNA
1898,GSM2082553,16,16,474,16,NA,3630,474,3632,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 16 | assayed molecule: Ribosome protected fragments
1899,GSM2082554,16,16,474,16,NA,3631,474,3633,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 16 | assayed molecule: Ribosome protected fragments
1900,GSM2082555,16,16,474,16,NA,3632,474,3630,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 16 | assayed molecule: mRNA
1901,GSM2082556,16,16,474,16,NA,3633,474,3631,GSE78960,Homo sapiens,16,16,16,"TSC2+/+ cells (number 16) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2+/+ | treatment: Rapamycin | cell line id: 16 | assayed molecule: mRNA
1902,GSM2082557,19,19,474,19,NA,3634,474,3636,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 19 | assayed molecule: Ribosome protected fragments
1903,GSM2082558,19,19,474,19,NA,3635,474,3637,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 19 | assayed molecule: Ribosome protected fragments
1904,GSM2082559,19,19,474,19,NA,3636,474,3634,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 19 | assayed molecule: mRNA
1905,GSM2082560,19,19,474,19,NA,3637,474,3635,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 19 | assayed molecule: mRNA
1906,GSM2082561,19,19,474,19,NA,3638,474,3640,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 19 | assayed molecule: Ribosome protected fragments
1907,GSM2082562,19,19,474,19,NA,3639,474,3641,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 19 | assayed molecule: Ribosome protected fragments
1908,GSM2082563,19,19,474,19,NA,3640,474,3638,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 19 | assayed molecule: mRNA
1909,GSM2082564,19,19,474,19,NA,3641,474,3639,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 19 | assayed molecule: mRNA
1910,GSM2082565,19,19,474,19,NA,3642,474,3644,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 19 | assayed molecule: Ribosome protected fragments
1911,GSM2082566,19,19,474,19,NA,3643,474,3645,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 19 | assayed molecule: Ribosome protected fragments
1912,GSM2082567,19,19,474,19,NA,3644,474,3642,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 19 | assayed molecule: mRNA
1913,GSM2082568,19,19,474,19,NA,3645,474,3643,GSE78960,Homo sapiens,19,19,19,"TSC2-/- cells (number 19) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 19 | assayed molecule: mRNA
1914,GSM2082569,20,20,474,20,NA,3646,474,3648,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 20 | assayed molecule: Ribosome protected fragments
1915,GSM2082570,20,20,474,20,NA,3647,474,3649,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with AZD-8055, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 20 | assayed molecule: Ribosome protected fragments
1916,GSM2082571,20,20,474,20,NA,3648,474,3646,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 20 | assayed molecule: mRNA
1917,GSM2082572,20,20,474,20,NA,3649,474,3647,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with AZD-8055, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: AZD-8055 | cell line id: 20 | assayed molecule: mRNA
1918,GSM2082573,20,20,474,20,NA,3650,474,3652,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 20 | assayed molecule: Ribosome protected fragments
1919,GSM2082574,20,20,474,20,NA,3651,474,3653,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with DMSO, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 20 | assayed molecule: Ribosome protected fragments
1920,GSM2082575,20,20,474,20,NA,3652,474,3650,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 20 | assayed molecule: mRNA
1921,GSM2082576,20,20,474,20,NA,3653,474,3651,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with DMSO, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: DMSO | cell line id: 20 | assayed molecule: mRNA
1922,GSM2082577,20,20,474,20,NA,3654,474,3656,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 20 | assayed molecule: Ribosome protected fragments
1923,GSM2082578,20,20,474,20,NA,3655,474,3657,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with Rapamycin, RPF",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 20 | assayed molecule: Ribosome protected fragments
1924,GSM2082579,20,20,474,20,NA,3656,474,3654,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 20 | assayed molecule: mRNA
1925,GSM2082580,20,20,474,20,NA,3657,474,3655,GSE78960,Homo sapiens,20,20,20,"TSC2-/- cells (number 20) treated with Rapamycin, total RNA",cell type: Embryonic stem cell-derived neurons | genotype/variation: TSC2-/- | treatment: Rapamycin | cell line id: 20 | assayed molecule: mRNA
1954,GSM2097522,HBE,HBE,701,HBE,NA,13801,701,NA,GSE79539,Homo sapiens,HBE,hbe,HBE,HBE,condition: Grown under normal condition | cell line: HBE
1955,GSM2097523,A549,A549,701,A549,NA,13802,701,NA,GSE79539,Homo sapiens,A549,a549,A549,A549,condition: Grown under normal condition | cell line: A549
1956,GSM2097524,H1299,H1299,701,H1299,NA,13803,701,NA,GSE79539,Homo sapiens,H1299,h1299,H1299,H1299,condition: Grown under normal condition | cell line: H1299
1957,GSM2100587,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3903,219,3912,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1958,GSM2100588,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3904,219,3913,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1959,GSM2100589,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3905,219,NA,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1960,GSM2100590,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3906,219,3914,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1961,GSM2100591,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3907,219,3915,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1962,GSM2100592,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3908,219,NA,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1963,GSM2100593,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3909,219,3916,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1964,GSM2100594,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3910,219,3917,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1965,GSM2100595,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3911,219,3918,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1966,GSM2100596,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3912,219,3903,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1967,GSM2100597,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3913,219,3904,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1968,GSM2100598,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3914,219,3906,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1969,GSM2100599,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3915,219,3907,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1970,GSM2100600,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3916,219,3909,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1971,GSM2100601,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3917,219,3910,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1972,GSM2100602,human cervical cancer cell line,human cervical cancer cell line,219,HeLa,,3918,219,3911,GSE79664,Homo sapiens,human cervical cancer cell line,hela,HeLa,HeLa,cell type: human cervical cancer cell line
1973,GSM2103060,U2OS,U2OS,761,U2OS,NA,14837,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1974,GSM2103061,U2OS,U2OS,761,U2OS,NA,14838,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1975,GSM2103062,U2OS,U2OS,761,U2OS,NA,14839,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against PUM1
1976,GSM2103063,U2OS,U2OS,761,U2OS,NA,14840,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against PUM1
1977,GSM2103064,U2OS,U2OS,761,U2OS,NA,14841,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against PUM2
1978,GSM2103065,U2OS,U2OS,761,U2OS,NA,14842,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against PUM2
1979,GSM2103066,U2OS,U2OS,761,U2OS,NA,14843,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: PUM1 plasmid
1980,GSM2103067,U2OS,U2OS,761,U2OS,NA,14844,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: PUM1 plasmid
1981,GSM2103068,U2OS,U2OS,761,U2OS,NA,14845,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: PUM2 plasmid
1982,GSM2103069,U2OS,U2OS,761,U2OS,NA,14846,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: PUM2 plasmid
1983,GSM2103070,U2OS,U2OS,761,U2OS,NA,14847,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control plasmid
1984,GSM2103071,U2OS,U2OS,761,U2OS,NA,14848,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1985,GSM2103072,U2OS,U2OS,761,U2OS,NA,14849,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against NORAD
1986,GSM2103073,U2OS,U2OS,761,U2OS,NA,14850,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA pool against NORAD
1987,GSM2103074,U2OS,U2OS,761,U2OS,NA,14851,761,14857,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1988,GSM2103075,U2OS,U2OS,761,U2OS,NA,14852,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1989,GSM2103076,U2OS,U2OS,761,U2OS,NA,14853,761,14858,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA1 against NORAD
1990,GSM2103077,U2OS,U2OS,761,U2OS,NA,14854,761,14859,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA2 against NORAD
1991,GSM2103078,U2OS,U2OS,761,U2OS,NA,14855,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: NORAD plasmid
1992,GSM2103079,U2OS,U2OS,761,U2OS,NA,14856,761,NA,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: NORAD plasmid
1993,GSM2103080,U2OS,U2OS,761,U2OS,NA,14857,761,14851,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: Control siRNA
1994,GSM2103081,U2OS,U2OS,761,U2OS,NA,14858,761,14853,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA1 against NORAD
1995,GSM2103082,U2OS,U2OS,761,U2OS,NA,14859,761,14854,GSE79804,Homo sapiens,U2OS,u2os,U2OS,U2OS cells,cell line: U2OS | sample treatment: siRNA2 against NORAD
1996,GSM2103083,HeLa,HeLa,761,HeLa,NA,14860,761,NA,GSE79804,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | sample treatment: siRNA buffer
1997,GSM2103084,HeLa,HeLa,761,HeLa,NA,14861,761,NA,GSE79804,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | sample treatment: siRNA pool against NORAD
1998,GSM2103085,HeLa,HeLa,761,HeLa,NA,14862,761,NA,GSE79804,Homo sapiens,HeLa,hela,HeLa,HeLa cells,cell line: HeLa | sample treatment: NORAD plasmid
2005,GSM2113580,HEK293,HEK293,221,HEK293,NA,3964,221,NA,GSE80156,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | tissue: Embryonic Kidney
2009,GSM2113584,HEK293,HEK293,221,HEK293,NA,3968,221,NA,GSE80156,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | tissue: Embryonic Kidney
2010,GSM2113585,HEK293,HEK293,221,HEK293,NA,3969,221,NA,GSE80156,Homo sapiens,HEK293,hek293,HEK293,Human Embryonic Kidney Cells,cell line: HEK293 | tissue: Embryonic Kidney
2078,GSM2175737,CD19+ B,CD19+ B,232,CD19+ B,NA,4138,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: pretreated for 2 minutes with harringtonine
2079,GSM2175738,CD19+ B,CD19+ B,232,CD19+ B,NA,4139,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: pretreated for 5 minutes with harringtonine
2080,GSM2175739,CD19+ B,CD19+ B,232,CD19+ B,NA,4140,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: pretreated for 2 minutes with harringtonine
2081,GSM2175740,CD19+ B,CD19+ B,232,CD19+ B,NA,4141,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: pretreated with cycloheximide
2082,GSM2175742,CD19+ B,CD19+ B,232,CD19+ B,NA,4142,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: pretreated for 2 minutes with harringtonine
2083,GSM2175743,CD19+ B,CD19+ B,232,CD19+ B,NA,4143,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: pretreated for 5 minutes with harringtonine
2084,GSM2175744,CD19+ B,CD19+ B,232,CD19+ B,NA,4144,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: pretreated for 2 minutes with harringtonine
2085,GSM2175745,CD19+ B,CD19+ B,232,CD19+ B,NA,4145,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: pretreated with cycloheximide
2086,GSM2175746,HEK293,HEK293,232,HEK293,NA,4146,232,NA,GSE81802,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney cells,cell type: HEK293 cells | in vitro transformed by: EBV strain B95-8 | treatment: pretreated for 2 minutes with harringtonine
3040,GSM2719989,CD19+ B,CD19+ B,232,CD19+ B,NA,4147,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: None
3041,GSM2719990,CD19+ B,CD19+ B,232,CD19+ B,NA,4148,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain B95-8 | treatment: None
3042,GSM2719991,CD19+ B,CD19+ B,232,CD19+ B,NA,4149,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: None
3043,GSM2719992,CD19+ B,CD19+ B,232,CD19+ B,NA,4150,232,NA,GSE81802,Homo sapiens,CD19+ B,cd19+ b,CD19+ B,B cells,cell type: CD19+ B cells | in vitro transformed by: EBV strain M81 | treatment: None
2090,GSM2186918,A549,A549,238,A549,NA,4254,238,4262,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_uninfected,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: none
2091,GSM2186919,A549,A549,238,A549,NA,4255,238,4263,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_2h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2092,GSM2186920,A549,A549,238,A549,NA,4256,238,4264,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_4h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2093,GSM2186921,A549,A549,238,A549,NA,4257,238,4265,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_8h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2094,GSM2186922,A549,A549,238,A549,NA,4258,238,4266,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_uninfected,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: none
2095,GSM2186923,A549,A549,238,A549,NA,4259,238,4267,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_2h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2096,GSM2186924,A549,A549,238,A549,NA,4260,238,4268,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_4h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2097,GSM2186925,A549,A549,238,A549,NA,4261,238,4269,GSE82232,Homo sapiens,A549,a549,A549,ribosome profiling_8h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2098,GSM2186926,A549,A549,238,A549,NA,4262,238,4254,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_uninfected,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: none
2099,GSM2186927,A549,A549,238,A549,NA,4263,238,4255,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_2h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2100,GSM2186928,A549,A549,238,A549,NA,4264,238,4256,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_4h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2101,GSM2186929,A549,A549,238,A549,NA,4265,238,4257,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_8h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2102,GSM2186930,A549,A549,238,A549,NA,4266,238,4258,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_uninfected,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: none
2103,GSM2186931,A549,A549,238,A549,NA,4267,238,4259,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_2h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2104,GSM2186932,A549,A549,238,A549,NA,4268,238,4260,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_4h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2105,GSM2186933,A549,A549,238,A549,NA,4269,238,4261,GSE82232,Homo sapiens,A549,a549,A549,RNA-seq_8h,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2106,GSM2188849,A549,A549,238,A549,NA,4270,238,NA,GSE82232,Homo sapiens,A549,a549,A549,human lung adenocarcinoma epithelial cells,cell line: A549 | cell type: human lung adenocarcinoma epithelial cells | pathogen: Influenza A | virus strain: A/Puerto Rico/8/1934 H1N1 (PR8)
2159,GSM2204381,HeLa S3,HeLa S3,752,HeLa S3,NA,14691,752,14699,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2160,GSM2204382,HeLa S3,HeLa S3,752,HeLa S3,NA,14692,752,14700,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2161,GSM2204383,HeLa S3,HeLa S3,752,HeLa S3,NA,14693,752,14701,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2162,GSM2204384,HeLa S3,HeLa S3,752,HeLa S3,NA,14694,752,14702,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2163,GSM2204385,HeLa S3,HeLa S3,752,HeLa S3,NA,14695,752,14703,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2164,GSM2204386,HeLa S3,HeLa S3,752,HeLa S3,NA,14696,752,14704,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2165,GSM2204387,HeLa S3,HeLa S3,752,HeLa S3,NA,14697,752,14705,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2166,GSM2204388,HeLa S3,HeLa S3,752,HeLa S3,NA,14698,752,14706,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2167,GSM2204389,HeLa S3,HeLa S3,752,HeLa S3,NA,14699,752,14691,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2168,GSM2204390,HeLa S3,HeLa S3,752,HeLa S3,NA,14700,752,14692,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2169,GSM2204391,HeLa S3,HeLa S3,752,HeLa S3,NA,14701,752,14693,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2170,GSM2204392,HeLa S3,HeLa S3,752,HeLa S3,NA,14702,752,14694,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: untreated
2171,GSM2204393,HeLa S3,HeLa S3,752,HeLa S3,NA,14703,752,14695,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2172,GSM2204394,HeLa S3,HeLa S3,752,HeLa S3,NA,14704,752,14696,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2173,GSM2204395,HeLa S3,HeLa S3,752,HeLa S3,NA,14705,752,14697,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2174,GSM2204396,HeLa S3,HeLa S3,752,HeLa S3,NA,14706,752,14698,GSE83493,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3,treatment: treated with Dox to induce knockdown
2218,GSM2280380,WM902B,WM902B,793,WM902B,NA,15218,793,15240,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR
2219,GSM2280381,WM902B,WM902B,793,WM902B,NA,15219,793,15241,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shSCR
2220,GSM2280382,WM902B,WM902B,793,WM902B,NA,15220,793,15242,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR
2221,GSM2280383,WM902B,WM902B,793,WM902B,NA,15221,793,15243,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,primary melanoma cell line WM902B,cell type: primary melanoma cell line | passage: 18 | melanoma mutation: BRAFV600E | infected shrna: shTINCR
2222,GSM2280384,WM902B,WM902B,793,WM902B,NA,15222,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shSCR expressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shSCR
2223,GSM2280385,WM902B,WM902B,793,WM902B,NA,15223,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shSCR expressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shSCR
2224,GSM2280386,WM902B,WM902B,793,WM902B,NA,15224,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shSCR expressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shSCR
2225,GSM2280387,WM902B,WM902B,793,WM902B,NA,15225,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shTINCRexpressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shTINCR
2226,GSM2280388,WM902B,WM902B,793,WM902B,NA,15226,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shTINCR expressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shTINCR
2227,GSM2280389,WM902B,WM902B,793,WM902B,NA,15227,793,NA,GSE85656,Homo sapiens,WM902B,wm902b,WM902B,mouse tumor  derived from  shTINCR expressing  WM902B cells,cell type: primary melanoma cell line derived xenograft tumors | melanoma mutation: BRAFV600E | infected shrna: shTINCR
2228,GSM2280390,,,793,metastasis of cutaneous melanoma,,15228,793,NA,GSE85656,Homo sapiens,,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,cell type: Metastatic melanoma clinical specimen
2229,GSM2280391,,,793,metastasis of cutaneous melanoma,,15229,793,NA,GSE85656,Homo sapiens,,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,cell type: Metastatic melanoma clinical specimen
2230,GSM2280392,,,793,metastasis of cutaneous melanoma,,15230,793,NA,GSE85656,Homo sapiens,,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,cell type: Metastatic melanoma clinical specimen
2231,GSM2280393,,,793,metastasis of cutaneous melanoma,,15231,793,NA,GSE85656,Homo sapiens,,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,cell type: Metastatic melanoma clinical specimen
2232,GSM2280394,,,793,metastasis of cutaneous melanoma,,15232,793,NA,GSE85656,Homo sapiens,,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,metastasis of cutaneous melanoma,cell type: Metastatic melanoma clinical specimen
2233,GSM2280395,,,793,Primary cutaneous  melanoma,,15233,793,NA,GSE85656,Homo sapiens,,Primary cutaneous  melanoma,Primary cutaneous  melanoma,Primary cutaneous  melanoma,cell type: Primary cutaneous melanoma specimen
2234,GSM2280396,,,793,Primary cutaneous  melanoma,,15234,793,NA,GSE85656,Homo sapiens,,Primary cutaneous  melanoma,Primary cutaneous  melanoma,Primary cutaneous  melanoma,cell type: Primary cutaneous melanoma specimen
2235,GSM2280397,,,793,Primary cutaneous  melanoma,,15235,793,NA,GSE85656,Homo sapiens,,Primary cutaneous  melanoma,Primary cutaneous  melanoma,Primary cutaneous  melanoma,cell type: Primary cutaneous melanoma specimen
2236,GSM2280398,,,793,Primary cutaneous  melanoma,,15236,793,NA,GSE85656,Homo sapiens,,Primary cutaneous  melanoma,Primary cutaneous  melanoma,Primary cutaneous  melanoma,cell type: Primary cutaneous melanoma specimen
2237,GSM2280399,,,793,Benign Nevus,,15237,793,NA,GSE85656,Homo sapiens,,Benign Nevus,Benign Nevus,Benign Nevus,cell type: Benign Nevus specimen
2238,GSM2280400,,,793,Benign Nevus,,15238,793,NA,GSE85656,Homo sapiens,,Benign Nevus,Benign Nevus,Benign Nevus,cell type: Benign Nevus  specimen
2239,GSM2280401,,,793,Benign Nevus,,15239,793,NA,GSE85656,Homo sapiens,,Benign Nevus,Benign Nevus,Benign Nevus,cell type: Benign Nevus  specimen
2240,GSM2285896,Platelet,Platelet,256,Platelet,NA,4578,256,NA,GSE85864,Homo sapiens,Platelet,platelet,Platelet,platelet,cell type: primary cell type | drug treatment: vehicle | rrna depletion: RiboZero-Gold rRNA depletion
2241,GSM2285897,Platelet,Platelet,256,Platelet,NA,4579,256,NA,GSE85864,Homo sapiens,Platelet,platelet,Platelet,platelet,cell type: primary cell type | drug treatment: 0.01U/ml thrombin for 60 min at 37C - replicate 1 | rrna depletion: RiboZero-Gold rRNA depletion
2242,GSM2285898,Platelet,Platelet,256,Platelet,NA,4580,256,NA,GSE85864,Homo sapiens,Platelet,platelet,Platelet,platelet,cell type: primary cell type | drug treatment: 0.01U/ml thrombin for 60 min at 37C - replicate 2 | rrna depletion: RiboZero-Gold rRNA depletion
2243,GSM2285899,Reticulocyte,Reticulocyte,256,Reticulocyte,NA,4581,256,NA,GSE85864,Homo sapiens,Reticulocyte,reticulocyte,Reticulocyte,reticulocyte,cell type: primary cell type | rrna depletion: RiboZero-Gold rRNA depletion
2244,GSM2285900,Reticulocyte,Reticulocyte,256,Reticulocyte,NA,4582,256,NA,GSE85864,Homo sapiens,Reticulocyte,reticulocyte,Reticulocyte,reticulocyte,cell type: primary cell type | rrna depletion: RiboZero-Gold rRNA depletion
2245,GSM2285901,Reticulocyte,Reticulocyte,256,Reticulocyte,NA,4583,256,NA,GSE85864,Homo sapiens,Reticulocyte,reticulocyte,Reticulocyte,reticulocyte,cell type: primary cell type | rrna depletion: Globin RNA depletion
2246,GSM2285902,Reticulocyte,Reticulocyte,256,Reticulocyte,NA,4584,256,NA,GSE85864,Homo sapiens,Reticulocyte,reticulocyte,Reticulocyte,reticulocyte,cell type: primary cell type | rrna depletion: Globin RNA depletion
2247,GSM2285909,Meg01 cells,Meg01,256,Meg01,NA,4591,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2248,GSM2285910,Meg01 cells,Meg01,256,Meg01,NA,4592,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2249,GSM2285911,Meg01 cells,Meg01,256,Meg01,NA,4593,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2250,GSM2285912,K562,K562,256,K562,NA,4594,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2251,GSM2285913,K562,K562,256,K562,NA,4595,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2252,GSM2285914,K562,K562,256,K562,NA,4596,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2253,GSM2285915,K562,K562,256,K562,NA,4597,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2254,GSM2285916,K562,K562,256,K562,NA,4598,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: untreated - 0 days | rrna depletion: RiboZero-Gold rRNA depletion
2255,GSM2285917,K562,K562,256,K562,NA,4599,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 2 days | rrna depletion: RiboZero-Gold rRNA depletion
2256,GSM2285918,K562,K562,256,K562,NA,4600,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 4 days | rrna depletion: RiboZero-Gold rRNA depletion
2257,GSM2285919,K562,K562,256,K562,NA,4606,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 6 days | rrna depletion: RiboZero-Gold rRNA depletion
2258,GSM2285920,K562,K562,256,K562,NA,4601,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: untreated - 0 days | rrna depletion: RiboZero-Gold rRNA depletion
2259,GSM2285921,K562,K562,256,K562,NA,4602,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 2 days | rrna depletion: RiboZero-Gold rRNA depletion
2260,GSM2285922,K562,K562,256,K562,NA,4603,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 4 days | rrna depletion: RiboZero-Gold rRNA depletion
2261,GSM2285923,K562,K562,256,K562,NA,4607,256,NA,GSE85864,Homo sapiens,K562,k562,K562,K562 cells,cell type: cell line | drug treatment: 50 micromolar hemin - 6 days | rrna depletion: RiboZero-Gold rRNA depletion
2262,GSM2285924,Meg01,Meg01,256,Meg01,NA,4604,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2263,GSM2285925,Meg01,Meg01,256,Meg01,NA,4605,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2264,GSM2285926,Meg01,Meg01,256,Meg01,NA,4608,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2265,GSM2285927,Meg01,Meg01,256,Meg01,NA,4609,256,NA,GSE85864,Homo sapiens,Meg01,meg01,Meg01,Meg01 cells,cell type: cell line | rrna depletion: RiboZero-Gold rRNA depletion
2543,GSM2424851,HeLa cells,HeLa,259,HeLa,NA,4772,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2544,GSM2424852,HeLa cells,HeLa,259,HeLa,NA,4773,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2545,GSM2424853,HeLa cells,HeLa,259,HeLa,NA,4774,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2546,GSM2424854,HeLa cells,HeLa,259,HeLa,NA,4775,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2547,GSM2424855,HeLa cells,HeLa,259,HeLa,NA,4776,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2548,GSM2424856,HeLa cells,HeLa,259,HeLa,NA,4777,259,NA,GSE86214,Homo sapiens,HeLa,hela,HeLa,HeLa,"cell line: HeLa cells | cell treatment: 40 nM siRNA knockdown for 48 hr, then 100 ug/ml Cycloheximide (CHX) incubation"
2383,GSM2327825,HCT116,HCT116,263,HCT116,NA,4824,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2384,GSM2327826,HCT116,HCT116,263,HCT116,NA,4825,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2385,GSM2327827,HCT116,HCT116,263,HCT116,NA,4826,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2386,GSM2327828,HCT116,HCT116,263,HCT116,NA,4827,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2387,GSM2327829,HCT116,HCT116,263,HCT116,NA,4822,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2388,GSM2327830,HCT116,HCT116,263,HCT116,NA,4823,263,NA,GSE87328,Homo sapiens,HCT116,hct116,HCT116,colorectal carcinoma cell line,tissue: colon | cell line: HCT116Ã‚Â  | phenotype: colorectal carcinoma
2447,GSM2360167,Erythroid,Erythroid,273,Erythroid,NA,4964,273,4972,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPL5 knockdown
2448,GSM2360168,Erythroid,Erythroid,273,Erythroid,NA,4965,273,4973,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPL5 knockdown
2449,GSM2360169,Erythroid,Erythroid,273,Erythroid,NA,4966,273,4974,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPS19 knockdown
2450,GSM2360170,Erythroid,Erythroid,273,Erythroid,NA,4967,273,4975,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPS19 knockdown
2451,GSM2360171,Erythroid,Erythroid,273,Erythroid,NA,4968,273,NA,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: TSR2 knockdown
2452,GSM2360172,Erythroid,Erythroid,273,Erythroid,NA,4969,273,NA,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: TSR2 knockdown
2453,GSM2360173,Erythroid,Erythroid,273,Erythroid,NA,4970,273,4976,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: Luc knockdown (control)
2454,GSM2360174,Erythroid,Erythroid,273,Erythroid,NA,4971,273,4977,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: Luc knockdown (control)
2455,GSM2360175,Erythroid,Erythroid,273,Erythroid,NA,4972,273,4964,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPL5 knockdown
2456,GSM2360176,Erythroid,Erythroid,273,Erythroid,NA,4973,273,4965,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPL5 knockdown
2457,GSM2360177,Erythroid,Erythroid,273,Erythroid,NA,4974,273,4966,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPS19 knockdown
2458,GSM2360178,Erythroid,Erythroid,273,Erythroid,NA,4975,273,4967,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: RPS19 knockdown
2459,GSM2360179,Erythroid,Erythroid,273,Erythroid,NA,4976,273,4970,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: Luc knockdown (control)
2460,GSM2360180,Erythroid,Erythroid,273,Erythroid,NA,4977,273,4971,GSE89183,Homo sapiens,Erythroid,erythroid,Erythroid,CD34+ hematopoietic cells,cell type: Erythroid cells | day: 7 | modulation: Luc knockdown (control)
2502,GSM2402496,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5139,279,5145,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2503,GSM2402497,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5140,279,5146,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2504,GSM2402498,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5141,279,5147,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2505,GSM2402499,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5142,279,5148,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2506,GSM2402500,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5143,279,5149,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2507,GSM2402501,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5144,279,5150,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2508,GSM2402502,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5145,279,5139,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2509,GSM2402503,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5146,279,5140,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2510,GSM2402504,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5147,279,5141,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,control dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
2511,GSM2402505,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5148,279,5142,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2512,GSM2402506,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5149,279,5143,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2513,GSM2402507,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,5150,279,5144,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,Parkinson's Disease patient-derived dopamine neurons,strain: -- | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
2567,GSM2445294,Flp-In T-REx-293,Flp-In T-REx-293,283,Flp-In T-REx-293,NA,5169,283,NA,GSE93133,Homo sapiens,Flp-In T-REx-293,flp-in t-rex-293,Flp-In T-REx-293,Flp-In T-REx-293,genotype: wild type | tissue: Kidney | cell line: Flp-In T-REx-293
2568,GSM2445295,Flp-In T-REx-293,Flp-In T-REx-293,283,Flp-In T-REx-293,NA,5170,283,NA,GSE93133,Homo sapiens,Flp-In T-REx-293,flp-in t-rex-293,Flp-In T-REx-293,Flp-In T-REx-293,genotype: wild type | tissue: Kidney | cell line: Flp-In T-REx-293
2569,GSM2445296,Flp-In T-REx-293,Flp-In T-REx-293,283,Flp-In T-REx-293,NA,5171,283,NA,GSE93133,Homo sapiens,Flp-In T-REx-293,flp-in t-rex-293,Flp-In T-REx-293,Flp-In T-REx-293,genotype: METTL21B knockout | tissue: Kidney | cell line: Flp-In T-REx-293
2570,GSM2445297,Flp-In T-REx-293,Flp-In T-REx-293,283,Flp-In T-REx-293,NA,5172,283,NA,GSE93133,Homo sapiens,Flp-In T-REx-293,flp-in t-rex-293,Flp-In T-REx-293,Flp-In T-REx-293,genotype: METTL21B knockout | tissue: Kidney | cell line: Flp-In T-REx-293
2571,GSM2474455,MEG-01,MEG-01,287,MEG-01,NA,5253,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet,tissue: primary cell type | rrna depletion: RiboZero-Gold rRNA depletion
2572,GSM2474456,MEG-01,MEG-01,287,MEG-01,NA,5254,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet,tissue: primary cell type | rrna depletion: RiboZero-Gold rRNA depletion
2573,GSM2474457,MEG-01,MEG-01,287,MEG-01,NA,5255,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2574,GSM2474458,MEG-01,MEG-01,287,MEG-01,NA,5256,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2575,GSM2474459,MEG-01,MEG-01,287,MEG-01,NA,5257,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2576,GSM2474460,MEG-01,MEG-01,287,MEG-01,NA,5258,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2577,GSM2474461,MEG-01,MEG-01,287,MEG-01,NA,5259,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2578,GSM2474462,MEG-01,MEG-01,287,MEG-01,NA,5260,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2579,GSM2474463,MEG-01,MEG-01,287,MEG-01,NA,5261,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2580,GSM2474464,MEG-01,MEG-01,287,MEG-01,NA,5262,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2581,GSM2474465,MEG-01,MEG-01,287,MEG-01,NA,5263,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2582,GSM2474466,MEG-01,MEG-01,287,MEG-01,NA,5264,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2583,GSM2474467,MEG-01,MEG-01,287,MEG-01,NA,5265,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2584,GSM2474468,MEG-01,MEG-01,287,MEG-01,NA,5266,287,NA,GSE94384,Homo sapiens,MEG-01,meg-01,MEG-01,platelet-like particle (PLP),tissue: cell line | drug treatment: 0.05ng Promega Firefly luciferase per 100ng Total RNA | rrna depletion: RiboZero-Gold rRNA depletion
2592,GSM2475997,Huh7,Huh7,289,Huh7,NA,5274,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2593,GSM2475998,Huh7,Huh7,289,Huh7,NA,5275,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2594,GSM2475999,Huh7,Huh7,289,Huh7,NA,5276,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2595,GSM2476000,Huh7,Huh7,289,Huh7,NA,5277,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2596,GSM2476001,Huh7,Huh7,289,Huh7,NA,5278,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2597,GSM2476002,Huh7,Huh7,289,Huh7,NA,5279,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2598,GSM2476003,Huh7,Huh7,289,Huh7,NA,5280,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2599,GSM2476004,Huh7,Huh7,289,Huh7,NA,5281,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2600,GSM2476005,Huh7,Huh7,289,Huh7,NA,5282,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_10 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 10 min | library type: ribo-seq
2601,GSM2476006,Huh7,Huh7,289,Huh7,NA,5283,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2602,GSM2476007,Huh7,Huh7,289,Huh7,NA,5284,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2603,GSM2476008,Huh7,Huh7,289,Huh7,NA,5285,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2604,GSM2476009,Huh7,Huh7,289,Huh7,NA,5286,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2605,GSM2476010,Huh7,Huh7,289,Huh7,NA,5287,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2606,GSM2476011,Huh7,Huh7,289,Huh7,NA,5288,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_0.3 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.3 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2607,GSM2476012,Huh7,Huh7,289,Huh7,NA,5289,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2608,GSM2476013,Huh7,Huh7,289,Huh7,NA,5290,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2609,GSM2476014,Huh7,Huh7,289,Huh7,NA,5291,289,NA,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2610,GSM2476015,Huh7,Huh7,289,Huh7,NA,5292,289,5296,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2611,GSM2476016,Huh7,Huh7,289,Huh7,NA,5293,289,5297,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_Veh_60 min_Ribo-seq,cell line: Huh7 | [pf-06446846]: 0 Ã‚ÂµM | treatment time: 60 min | library type: Ribo-seq
2612,GSM2476017,Huh7,Huh7,289,Huh7,NA,5294,289,5298,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_1.5 Ã‚ÂµM PF-067446846_60 min_ribo-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: ribo-seq
2613,GSM2476018,Huh7,Huh7,289,Huh7,NA,5295,289,5299,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehcile_60 min_Ribo-seq,cell line: Huh7 | [pf-06446846]: 0 Ã‚ÂµM | treatment time: 60 min | library type: Ribo-seq
2614,GSM2476019,Huh7,Huh7,289,Huh7,NA,5296,289,5292,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_PF-06446846_60 min_mRNA-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: mRNA-seq
2615,GSM2476020,Huh7,Huh7,289,Huh7,NA,5297,289,5293,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_60 min_RNA-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 60 min | library type: polyA-seq
2616,GSM2476021,Huh7,Huh7,289,Huh7,NA,5298,289,5294,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_PF-06446846_60 min_mRNA-seq,cell line: Huh7 | [pf-06446846]: 1.5 Ã‚ÂµM | treatment time: 60 min | library type: mRNA-seq
2617,GSM2476022,Huh7,Huh7,289,Huh7,NA,5299,289,5295,GSE94454,Homo sapiens,Huh7,huh7,Huh7,Huh7_vehicle_60 min_RNA-seq,cell line: Huh7 | [pf-06446846]: 0.0 Ã‚ÂµM | treatment time: 60 min | library type: polyA-seq
2618,GSM2476121,HEK293,HEK293,290,HEK293,NA,5300,290,NA,GSE94460,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cell line,cell line: HEK293
2619,GSM2476122,HEK293,HEK293,290,HEK293,NA,5301,290,NA,GSE94460,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cell line,cell line: HEK293
3352,GSM2867900,HEK293,HEK293,290,HEK293,NA,5302,290,NA,GSE94460,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293
2620,GSM2481046,MOLM-13,MOLM-13,291,MOLM-13,NA,5303,291,5309,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: TGACCA | genotype/variation: Scramble shRNA | time: Day 5
2621,GSM2481047,MOLM-13,MOLM-13,291,MOLM-13,NA,5304,291,5310,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: TAGCTT | genotype/variation: Scramble shRNA | time: Day 8
2622,GSM2481048,MOLM-13,MOLM-13,291,MOLM-13,NA,5305,291,5311,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: ACAGTG | genotype/variation: METTL3 KD1 shRNA | time: Day 5
2623,GSM2481049,MOLM-13,MOLM-13,291,MOLM-13,NA,5306,291,5312,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GGCTAC | genotype/variation: METTL3 KD1 shRNA | time: Day 8
2624,GSM2481050,MOLM-13,MOLM-13,291,MOLM-13,NA,5307,291,5313,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GCCAAT | genotype/variation: METTL3 KD2 shRNA | time: Day 5
2625,GSM2481051,MOLM-13,MOLM-13,291,MOLM-13,NA,5308,291,5314,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: CTTGTA | genotype/variation: METTL3 KD2 shRNA | time: Day 8
2626,GSM2481052,MOLM-13,MOLM-13,291,MOLM-13,NA,5309,291,5303,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: ATCACG | genotype/variation: Scramble shRNA | time: Day 5
2627,GSM2481053,MOLM-13,MOLM-13,291,MOLM-13,NA,5310,291,5304,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: CAGATC | genotype/variation: Scramble shRNA | time: Day 8
2628,GSM2481054,MOLM-13,MOLM-13,291,MOLM-13,NA,5311,291,5305,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: CGATGT | genotype/variation: METTL3 KD1 shRNA | time: Day 5
2629,GSM2481055,MOLM-13,MOLM-13,291,MOLM-13,NA,5312,291,5306,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: ACTTGA | genotype/variation: METTL3 KD1 shRNA | time: Day 8
2630,GSM2481056,MOLM-13,MOLM-13,291,MOLM-13,NA,5313,291,5307,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: TTAGGC | genotype/variation: METTL3 KD2 shRNA | time: Day 5
2631,GSM2481057,MOLM-13,MOLM-13,291,MOLM-13,NA,5314,291,5308,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GATCAG | genotype/variation: METTL3 KD2 shRNA | time: Day 8
2632,GSM2481058,MOLM-13,MOLM-13,291,MOLM-13,NA,5315,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GTGAAA | genotype/variation: Scramble shRNA | ip antibody: none
2633,GSM2481059,MOLM-13,MOLM-13,291,MOLM-13,NA,5316,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GTGGCC | genotype/variation: Scramble shRNA | ip antibody: none
2634,GSM2481060,MOLM-13,MOLM-13,291,MOLM-13,NA,5317,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GTTTCG | genotype/variation: METTL3 KD1 shRNA | time: Day8 | ip antibody: none
2635,GSM2481061,MOLM-13,MOLM-13,291,MOLM-13,NA,5318,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: CGTACG | genotype/variation: METTL3 KD1 shRNA | time: Day8 | ip antibody: none
2636,GSM2481062,MOLM-13,MOLM-13,291,MOLM-13,NA,5319,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: GAGTGG | genotype/variation: METTL3 KD2 shRNA | time: Day8 | ip antibody: none
2637,GSM2481063,MOLM-13,MOLM-13,291,MOLM-13,NA,5320,291,NA,GSE94613,Homo sapiens,MOLM-13,molm-13,MOLM-13,Whole cell,cell line: leukemia cell line MOLM13 | truseq barcode: TAGCTT | genotype/variation: METTL3 KD2 shRNA | time: Day8 | ip antibody: none
2638,GSM2486191,NCI-H929,NCI-H929,293,NCI-H929,NA,5355,293,NA,GSE94827,Homo sapiens,NCI-H929,nci-h929,NCI-H929,NCI-H929 cell line,cell line: NCI-H929 | cell type: Multiple Myeloma cell line | condition: DMSO-treated
2639,GSM2486192,NCI-H929,NCI-H929,293,NCI-H929,NA,5356,293,NA,GSE94827,Homo sapiens,NCI-H929,nci-h929,NCI-H929,NCI-H929 cell line,cell line: NCI-H929 | cell type: Multiple Myeloma cell line | condition: CMLD010509-treated 50nM 6 hours
2640,GSM2486193,NAMALWA,NAMALWA,293,NAMALWA,NA,5357,293,NA,GSE94827,Homo sapiens,NAMALWA,namalwa,NAMALWA,NAMALWA cell line,cell line: NAMALWA | cell type: Burkitt Lymphoma cell line | condition: DMSO-treated
2641,GSM2486194,NAMALWA,NAMALWA,293,NAMALWA,NA,5358,293,NA,GSE94827,Homo sapiens,NAMALWA,namalwa,NAMALWA,NAMALWA cell line,cell line: NAMALWA | cell type: Burkitt Lymphoma cell line | condition: CMLD010509-treated 50nM 6 hours
2642,GSM2486195,MM1S,MM1.S,293,MM1.S,NA,5359,293,NA,GSE94827,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1S cell line,cell line: MM1S | cell type: Multiple Myeloma cell line | condition: DMSO-treated
2643,GSM2486196,MM1S,MM1.S,293,MM1.S,NA,5360,293,NA,GSE94827,Homo sapiens,MM1.S,mm1.s,MM1.S,MM1S cell line,cell line: MM1S | cell type: Multiple Myeloma cell line | condition: CMLD010509-treated 50nM 6 hours
2644,GSM2486197,OPM2,OPM2,293,OPM2,NA,5361,293,NA,GSE94827,Homo sapiens,OPM2,opm2,OPM2,OPM2 cell line,cell line: OPM2 | cell type: Multiple Myeloma cell line | condition: DMSO-treated
2645,GSM2486198,OPM2,OPM2,293,OPM2,NA,5362,293,NA,GSE94827,Homo sapiens,OPM2,opm2,OPM2,OPM2 cell line,cell line: OPM2 | cell type: Multiple Myeloma cell line | condition: CMLD010509-treated 50nM 6 hours
2646,GSM2486199,U266,U266,293,U266,NA,5363,293,NA,GSE94827,Homo sapiens,U266,u266,U266,U266 cell line,cell line: U266 | cell type: Multiple Myeloma cell line | condition: DMSO-treated
2647,GSM2486200,U266,U266,293,U266,NA,5364,293,NA,GSE94827,Homo sapiens,U266,u266,U266,U266 cell line,cell line: U266 | cell type: Multiple Myeloma cell line | condition: CMLD010509-treated 50nM 6 hours
2739,GSM2537139,MCF7,MCF7,755,MCF7,NA,14715,755,14719,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2740,GSM2537140,MCF7,MCF7,755,MCF7,NA,14716,755,14720,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2741,GSM2537141,MCF7,MCF7,755,MCF7,NA,14717,755,14721,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: CPT
2742,GSM2537142,MCF7,MCF7,755,MCF7,NA,14718,755,14722,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: CPT
2743,GSM2537143,MCF7,MCF7,755,MCF7,NA,14719,755,14715,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2744,GSM2537144,MCF7,MCF7,755,MCF7,NA,14720,755,14716,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2745,GSM2537145,MCF7,MCF7,755,MCF7,NA,14721,755,14717,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: CPT
2746,GSM2537146,MCF7,MCF7,755,MCF7,NA,14722,755,14718,GSE96643,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: CPT
2747,GSM2538879,MCF7,MCF7,754,MCF7,NA,14711,754,14713,GSE96714,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2748,GSM2538882,MCF7,MCF7,754,MCF7,NA,14712,754,14714,GSE96714,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: Nutlin3a
2749,GSM2538884,MCF7,MCF7,754,MCF7,NA,14713,754,14711,GSE96714,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: control
2750,GSM2538886,MCF7,MCF7,754,MCF7,NA,14714,754,14712,GSE96714,Homo sapiens,MCF7,mcf7,MCF7,MCF7,cell line: MCF7 | treatment: Nutlin3a
2751,GSM2538901,PC9,PC9,753,PC9,NA,14707,753,14709,GSE96716,Homo sapiens,PC9,pc9,PC9,PC9,cell line: PC9 | treatment: control
2752,GSM2538902,H1933,H1933,753,H1933,NA,14708,753,14710,GSE96716,Homo sapiens,H1933,h1933,H1933,H1933,cell line: H1933 | treatment: control
2753,GSM2538903,PC9,PC9,753,PC9,NA,14709,753,14707,GSE96716,Homo sapiens,PC9,pc9,PC9,PC9,cell line: PC9 | treatment: control
2754,GSM2538904,H1933,H1933,753,H1933,NA,14710,753,14708,GSE96716,Homo sapiens,H1933,h1933,H1933,H1933,cell line: H1933 | treatment: control
2759,GSM2552191,HAP-1,HAP-1,303,HAP-1,NA,5482,303,5487,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_ribosomal profiling,"commercial name: Horizon Genomics, HZGHC000530c010 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2760,GSM2552192,HAP-1,HAP-1,303,HAP-1,NA,5483,303,5488,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_ribosomal profiling,"commercial name: Horizon Genomics, HZGHC000530c011 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2761,GSM2552193,HAP-1,HAP-1,303,HAP-1,NA,5484,303,5489,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_ribosomal profiling,"commercial name: Horizon Genomics, HZGHC000530c012 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2762,GSM2552196,HAP-1,HAP-1,303,HAP-1,NA,5487,303,5482,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_RNA-seq,"commercial name: Horizon Genomics, HZGHC000530c013 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2763,GSM2552197,HAP-1,HAP-1,303,HAP-1,NA,5488,303,5483,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_RNA-seq,"commercial name: Horizon Genomics, HZGHC000530c014 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2764,GSM2552198,HAP-1,HAP-1,303,HAP-1,NA,5489,303,5484,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 EEF1AKMT4_RNA-seq,"commercial name: Horizon Genomics, HZGHC000530c015 | cell line: HAP-1 | genotype: EEF1AKMT4 KO"
2765,GSM2552199,HAP-1,HAP-1,303,HAP-1,NA,5490,303,NA,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 wild-type_RNA-seq,"commercial name: Horizon Genomics, HAP1 | cell line: HAP-1 | genotype: wildtype"
2766,GSM2552200,HAP-1,HAP-1,303,HAP-1,NA,5491,303,NA,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 wild-type_RNA-seq,"commercial name: Horizon Genomics, HAP1 | cell line: HAP-1 | genotype: wildtype"
2767,GSM2552201,HAP-1,HAP-1,303,HAP-1,NA,5492,303,NA,GSE97140,Homo sapiens,HAP-1,hap-1,HAP-1,HAP-1 wild-type_RNA-seq,"commercial name: Horizon Genomics, HAP1 | cell line: HAP-1 | genotype: wildtype"
2792,GSM2563629,HEK293T,HEK293T,305,HEK293T,NA,5517,305,5521,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2793,GSM2563630,HEK293T,HEK293T,305,HEK293T,NA,5518,305,5522,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2794,GSM2563631,HEK293T,HEK293T,305,HEK293T,NA,5519,305,5523,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2795,GSM2563632,HEK293T,HEK293T,305,HEK293T,NA,5520,305,5524,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2796,GSM2563633,HEK293T,HEK293T,305,HEK293T,NA,5521,305,5517,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2797,GSM2563634,HEK293T,HEK293T,305,HEK293T,NA,5522,305,5518,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2798,GSM2563635,HEK293T,HEK293T,305,HEK293T,NA,5523,305,5519,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2799,GSM2563636,HEK293T,HEK293T,305,HEK293T,NA,5524,305,5520,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: adapter ligation
2800,GSM2563637,HEK293T,HEK293T,305,HEK293T,NA,5525,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2801,GSM2563638,HEK293T,HEK293T,305,HEK293T,NA,5526,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2802,GSM2563639,HEK293T,HEK293T,305,HEK293T,NA,5527,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2803,GSM2563640,HEK293T,HEK293T,305,HEK293T,NA,5528,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2804,GSM2563641,HEK293T,HEK293T,305,HEK293T,NA,5529,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2805,GSM2563642,HEK293T,HEK293T,305,HEK293T,NA,5530,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2806,GSM2563643,HEK293T,HEK293T,305,HEK293T,NA,5531,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,ATF4 -/- HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2807,GSM2563644,HEK293T,HEK293T,305,HEK293T,NA,5532,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,ATF4 -/- HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2808,GSM2563645,HEK293T,HEK293T,305,HEK293T,NA,5533,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,ATF4 -/- HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2809,GSM2563646,HEK293T,HEK293T,305,HEK293T,NA,5534,305,NA,GSE97384,Homo sapiens,HEK293T,hek293t,HEK293T,ATF4 -/- HEK293T cells,source: cell culture | library protocol: Clontech SMARTer RNA-seq kit
2826,GSM2602073,MOLM13,MOLM-13,745,MOLM-13,NA,14621,745,14633,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2827,GSM2602074,MOLM13,MOLM-13,745,MOLM-13,NA,14622,745,14634,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2828,GSM2602075,MOLM13,MOLM-13,745,MOLM-13,NA,14623,745,14635,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2829,GSM2602076,MOLM13,MOLM-13,745,MOLM-13,NA,14624,745,14630,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2830,GSM2602077,MOLM13,MOLM-13,745,MOLM-13,NA,14625,745,14631,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2831,GSM2602078,MOLM13,MOLM-13,745,MOLM-13,NA,14626,745,14632,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2832,GSM2602079,MOLM13,MOLM-13,745,MOLM-13,NA,14627,745,14636,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2833,GSM2602080,MOLM13,MOLM-13,745,MOLM-13,NA,14628,745,14637,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2834,GSM2602081,MOLM13,MOLM-13,745,MOLM-13,NA,14629,745,14638,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2835,GSM2602082,MOLM13,MOLM-13,745,MOLM-13,NA,14630,745,14624,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2836,GSM2602083,MOLM13,MOLM-13,745,MOLM-13,NA,14631,745,14625,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2837,GSM2602084,MOLM13,MOLM-13,745,MOLM-13,NA,14632,745,14626,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: Control shRNA
2838,GSM2602085,MOLM13,MOLM-13,745,MOLM-13,NA,14633,745,14621,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2839,GSM2602086,MOLM13,MOLM-13,745,MOLM-13,NA,14634,745,14622,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2840,GSM2602087,MOLM13,MOLM-13,745,MOLM-13,NA,14635,745,14623,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #9
2841,GSM2602088,MOLM13,MOLM-13,745,MOLM-13,NA,14636,745,14627,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2842,GSM2602089,MOLM13,MOLM-13,745,MOLM-13,NA,14637,745,14628,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2843,GSM2602090,MOLM13,MOLM-13,745,MOLM-13,NA,14638,745,14629,GSE98623,Homo sapiens,MOLM-13,molm-13,MOLM-13,MOLM13 ribosome-depleted RNA,cell type: Acute myeloid leukemia | antibody name: NA | number of replicates: 3 | barcodes: NA | shRNA: METTL3 shRNA #12
2549,GSM2443010,HEK293,HEK293,798,HEK293,NA,15278,798,12440,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293
2550,GSM2443011,HEK293,HEK293,798,HEK293,NA,15279,798,12441,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293
2551,GSM2443012,HEK293,HEK293,798,HEK293,NA,15280,798,12442,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell line: HEK293
2552,GSM2443013,HEK293,HEK293,798,HEK293,NA,15281,798,12446,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | cell line: HEK293
2553,GSM2443014,HEK293,HEK293,798,HEK293,NA,15282,798,12447,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | cell line: HEK293
2554,GSM2443015,HEK293,HEK293,798,HEK293,NA,15283,798,12448,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | cell line: HEK293
2555,GSM2443016,HEK293,HEK293,798,HEK293,NA,12437,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Harringtonine-Chyclohexamide treated | cell line: HEK293
2556,GSM2443017,HEK293,HEK293,798,HEK293,NA,12438,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Harringtonine-Chyclohexamide treated | cell line: HEK293
2557,GSM2443018,HEK293,HEK293,798,HEK293,NA,12439,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Harringtonine-Chyclohexamide treated | cell line: HEK293
2558,GSM2443019,HEK293,HEK293,798,HEK293,NA,12440,798,15278,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Cyclohexamide treated | cell line: HEK293
2559,GSM2443020,HEK293,HEK293,798,HEK293,NA,12441,798,15279,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Cyclohexamide treated | cell line: HEK293
2560,GSM2443021,HEK293,HEK293,798,HEK293,NA,12442,798,15280,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Cyclohexamide treated | cell line: HEK293
2561,GSM2443022,HEK293,HEK293,798,HEK293,NA,12443,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Cyclohexamide treated | cell line: HEK293
2562,GSM2443023,HEK293,HEK293,798,HEK293,NA,12444,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,treatment: Cyclohexamide treated | cell line: HEK293
2563,GSM2443024,HEK293,HEK293,798,HEK293,NA,12445,798,NA,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | treatment: Harringtonine-Chyclohexamide treated | cell line: HEK293
2564,GSM2443025,HEK293,HEK293,798,HEK293,NA,12446,798,15281,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | treatment: Cyclohexamide treated | cell line: HEK293
2565,GSM2443026,HEK293,HEK293,798,HEK293,NA,12447,798,15282,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | treatment: Cyclohexamide treated | cell line: HEK293
2566,GSM2443027,HEK293,HEK293,798,HEK293,NA,12448,798,15283,,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,cell type: CRISPR-cas9 mediated CNBP knockout | treatment: Cyclohexamide treated | cell line: HEK293
3202,GSM2795496,CFBE,CFBE,582,CFBE,NA,11392,582,11393,GSE104329,Homo sapiens,CFBE,cfbe,CFBE,"CFBE mRNA with RPL12 siRNA treatment, harringtonine chased for 90s",cell type: CFBE cells
3203,GSM2795497,CFBE,CFBE,582,CFBE,NA,11393,582,11392,GSE104329,Homo sapiens,CFBE,cfbe,CFBE,"CFBE RPF with RPL12 siRNA treatment, harringtonine chased for 90s",cell type: CFBE cells
3204,GSM2795498,CFBE,CFBE,582,CFBE,NA,11394,582,NA,GSE104329,Homo sapiens,CFBE,cfbe,CFBE,CFBE RPF with scrambled siRNA treatment,cell type: CFBE cells
3205,GSM2795499,CFBE,CFBE,582,CFBE,NA,11395,582,NA,GSE104329,Homo sapiens,CFBE,cfbe,CFBE,CFBE RPF without siRNA treatment,cell type: CFBE cells
3206,GSM2795500,CFBE,CFBE,582,CFBE,NA,11396,582,NA,GSE104329,Homo sapiens,CFBE,cfbe,CFBE,CFBE RPF with RPL12 siRNA treatment,cell type: CFBE cells
3664,GSM3067420,SW480,SW480,387,SW480,NA,7336,387,7337,GSE112305,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | cell type: intestinal epithelial | genotype: wild type | library type: Ribosome-protected fragments
3665,GSM3067421,SW480,SW480,387,SW480,NA,7337,387,7336,GSE112305,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW840 | cell type: intestinal epithelial | genotype: wild type | library type: Total RNA
3666,GSM3067422,SW480,SW480,387,SW480,NA,7338,387,7339,GSE112305,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | cell type: intestinal epithelial | genotype: IMP1-/- | library type: Ribosome-protected fragments
3667,GSM3067423,SW480,SW480,387,SW480,NA,7339,387,7338,GSE112305,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | cell type: intestinal epithelial | genotype: IMP1-/- | library type: Total RNA
3696,GSM3074846,HEK293T,HEK293T,391,HEK293T,NA,7471,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Control, AA sufficient, CHX pre-treated"
3697,GSM3074847,HEK293T,HEK293T,391,HEK293T,NA,7472,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Control, AA sufficient, no CHX pre-treated"
3698,GSM3074848,HEK293T,HEK293T,391,HEK293T,NA,7473,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Arg starvation over night, CHX pre-treated"
3699,GSM3074849,HEK293T,HEK293T,391,HEK293T,NA,7474,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Arg starvation over night, no CHX pre-treated"
3700,GSM3074850,HEK293T,HEK293T,391,HEK293T,NA,7475,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Leu starvation over night, CHX pre-treated"
3701,GSM3074851,HEK293T,HEK293T,391,HEK293T,NA,7476,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Leu starvation over night, no CHX pre-treated"
3702,GSM3074852,HEK293T,HEK293T,391,HEK293T,NA,7477,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Met starvation over night, CHX pre-treated"
3703,GSM3074853,HEK293T,HEK293T,391,HEK293T,NA,7478,391,NA,GSE112643,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,"cell line: HEK293T cells immortalized with SV40 Large T antigen | molecule: ribosomes protected RNA | condition: Met starvation over night, no CHX pre-treated"
4045,GSM3186648,SW480,SW480,413,SW480,NA,7898,413,7899,GSE115647,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | genotype/variation: LIN28B OE
4046,GSM3186649,SW480,SW480,413,SW480,NA,7899,413,7898,GSE115647,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW840 | genotype/variation: LIN28B OE
4047,GSM3186650,SW480,SW480,413,SW480,NA,7900,413,7901,GSE115647,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | genotype/variation: LIN28B OE+IMP1-/- knockout
4048,GSM3186651,SW480,SW480,413,SW480,NA,7901,413,7900,GSE115647,Homo sapiens,SW480,sw480,SW480,SW480 cell lines,cell line: SW480 | genotype/variation: LIN28B OE+IMP1-/- knockout
4322,GSM3399566,MCF10A,MCF10A,679,MCF10A,NA,13276,679,NA,GSE120383,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cells,cell type: MCF10A | barcode: GATCA
4323,GSM3399567,MCF10A,MCF10A,679,MCF10A,NA,13277,679,NA,GSE120383,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cells,cell type: MCF10A | barcode: GCATA
4324,GSM3399568,MCF10A,MCF10A,679,MCF10A,NA,13278,679,NA,GSE120383,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cells,cell type: MCF10A | barcode: TAGAC
4325,GSM3399569,MCF10A,MCF10A,679,MCF10A,NA,13279,679,NA,GSE120383,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cells,cell type: MCF10A | barcode: TCTAG
4326,GSM3399570,MCF10A,MCF10A,679,MCF10A,NA,13280,679,NA,GSE120383,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10A cells,cell type: MCF10A
4397,GSM3450377,HepG2,HepG2,727,HepG2,NA,14342,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: untreated | time point: 0h
4398,GSM3450378,HepG2,HepG2,727,HepG2,NA,14343,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: untreated | time point: 0h
4399,GSM3450379,HepG2,HepG2,727,HepG2,NA,14344,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 1h
4400,GSM3450380,HepG2,HepG2,727,HepG2,NA,14345,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 1h
4401,GSM3450381,HepG2,HepG2,727,HepG2,NA,14346,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 3h
4402,GSM3450382,HepG2,HepG2,727,HepG2,NA,14347,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 3h
4403,GSM3450383,HepG2,HepG2,727,HepG2,NA,14348,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 6h
4404,GSM3450384,HepG2,HepG2,727,HepG2,NA,14349,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: non-specific control | treatment: 5 ug/mL actinomycin D | time point: 6h
4405,GSM3450385,HepG2,HepG2,727,HepG2,NA,14350,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: untreated | time point: 0h
4406,GSM3450386,HepG2,HepG2,727,HepG2,NA,14351,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: untreated | time point: 0h
4407,GSM3450387,HepG2,HepG2,727,HepG2,NA,14352,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 1h
4408,GSM3450388,HepG2,HepG2,727,HepG2,NA,14353,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 1h
4409,GSM3450389,HepG2,HepG2,727,HepG2,NA,14354,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 3h
4410,GSM3450390,HepG2,HepG2,727,HepG2,NA,14355,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 3h
4411,GSM3450391,HepG2,HepG2,727,HepG2,NA,14356,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 6h
4412,GSM3450392,HepG2,HepG2,727,HepG2,NA,14357,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | treatment: 5 ug/mL actinomycin D | time point: 6h
4413,GSM3450393,HepG2,HepG2,727,HepG2,NA,14358,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: untreated | time point: 0h
4414,GSM3450394,HepG2,HepG2,727,HepG2,NA,14359,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: untreated | time point: 0h
4415,GSM3450395,HepG2,HepG2,727,HepG2,NA,14360,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 1h
4416,GSM3450396,HepG2,HepG2,727,HepG2,NA,14361,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 1h
4417,GSM3450397,HepG2,HepG2,727,HepG2,NA,14362,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 3h
4418,GSM3450398,HepG2,HepG2,727,HepG2,NA,14363,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 3h
4419,GSM3450399,HepG2,HepG2,727,HepG2,NA,14364,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 6h
4420,GSM3450400,HepG2,HepG2,727,HepG2,NA,14365,727,NA,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTl14 | treatment: 5 ug/mL actinomycin D | time point: 6h
4421,GSM3450413,HepG2,HepG2,727,HepG2,NA,8351,727,8357,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: Non specific control | fraction: input
4422,GSM3450414,HepG2,HepG2,727,HepG2,NA,8352,727,8358,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: Non specific control | fraction: input
4423,GSM3450415,HepG2,HepG2,727,HepG2,NA,8353,727,8359,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTL14 | fraction: input
4424,GSM3450416,HepG2,HepG2,727,HepG2,NA,8354,727,8360,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shMETTL14 | fraction: input
4425,GSM3450417,HepG2,HepG2,727,HepG2,NA,8355,727,8361,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | fraction: input
4426,GSM3450418,HepG2,HepG2,727,HepG2,NA,8356,727,8362,GSE110323,Homo sapiens,HepG2,hepg2,HepG2,HepG2 cells,cell line: HepG2 | shRNA: shSETD2 | fraction: input
4453,GSM3466808,HepG2,HepG2,732,HepG2,NA,14439,732,NA,GSE122461,Homo sapiens,HepG2,hepg2,HepG2,Human liver epithelial cells,cell line: HepG2
4454,GSM3466809,HepG2,HepG2,732,HepG2,NA,14440,732,NA,GSE122461,Homo sapiens,HepG2,hepg2,HepG2,Human liver epithelial cells,cell line: HepG2
4775,GSM3544711,HEK293T,HEK293T,645,HEK293T,NA,12429,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,Transgenic cells_+NAEK,cell line: HEK293T cells stably transfected with Mb pyltRNA | treatment: with the addition of 1mM NAEK
4776,GSM3544712,HEK293T,HEK293T,645,HEK293T,NA,12430,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,Transgenic cells_+NAEK,cell line: HEK293T cells stably transfected with Mb pyltRNA | treatment: with the addition of 1mM NAEK
4777,GSM3544713,HEK293T,HEK293T,645,HEK293T,NA,12431,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,Transgenic cells_-NAEK,cell line: HEK293T cells stably transfected with Mb pyltRNA | treatment: NA
4778,GSM3544714,HEK293T,HEK293T,645,HEK293T,NA,12432,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,Transgenic cells_-NAEK,cell line: HEK293T cells stably transfected with Mb pyltRNA | treatment: NA
4779,GSM3544715,HEK293T,HEK293T,645,HEK293T,NA,12433,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells_+NAEK,cell line: HEK293T | treatment: with the addition of 1mM NAEK
4780,GSM3544716,HEK293T,HEK293T,645,HEK293T,NA,12434,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells_+NAEK,cell line: HEK293T | treatment: with the addition of 1mM NAEK
4781,GSM3544717,HEK293T,HEK293T,645,HEK293T,NA,12435,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells_-NAEK,cell line: HEK293T | treatment: NA
4782,GSM3544718,HEK293T,HEK293T,645,HEK293T,NA,12436,645,NA,GSE124737,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells_-NAEK,cell line: HEK293T | treatment: NA
5055,GSM3671370,HuH-7,Huh7,592,Huh7,NA,11473,592,NA,GSE128320,Homo sapiens,Huh7,huh7,Huh7,HuH-7,genotype: wild type | cell line: HuH-7
5056,GSM3671371,HuH-7,Huh7,592,Huh7,NA,11474,592,NA,GSE128320,Homo sapiens,Huh7,huh7,Huh7,HuH-7,genotype: wild type | cell line: HuH-7
5057,GSM3671384,HFF,HFF,603,foreskin fibroblasts,,11591,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 2 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNAATANN"
5058,GSM3671385,HFF,HFF,603,foreskin fibroblasts,,11592,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNTTAANN"
5059,GSM3671386,HFF,HFF,603,foreskin fibroblasts,,11593,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,cell type: human foreskin fibroblasts | time post infection: mock | infection with: mock | barcode: NNNTTGTNN
5060,GSM3671387,HFF,HFF,603,foreskin fibroblasts,,11594,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 4 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCAATNN"
5061,GSM3671388,HFF,HFF,603,foreskin fibroblasts,,11595,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNCCGGNN"
5062,GSM3671389,HFF,HFF,603,foreskin fibroblasts,,11596,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 2 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNAATANN"
5063,GSM3671390,HFF,HFF,603,foreskin fibroblasts,,11597,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNTTAANN"
5064,GSM3671391,HFF,HFF,603,foreskin fibroblasts,,11598,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,cell type: human foreskin fibroblasts | time post infection: mock | infection with: mock | barcode: NNNCGGANN
5065,GSM3671392,HFF,HFF,603,foreskin fibroblasts,,11599,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 4 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNAATAANN"
5066,GSM3671393,HFF,HFF,603,foreskin fibroblasts,,11600,603,NA,GSE128324,Homo sapiens,HFF,human foreskin fibroblasts,foreskin fibroblasts,Ribosome profiling,"cell type: human foreskin fibroblasts | time post infection: 8 h p.i. | infection with: Herpes simplex virus 1, strain 17 | barcode: NNNTTAANN"
5067,GSM3671668,iPSC,iPSC,691,iPSC,NA,13659,691,13671,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5068,GSM3671669,iPSC,iPSC,691,iPSC,NA,13660,691,13672,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5069,GSM3671670,iPSC,iPSC,691,iPSC,NA,13661,691,13673,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5070,GSM3671671,iPSC,iPSC,691,iPSC,NA,13662,691,13674,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5071,GSM3671672,iPSC,iPSC,691,iPSC,NA,13663,691,13675,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5072,GSM3671673,iPSC,iPSC,691,iPSC,NA,13664,691,13676,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5073,GSM3671674,iPSC,iPSC,691,iPSC,NA,13665,691,13677,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5074,GSM3671675,iPSC,iPSC,691,iPSC,NA,13666,691,13678,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5075,GSM3671676,iPSC,iPSC,691,iPSC,NA,13667,691,13679,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5076,GSM3671677,iPSC,iPSC,691,iPSC,NA,13668,691,13680,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5077,GSM3671678,iPSC,iPSC,691,iPSC,NA,13669,691,13681,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5078,GSM3671679,iPSC,iPSC,691,iPSC,NA,13670,691,13682,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5079,GSM3671680,iPSC,iPSC,691,iPSC,NA,13671,691,13659,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5080,GSM3671681,iPSC,iPSC,691,iPSC,NA,13672,691,13660,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5081,GSM3671682,iPSC,iPSC,691,iPSC,NA,13673,691,13661,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,wiltype iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: none
5082,GSM3671683,iPSC,iPSC,691,iPSC,NA,13674,691,13662,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5083,GSM3671684,iPSC,iPSC,691,iPSC,NA,13675,691,13663,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5084,GSM3671685,iPSC,iPSC,691,iPSC,NA,13676,691,13664,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe
5085,GSM3671686,iPSC,iPSC,691,iPSC,NA,13677,691,13665,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5086,GSM3671687,iPSC,iPSC,691,iPSC,NA,13678,691,13666,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5087,GSM3671688,iPSC,iPSC,691,iPSC,NA,13679,691,13667,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,PSEN1 mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: PSEN1 M146V/M146V
5088,GSM3671689,iPSC,iPSC,691,iPSC,NA,13680,691,13668,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5089,GSM3671690,iPSC,iPSC,691,iPSC,NA,13681,691,13669,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5090,GSM3671691,iPSC,iPSC,691,iPSC,NA,13682,691,13670,GSE128343,Homo sapiens,iPSC,ipsc,iPSC,APP/PSEN1 double mutant iPSC-derived neurons,cell line background: 7889SA parental cell line | cell line source: 80 day old cortical neurons | cell type: co-isogenic iPS cells | mutation: APP Swe/Swe; PSEN1 M146V/M146V
5091,GSM3679617,RPEI,RPEI,630,RPEI,NA,12044,630,12050,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: DMSO | spike-in: Saccharomyces cerevisiae
5092,GSM3679618,RPEI,RPEI,630,RPEI,NA,12045,630,12051,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: RO-3306 | spike-in: Saccharomyces cerevisiae
5093,GSM3679619,RPEI,RPEI,630,RPEI,NA,12046,630,12052,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: DMSO | spike-in: Saccharomyces cerevisiae
5094,GSM3679620,RPEI,RPEI,630,RPEI,NA,12047,630,12053,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: RO-3305 | spike-in: Saccharomyces cerevisiae
5095,GSM3679621,RPEI,RPEI,630,RPEI,NA,12048,630,12054,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: DMSO | spike-in: Saccharomyces cerevisiae
5096,GSM3679622,RPEI,RPEI,630,RPEI,NA,12049,630,12055,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: cytoplasmic lysate (input) | agent: RO-3304 | spike-in: Saccharomyces cerevisiae
5097,GSM3679623,RPEI,RPEI,630,RPEI,NA,12050,630,12044,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: DMSO | spike-in: Saccharomyces cerevisiae
5098,GSM3679624,RPEI,RPEI,630,RPEI,NA,12051,630,12045,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: RO-3303 | spike-in: Saccharomyces cerevisiae
5099,GSM3679625,RPEI,RPEI,630,RPEI,NA,12052,630,12046,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: DMSO | spike-in: Saccharomyces cerevisiae
5100,GSM3679626,RPEI,RPEI,630,RPEI,NA,12053,630,12047,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: RO-3302 | spike-in: Saccharomyces cerevisiae
5101,GSM3679627,RPEI,RPEI,630,RPEI,NA,12054,630,12048,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: DMSO | spike-in: Saccharomyces cerevisiae
5102,GSM3679628,RPEI,RPEI,630,RPEI,NA,12055,630,12049,GSE128538,Homo sapiens,RPEI,rpei,RPEI,RPEI/yeast cells,fraction: Ribosome protected fragments | agent: RO-3301 | spike-in: Saccharomyces cerevisiae
5103,GSM3692340,K562,K562,594,K562,NA,11483,594,NA,GSE129061,Homo sapiens,K562,k562,K562,K562,cell line: K562
5104,GSM3692341,K562,K562,594,K562,NA,11484,594,NA,GSE129061,Homo sapiens,K562,k562,K562,K562,cell line: K562
5105,GSM3692342,HepG2,HepG2,594,HepG2,NA,11485,594,NA,GSE129061,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2
5106,GSM3692343,HepG2,HepG2,594,HepG2,NA,11486,594,NA,GSE129061,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2
5109,GSM3702258,HEK293T,HEK293T,712,HEK293T,NA,13950,712,13956,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: shScram
5110,GSM3702259,HEK293T,HEK293T,712,HEK293T,NA,13951,712,13957,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: sh-YTHDC2
5111,GSM3702260,HEK293T,HEK293T,712,HEK293T,NA,13952,712,13958,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: shScram
5112,GSM3702261,HEK293T,HEK293T,712,HEK293T,NA,13953,712,13959,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: sh-YTHDC2
5113,GSM3702262,HEK293T,HEK293T,712,HEK293T,NA,13954,712,NA,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: shScram
5114,GSM3702263,HEK293T,HEK293T,712,HEK293T,NA,13955,712,NA,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: sh-YTHDC2
5115,GSM3702264,HEK293T,HEK293T,712,HEK293T,NA,13956,712,13950,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: shScram
5116,GSM3702265,HEK293T,HEK293T,712,HEK293T,NA,13957,712,13951,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: sh-YTHDC2
5117,GSM3702266,HEK293T,HEK293T,712,HEK293T,NA,13958,712,13952,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: shScram
5118,GSM3702267,HEK293T,HEK293T,712,HEK293T,NA,13959,712,13953,GSE129194,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney 293,cell line: 293T | cell type: Human embryonic kidney | knockdown: sh-YTHDC2
5119,GSM3704305,HeLa S3,HeLa S3,829,HeLa S3,NA,15843,829,15846,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: MeOH | cell line: HeLa S3
5120,GSM3704306,HeLa S3,HeLa S3,829,HeLa S3,NA,15844,829,15847,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: MeOH | cell line: HeLa S3
5121,GSM3704307,HeLa S3,HeLa S3,829,HeLa S3,NA,15845,829,15848,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: SSA | cell line: HeLa S3
5122,GSM3704308,HeLa S3,HeLa S3,829,HeLa S3,NA,15846,829,15843,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: MeOH | cell line: HeLa S3
5123,GSM3704309,HeLa S3,HeLa S3,829,HeLa S3,NA,15847,829,15844,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: MeOH | cell line: HeLa S3
5124,GSM3704310,HeLa S3,HeLa S3,829,HeLa S3,NA,15848,829,15845,GSE129305,Homo sapiens,HeLa S3,hela s3,HeLa S3,HeLa S3 cells,treatment: SSA | cell line: HeLa S3
5125,GSM3718424,A549,A549,602,A549,NA,11583,602,11587,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5126,GSM3718425,A549,A549,602,A549,NA,11584,602,11588,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5127,GSM3718426,A549,A549,602,A549,NA,11585,602,11589,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5128,GSM3718427,A549,A549,602,A549,NA,11586,602,11590,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5129,GSM3718428,A549,A549,602,A549,NA,11587,602,11583,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5130,GSM3718429,A549,A549,602,A549,NA,11588,602,11584,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5131,GSM3718430,A549,A549,602,A549,NA,11589,602,11585,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5132,GSM3718431,A549,A549,602,A549,NA,11590,602,11586,GSE129654,Homo sapiens,A549,a549,A549,Lung adeocarcinoma cells control,cell type: A549 pulmonary adenocarcinomic human alveolar basal epithelial cells
5133,GSM3720421,A2780,A2780,607,A2780,NA,11657,607,11661,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_vehicle,cell line: A2780
5134,GSM3720422,A2780,A2780,607,A2780,NA,11658,607,11662,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_cisplatin,cell line: A2780
5135,GSM3720423,A2780,A2780,607,A2780,NA,11659,607,11663,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780cis_vehicle,cell line: A2780cis
5136,GSM3720424,A2780,A2780,607,A2780,NA,11660,607,11664,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780cis_cisplatin,cell line: A2780cis
5137,GSM3720425,A2780,A2780,607,A2780,NA,11661,607,11657,GSE129702,Homo sapiens,A2780,a2780,A2780,Ribosome_profiling_A2780_vehicle,cell line: A2780
5138,GSM3720426,A2780,A2780,607,A2780,NA,11662,607,11658,GSE129702,Homo sapiens,A2780,a2780,A2780,Ribosome_profiling_A2780_cisplatin,cell line: A2780
5139,GSM3720427,A2780,A2780,607,A2780,NA,11663,607,11659,GSE129702,Homo sapiens,A2780,a2780,A2780,Ribosome_profiling_A2780cis_vehicle,cell line: A2780cis
5140,GSM3720428,A2780,A2780,607,A2780,NA,11664,607,11660,GSE129702,Homo sapiens,A2780,a2780,A2780,Ribosome_profiling_A2780cis_cisplatin,cell line: A2780cis
5141,GSM3720431,A2780,A2780,607,A2780,NA,11667,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_CRISPRcontrol,cell line: A2780
5142,GSM3720432,A2780,A2780,607,A2780,NA,11668,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_CRISPRi_R#1,cell line: A2780-CRISPR/dCas9-KRAB-modified
5143,GSM3720433,A2780,A2780,607,A2780,NA,11669,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_CRISPRi_R#2,cell line: A2780-CRISPR/dCas9-KRAB-modified
5144,GSM3720434,A2780,A2780,607,A2780,NA,11670,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780cis_CRISPRcontrol,cell line: A2780cis
5145,GSM3720435,A2780,A2780,607,A2780,NA,11671,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780cis_CRISPRa_R#1,cell line: A2780cis-CRISPR/dCas9-VP64-modified
5146,GSM3720436,A2780,A2780,607,A2780,NA,11672,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780cis_CRISPRa_R#2,cell line: A2780cis-CRISPR/dCas9-VP64-modified
5147,GSM3720437,A2780,A2780,607,A2780,NA,11673,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_lowISL1sorted,cell line: A2780 | cell type: Cells sorted based on ISL1 protein levels
5148,GSM3720438,A2780,A2780,607,A2780,NA,11674,607,NA,GSE129702,Homo sapiens,A2780,a2780,A2780,RNAseq_A2780_highISL1sorted,cell line: A2780 | cell type: Cells sorted based on ISL1 protein levels
5149,GSM3721649,LN-308,LN-308,591,LN-308,NA,11451,591,11462,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5150,GSM3721650,LN-308,LN-308,591,LN-308,NA,11452,591,11463,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5151,GSM3721651,LN-308,LN-308,591,LN-308,NA,11453,591,11464,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5152,GSM3721652,LN-308,LN-308,591,LN-308,NA,11454,591,11465,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5153,GSM3721653,LN-308,LN-308,591,LN-308,NA,11455,591,11466,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5154,GSM3721654,LN-308,LN-308,591,LN-308,NA,11456,591,11467,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5155,GSM3721655,LN-308,LN-308,591,LN-308,NA,11457,591,11468,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5156,GSM3721656,LN-308,LN-308,591,LN-308,NA,11458,591,11469,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5157,GSM3721657,LN-308,LN-308,591,LN-308,NA,11459,591,11470,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5158,GSM3721658,LN-308,LN-308,591,LN-308,NA,11460,591,11471,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: thapsigargin
5159,GSM3721659,LN-308,LN-308,591,LN-308,NA,11461,591,11472,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: thapsigargin
5160,GSM3721660,LN-308,LN-308,591,LN-308,NA,11462,591,11451,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5161,GSM3721661,LN-308,LN-308,591,LN-308,NA,11463,591,11452,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5162,GSM3721662,LN-308,LN-308,591,LN-308,NA,11464,591,11453,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 0 h | treatment: untreated
5163,GSM3721663,LN-308,LN-308,591,LN-308,NA,11465,591,11454,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5164,GSM3721664,LN-308,LN-308,591,LN-308,NA,11466,591,11455,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5165,GSM3721665,LN-308,LN-308,591,LN-308,NA,11467,591,11456,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: tunicamycin
5166,GSM3721666,LN-308,LN-308,591,LN-308,NA,11468,591,11457,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5167,GSM3721667,LN-308,LN-308,591,LN-308,NA,11469,591,11458,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5168,GSM3721668,LN-308,LN-308,591,LN-308,NA,11470,591,11459,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: tunicamycin
5169,GSM3721669,LN-308,LN-308,591,LN-308,NA,11471,591,11460,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 2 h | treatment: thapsigargin
5170,GSM3721670,LN-308,LN-308,591,LN-308,NA,11472,591,11461,GSE129757,Homo sapiens,LN-308,ln-308,LN-308,LN308 cell line,cell line: LN308 | cell type: Astrocytoma-derived p53-deficient glial cells | time: 6 h | treatment: thapsigargin
5231,GSM3739076,normal prostate,normal prostate,826,normal prostate,NA,15739,826,15744,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5232,GSM3739077,normal prostate,normal prostate,826,normal prostate,NA,15740,826,15745,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5233,GSM3739078,normal prostate,normal prostate,826,normal prostate,NA,15741,826,15746,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5234,GSM3739079,normal prostate,normal prostate,826,normal prostate,NA,15742,826,15747,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5235,GSM3739080,normal prostate,normal prostate,826,normal prostate,NA,15743,826,15748,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5236,GSM3739081,normal prostate,normal prostate,826,normal prostate,NA,15744,826,15739,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5237,GSM3739082,normal prostate,normal prostate,826,normal prostate,NA,15745,826,15740,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5238,GSM3739083,normal prostate,normal prostate,826,normal prostate,NA,15746,826,15741,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5239,GSM3739084,normal prostate,normal prostate,826,normal prostate,NA,15747,826,15742,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5240,GSM3739085,normal prostate,normal prostate,826,normal prostate,NA,15748,826,15743,GSE130465,Homo sapiens,normal prostate,normal prostate,normal prostate,Normal prostate tissue,tissue: Normal prostate | genotype/variation: wild type/ normal
5241,GSM3753501,HEK293T,HEK293T,644,HEK293T,NA,12388,644,12391,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type
5242,GSM3753502,HEK293T,HEK293T,644,HEK293T,NA,12389,644,12392,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type
5243,GSM3753503,HEK293T,HEK293T,644,HEK293T,NA,12390,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type
5244,GSM3753504,HEK293T,HEK293T,644,HEK293T,NA,12391,644,12388,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type
5245,GSM3753505,HEK293T,HEK293T,644,HEK293T,NA,12392,644,12389,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type
5246,GSM3753506,HEK293T,HEK293T,644,HEK293T,NA,12393,644,12395,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type+HA
5247,GSM3753507,HEK293T,HEK293T,644,HEK293T,NA,12394,644,12396,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type+HA
5248,GSM3753508,HEK293T,HEK293T,644,HEK293T,NA,12395,644,12393,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type+HA
5249,GSM3753509,HEK293T,HEK293T,644,HEK293T,NA,12396,644,12394,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type+HA
5250,GSM3753510,HEK293T,HEK293T,644,HEK293T,NA,12397,644,12399,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type+HA-YB-1
5251,GSM3753511,HEK293T,HEK293T,644,HEK293T,NA,12398,644,12400,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: wild type+HA-YB-1
5252,GSM3753512,HEK293T,HEK293T,644,HEK293T,NA,12399,644,12397,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type+HA-YB-1
5253,GSM3753513,HEK293T,HEK293T,644,HEK293T,NA,12400,644,12398,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: wild type+HA-YB-1
5254,GSM3753514,HEK293T,HEK293T,644,HEK293T,NA,12401,644,12404,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: deltaYB-1
5255,GSM3753515,HEK293T,HEK293T,644,HEK293T,NA,12402,644,12405,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: deltaYB-1
5256,GSM3753516,HEK293T,HEK293T,644,HEK293T,NA,12403,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: deltaYB-1
5257,GSM3753517,HEK293T,HEK293T,644,HEK293T,NA,12404,644,12401,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: deltaYB-1
5258,GSM3753518,HEK293T,HEK293T,644,HEK293T,NA,12405,644,12402,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: deltaYB-1
5259,GSM3753519,HEK293T,HEK293T,644,HEK293T,NA,12406,644,12408,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: deltaYB-1+HA
5260,GSM3753520,HEK293T,HEK293T,644,HEK293T,NA,12407,644,12409,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Ribo-Seq | genotype: deltaYB-1+HA
5261,GSM3753521,HEK293T,HEK293T,644,HEK293T,NA,12408,644,12406,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: deltaYB-1+HA
5262,GSM3753522,HEK293T,HEK293T,644,HEK293T,NA,12409,644,12407,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: Size-matched RNA-Seq | genotype: deltaYB-1+HA
5263,GSM3753530,HEK293T,HEK293T,644,HEK293T,NA,12417,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5264,GSM3753531,HEK293T,HEK293T,644,HEK293T,NA,12418,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5265,GSM3753532,HEK293T,HEK293T,644,HEK293T,NA,12419,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5266,GSM3753533,HEK293T,HEK293T,644,HEK293T,NA,12420,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5267,GSM3753534,HEK293T,HEK293T,644,HEK293T,NA,12421,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5268,GSM3753535,HEK293T,HEK293T,644,HEK293T,NA,12422,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: wild type
5269,GSM3753537,HEK293T,HEK293T,644,HEK293T,NA,12424,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: deltaYB-1
5270,GSM3753538,HEK293T,HEK293T,644,HEK293T,NA,12425,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: deltaYB-1
5271,GSM3753539,HEK293T,HEK293T,644,HEK293T,NA,12426,644,NA,GSE130781,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney,cell line: HEK293T | experiment type: RNA-Seq | genotype: deltaYB-1
5326,GSM3755934,Huh7,Huh7,694,Huh7,NA,13753,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_WT_rep1,cell type: Huh-7 | strain: JCRB0403 | genotype: -
5327,GSM3755935,Huh7,Huh7,694,Huh7,NA,13754,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_WT_rep2,cell type: Huh-7 | strain: JCRB0403 | genotype: -
5328,GSM3755936,Huh7,Huh7,694,Huh7,NA,13755,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_WT_rep3,cell type: Huh-7 | strain: JCRB0403 | genotype: -
5329,GSM3755937,Huh7,Huh7,694,Huh7,NA,13756,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_Trim71KO_rep1,cell type: Huh-7 | strain: JCRB0403 | genotype: TRIM71 -/-
5330,GSM3755938,Huh7,Huh7,694,Huh7,NA,13757,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_Trim71KO_rep2,cell type: Huh-7 | strain: JCRB0403 | genotype: TRIM71 -/-
5331,GSM3755939,Huh7,Huh7,694,Huh7,NA,13758,694,NA,GSE134125,Homo sapiens,Huh7,huh7,Huh7,Huh7_Trim71KO_rep3,cell type: Huh-7 | strain: JCRB0403 | genotype: TRIM71 -/-
5340,GSM3762993,MCF10-A,MCF10A,575,MCF10A,NA,11236,575,11242,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5341,GSM3762994,MCF10-A,MCF10A,575,MCF10A,NA,11237,575,11243,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5342,GSM3762995,MCF10-A,MCF10A,575,MCF10A,NA,11238,575,11244,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5343,GSM3762996,MCF10-A,MCF10A,575,MCF10A,NA,11239,575,11245,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5344,GSM3762997,MCF10-A,MCF10A,575,MCF10A,NA,11240,575,11246,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5345,GSM3762998,MCF10-A,MCF10A,575,MCF10A,NA,11241,575,11247,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5346,GSM3762999,MCF10-A,MCF10A,575,MCF10A,NA,11242,575,11236,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5347,GSM3763000,MCF10-A,MCF10A,575,MCF10A,NA,11243,575,11237,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5348,GSM3763001,MCF10-A,MCF10A,575,MCF10A,NA,11244,575,11238,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: eIF3e siRNA
5349,GSM3763002,MCF10-A,MCF10A,575,MCF10A,NA,11245,575,11239,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5350,GSM3763003,MCF10-A,MCF10A,575,MCF10A,NA,11246,575,11240,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5351,GSM3763004,MCF10-A,MCF10A,575,MCF10A,NA,11247,575,11241,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Control siRNA
5352,GSM3763005,MCF10-A,MCF10A,575,MCF10A,NA,11248,575,NA,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Total RPF (all the ribosome protected footprints from the 80S ribosomes isolated from total cell lysate)
5353,GSM3763006,MCF10-A,MCF10A,575,MCF10A,NA,11249,575,NA,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell line,cell line: MCF10-A | cell type: epithelial | treatment: Selective RPF (eIF3B-bound ribosomes protected footprints)
5354,GSM3763596,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13246,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq | disease state: end-stage DCM
5355,GSM3763597,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13247,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5356,GSM3763598,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13248,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5357,GSM3763599,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13249,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5358,GSM3763600,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13250,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5359,GSM3763601,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13251,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5360,GSM3763602,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13252,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5361,GSM3763603,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13253,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5362,GSM3763604,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13254,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5363,GSM3763605,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13255,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5364,GSM3763606,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13256,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5365,GSM3763607,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13257,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5366,GSM3763608,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13258,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5367,GSM3763609,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13259,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5368,GSM3763610,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13260,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5369,GSM3763611,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13261,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5370,GSM3763612,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13262,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5371,GSM3763613,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13263,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5372,GSM3763614,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13264,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5373,GSM3763615,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13265,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5374,GSM3763616,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13266,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5375,GSM3763617,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13267,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5376,GSM3763618,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13268,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5377,GSM3763619,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13269,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5378,GSM3763620,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13270,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5379,GSM3763621,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13271,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5380,GSM3763622,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13272,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5381,GSM3763623,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13273,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5382,GSM3763624,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13274,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5383,GSM3763625,left ventricle tissue,left ventricle tissue,676,left ventricle tissue,NA,13275,676,NA,GSE131112,Homo sapiens,left ventricle tissue,left ventricle tissue,left ventricle tissue,Left ventricle tissue of end-stage DCM patients,cell type: Left ventricle tissue | sequencing: Ribo-seq
5392,GSM3791723,WTC-11,WTC-11,619,WTC-11,NA,11803,619,NA,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: harringtonine
5393,GSM3791724,WTC-11,WTC-11,619,WTC-11,NA,11804,619,NA,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: harringtonine
5394,GSM3791725,WTC-11,WTC-11,619,WTC-11,NA,11805,619,11811,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5395,GSM3791726,WTC-11,WTC-11,619,WTC-11,NA,11806,619,11812,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5396,GSM3791727,WTC-11,WTC-11,619,WTC-11,NA,11807,619,11813,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5397,GSM3791728,WTC-11,WTC-11,619,WTC-11,NA,11808,619,11814,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5398,GSM3791729,WTC-11,WTC-11,619,WTC-11,NA,11809,619,11815,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5399,GSM3791730,WTC-11,WTC-11,619,WTC-11,NA,11810,619,11816,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5400,GSM3791731,WTC-11,WTC-11,619,WTC-11,NA,11811,619,11805,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5401,GSM3791732,WTC-11,WTC-11,619,WTC-11,NA,11812,619,11806,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5402,GSM3791733,WTC-11,WTC-11,619,WTC-11,NA,11813,619,11807,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC | cell line: WTC-11 | drug treatment: no drug
5403,GSM3791734,WTC-11,WTC-11,619,WTC-11,NA,11814,619,11808,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5404,GSM3791735,WTC-11,WTC-11,619,WTC-11,NA,11815,619,11809,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5405,GSM3791736,WTC-11,WTC-11,619,WTC-11,NA,11816,619,11810,GSE131650,Homo sapiens,WTC-11,wtc-11,WTC-11,cell lysate,cell type: iPSC-derived cardiomyocytes | cell line: WTC-11 | drug treatment: no drug
5406,GSM3820024,HSPCs,HSPCs,663,HSPCs,NA,12976,663,12984,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5407,GSM3820025,HSPCs,HSPCs,663,HSPCs,NA,12977,663,12985,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5408,GSM3820026,HSPCs,HSPCs,663,HSPCs,NA,12978,663,12986,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5409,GSM3820027,HSPCs,HSPCs,663,HSPCs,NA,12979,663,12987,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5410,GSM3820028,HSPCs,HSPCs,663,HSPCs,NA,12980,663,12988,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5411,GSM3820029,HSPCs,HSPCs,663,HSPCs,NA,12981,663,12989,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5412,GSM3820030,HSPCs,HSPCs,663,HSPCs,NA,12982,663,12990,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5413,GSM3820031,HSPCs,HSPCs,663,HSPCs,NA,12983,663,12991,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5414,GSM3820032,HSPCs,HSPCs,663,HSPCs,NA,12984,663,12976,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5415,GSM3820033,HSPCs,HSPCs,663,HSPCs,NA,12985,663,12977,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5416,GSM3820034,HSPCs,HSPCs,663,HSPCs,NA,12986,663,12978,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5417,GSM3820035,HSPCs,HSPCs,663,HSPCs,NA,12987,663,12979,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,adult erythroid cells,cell type: hematopoetic cells | cell type: adult erythroid cells
5418,GSM3820036,HSPCs,HSPCs,663,HSPCs,NA,12988,663,12980,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5419,GSM3820037,HSPCs,HSPCs,663,HSPCs,NA,12989,663,12981,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5420,GSM3820038,HSPCs,HSPCs,663,HSPCs,NA,12990,663,12982,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5421,GSM3820039,HSPCs,HSPCs,663,HSPCs,NA,12991,663,12983,GSE131809,Homo sapiens,HSPCs,hspcs,HSPCs,newborn erythroid cells,cell type: hematopoetic cells | cell type: newborn erythroid cells
5422,GSM3834396,HCT116,HCT116,653,HCT116,NA,12644,653,12650,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: EIF5A-/- | sgrna received: EIF5A sgRNA #1 | tissue: HCT116 colon cancer cell line
5423,GSM3834397,HCT116,HCT116,653,HCT116,NA,12645,653,12651,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: EIF5A-/- | sgrna received: EIF5A sgRNA #2 | tissue: HCT116 colon cancer cell line
5424,GSM3834398,HCT116,HCT116,653,HCT116,NA,12646,653,12652,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: DOHH-/- | sgrna received: DOHH sgRNA #1 | tissue: HCT116 colon cancer cell line
5425,GSM3834399,HCT116,HCT116,653,HCT116,NA,12647,653,12653,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: DOHH-/- | sgrna received: DOHH sgRNA #2 | tissue: HCT116 colon cancer cell line
5426,GSM3834400,HCT116,HCT116,653,HCT116,NA,12648,653,12654,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: NT sgRNA #1 | tissue: HCT116 colon cancer cell line
5427,GSM3834401,HCT116,HCT116,653,HCT116,NA,12649,653,12655,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: NT sgRNA #2 | tissue: HCT116 colon cancer cell line
5428,GSM3834402,HCT116,HCT116,653,HCT116,NA,12650,653,12644,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: EIF5A-/- | sgrna received: EIF5A sgRNA #1 | tissue: HCT116 colon cancer cell line
5429,GSM3834403,HCT116,HCT116,653,HCT116,NA,12651,653,12645,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: EIF5A-/- | sgrna received: EIF5A sgRNA #2 | tissue: HCT116 colon cancer cell line
5430,GSM3834404,HCT116,HCT116,653,HCT116,NA,12652,653,12646,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: DOHH-/- | sgrna received: DOHH sgRNA #1 | tissue: HCT116 colon cancer cell line
5431,GSM3834405,HCT116,HCT116,653,HCT116,NA,12653,653,12647,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: DOHH-/- | sgrna received: DOHH sgRNA #2 | tissue: HCT116 colon cancer cell line
5432,GSM3834406,HCT116,HCT116,653,HCT116,NA,12654,653,12648,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: NT sgRNA #1 | tissue: HCT116 colon cancer cell line
5433,GSM3834407,HCT116,HCT116,653,HCT116,NA,12655,653,12649,GSE132010,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: NT sgRNA #2 | tissue: HCT116 colon cancer cell line
5434,GSM3889077,HEK293T,HEK293T,628,HEK293T,NA,12012,628,12016,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: DMSO
5435,GSM3889078,HEK293T,HEK293T,628,HEK293T,NA,12013,628,12017,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: DMSO
5436,GSM3889079,HEK293T,HEK293T,628,HEK293T,NA,12014,628,12018,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: Torin 1
5437,GSM3889080,HEK293T,HEK293T,628,HEK293T,NA,12015,628,12019,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: Torin 1
5438,GSM3889081,HEK293T,HEK293T,628,HEK293T,NA,12016,628,12012,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: DMSO
5439,GSM3889082,HEK293T,HEK293T,628,HEK293T,NA,12017,628,12013,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: DMSO
5440,GSM3889083,HEK293T,HEK293T,628,HEK293T,NA,12018,628,12014,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: Torin 1
5441,GSM3889084,HEK293T,HEK293T,628,HEK293T,NA,12019,628,12015,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,HEK-293T,cell line: HEK-293T | genotype/variation: wild-type | treatment: Torin 1
5442,GSM3889085,HEK293T,HEK293T,628,HEK293T,NA,12020,628,12024,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: DMSO
5443,GSM3889086,HEK293T,HEK293T,628,HEK293T,NA,12021,628,12025,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: DMSO
5444,GSM3889087,HEK293T,HEK293T,628,HEK293T,NA,12022,628,12026,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: Torin 1
5445,GSM3889088,HEK293T,HEK293T,628,HEK293T,NA,12023,628,12027,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: Torin 1
5446,GSM3889089,HEK293T,HEK293T,628,HEK293T,NA,12024,628,12020,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: DMSO
5447,GSM3889090,HEK293T,HEK293T,628,HEK293T,NA,12025,628,12021,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: DMSO
5448,GSM3889091,HEK293T,HEK293T,628,HEK293T,NA,12026,628,12022,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: Torin 1
5449,GSM3889092,HEK293T,HEK293T,628,HEK293T,NA,12027,628,12023,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1",cell line: HEK-293T | genotype/variation: sgLARP1 | treatment: Torin 1
5450,GSM3889093,HEK293T,HEK293T,628,HEK293T,NA,12028,628,12032,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: DMSO
5451,GSM3889094,HEK293T,HEK293T,628,HEK293T,NA,12029,628,12033,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: DMSO
5452,GSM3889095,HEK293T,HEK293T,628,HEK293T,NA,12030,628,12034,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: Torin 1
5453,GSM3889096,HEK293T,HEK293T,628,HEK293T,NA,12031,628,12035,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: Torin 1
5454,GSM3889097,HEK293T,HEK293T,628,HEK293T,NA,12032,628,12028,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: DMSO
5455,GSM3889098,HEK293T,HEK293T,628,HEK293T,NA,12033,628,12029,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: DMSO
5456,GSM3889099,HEK293T,HEK293T,628,HEK293T,NA,12034,628,12030,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: Torin 1
5457,GSM3889100,HEK293T,HEK293T,628,HEK293T,NA,12035,628,12031,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,"HEK-293T, sgLARP1+sgLARP1B",cell line: HEK-293T | genotype/variation: sgLARP1/1B | treatment: Torin 1
5458,GSM3890764,HEK293T,HEK293T,700,HEK293T,NA,13793,700,13797,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type
5459,GSM3890765,HEK293T,HEK293T,700,HEK293T,NA,13794,700,13798,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type
5460,GSM3890766,HEK293T,HEK293T,700,HEK293T,NA,13795,700,13799,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: XRN1-null
5461,GSM3890767,HEK293T,HEK293T,700,HEK293T,NA,13796,700,13800,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: XRN1-null
5462,GSM3890768,HEK293T,HEK293T,700,HEK293T,NA,13797,700,13793,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type
5463,GSM3890769,HEK293T,HEK293T,700,HEK293T,NA,13798,700,13794,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type
5464,GSM3890770,HEK293T,HEK293T,700,HEK293T,NA,13799,700,13795,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: XRN1-null
5465,GSM3890771,HEK293T,HEK293T,700,HEK293T,NA,13800,700,13796,GSE132725,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: XRN1-null
5466,GSM3900208,,,719,A549,,14054,719,14060,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5467,GSM3900209,,,719,A549,,14055,719,14061,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5468,GSM3900210,,,719,A549,,14056,719,14062,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5469,GSM3900211,,,719,A549,,14057,719,14063,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP1_1 | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5470,GSM3900212,,,719,A549,,14058,719,14064,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP2_1 | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5471,GSM3900213,,,719,A549,,14059,719,14065,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP2_4 | viral strain: Dengue 2, strain New Guinea C | sample treatment: Ribo seq"
5472,GSM3900214,,,719,A549,,14060,719,14054,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5473,GSM3900215,,,719,A549,,14061,719,14055,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5474,GSM3900216,,,719,A549,,14062,719,14056,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: Control | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5475,GSM3900217,,,719,A549,,14063,719,14057,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP1_1 | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5476,GSM3900218,,,719,A549,,14064,719,14058,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP2_1 | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5477,GSM3900219,,,719,A549,,14065,719,14059,GSE133111,Homo sapiens,,A549,A549,RPLP1 and RPLP2 depleted A549 cells infected with DENV.,"cell type: A549 | sirna: siP2_4 | viral strain: Dengue 2, strain New Guinea C | sample treatment: RNA seq"
5478,GSM3905622,HEK293T,HEK293T,690,HEK293T,NA,13657,690,NA,GSE133315,Homo sapiens,HEK293T,hek293t,HEK293T,Human Embryonic Kidney_Flp-InÃ¢Â„Â¢ 293Ã‚Â T-REx,genotype: Wildtype
5479,GSM3905623,HEK293T,HEK293T,690,HEK293T,NA,13658,690,NA,GSE133315,Homo sapiens,HEK293T,hek293t,HEK293T,Human Embryonic Kidney_Flp-InÃ¢Â„Â¢ 293Ã‚Â T-REx,genotype: C6orf203 -/-
5480,GSM3907597,HEK293,HEK293,585,HEK293,NA,11427,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,monosome_rep1,genotype: WT | cell line: HEK293
5481,GSM3907598,HEK293,HEK293,585,HEK293,NA,11428,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,monosome_rep2,genotype: WT | cell line: HEK293
5482,GSM3907599,HEK293,HEK293,585,HEK293,NA,11429,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,disome_rep1,genotype: WT | cell line: HEK293
5483,GSM3907600,HEK293,HEK293,585,HEK293,NA,11430,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,disome_rep2,genotype: WT | cell line: HEK293
5520,GSM3930171,MOLM-13,MOLM-13,708,MOLM-13,NA,13880,708,13884,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5521,GSM3930172,MOLM-13,MOLM-13,708,MOLM-13,NA,13881,708,13885,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5522,GSM3930173,MOLM-13,MOLM-13,708,MOLM-13,NA,13882,708,13886,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5523,GSM3930174,MOLM-13,MOLM-13,708,MOLM-13,NA,13883,708,13887,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5524,GSM3930175,MOLM-13,MOLM-13,708,MOLM-13,NA,13884,708,13880,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5525,GSM3930176,MOLM-13,MOLM-13,708,MOLM-13,NA,13885,708,13881,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5526,GSM3930177,MOLM-13,MOLM-13,708,MOLM-13,NA,13886,708,13882,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5527,GSM3930178,MOLM-13,MOLM-13,708,MOLM-13,NA,13887,708,13883,GSE133925,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: MOLM-13 | cell type: acute myeloid leukemia cells
5560,GSM3940762,MCF10-A,MCF10A,575,MCF10A,NA,11250,575,NA,GSE131074,Homo sapiens,MCF10A,mcf10a,MCF10A,MCF10-A cell lines,cell line: MCF10-A | cell type: epithelial | treatment: Selective RPF
5573,GSM3944586,HeLa,HeLa,572,HeLa,NA,11165,572,11185,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA
5574,GSM3944587,HeLa,HeLa,572,HeLa,NA,11166,572,11186,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA
5575,GSM3944588,HeLa,HeLa,572,HeLa,NA,11167,572,11187,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA
5576,GSM3944589,HeLa,HeLa,572,HeLa,NA,11168,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5577,GSM3944590,HeLa,HeLa,572,HeLa,NA,11169,572,11188,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA
5578,GSM3944591,HeLa,HeLa,572,HeLa,NA,11170,572,11189,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA
5579,GSM3944592,HeLa,HeLa,572,HeLa,NA,11171,572,11190,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA
5580,GSM3944593,HeLa,HeLa,572,HeLa,NA,11172,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5581,GSM3944594,HeLa,HeLa,572,HeLa,NA,11173,572,11191,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA
5582,GSM3944595,HeLa,HeLa,572,HeLa,NA,11174,572,11192,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA
5583,GSM3944596,HeLa,HeLa,572,HeLa,NA,11175,572,11193,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA
5584,GSM3944597,HeLa,HeLa,572,HeLa,NA,11176,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5585,GSM3944598,HeLa,HeLa,572,HeLa,NA,11177,572,11194,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA
5586,GSM3944599,HeLa,HeLa,572,HeLa,NA,11178,572,11195,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA
5587,GSM3944600,HeLa,HeLa,572,HeLa,NA,11179,572,11196,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA
5588,GSM3944601,HeLa,HeLa,572,HeLa,NA,11180,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5589,GSM3944602,HeLa,HeLa,572,HeLa,NA,11181,572,11197,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA"
5590,GSM3944603,HeLa,HeLa,572,HeLa,NA,11182,572,11198,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA"
5591,GSM3944604,HeLa,HeLa,572,HeLa,NA,11183,572,11199,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA"
5592,GSM3944605,HeLa,HeLa,572,HeLa,NA,11184,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in"
5593,GSM3944606,HeLa,HeLa,572,HeLa,NA,11185,572,11165,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: RNase digested and rRNA depleted RNA
5594,GSM3944607,HeLa,HeLa,572,HeLa,NA,11186,572,11166,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: RNase digested and rRNA depleted RNA
5595,GSM3944608,HeLa,HeLa,572,HeLa,NA,11187,572,11167,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: RNase digested and rRNA depleted RNA
5596,GSM3944609,HeLa,HeLa,572,HeLa,NA,11188,572,11169,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: RNase digested and rRNA depleted RNA
5597,GSM3944610,HeLa,HeLa,572,HeLa,NA,11189,572,11170,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: RNase digested and rRNA depleted RNA
5598,GSM3944611,HeLa,HeLa,572,HeLa,NA,11190,572,11171,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: RNase digested and rRNA depleted RNA
5599,GSM3944612,HeLa,HeLa,572,HeLa,NA,11191,572,11173,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: RNase digested and rRNA depleted RNA
5600,GSM3944613,HeLa,HeLa,572,HeLa,NA,11192,572,11174,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: RNase digested and rRNA depleted RNA
5601,GSM3944614,HeLa,HeLa,572,HeLa,NA,11193,572,11175,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: RNase digested and rRNA depleted RNA
5602,GSM3944615,HeLa,HeLa,572,HeLa,NA,11194,572,11177,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: RNase digested and rRNA depleted RNA
5603,GSM3944616,HeLa,HeLa,572,HeLa,NA,11195,572,11178,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: RNase digested and rRNA depleted RNA
5604,GSM3944617,HeLa,HeLa,572,HeLa,NA,11196,572,11179,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: RNase digested and rRNA depleted RNA
5605,GSM3944618,HeLa,HeLa,572,HeLa,NA,11197,572,11181,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: RNase digested and rRNA depleted RNA"
5606,GSM3944619,HeLa,HeLa,572,HeLa,NA,11198,572,11182,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: RNase digested and rRNA depleted RNA"
5607,GSM3944620,HeLa,HeLa,572,HeLa,NA,11199,572,11183,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: RNase digested and rRNA depleted RNA"
5608,GSM3944621,HeLa,HeLa,572,HeLa,NA,11200,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 and DF2 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5609,GSM3944622,HeLa,HeLa,572,HeLa,NA,11201,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 and DF2 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5610,GSM3944623,HeLa,HeLa,572,HeLa,NA,11202,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 and DF3 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5611,GSM3944624,HeLa,HeLa,572,HeLa,NA,11203,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 and DF3 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5612,GSM3944625,HeLa,HeLa,572,HeLa,NA,11204,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5613,GSM3944626,HeLa,HeLa,572,HeLa,NA,11205,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA | spike-in: ERCC-1 spike in
5614,GSM3944627,HeLa,HeLa,572,HeLa,NA,11206,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5615,GSM3944628,HeLa,HeLa,572,HeLa,NA,11207,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: control siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5616,GSM3944629,HeLa,HeLa,572,HeLa,NA,11208,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5617,GSM3944630,HeLa,HeLa,572,HeLa,NA,11209,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF1 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5618,GSM3944631,HeLa,HeLa,572,HeLa,NA,11210,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5619,GSM3944632,HeLa,HeLa,572,HeLa,NA,11211,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF2 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5620,GSM3944633,HeLa,HeLa,572,HeLa,NA,11212,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5621,GSM3944634,HeLa,HeLa,572,HeLa,NA,11213,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,sirna: DF3 siRNA | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in
5622,GSM3944635,HeLa,HeLa,572,HeLa,NA,11214,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in"
5623,GSM3944636,HeLa,HeLa,572,HeLa,NA,11215,572,NA,GSE134380,Homo sapiens,HeLa,hela,HeLa,HeLa,"sirna: DF1,DF2 and DF3 siRNAs | rna processing: rRNA depleted RNA | treatment: Actinomycin D for 2 hours | spike-in: ERCC-1 spike in"
5624,GSM3954920,HEK293,HEK293,675,HEK293,NA,13200,675,13203,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5625,GSM3954921,HEK293,HEK293,675,HEK293,NA,13201,675,13204,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5626,GSM3954922,HEK293,HEK293,675,HEK293,NA,13202,675,13205,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5627,GSM3954923,HEK293,HEK293,675,HEK293,NA,13203,675,13200,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5628,GSM3954924,HEK293,HEK293,675,HEK293,NA,13204,675,13201,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5629,GSM3954925,HEK293,HEK293,675,HEK293,NA,13205,675,13202,GSE134517,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna treatment: Control siRNA | cell line: HEK293
5690,GSM3966943,HEK293T,HEK293T,647,HEK293T,NA,12449,647,12455,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5691,GSM3966944,HEK293T,HEK293T,647,HEK293T,NA,12450,647,12456,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5692,GSM3966945,HEK293T,HEK293T,647,HEK293T,NA,12451,647,12457,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72Hmax and 46med
5693,GSM3966946,HEK293T,HEK293T,647,HEK293T,NA,12452,647,12458,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72Hmax and 46med
5694,GSM3966947,HEK293T,HEK293T,647,HEK293T,NA,12453,647,12459,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72min
5695,GSM3966948,HEK293T,HEK293T,647,HEK293T,NA,12454,647,12460,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72min
5696,GSM3966949,HEK293T,HEK293T,647,HEK293T,NA,12455,647,12449,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5697,GSM3966950,HEK293T,HEK293T,647,HEK293T,NA,12456,647,12450,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5698,GSM3966951,HEK293T,HEK293T,647,HEK293T,NA,12457,647,12451,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72Hmax and 46med
5699,GSM3966952,HEK293T,HEK293T,647,HEK293T,NA,12458,647,12452,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72Hmax and 46med
5700,GSM3966953,HEK293T,HEK293T,647,HEK293T,NA,12459,647,12453,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72min
5701,GSM3966954,HEK293T,HEK293T,647,HEK293T,NA,12460,647,12454,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,na constructs: 72min
5702,GSM3966955,HEK293T,HEK293T,647,HEK293T,NA,12461,647,12462,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5703,GSM3966956,HEK293T,HEK293T,647,HEK293T,NA,12462,647,12461,GSE134752,Homo sapiens,HEK293T,hek293t,HEK293T,Transfected HEK 293T cells,"na constructs: 27wt, 72Lmax and 27min"
5704,GSM3984242,HEK293T,HEK293T,661,HEK293T,NA,12768,661,12765,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: total RNA input
5705,GSM3984243,HEK293T,HEK293T,661,HEK293T,NA,12769,661,12768,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5706,GSM3984244,HEK293T,HEK293T,661,HEK293T,NA,12770,661,12771,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: total RNA input
5707,GSM3984245,HEK293T,HEK293T,661,HEK293T,NA,12771,661,12766,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5708,GSM3984246,HEK293T,HEK293T,661,HEK293T,NA,12772,661,12773,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: total RNA input
5709,GSM3984247,HEK293T,HEK293T,661,HEK293T,NA,12773,661,12772,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5710,GSM3984248,HEK293T,HEK293T,661,HEK293T,NA,12774,661,12775,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: total RNA input
5711,GSM3984249,HEK293T,HEK293T,661,HEK293T,NA,12775,661,12774,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: WT | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5712,GSM3984250,HEK293T,HEK293T,661,HEK293T,NA,12776,661,12777,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: total RNA input
5713,GSM3984251,HEK293T,HEK293T,661,HEK293T,NA,12777,661,12776,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5714,GSM3984252,HEK293T,HEK293T,661,HEK293T,NA,12778,661,12779,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: total RNA input
5715,GSM3984253,HEK293T,HEK293T,661,HEK293T,NA,12779,661,12778,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5716,GSM3984254,HEK293T,HEK293T,661,HEK293T,NA,12780,661,12781,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: total RNA input
5717,GSM3984255,HEK293T,HEK293T,661,HEK293T,NA,12781,661,12780,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5718,GSM3984256,HEK293T,HEK293T,661,HEK293T,NA,12782,661,12783,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: total RNA input
5719,GSM3984257,HEK293T,HEK293T,661,HEK293T,NA,12783,661,12782,GSE124558,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: PUS10 -/- | cell line: HEK293T | molecule subtype: Ribosome protected RNA
5720,GSM4006924,HSB2,HSB2,689,HSB2,NA,13643,689,13646,GSE135363,Homo sapiens,HSB2,hsb2,HSB2,HSB2 infected with HHV-6A 72hpi,cell line: HSB2 | strain: HHV-6A GS | hours post infection: 72
5721,GSM4006925,HSB2,HSB2,689,HSB2,NA,13644,689,NA,GSE135363,Homo sapiens,HSB2,hsb2,HSB2,HSB2 infected with HHV-6A 72hpi,cell line: HSB2 | strain: HHV-6A GS | hours post infection: 72
5722,GSM4006926,HSB2,HSB2,689,HSB2,NA,13645,689,NA,GSE135363,Homo sapiens,HSB2,hsb2,HSB2,HSB2 infected with HHV-6A 72hpi,cell line: HSB2 | strain: HHV-6A GS | hours post infection: 72
5723,GSM4006927,HSB2,HSB2,689,HSB2,NA,13646,689,13643,GSE135363,Homo sapiens,HSB2,hsb2,HSB2,HSB2 infected with HHV-6A 72hpi,cell line: HSB2 | strain: HHV-6A GS | hours post infection: 72
5724,GSM4006928,Molt-3,Molt-3,689,Molt-3,NA,13647,689,13650,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5725,GSM4006929,Molt-3,Molt-3,689,Molt-3,NA,13648,689,NA,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5726,GSM4006930,Molt-3,Molt-3,689,Molt-3,NA,13649,689,NA,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5727,GSM4006931,Molt-3,Molt-3,689,Molt-3,NA,13650,689,13647,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5728,GSM4006932,Molt-3,Molt-3,689,Molt-3,NA,13651,689,13654,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 05hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 5
5729,GSM4006933,Molt-3,Molt-3,689,Molt-3,NA,13652,689,13655,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 24hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 24
5730,GSM4006934,Molt-3,Molt-3,689,Molt-3,NA,13653,689,13656,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5731,GSM4006935,Molt-3,Molt-3,689,Molt-3,NA,13654,689,13651,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 05hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 5
5732,GSM4006936,Molt-3,Molt-3,689,Molt-3,NA,13655,689,13652,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 24hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 24
5733,GSM4006937,Molt-3,Molt-3,689,Molt-3,NA,13656,689,13653,GSE135363,Homo sapiens,Molt-3,molt-3,Molt-3,Molt-3 cells infected with HHV-6B 72hpi,cell line: Molt-3 | strain: HHV-6B Z29 | hours post infection: 72
5802,GSM4054749,HCT116,HCT116,686,HCT116,NA,13580,686,13584,GSE136664,Homo sapiens,HCT116,hct116,HCT116,Ribo-seq after YTHDF1 knockdown with shY1,cell line: HCT116 | genotype/variation: YTHDF1 knockdown with shY1
5803,GSM4054750,HCT116,HCT116,686,HCT116,NA,13581,686,13585,GSE136664,Homo sapiens,HCT116,hct116,HCT116,Ribo-seq after YTHDF1 knockdown with shY1,cell line: HCT116 | genotype/variation: YTHDF1 knockdown with shY1
5804,GSM4054751,HCT116,HCT116,686,HCT116,NA,13582,686,13583,GSE136664,Homo sapiens,HCT116,hct116,HCT116,Ribo-seq fom control cells,cell line: HCT116 | genotype/variation: control
5805,GSM4054752,HCT116,HCT116,686,HCT116,NA,13583,686,13582,GSE136664,Homo sapiens,HCT116,hct116,HCT116,mRNA-seq fom control cells,cell line: HCT116 | genotype/variation: control
5806,GSM4054753,HCT116,HCT116,686,HCT116,NA,13584,686,13580,GSE136664,Homo sapiens,HCT116,hct116,HCT116,mRNA-seq after YTHDF1 knockdown with shY1,cell line: HCT116 | genotype/variation: YTHDF1 knockdown with shY1
5807,GSM4054754,HCT116,HCT116,686,HCT116,NA,13585,686,13581,GSE136664,Homo sapiens,HCT116,hct116,HCT116,mRNA-seq after YTHDF1 knockdown with shY1,cell line: HCT116 | genotype/variation: YTHDF1 knockdown with shY1
5808,GSM4054755,HCT116,HCT116,686,HCT116,NA,13586,686,NA,GSE136664,Homo sapiens,HCT116,hct116,HCT116,mRNA-seq from whole cell lysate,cell line: HCT116 | genotype/variation: control
5809,GSM4062072,HEK 293T,HEK293T,816,HEK293T,NA,15508,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Pre-treated with CHX, lyzed in buffer containing CHX"
5810,GSM4062073,HEK 293T,HEK293T,816,HEK293T,NA,15509,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Pre-treated with CHX, lyzed in buffer containing CHX"
5811,GSM4062074,HEK 293T,HEK293T,816,HEK293T,NA,15510,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Pre-treated with CHX, lyzed in buffer containing CHX"
5812,GSM4062075,HEK 293T,HEK293T,816,HEK293T,NA,15511,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, lyzed in buffer containing CHX"
5813,GSM4062076,HEK 293T,HEK293T,816,HEK293T,NA,15512,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, lyzed in buffer containing CHX"
5814,GSM4062077,HEK 293T,HEK293T,816,HEK293T,NA,15513,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, lyzed in buffer containing CHX"
5815,GSM4062078,HEK 293T,HEK293T,816,HEK293T,NA,15514,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, not lyzed in buffer containing CHX"
5816,GSM4062079,HEK 293T,HEK293T,816,HEK293T,NA,15515,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, not lyzed in buffer containing CHX"
5817,GSM4062080,HEK 293T,HEK293T,816,HEK293T,NA,15516,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,"cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: Not pre-treated with CHX, not lyzed in buffer containing CHX"
5818,GSM4062081,HEK 293T,HEK293T,816,HEK293T,NA,15517,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 2min 100ug CHX
5819,GSM4062082,HEK 293T,HEK293T,816,HEK293T,NA,15518,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 5min 100ug CHX
5820,GSM4062083,HEK 293T,HEK293T,816,HEK293T,NA,15519,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 1min 200ug CHX
5821,GSM4062084,HEK 293T,HEK293T,816,HEK293T,NA,15520,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 2min 200ug CHX
5822,GSM4062085,HEK 293T,HEK293T,816,HEK293T,NA,15521,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 300U RNaseI
5823,GSM4062086,HEK 293T,HEK293T,816,HEK293T,NA,15522,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 500U RNaseI
5824,GSM4062087,HEK 293T,HEK293T,816,HEK293T,NA,15523,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 700U RNaseI
5825,GSM4062088,HEK 293T,HEK293T,816,HEK293T,NA,15524,816,NA,GSE136940,Homo sapiens,HEK293T,hek293t,HEK293T,Human embryonic kidney cells,cell line: HEK 293T | cell type: Embryonic kidney cell line | treatment: 900U RNaseI
5826,GSM4075578,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,15270,279,15274,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,human dopamine neurons,strain: mutation-corrected | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
5827,GSM4075579,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,15271,279,15275,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,human dopamine neurons,strain: mutation-corrected | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: wild-type
5828,GSM4075580,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,15272,279,15276,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,human dopamine neurons,strain: patient-derived | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
5829,GSM4075581,iPSC-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,279,iPSC-differentiated dopamine neurons,NA,15273,279,15277,GSE90469,Homo sapiens,iPSC-differentiated dopamine neurons,ipsc-differentiated dopamine neurons,iPSC-differentiated dopamine neurons,human dopamine neurons,strain: patient-derived | tissue: iPSC-differentiated dopamine neurons | age: Differentiation day 60 | genotype: G2019S LRRK2
5846,GSM4110749,RPE-1,RPE-1,636,RPE-1,NA,12327,636,12333,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5847,GSM4110750,RPE-1,RPE-1,636,RPE-1,NA,12328,636,12334,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5848,GSM4110751,RPE-1,RPE-1,636,RPE-1,NA,12329,636,12335,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5849,GSM4110752,RPE-1,RPE-1,636,RPE-1,NA,12330,636,12336,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5850,GSM4110753,RPE-1,RPE-1,636,RPE-1,NA,12331,636,12337,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5851,GSM4110754,RPE-1,RPE-1,636,RPE-1,NA,12332,636,12338,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5852,GSM4110755,RPE-1,RPE-1,636,RPE-1,NA,12333,636,12327,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5853,GSM4110756,RPE-1,RPE-1,636,RPE-1,NA,12334,636,12328,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5854,GSM4110757,RPE-1,RPE-1,636,RPE-1,NA,12335,636,12329,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: PDCD4-siRNA2 (100 nM) | passages: 12-14
5855,GSM4110758,RPE-1,RPE-1,636,RPE-1,NA,12336,636,12330,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5856,GSM4110759,RPE-1,RPE-1,636,RPE-1,NA,12337,636,12331,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5857,GSM4110760,RPE-1,RPE-1,636,RPE-1,NA,12338,636,12332,GSE138533,Homo sapiens,RPE-1,rpe-1,RPE-1,hTERT-RPE-1,cell type: hTERT-immortalized retinal pigment epithelial cell line | treatment: control-siRNA (100 nM) | passages: 12-14
5858,GSM4114767,HEK293T,HEK293T,637,HEK293T,NA,12339,637,12357,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling A,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5859,GSM4114768,HEK293T,HEK293T,637,HEK293T,NA,12340,637,12358,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling B,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5860,GSM4114769,HEK293T,HEK293T,637,HEK293T,NA,12341,637,12359,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL ribosome profiling A,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5861,GSM4114770,HEK293T,HEK293T,637,HEK293T,NA,12342,637,12360,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL ribosome profiling B,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5862,GSM4114771,HEK293T,HEK293T,637,HEK293T,NA,12343,637,12361,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 2000 ug/mL ribosome profiling A,cell line: HEK293T cells | treatment: G418 | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5863,GSM4114772,HEK293T,HEK293T,637,HEK293T,NA,12344,637,12362,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 2000 ug/mL ribosome profiling B,cell line: HEK293T cells | treatment: G418 | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5864,GSM4114773,HEK293T,HEK293T,637,HEK293T,NA,12345,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Gentamicin ribosome profiling A,cell line: HEK293T cells | treatment: Gentamicin | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5865,GSM4114774,HEK293T,HEK293T,637,HEK293T,NA,12346,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Gentamicin ribosome profiling B,cell line: HEK293T cells | treatment: Gentamicin | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5866,GSM4114775,HEK293T,HEK293T,637,HEK293T,NA,12347,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Paromomycin ribosome profiling A,cell line: HEK293T cells | treatment: Paromomycin | concentration: 3000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5867,GSM4114776,HEK293T,HEK293T,637,HEK293T,NA,12348,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Paromomycin ribosome profiling B,cell line: HEK293T cells | treatment: Paromomycin | concentration: 3000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5868,GSM4114777,HEK293T,HEK293T,637,HEK293T,NA,12349,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Neomycin ribosome profiling A,cell line: HEK293T cells | treatment: Neomycin | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5869,GSM4114778,HEK293T,HEK293T,637,HEK293T,NA,12350,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Neomycin ribosome profiling B,cell line: HEK293T cells | treatment: Neomycin | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5870,GSM4114779,HEK293T,HEK293T,637,HEK293T,NA,12351,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Tobramycin ribosome profiling A,cell line: HEK293T cells | treatment: Tobramycin | concentration: 1000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5871,GSM4114780,HEK293T,HEK293T,637,HEK293T,NA,12352,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Tobramycin ribosome profiling B,cell line: HEK293T cells | treatment: Tobramycin | concentration: 1000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5872,GSM4114781,HEK293T,HEK293T,637,HEK293T,NA,12353,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Amikacin ribosome profiling A,cell line: HEK293T cells | treatment: Amikacin | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5873,GSM4114782,HEK293T,HEK293T,637,HEK293T,NA,12354,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Amikacin ribosome profiling B,cell line: HEK293T cells | treatment: Amikcain | concentration: 2000 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5874,GSM4114783,HEK293T,HEK293T,637,HEK293T,NA,12355,637,12363,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL 10-min ribosome profiling A,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 10 minutes | adapter: NNNNNNCACTCGGGCACCAAGGAC
5875,GSM4114784,HEK293T,HEK293T,637,HEK293T,NA,12356,637,12364,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL 10-min ribosome profiling B,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 10 minutes | adapter: NNNNNNCACTCGGGCACCAAGGAC
5876,GSM4114785,HEK293T,HEK293T,637,HEK293T,NA,12357,637,12339,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated RNAseq A,"cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5877,GSM4114786,HEK293T,HEK293T,637,HEK293T,NA,12358,637,12340,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated RNAseq B,"cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5878,GSM4114787,HEK293T,HEK293T,637,HEK293T,NA,12359,637,12341,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL RNAseq A,"cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5879,GSM4114788,HEK293T,HEK293T,637,HEK293T,NA,12360,637,12342,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL RNAseq B,"cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5880,GSM4114789,HEK293T,HEK293T,637,HEK293T,NA,12361,637,12343,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 2000 ug/mL RNAseq A,"cell line: HEK293T cells | treatment: G418 | concentration: 2000 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5881,GSM4114790,HEK293T,HEK293T,637,HEK293T,NA,12362,637,12344,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 2000 ug/mL RNAseq B,"cell line: HEK293T cells | treatment: G418 | concentration: 2000 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5882,GSM4114791,HEK293T,HEK293T,637,HEK293T,NA,12363,637,12355,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL 10-min RNAseq A,"cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 10 minutes | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5883,GSM4114792,HEK293T,HEK293T,637,HEK293T,NA,12364,637,12356,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL 10-min RNAseq B,"cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 10 minutes | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5884,GSM4114793,HEK293T,HEK293T,637,HEK293T,NA,12365,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling A,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5885,GSM4114794,HEK293T,HEK293T,637,HEK293T,NA,12366,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling B,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5886,GSM4114795,HEK293T,HEK293T,637,HEK293T,NA,12367,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL ribosome profiling A,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5887,GSM4114796,HEK293T,HEK293T,637,HEK293T,NA,12368,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL ribosome profiling B,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5888,GSM4114797,HEK293T,HEK293T,637,HEK293T,NA,12369,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling A,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: CTGTAGGCACCATCAAT
5889,GSM4114798,HEK293T,HEK293T,637,HEK293T,NA,12370,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling B,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: CTGTAGGCACCATCAAT
5890,GSM4114799,HEK293T,HEK293T,637,HEK293T,NA,12371,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 500 ug/mL ribosome profiling A,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: CTGTAGGCACCATCAAT
5891,GSM4114800,HEK293T,HEK293T,637,HEK293T,NA,12372,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,Untreated ribosome profiling A,cell line: HEK293T cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5892,GSM4114801,HEK293T,HEK293T,637,HEK293T,NA,12373,637,NA,GSE138643,Homo sapiens,HEK293T,hek293t,HEK293T,G418 ribosome profiilng A,cell line: HEK293T cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC
5893,GSM4114802,Calu-6,Calu-6,637,Calu-6,NA,12374,637,12376,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,Untreated ribosome profiling A,cell line: Calu-6 cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: CTGTAGGCACCATCAAT
5894,GSM4114803,Calu-6,Calu-6,637,Calu-6,NA,12375,637,12378,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,G418 500 ug/mL ribosome profiling A,cell line: Calu-6 cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: CTGTAGGCACCATCAAT
5895,GSM4114804,Calu-6,Calu-6,637,Calu-6,NA,12376,637,12374,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,Untreated RNA-seq A,"cell line: Calu-6 cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5896,GSM4114805,Calu-6,Calu-6,637,Calu-6,NA,12377,637,NA,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,Untreated RNA-seq B,"cell line: Calu-6 cells | treatment: Untreated | concentration: 0 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5897,GSM4114806,Calu-6,Calu-6,637,Calu-6,NA,12378,637,12375,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,G418 500 ug/mL RNA-seq A,"cell line: Calu-6 cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5898,GSM4114807,Calu-6,Calu-6,637,Calu-6,NA,12379,637,NA,GSE138643,Homo sapiens,Calu-6,calu-6,Calu-6,G418 500 ug/mL RNA-seq B,"cell line: Calu-6 cells | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: AGATCGGAAGAGCACACGTCTGAACTCCAGTCAC, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGTA"
5899,GSM4131413,HEK293T,HEK293T,560,HEK293T,NA,10958,560,NA,,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,antibody: no | cell line: HEK293T | protocol: RNA-seq
5900,GSM4134480,TS543,TS543,673,TS543,NA,13184,673,13190,,Homo sapiens,TS543,ts543,TS543,,
5901,GSM4134481,TS543,TS543,673,TS543,NA,13185,673,13191,,Homo sapiens,TS543,ts543,TS543,,
5902,GSM4134482,TS543,TS543,673,TS543,NA,13186,673,13192,,Homo sapiens,TS543,ts543,TS543,,
5903,GSM4134483,TS543,TS543,673,TS543,NA,13187,673,13193,,Homo sapiens,TS543,ts543,TS543,,
5904,GSM4134484,TS543,TS543,673,TS543,NA,13188,673,13194,,Homo sapiens,TS543,ts543,TS543,,
5905,GSM4134485,TS543,TS543,673,TS543,NA,13189,673,13195,,Homo sapiens,TS543,ts543,TS543,,
5906,GSM4134486,TS543,TS543,673,TS543,NA,13190,673,13184,,Homo sapiens,TS543,ts543,TS543,,
5907,GSM4134487,TS543,TS543,673,TS543,NA,13191,673,13185,,Homo sapiens,TS543,ts543,TS543,,
5908,GSM4134488,TS543,TS543,673,TS543,NA,13192,673,13186,,Homo sapiens,TS543,ts543,TS543,,
5909,GSM4134489,TS543,TS543,673,TS543,NA,13193,673,13187,,Homo sapiens,TS543,ts543,TS543,,
5910,GSM4134490,TS543,TS543,673,TS543,NA,13194,673,13188,,Homo sapiens,TS543,ts543,TS543,,
5911,GSM4134491,TS543,TS543,673,TS543,NA,13195,673,13189,,Homo sapiens,TS543,ts543,TS543,,
5920,GSM4146393,HEK293T,HEK293T,628,HEK293T,NA,12036,628,NA,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,RPF from sgLARP1+sgLARP1B HEK-293T cells treated with DMSO for 2h,cell line: HEK-293T | genotype/variation: sgLARP1+sgLARP1B | treatment: DMSO for 2h | molecule subtype: RNA  (RPFs)
5921,GSM4146394,HEK293T,HEK293T,628,HEK293T,NA,12037,628,NA,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,RPF from sgLARP1+sgLARP1B HEK-293T cells treated with DMSO for 2h,cell line: HEK-293T | genotype/variation: sgLARP1+sgLARP1B | treatment: DMSO for 2h | molecule subtype: RNA  (RPFs)
5922,GSM4146395,HEK293T,HEK293T,628,HEK293T,NA,12038,628,NA,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,RPF from sgLARP1+sgLARP1B HEK-293T cells treated with 250 nM Torin 1 for 2h,cell line: HEK-293T | genotype/variation: sgLARP1+sgLARP1B | treatment: 250 nM Torin 1 for 2h | molecule subtype: RNA  (RPFs)
5923,GSM4146396,HEK293T,HEK293T,628,HEK293T,NA,12039,628,NA,GSE132703,Homo sapiens,HEK293T,hek293t,HEK293T,RPF from sgLARP1+sgLARP1B HEK-293T cells treated with 250 nM Torin 1 for 2h,cell line: HEK-293T | genotype/variation: sgLARP1+sgLARP1B | treatment: 250 nM Torin 1 for 2h | molecule subtype: RNA  (RPFs)
5924,GSM4148613,PATU-8902,PATU-8902,505,PATU-8902,NA,9750,505,9756,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5925,GSM4148614,PATU-8902,PATU-8902,505,PATU-8902,NA,9751,505,9757,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5926,GSM4148615,PATU-8902,PATU-8902,505,PATU-8902,NA,9752,505,9758,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5927,GSM4148616,PATU-8902,PATU-8902,505,PATU-8902,NA,9753,505,9759,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5928,GSM4148617,PATU-8902,PATU-8902,505,PATU-8902,NA,9754,505,9760,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5929,GSM4148618,PATU-8902,PATU-8902,505,PATU-8902,NA,9755,505,9761,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5930,GSM4148619,PATU-8902,PATU-8902,505,PATU-8902,NA,9756,505,9750,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5931,GSM4148620,PATU-8902,PATU-8902,505,PATU-8902,NA,9757,505,9751,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5932,GSM4148621,PATU-8902,PATU-8902,505,PATU-8902,NA,9758,505,9752,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: +Ser/Gly
5933,GSM4148622,PATU-8902,PATU-8902,505,PATU-8902,NA,9759,505,9753,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5934,GSM4148623,PATU-8902,PATU-8902,505,PATU-8902,NA,9760,505,9754,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5935,GSM4148624,PATU-8902,PATU-8902,505,PATU-8902,NA,9761,505,9755,GSE139910,Homo sapiens,PATU-8902,patu-8902,PATU-8902,PATU-8902,cell line: PATU-8902 | cell type: Pancreactic Ductal Adenocarcinoma Cell Line | treatment: -Ser/Gly
5936,GSM4154182,Hela,HeLa,551,HeLa,NA,10775,551,10778,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: WT | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: CGTGAT
5937,GSM4154183,Hela,HeLa,551,HeLa,NA,10776,551,10779,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: CTGATC
5938,GSM4154184,Hela,HeLa,551,HeLa,NA,10777,551,10780,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: TACAAG
5939,GSM4154185,Hela,HeLa,551,HeLa,NA,10778,551,10775,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: WT | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: GCTGTA
5940,GSM4154186,Hela,HeLa,551,HeLa,NA,10779,551,10776,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: ATTATA
5941,GSM4154187,Hela,HeLa,551,HeLa,NA,10780,551,10777,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Nextflex small RNA | rrna depletion: Ribo Zero Gold Illumina | index sequence: GAATGA
5942,GSM4160132,HEK293,HEK293,532,HEK293,NA,10469,532,10475,GSE140367,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None
5943,GSM4160133,HEK293,HEK293,532,HEK293,NA,10470,532,10476,GSE140367,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None
5944,GSM4160134,HEK293,HEK293,532,HEK293,NA,10471,532,10477,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-1
5945,GSM4160135,HEK293,HEK293,532,HEK293,NA,10472,532,10478,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-1
5946,GSM4160136,HEK293,HEK293,532,HEK293,NA,10473,532,10479,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-122
5947,GSM4160137,HEK293,HEK293,532,HEK293,NA,10474,532,10480,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-122
5948,GSM4160138,HEK293,HEK293,532,HEK293,NA,10475,532,10469,GSE140367,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None
5949,GSM4160139,HEK293,HEK293,532,HEK293,NA,10476,532,10470,GSE140367,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None
5950,GSM4160140,HEK293,HEK293,532,HEK293,NA,10477,532,10471,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-1
5951,GSM4160141,HEK293,HEK293,532,HEK293,NA,10478,532,10472,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-1
5952,GSM4160142,HEK293,HEK293,532,HEK293,NA,10479,532,10473,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-122
5953,GSM4160143,HEK293,HEK293,532,HEK293,NA,10480,532,10474,GSE140367,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: has-miR-122
6013,GSM4176097,HEK293,HEK293,585,HEK293,NA,11431,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"disome_rep1, anisomycin","treatment: anisomycin | genetic background: WT | cell line: HEK293 | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
6014,GSM4176098,HEK293,HEK293,585,HEK293,NA,11432,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"disome_rep2, anisomycin","treatment: anisomycin | genetic background: WT | cell line: HEK293 | extracted molecule: total RNA | extract_protocol: Rnase I footprinting, ribosome pelleting, RNA extraction"
6015,GSM4192092,HEK293,HEK293,499,HEK293,NA,9605,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 1 nucleotide indel) | batch: 4
6016,GSM4192093,HEK293,HEK293,499,HEK293,NA,9606,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 1 nucleotide indel) | batch: 4
6017,GSM4192094,HEK293,HEK293,499,HEK293,NA,9607,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 1 nucleotide indel) | batch: 4
6018,GSM4192095,HEK293,HEK293,499,HEK293,NA,9608,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 1 nucleotide indel) | batch: 4
6019,GSM4192096,HEK293,HEK293,499,HEK293,NA,9609,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 2 nucleotide indel) | batch: 4
6020,GSM4192097,HEK293,HEK293,499,HEK293,NA,9610,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 2 nucleotide indel) | batch: 4
6021,GSM4192098,HEK293,HEK293,499,HEK293,NA,9611,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 2 nucleotide indel) | batch: 4
6022,GSM4192099,HEK293,HEK293,499,HEK293,NA,9612,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Nsun6 knockout (Clone 2 nucleotide indel) | batch: 4
6023,GSM4192100,HEK293,HEK293,499,HEK293,NA,9613,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Control (Wild-type) | batch: 4
6024,GSM4192101,HEK293,HEK293,499,HEK293,NA,9614,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Control (Wild-type) | batch: 4
6025,GSM4192102,HEK293,HEK293,499,HEK293,NA,9615,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Control (Wild-type) | batch: 4
6026,GSM4192103,HEK293,HEK293,499,HEK293,NA,9616,499,NA,GSE140997,Homo sapiens,HEK293,hek293,HEK293,human embryonic kidney 293 cells,cell line: HEK293 | genotype: Control (Wild-type) | batch: 4
6027,GSM4192104,H9,H9,499,H9,NA,9617,499,9640,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6028,GSM4192105,H9,H9,499,H9,NA,9618,499,9641,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6029,GSM4192106,H9,H9,499,H9,NA,9619,499,9642,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6030,GSM4192107,H9,H9,499,H9,NA,9620,499,9643,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6031,GSM4192108,H9,H9,499,H9,NA,9621,499,9644,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6032,GSM4192109,H9,H9,499,H9,NA,9622,499,9645,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6033,GSM4192110,H9,H9,499,H9,NA,9623,499,9646,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6034,GSM4192111,H9,H9,499,H9,NA,9624,499,NA,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6035,GSM4192112,H9,H9,499,H9,NA,9625,499,9647,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 3 nucleotide indel exon9) | batch: 3
6036,GSM4192113,H9,H9,499,H9,NA,9626,499,9648,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 3 nucleotide indel exon9) | batch: 3
6037,GSM4192114,H9,H9,499,H9,NA,9627,499,9650,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6038,GSM4192115,H9,H9,499,H9,NA,9628,499,9651,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6039,GSM4192116,H9,H9,499,H9,NA,9629,499,9652,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6040,GSM4192117,H9,H9,499,H9,NA,9630,499,9653,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6041,GSM4192118,H9,H9,499,H9,NA,9631,499,9654,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6042,GSM4192119,H9,H9,499,H9,NA,9632,499,9655,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6043,GSM4192120,H9,H9,499,H9,NA,9633,499,9656,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6044,GSM4192121,H9,H9,499,H9,NA,9634,499,9657,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6045,GSM4192122,H9,H9,499,H9,NA,9635,499,9658,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6046,GSM4192123,H9,H9,499,H9,NA,9636,499,9659,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6047,GSM4192124,H9,H9,499,H9,NA,9637,499,9660,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6048,GSM4192125,H9,H9,499,H9,NA,9638,499,9661,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6049,GSM4192126,H9,H9,499,H9,NA,9639,499,9662,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6050,GSM4192127,H9,H9,499,H9,NA,9640,499,9617,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6051,GSM4192128,H9,H9,499,H9,NA,9641,499,9618,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6052,GSM4192129,H9,H9,499,H9,NA,9642,499,9619,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6053,GSM4192130,H9,H9,499,H9,NA,9643,499,9620,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 1 nucleotide indel exon2) | batch: 1
6054,GSM4192131,H9,H9,499,H9,NA,9644,499,9621,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6055,GSM4192132,H9,H9,499,H9,NA,9645,499,9622,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6056,GSM4192133,H9,H9,499,H9,NA,9646,499,9623,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 2 nucleotide indel exon2) | batch: 2
6057,GSM4192134,H9,H9,499,H9,NA,9647,499,9625,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 3 nucleotide indel exon9) | batch: 3
6058,GSM4192135,H9,H9,499,H9,NA,9648,499,9626,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 3 nucleotide indel exon9) | batch: 3
6059,GSM4192136,H9,H9,499,H9,NA,9649,499,NA,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 3 nucleotide indel exon9) | batch: 3
6060,GSM4192137,H9,H9,499,H9,NA,9650,499,9627,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6061,GSM4192138,H9,H9,499,H9,NA,9651,499,9628,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6062,GSM4192139,H9,H9,499,H9,NA,9652,499,9629,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Nsun6 knockout (Clone 4 nucleotide indel exon2) | batch: 2
6063,GSM4192140,H9,H9,499,H9,NA,9653,499,9630,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6064,GSM4192141,H9,H9,499,H9,NA,9654,499,9631,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6065,GSM4192142,H9,H9,499,H9,NA,9655,499,9632,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6066,GSM4192143,H9,H9,499,H9,NA,9656,499,9633,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 1
6067,GSM4192144,H9,H9,499,H9,NA,9657,499,9634,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6068,GSM4192145,H9,H9,499,H9,NA,9658,499,9635,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6069,GSM4192146,H9,H9,499,H9,NA,9659,499,9636,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type) | batch: 2
6070,GSM4192147,H9,H9,499,H9,NA,9660,499,9637,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6071,GSM4192148,H9,H9,499,H9,NA,9661,499,9638,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6072,GSM4192149,H9,H9,499,H9,NA,9662,499,9639,GSE140997,Homo sapiens,H9,h9,H9,human embryonic stem cells,cell line: H9 | genotype: Control (Wild-type Crispr control (random)) | batch: 3
6073,GSM4192408,U-251 MG,U-251 MG,660,U-251 MG,NA,12712,660,12729,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T0,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6074,GSM4192409,U-251 MG,U-251 MG,660,U-251 MG,NA,12713,660,12730,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6075,GSM4192410,U-251 MG,U-251 MG,660,U-251 MG,NA,12714,660,12731,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6076,GSM4192411,U-251 MG,U-251 MG,660,U-251 MG,NA,12715,660,12732,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T0,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6077,GSM4192412,U-251 MG,U-251 MG,660,U-251 MG,NA,12716,660,12733,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6078,GSM4192413,U-251 MG,U-251 MG,660,U-251 MG,NA,12717,660,12734,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6079,GSM4192414,U-251 MG,U-251 MG,660,U-251 MG,NA,12718,660,12735,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6080,GSM4192415,U-251 MG,U-251 MG,660,U-251 MG,NA,12719,660,12736,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_RNAseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6081,GSM4192416,U-343 MG,U-343 MG,660,U-343 MG,NA,12720,660,12737,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6082,GSM4192417,U-343 MG,U-343 MG,660,U-343 MG,NA,12721,660,12738,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6083,GSM4192418,U-343 MG,U-343 MG,660,U-343 MG,NA,12722,660,12739,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6084,GSM4192419,U-343 MG,U-343 MG,660,U-343 MG,NA,12723,660,12740,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6085,GSM4192420,U-343 MG,U-343 MG,660,U-343 MG,NA,12724,660,12741,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6086,GSM4192421,U-343 MG,U-343 MG,660,U-343 MG,NA,12725,660,12742,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6087,GSM4192422,U-343 MG,U-343 MG,660,U-343 MG,NA,12726,660,12743,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6088,GSM4192423,U-343 MG,U-343 MG,660,U-343 MG,NA,12727,660,12744,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6089,GSM4192424,U-343 MG,U-343 MG,660,U-343 MG,NA,12728,660,12745,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_RNAseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6090,GSM4192425,U-251 MG,U-251 MG,660,U-251 MG,NA,12729,660,12712,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T0,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6091,GSM4192426,U-251 MG,U-251 MG,660,U-251 MG,NA,12730,660,12713,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6092,GSM4192427,U-251 MG,U-251 MG,660,U-251 MG,NA,12731,660,12714,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6093,GSM4192428,U-251 MG,U-251 MG,660,U-251 MG,NA,12732,660,12715,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T0,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6094,GSM4192429,U-251 MG,U-251 MG,660,U-251 MG,NA,12733,660,12716,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6095,GSM4192430,U-251 MG,U-251 MG,660,U-251 MG,NA,12734,660,12717,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6096,GSM4192431,U-251 MG,U-251 MG,660,U-251 MG,NA,12735,660,12718,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T1,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6097,GSM4192432,U-251 MG,U-251 MG,660,U-251 MG,NA,12736,660,12719,GSE141013,Homo sapiens,U-251 MG,u-251 mg,U-251 MG,U251_Riboseq_T24,"cell_line: U251 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6098,GSM4192433,U-343 MG,U-343 MG,660,U-343 MG,NA,12737,660,12720,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6099,GSM4192434,U-343 MG,U-343 MG,660,U-343 MG,NA,12738,660,12721,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6100,GSM4192435,U-343 MG,U-343 MG,660,U-343 MG,NA,12739,660,12722,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6101,GSM4192436,U-343 MG,U-343 MG,660,U-343 MG,NA,12740,660,12723,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6102,GSM4192437,U-343 MG,U-343 MG,660,U-343 MG,NA,12741,660,12724,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6103,GSM4192438,U-343 MG,U-343 MG,660,U-343 MG,NA,12742,660,12725,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6104,GSM4192439,U-343 MG,U-343 MG,660,U-343 MG,NA,12743,660,12726,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T0,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T0 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6105,GSM4192440,U-343 MG,U-343 MG,660,U-343 MG,NA,12744,660,12727,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T1,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T1 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6106,GSM4192441,U-343 MG,U-343 MG,660,U-343 MG,NA,12745,660,12728,GSE141013,Homo sapiens,U-343 MG,u-343 mg,U-343 MG,U343_Riboseq_T24,"cell_line: U343 | cell_type: glioblastoma cell line | time_point: T24 | tissue source: brain/CNS | disease: Glioblastoma,ud | disease_stage: Grade IV | ethinicity: caucasian"
6107,GSM4203634,HeLa,HeLa,526,HeLa,NA,10384,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,Immunoprecipitated sample,cell line: HeLa | plasmid(s): ZAK-FLAG
6108,GSM4203635,HeLa,HeLa,526,HeLa,NA,10385,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,Immunoprecipitated sample,cell line: HeLa | plasmid(s): ZAK-FLAG
6109,GSM4203636,HeLa,HeLa,526,HeLa,NA,10386,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,Immunoprecipitated sample,cell line: HeLa | plasmid(s): ZAK-FLAG
6110,GSM4203637,HeLa,HeLa,526,HeLa,NA,10387,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,Immunoprecipitated sample,cell line: HeLa | plasmid(s): ZAK-FLAG
6138,GSM4240629,12T,12T,511,12T,NA,9845,511,9889,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6139,GSM4240630,12T,12T,511,12T,NA,9846,511,9890,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6140,GSM4240631,12T,12T,511,12T,NA,9847,511,9892,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6141,GSM4240632,12T,12T,511,12T,NA,9848,511,9893,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6142,GSM4240633,12T,12T,511,12T,NA,9849,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6143,GSM4240634,12T,12T,511,12T,NA,9850,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6144,GSM4240635,108T,108T,511,108T,NA,9851,511,9894,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: Control
6145,GSM4240636,108T,108T,511,108T,NA,9852,511,9895,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: Control
6146,GSM4240637,108T,108T,511,108T,NA,9853,511,9896,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6147,GSM4240638,108T,108T,511,108T,NA,9854,511,9897,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6148,GSM4240639,108T,108T,511,108T,NA,9855,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: Control
6149,GSM4240640,108T,108T,511,108T,NA,9856,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6150,GSM4240641,MD55A3,MD55A3,511,MD55A3,NA,9857,511,9898,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: Control
6151,GSM4240642,MD55A3,MD55A3,511,MD55A3,NA,9858,511,9899,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: Control
6152,GSM4240643,MD55A3,MD55A3,511,MD55A3,NA,9859,511,9900,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: IFNg
6153,GSM4240644,MD55A3,MD55A3,511,MD55A3,NA,9860,511,9901,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: IFNg
6154,GSM4240645,MD55A3,MD55A3,511,MD55A3,NA,9861,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: Control
6155,GSM4240646,MD55A3,MD55A3,511,MD55A3,NA,9862,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: IFNg
6156,GSM4240647,12T,12T,511,12T,NA,9863,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6157,GSM4240648,12T,12T,511,12T,NA,9864,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6158,GSM4240649,12T,12T,511,12T,NA,9865,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6159,GSM4240650,12T,12T,511,12T,NA,9866,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6160,GSM4240651,12T,12T,511,12T,NA,9867,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO
6161,GSM4240652,12T,12T,511,12T,NA,9868,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO
6162,GSM4240653,12T,12T,511,12T,NA,9869,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO + IFNg
6163,GSM4240654,12T,12T,511,12T,NA,9870,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO + IFNg
6164,GSM4240655,12T,12T,511,12T,NA,9871,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO + IFNg
6165,GSM4240656,12T,12T,511,12T,NA,9872,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IDO
6166,GSM4240657,12T,12T,511,12T,NA,9873,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6167,GSM4240658,12T,12T,511,12T,NA,9874,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6168,GSM4240659,108T,108T,511,108T,NA,9875,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 24h"
6169,GSM4240660,108T,108T,511,108T,NA,9876,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 24h"
6170,GSM4240661,108T,108T,511,108T,NA,9877,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 24h"
6171,GSM4240662,108T,108T,511,108T,NA,9878,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: starvation media + Tryptophan addition for 24h
6172,GSM4240663,108T,108T,511,108T,NA,9879,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 48h"
6173,GSM4240664,108T,108T,511,108T,NA,9880,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 48h"
6174,GSM4240665,108T,108T,511,108T,NA,9881,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tryptophan depletion for 48h"
6175,GSM4240666,108T,108T,511,108T,NA,9882,511,NA,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: starvation media + Tryptophan addition for 48h
6176,GSM4240667,MD55A3,MD55A3,511,MD55A3,NA,9883,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: starvation media + Tyrosine addition
6177,GSM4240668,MD55A3,MD55A3,511,MD55A3,NA,9884,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: starvation media + Tyrosine addition
6178,GSM4240669,MD55A3,MD55A3,511,MD55A3,NA,9885,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tyrosine depletion"
6179,GSM4240670,MD55A3,MD55A3,511,MD55A3,NA,9886,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tyrosine depletion"
6180,GSM4240671,MD55A3,MD55A3,511,MD55A3,NA,9887,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: starvation media + Tyrosine addition
6181,GSM4240672,MD55A3,MD55A3,511,MD55A3,NA,9888,511,NA,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,"cell type: Melanoma  cancer cells | treatment: starvation media, Tyrosine depletion"
6182,GSM4240673,12T,12T,511,12T,NA,9889,511,9845,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6183,GSM4240674,12T,12T,511,12T,NA,9890,511,9846,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6184,GSM4240675,12T,12T,511,12T,NA,9891,511,NA,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: Control
6185,GSM4240676,12T,12T,511,12T,NA,9892,511,9847,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6186,GSM4240677,12T,12T,511,12T,NA,9893,511,9848,GSE142822,Homo sapiens,12T,12t,12T,12T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6187,GSM4240678,108T,108T,511,108T,NA,9894,511,9851,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: Control
6188,GSM4240679,108T,108T,511,108T,NA,9895,511,9852,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: Control
6189,GSM4240680,108T,108T,511,108T,NA,9896,511,9853,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6190,GSM4240681,108T,108T,511,108T,NA,9897,511,9854,GSE142822,Homo sapiens,108T,108t,108T,108T cells,cell type: Melanoma  cancer cells | treatment: IFNg
6191,GSM4240682,MD55A3,MD55A3,511,MD55A3,NA,9898,511,9857,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: Control
6192,GSM4240683,MD55A3,MD55A3,511,MD55A3,NA,9899,511,9858,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: Control
6193,GSM4240684,MD55A3,MD55A3,511,MD55A3,NA,9900,511,9859,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: IFNg
6194,GSM4240685,MD55A3,MD55A3,511,MD55A3,NA,9901,511,9860,GSE142822,Homo sapiens,MD55A3,md55a3,MD55A3,MD55A3 cells,cell type: Melanoma  cancer cells | treatment: IFNg
6195,GSM4247190,HEK293,HEK293,531,HEK293,NA,10421,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None | batch: 1
6196,GSM4247191,HEK293,HEK293,531,HEK293,NA,10422,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None | batch: 1
6197,GSM4247192,HEK293,HEK293,531,HEK293,NA,10423,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-1 | batch: 1
6198,GSM4247193,HEK293,HEK293,531,HEK293,NA,10424,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-1 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-1 | batch: 1
6199,GSM4247194,HEK293,HEK293,531,HEK293,NA,10425,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-122 | batch: 1
6200,GSM4247195,HEK293,HEK293,531,HEK293,NA,10426,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-122 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-122 | batch: 1
6201,GSM4247196,HEK293,HEK293,531,HEK293,NA,10427,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None | batch: 2
6202,GSM4247197,HEK293,HEK293,531,HEK293,NA,10428,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None | batch: 2
6203,GSM4247198,HEK293,HEK293,531,HEK293,NA,10429,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,Empty vector control,cell line: Flp-In T-REx 293 Cell | induced mirna: None | batch: 2
6204,GSM4247199,HEK293,HEK293,531,HEK293,NA,10430,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-133a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-133a | batch: 2
6205,GSM4247200,HEK293,HEK293,531,HEK293,NA,10431,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-133a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-133a | batch: 2
6206,GSM4247201,HEK293,HEK293,531,HEK293,NA,10432,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-133a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-133a | batch: 2
6207,GSM4247202,HEK293,HEK293,531,HEK293,NA,10433,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-155 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-155 | batch: 2
6208,GSM4247203,HEK293,HEK293,531,HEK293,NA,10434,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-155 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-155 | batch: 2
6209,GSM4247204,HEK293,HEK293,531,HEK293,NA,10435,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-155 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-155 | batch: 2
6210,GSM4247205,HEK293,HEK293,531,HEK293,NA,10436,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-302a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-302a | batch: 2
6211,GSM4247206,HEK293,HEK293,531,HEK293,NA,10437,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-302a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-302a | batch: 2
6212,GSM4247207,HEK293,HEK293,531,HEK293,NA,10438,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-302a expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-302a | batch: 2
6213,GSM4247208,HEK293,HEK293,531,HEK293,NA,10439,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-372 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-372 | batch: 2
6214,GSM4247209,HEK293,HEK293,531,HEK293,NA,10440,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-372 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-372 | batch: 2
6215,GSM4247210,HEK293,HEK293,531,HEK293,NA,10441,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-372 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-372 | batch: 2
6216,GSM4247211,HEK293,HEK293,531,HEK293,NA,10442,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-373 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-373 | batch: 2
6217,GSM4247212,HEK293,HEK293,531,HEK293,NA,10443,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-373 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-373 | batch: 2
6218,GSM4247213,HEK293,HEK293,531,HEK293,NA,10444,531,NA,GSE142895,Homo sapiens,HEK293,hek293,HEK293,miR-373 expressing cells,cell line: Flp-In T-REx 293 Cell | induced mirna: hsa-miR-373 | batch: 2
6219,GSM4255693,B721.221,B721.221,538,B721.221,NA,10580,538,NA,GSE143263,Homo sapiens,B721.221,b721.221,B721.221,B721.221,cell line: B721.221 | cell type: B-lymphoblastoidÃ‚Â cell line | treatment: - | hla allele: A0101
6220,GSM4255694,B721.221,B721.221,538,B721.221,NA,10581,538,NA,GSE143263,Homo sapiens,B721.221,b721.221,B721.221,B721.221,cell line: B721.221 | cell type: B-lymphoblastoidÃ‚Â cell line | treatment: - | hla allele: A3303
6221,GSM4255695,B721.221,B721.221,538,B721.221,NA,10582,538,NA,GSE143263,Homo sapiens,B721.221,b721.221,B721.221,B721.221,cell line: B721.221 | cell type: B-lymphoblastoidÃ‚Â cell line | treatment: - | hla allele: B1501
6222,GSM4255696,B721.221,B721.221,538,B721.221,NA,10583,538,NA,GSE143263,Homo sapiens,B721.221,b721.221,B721.221,B721.221,cell line: B721.221 | cell type: B-lymphoblastoidÃ‚Â cell line | treatment: - | hla allele: B4402
6223,GSM4255697,A375,A375,538,A375,NA,10584,538,NA,GSE143263,Homo sapiens,A375,a375,A375,A375,cell line: A375 | cell type: malignant melanoma cell line | treatment: -
6224,GSM4255698,HCT116,HCT116,538,HCT116,NA,10585,538,NA,GSE143263,Homo sapiens,HCT116,hct116,HCT116,HCT116,"cell line: HCT116 | cell type: colorectal carcinoma cell line | treatment: cycloheximide 10 minutes, 0.1mg/ml"
6225,GSM4255699,HCT116,HCT116,538,HCT116,NA,10586,538,NA,GSE143263,Homo sapiens,HCT116,hct116,HCT116,HCT116,cell line: HCT116 | cell type: colorectal carcinoma cell line | treatment: -
6226,GSM4255700,Hmel,Hmel,538,Hmel,NA,10587,538,NA,GSE143263,Homo sapiens,Hmel,hmel,Hmel,Hmel,"cell line: Hmel | cell type: Epidermal Melanocytes, neonatal | treatment: cycloheximide 5 minutes, 0.1mg/ml"
6227,GSM4255701,Hmel,Hmel,538,Hmel,NA,10588,538,NA,GSE143263,Homo sapiens,Hmel,hmel,Hmel,Hmel,"cell line: Hmel | cell type: Epidermal Melanocytes, neonatal | treatment: cycloheximide 5 minutes, 0.1mg/ml"
6228,GSM4255702,Hmel,Hmel,538,Hmel,NA,10589,538,NA,GSE143263,Homo sapiens,Hmel,hmel,Hmel,Hmel,"cell line: Hmel | cell type: Epidermal Melanocytes, neonatal | treatment: cycloheximide 5 minutes, 0.1mg/ml"
6229,GSM4256659,HeLa cells,HeLa,559,HeLa,NA,10932,559,10944,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 01 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6230,GSM4256660,HeLa cells,HeLa,559,HeLa,NA,10933,559,10945,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 02 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6231,GSM4256661,HeLa cells,HeLa,559,HeLa,NA,10934,559,10946,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 03 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6232,GSM4256662,HeLa cells,HeLa,559,HeLa,NA,10935,559,10947,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 01 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6233,GSM4256663,HeLa cells,HeLa,559,HeLa,NA,10936,559,10948,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 02 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6234,GSM4256664,HeLa cells,HeLa,559,HeLa,NA,10937,559,10949,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 03 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6235,GSM4256665,HeLa cells,HeLa,559,HeLa,NA,10938,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 01 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6236,GSM4256666,HeLa cells,HeLa,559,HeLa,NA,10939,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 02 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6237,GSM4256667,HeLa cells,HeLa,559,HeLa,NA,10940,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 03 - riboseq,cell line: HeLa cells | genotype: control | strategy: Ribo-Seq
6238,GSM4256668,HeLa cells,HeLa,559,HeLa,NA,10941,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 01 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6239,GSM4256669,HeLa cells,HeLa,559,HeLa,NA,10942,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 02 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6240,GSM4256670,HeLa cells,HeLa,559,HeLa,NA,10943,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 03 - riboseq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: Ribo-Seq
6241,GSM4256671,HeLa cells,HeLa,559,HeLa,NA,10944,559,10932,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 01 - total RNA seq,cell line: HeLa cells | genotype: control | strategy: RNA-Seq
6242,GSM4256672,HeLa cells,HeLa,559,HeLa,NA,10945,559,10933,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 02 - total RNA seq,cell line: HeLa cells | genotype: control | strategy: RNA-Seq
6243,GSM4256673,HeLa cells,HeLa,559,HeLa,NA,10946,559,10934,GSE143301,Homo sapiens,HeLa,hela,HeLa,CTRL KD 03 - total RNA seq,cell line: HeLa cells | genotype: control | strategy: RNA-Seq
6244,GSM4256674,HeLa cells,HeLa,559,HeLa,NA,10947,559,10935,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 01 - total RNA seq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: RNA-Seq
6245,GSM4256675,HeLa cells,HeLa,559,HeLa,NA,10948,559,10936,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 02 - total RNA seq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: RNA-Seq
6246,GSM4256676,HeLa cells,HeLa,559,HeLa,NA,10949,559,10937,GSE143301,Homo sapiens,HeLa,hela,HeLa,ABCE1 KD 03 - total RNA seq,cell line: HeLa cells | genotype: siRNA-mediated ABCE1 KD | strategy: RNA-Seq
6252,GSM4258279,Mutu,Mutu,812,Mutu,NA,15426,812,15437,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 24 | molecule: polyA RNA
6253,GSM4258280,Mutu,Mutu,812,Mutu,NA,15427,812,15438,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 24 | molecule: polyA RNA
6254,GSM4258281,Mutu,Mutu,812,Mutu,NA,15428,812,15439,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 48 | molecule: polyA RNA
6255,GSM4258282,Mutu,Mutu,812,Mutu,NA,15429,812,15440,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 48 | molecule: polyA RNA
6256,GSM4258283,Mutu,Mutu,812,Mutu,NA,15430,812,NA,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 48 | molecule: polyA RNA
6257,GSM4258284,Mutu,Mutu,812,Mutu,NA,15431,812,15441,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6258,GSM4258285,Mutu,Mutu,812,Mutu,NA,15432,812,15443,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6259,GSM4258286,Mutu,Mutu,812,Mutu,NA,15433,812,15442,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6260,GSM4258287,Mutu,Mutu,812,Mutu,NA,15434,812,NA,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6261,GSM4258288,Mutu,Mutu,812,Mutu,NA,15435,812,15444,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6262,GSM4258289,Mutu,Mutu,812,Mutu,NA,15436,812,NA,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6263,GSM4258290,Mutu,Mutu,812,Mutu,NA,15437,812,15426,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 24 | molecule: Ribosomal footprints
6264,GSM4258291,Mutu,Mutu,812,Mutu,NA,15438,812,15427,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 24 | molecule: Ribosomal footprints
6265,GSM4258292,Mutu,Mutu,812,Mutu,NA,15439,812,15428,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 48 | molecule: Ribosomal footprints
6266,GSM4258293,Mutu,Mutu,812,Mutu,NA,15440,812,15429,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: control | time (h): 48 | molecule: Ribosomal footprints
6267,GSM4258294,Mutu,Mutu,812,Mutu,NA,15441,812,15431,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6268,GSM4258295,Mutu,Mutu,812,Mutu,NA,15442,812,15433,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6269,GSM4258296,Mutu,Mutu,812,Mutu,NA,15443,812,15432,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6270,GSM4258297,Mutu,Mutu,812,Mutu,NA,15444,812,15435,GSE143393,Homo sapiens,Mutu,mutu,Mutu,Mutu cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6271,GSM4258298,U2392,U2392,812,U2392,NA,15445,812,15456,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 24 | molecule: polyA RNA
6272,GSM4258299,U2392,U2392,812,U2392,NA,15446,812,15457,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 24 | molecule: polyA RNA
6273,GSM4258300,U2392,U2392,812,U2392,NA,15447,812,NA,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 24 | molecule: polyA RNA
6274,GSM4258301,U2392,U2392,812,U2392,NA,15448,812,15458,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 48 | molecule: polyA RNA
6275,GSM4258302,U2392,U2392,812,U2392,NA,15449,812,15459,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 48 | molecule: polyA RNA
6276,GSM4258303,U2392,U2392,812,U2392,NA,15450,812,15460,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6277,GSM4258304,U2392,U2392,812,U2392,NA,15451,812,15461,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6278,GSM4258305,U2392,U2392,812,U2392,NA,15452,812,15462,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6279,GSM4258306,U2392,U2392,812,U2392,NA,15453,812,15463,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: polyA RNA
6280,GSM4258307,U2392,U2392,812,U2392,NA,15454,812,15464,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6281,GSM4258308,U2392,U2392,812,U2392,NA,15455,812,15466,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: polyA RNA
6282,GSM4258309,U2392,U2392,812,U2392,NA,15456,812,15445,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 24 | molecule: Ribosomal footprints
6283,GSM4258310,U2392,U2392,812,U2392,NA,15457,812,15446,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 24 | molecule: Ribosomal footprints
6284,GSM4258311,U2392,U2392,812,U2392,NA,15458,812,15448,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 48 | molecule: Ribosomal footprints
6285,GSM4258312,U2392,U2392,812,U2392,NA,15459,812,15449,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: control | time (h): 48 | molecule: Ribosomal footprints
6286,GSM4258313,U2392,U2392,812,U2392,NA,15460,812,15450,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6287,GSM4258314,U2392,U2392,812,U2392,NA,15461,812,15451,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6288,GSM4258315,U2392,U2392,812,U2392,NA,15462,812,15452,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6289,GSM4258316,U2392,U2392,812,U2392,NA,15463,812,15453,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 24 | molecule: Ribosomal footprints
6290,GSM4258317,U2392,U2392,812,U2392,NA,15464,812,15454,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6291,GSM4258318,U2392,U2392,812,U2392,NA,15465,812,NA,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6292,GSM4258319,U2392,U2392,812,U2392,NA,15466,812,15455,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6293,GSM4258320,U2392,U2392,812,U2392,NA,15467,812,NA,GSE143393,Homo sapiens,U2392,u2392,U2392,U2392 cell line,condition: DDX3Xsh | time (h): 48 | molecule: Ribosomal footprints
6294,GSM4263926,BRx-142,BRx-142,629,BRx-142,NA,12040,629,15266,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: control | batch: batch1 | molecule subtype: ribosome-bound mRNA
6295,GSM4263927,BRx-142,BRx-142,629,BRx-142,NA,12041,629,15268,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: RPL15 overexpressing | batch: batch1 | molecule subtype: ribosome-bound mRNA
6296,GSM4263928,BRx-142,BRx-142,629,BRx-142,NA,12042,629,15267,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: control | batch: batch2 | molecule subtype: ribosome-bound mRNA
6297,GSM4263929,BRx-142,BRx-142,629,BRx-142,NA,12043,629,15269,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: RPL15 overexpressing | batch: batch2 | molecule subtype: ribosome-bound mRNA
6298,GSM4263930,BRx-142,BRx-142,629,BRx-142,NA,15266,629,12040,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: control
6299,GSM4263931,BRx-142,BRx-142,629,BRx-142,NA,15267,629,12042,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: RPL15 overexpressing
6300,GSM4263932,BRx-142,BRx-142,629,BRx-142,NA,15268,629,12041,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: control
6301,GSM4263933,BRx-142,BRx-142,629,BRx-142,NA,15269,629,12043,GSE143623,Homo sapiens,BRx-142,brx-142,BRx-142,circulating tumor cell - derived cell line,tissue: circulating tumor cell - derived cell line | rpl15 overexpressing: RPL15 overexpressing
6333,GSM4277532,C4-2,C4-2,488,C4-2,NA,9130,488,9136,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shCTRL_rep1_RNA_seq,genotype: shCTRL | cell line: Human PCa cell line C4-2
6334,GSM4277533,C4-2,C4-2,488,C4-2,NA,9131,488,9137,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shCTRL_rep2_RNA_seq,genotype: shCTRL | cell line: Human PCa cell line C4-2
6335,GSM4277534,C4-2,C4-2,488,C4-2,NA,9132,488,9138,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shEZH2_rep1_RNA_seq,genotype: shEZH2 | cell line: Human PCa cell line C4-2
6336,GSM4277535,C4-2,C4-2,488,C4-2,NA,9133,488,9139,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shEZH2_rep2_RNA_seq,genotype: shEZH2 | cell line: Human PCa cell line C4-2
6337,GSM4277536,C4-2,C4-2,488,C4-2,NA,9134,488,9140,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shFBL_rep1_RNA_seq,genotype: shFBL | cell line: Human PCa cell line C4-2
6338,GSM4277537,C4-2,C4-2,488,C4-2,NA,9135,488,9141,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shFBL_rep2_RNA_seq,genotype: shFBL | cell line: Human PCa cell line C4-2
6339,GSM4277538,C4-2,C4-2,488,C4-2,NA,9136,488,9130,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shCTRL_rep1_Ribo_seq,genotype: shCTRL | cell line: Human PCa cell line C4-2
6340,GSM4277539,C4-2,C4-2,488,C4-2,NA,9137,488,9131,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shCTRL_rep2_Ribo_seq,genotype: shCTRL | cell line: Human PCa cell line C4-2
6341,GSM4277540,C4-2,C4-2,488,C4-2,NA,9138,488,9132,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shEZH2_rep1_Ribo_seq,genotype: shEZH2 | cell line: Human PCa cell line C4-2
6342,GSM4277541,C4-2,C4-2,488,C4-2,NA,9139,488,9133,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shEZH2_rep2_Ribo_seq,genotype: shEZH2 | cell line: Human PCa cell line C4-2
6343,GSM4277542,C4-2,C4-2,488,C4-2,NA,9140,488,9134,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shFBL_rep1_Ribo_seq,genotype: shFBL | cell line: Human PCa cell line C4-2
6344,GSM4277543,C4-2,C4-2,488,C4-2,NA,9141,488,9135,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shFBL_rep2_Ribo_seq,genotype: shFBL | cell line: Human PCa cell line C4-2
6374,GSM4282032,HEK293T,HEK293T,493,HEK293T,NA,9289,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_DMSO ribosome profiling,cell line: HEK293T | treatment: DMSO | concentration: 0.10% | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6375,GSM4282033,HEK293T,HEK293T,493,HEK293T,NA,9290,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_DMSO ribosome profiling,cell line: HEK293T | treatment: DMSO | concentration: 0.10% | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6376,GSM4282034,HEK293T,HEK293T,493,HEK293T,NA,9291,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_DMSO ribosome profiling,cell line: HEK293T | treatment: DMSO | concentration: 0.10% | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6377,GSM4282035,HEK293T,HEK293T,493,HEK293T,NA,9292,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_G418 500 ug/mL ribosome profiling,cell line: HEK293T | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6378,GSM4282036,HEK293T,HEK293T,493,HEK293T,NA,9293,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_G418 500 ug/mL ribosome profiling,cell line: HEK293T | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6379,GSM4282037,HEK293T,HEK293T,493,HEK293T,NA,9294,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_G418 500 ug/mL ribosome profiling,cell line: HEK293T | treatment: G418 | concentration: 500 ug/mL | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6380,GSM4282038,HEK293T,HEK293T,493,HEK293T,NA,9295,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_SRI37240 10 uM ribosome profiling,cell line: HEK293T | treatment: SRI37240 | concentration: 10 uM | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6381,GSM4282039,HEK293T,HEK293T,493,HEK293T,NA,9296,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_SRI37240 10 uM ribosome profiling,cell line: HEK293T | treatment: SRI37240 | concentration: 10 uM | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6382,GSM4282040,HEK293T,HEK293T,493,HEK293T,NA,9297,493,NA,GSE144140,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T_SRI37240 10 uM ribosome profiling,cell line: HEK293T | treatment: SRI37240 | concentration: 10 uM | duration: 24 hours | adapter: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6383,GSM4282352,HCT116,HCT116,553,HCT116,NA,10794,553,10798,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: ABCE1-/- | sgrna received: sgABCE1-1 | cell line: NMD reporter
6384,GSM4282353,HCT116,HCT116,553,HCT116,NA,10795,553,10799,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: ABCE1-/- | sgrna received: sgABCE1-2 | cell line: NMD reporter
6385,GSM4282354,HCT116,HCT116,553,HCT116,NA,10796,553,10800,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: sgNT1 | cell line: NMD reporter
6386,GSM4282355,HCT116,HCT116,553,HCT116,NA,10797,553,10801,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: sgNT2 | cell line: NMD reporter
6387,GSM4282356,HCT116,HCT116,553,HCT116,NA,10798,553,10794,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: ABCE1-/- | sgrna received: sgABCE1-1 | cell line: NMD reporter
6388,GSM4282357,HCT116,HCT116,553,HCT116,NA,10799,553,10795,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: ABCE1-/- | sgrna received: sgABCE1-2 | cell line: NMD reporter
6389,GSM4282358,HCT116,HCT116,553,HCT116,NA,10800,553,10796,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: sgNT1 | cell line: NMD reporter
6390,GSM4282359,HCT116,HCT116,553,HCT116,NA,10801,553,10797,GSE144165,Homo sapiens,HCT116,hct116,HCT116,HCT116 colon cancer cell line,genotype: +/+ | sgrna received: sgNT2 | cell line: NMD reporter
6411,GSM4293560,H1 hESC,H1 hESC,537,H1,,10497,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: WT | library: polyA, stranded"
6412,GSM4293561,H1 hESC,H1 hESC,537,H1,,10498,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: WT | library: polyA, stranded"
6413,GSM4293562,H1 hESC,H1 hESC,537,H1,,10499,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,GATA6-AS1 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: GATA6-AS1-/- | library: polyA, stranded"
6414,GSM4293563,H1 hESC,H1 hESC,537,H1,,10500,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,GATA6-AS1 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: GATA6-AS1-/- | library: polyA, stranded"
6415,GSM4293564,H1 hESC,H1 hESC,537,H1,,10501,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-445F12.1 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: RP11-445F12.1-/- | library: polyA, stranded"
6416,GSM4293565,H1 hESC,H1 hESC,537,H1,,10502,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-445F12.1 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: RP11-445F12.1-/- | library: polyA, stranded"
6417,GSM4293566,H1 hESC,H1 hESC,537,H1,,10503,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: LINC00261-/- | library: polyA, stranded"
6418,GSM4293567,H1 hESC,H1 hESC,537,H1,,10504,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the definitive endoderm stage,"cell line: H1 ES cells | cell type: ES-derived definitive endoderm cells | genotype: LINC00261-/- | library: polyA, stranded"
6419,GSM4293568,H1 hESC,H1 hESC,537,H1,,10505,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6420,GSM4293569,H1 hESC,H1 hESC,537,H1,,10506,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6421,GSM4293570,H1 hESC,H1 hESC,537,H1,,10507,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6422,GSM4293571,H1 hESC,H1 hESC,537,H1,,10508,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6423,GSM4293572,H1 hESC,H1 hESC,537,H1,,10509,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6424,GSM4293573,H1 hESC,H1 hESC,537,H1,,10510,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6425,GSM4293574,H1 hESC,H1 hESC,537,H1,,10511,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6426,GSM4293575,H1 hESC,H1 hESC,537,H1,,10512,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6427,GSM4293576,H1 hESC,H1 hESC,537,H1,,10513,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,PDX1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: PDX1-/- | library: polyA, stranded"
6428,GSM4293577,H1 hESC,H1 hESC,537,H1,,10514,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,PDX1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: PDX1-/- | library: polyA, stranded"
6429,GSM4293578,H1 hESC,H1 hESC,537,H1,,10515,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,GATA6-AS1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: GATA6-AS1-/- | library: polyA, stranded"
6430,GSM4293579,H1 hESC,H1 hESC,537,H1,,10516,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,GATA6-AS1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: GATA6-AS1-/- | library: polyA, stranded"
6431,GSM4293580,H1 hESC,H1 hESC,537,H1,,10517,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,TUNAR KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: TUNAR-/- | library: polyA, stranded"
6432,GSM4293581,H1 hESC,H1 hESC,537,H1,,10518,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,TUNAR KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: TUNAR-/- | library: polyA, stranded"
6433,GSM4293582,H1 hESC,H1 hESC,537,H1,,10519,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00479 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00479-/- | library: polyA, stranded"
6434,GSM4293583,H1 hESC,H1 hESC,537,H1,,10520,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00479 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00479-/- | library: polyA, stranded"
6435,GSM4293584,H1 hESC,H1 hESC,537,H1,,10521,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LHFPL3-AS2 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LHFPL3-AS2-/- | library: polyA, stranded"
6436,GSM4293585,H1 hESC,H1 hESC,537,H1,,10522,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LHFPL3-AS2 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LHFPL3-AS2-/- | library: polyA, stranded"
6437,GSM4293586,H1 hESC,H1 hESC,537,H1,,10523,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,SOX9-AS1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: SOX9-AS1-/- | library: polyA, stranded"
6438,GSM4293587,H1 hESC,H1 hESC,537,H1,,10524,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,SOX9-AS1 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: SOX9-AS1-/- | library: polyA, stranded"
6439,GSM4293588,H1 hESC,H1 hESC,537,H1,,10525,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,MIR7-3HG KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: MIR7-3HG-/- | library: polyA, stranded"
6440,GSM4293589,H1 hESC,H1 hESC,537,H1,,10526,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,MIR7-3HG KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: MIR7-3HG-/- | library: polyA, stranded"
6441,GSM4293590,H1 hESC,H1 hESC,537,H1,,10527,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-834C11.4 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: RP11-834C11.4-/- | library: polyA, stranded"
6442,GSM4293591,H1 hESC,H1 hESC,537,H1,,10528,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-834C11.4 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: RP11-834C11.4-/- | library: polyA, stranded"
6443,GSM4293592,H1 hESC,H1 hESC,537,H1,,10529,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-834C11.4 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: RP11-834C11.4-/- | library: polyA, stranded"
6444,GSM4293593,H1 hESC,H1 hESC,537,H1,,10530,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,RP11-834C11.4 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: RP11-834C11.4-/- | library: polyA, stranded"
6445,GSM4293594,H1 hESC,H1 hESC,537,H1,,10531,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6446,GSM4293595,H1 hESC,H1 hESC,537,H1,,10532,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6447,GSM4293596,H1 hESC,H1 hESC,537,H1,,10533,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6448,GSM4293597,H1 hESC,H1 hESC,537,H1,,10534,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6449,GSM4293598,H1 hESC,H1 hESC,537,H1,,10535,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6450,GSM4293599,H1 hESC,H1 hESC,537,H1,,10536,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,LINC00261 KO hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261-/- | library: polyA, stranded"
6451,GSM4293600,H1 hESC,H1 hESC,537,H1,,10537,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,hESCs with bilallelic frameshifts in LINC00261 sORF1 were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261 sORF1 frameshift | library: polyA, stranded"
6452,GSM4293601,H1 hESC,H1 hESC,537,H1,,10538,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,hESCs with bilallelic frameshifts in LINC00261 sORF1 were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: LINC00261 sORF1 frameshift | library: polyA, stranded"
6453,GSM4293602,H1 hESC,H1 hESC,537,H1,,10539,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage. RNA from nuclear and cytosolic fractions was isolated.,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribo-depleted, stranded"
6454,GSM4293603,H1 hESC,H1 hESC,537,H1,,10540,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage. RNA from nuclear and cytosolic fractions was isolated.,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribo-depleted, stranded"
6455,GSM4293604,H1 hESC,H1 hESC,537,H1,,10541,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage. RNA from nuclear and cytosolic fractions was isolated.,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribo-depleted, stranded"
6456,GSM4293605,H1 hESC,H1 hESC,537,H1,,10542,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage. RNA from nuclear and cytosolic fractions was isolated.,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribo-depleted, stranded"
6457,GSM4293606,EndoC-bH1,EndoC-bH1,537,EndoC-BH1,,10543,537,NA,GSE144682,Homo sapiens,EndoC-bH1,endoc-bh1,EndoC-BH1,EndoC-bH1 cells grown under standard conditions.,"cell line: EndoC-bH1 | cell type: Human beta cell line | genotype: WT | library: polyA, stranded"
6458,GSM4293607,H1 hESC,H1 hESC,537,H1,,10544,537,10574,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6459,GSM4293608,H1 hESC,H1 hESC,537,H1,,10545,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6460,GSM4293609,H1 hESC,H1 hESC,537,H1,,10546,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6461,GSM4293610,H1 hESC,H1 hESC,537,H1,,10547,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6462,GSM4293611,H1 hESC,H1 hESC,537,H1,,10548,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6463,GSM4293612,H1 hESC,H1 hESC,537,H1,,10549,537,10575,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6464,GSM4293613,H1 hESC,H1 hESC,537,H1,,10550,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6465,GSM4293614,H1 hESC,H1 hESC,537,H1,,10551,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6466,GSM4293615,H1 hESC,H1 hESC,537,H1,,10552,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6467,GSM4293616,H1 hESC,H1 hESC,537,H1,,10553,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6468,GSM4293617,H1 hESC,H1 hESC,537,H1,,10554,537,10576,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6469,GSM4293618,H1 hESC,H1 hESC,537,H1,,10555,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6470,GSM4293619,H1 hESC,H1 hESC,537,H1,,10556,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6471,GSM4293620,H1 hESC,H1 hESC,537,H1,,10557,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6472,GSM4293621,H1 hESC,H1 hESC,537,H1,,10558,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6473,GSM4293622,H1 hESC,H1 hESC,537,H1,,10559,537,10577,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6474,GSM4293623,H1 hESC,H1 hESC,537,H1,,10560,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6475,GSM4293624,H1 hESC,H1 hESC,537,H1,,10561,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6476,GSM4293625,H1 hESC,H1 hESC,537,H1,,10562,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6477,GSM4293626,H1 hESC,H1 hESC,537,H1,,10563,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6478,GSM4293627,H1 hESC,H1 hESC,537,H1,,10564,537,10578,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6479,GSM4293628,H1 hESC,H1 hESC,537,H1,,10565,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6480,GSM4293629,H1 hESC,H1 hESC,537,H1,,10566,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6481,GSM4293630,H1 hESC,H1 hESC,537,H1,,10567,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6482,GSM4293631,H1 hESC,H1 hESC,537,H1,,10568,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6483,GSM4293632,H1 hESC,H1 hESC,537,H1,,10569,537,10579,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6484,GSM4293633,H1 hESC,H1 hESC,537,H1,,10570,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6485,GSM4293634,H1 hESC,H1 hESC,537,H1,,10571,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6486,GSM4293635,H1 hESC,H1 hESC,537,H1,,10572,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6487,GSM4293636,H1 hESC,H1 hESC,537,H1,,10573,537,NA,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: ribosome-protected
6488,GSM4293637,H1 hESC,H1 hESC,537,H1,,10574,537,10544,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6489,GSM4293638,H1 hESC,H1 hESC,537,H1,,10575,537,10549,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6490,GSM4293639,H1 hESC,H1 hESC,537,H1,,10576,537,10554,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6491,GSM4293640,H1 hESC,H1 hESC,537,H1,,10577,537,10559,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6492,GSM4293641,H1 hESC,H1 hESC,537,H1,,10578,537,10564,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6493,GSM4293642,H1 hESC,H1 hESC,537,H1,,10579,537,10569,GSE144682,Homo sapiens,H1 hESC,h1,H1,Unmodified hESCs were differentiated to the PP2 stage,"cell line: H1 ES cells | cell type: ES-derived late pancreatic progenitor cells | genotype: WT | library: polyA, stranded"
6494,GSM4299125,HEK293T,HEK293T,509,HEK293T,NA,9825,509,9831,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type | strategy: RNA-Seq
6495,GSM4299126,HEK293T,HEK293T,509,HEK293T,NA,9826,509,9832,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type | strategy: RNA-Seq
6496,GSM4299127,HEK293T,HEK293T,509,HEK293T,NA,9827,509,9833,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: 4EHP-null | strategy: RNA-Seq
6497,GSM4299128,HEK293T,HEK293T,509,HEK293T,NA,9828,509,9834,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: 4EHP-null | strategy: RNA-Seq
6498,GSM4299129,HEK293T,HEK293T,509,HEK293T,NA,9829,509,9835,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: GIGYF1/2-null | strategy: RNA-Seq
6499,GSM4299130,HEK293T,HEK293T,509,HEK293T,NA,9830,509,9836,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: GIGYF1/2-null | strategy: RNA-Seq
6500,GSM4299131,HEK293T,HEK293T,509,HEK293T,NA,9831,509,9825,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type | strategy: Ribo-Seq
6501,GSM4299132,HEK293T,HEK293T,509,HEK293T,NA,9832,509,9826,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: Wild-type | strategy: Ribo-Seq
6502,GSM4299133,HEK293T,HEK293T,509,HEK293T,NA,9833,509,9827,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: 4EHP-null | strategy: Ribo-Seq
6503,GSM4299134,HEK293T,HEK293T,509,HEK293T,NA,9834,509,9828,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: 4EHP-null | strategy: Ribo-Seq
6504,GSM4299135,HEK293T,HEK293T,509,HEK293T,NA,9835,509,9829,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: GIGYF1/2-null | strategy: Ribo-Seq
6505,GSM4299136,HEK293T,HEK293T,509,HEK293T,NA,9836,509,9830,GSE144841,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,cell line: HEK293T | genotype: GIGYF1/2-null | strategy: Ribo-Seq
6514,GSM4331576,HEK293,HEK293,585,HEK293,NA,11433,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"HEK293, siRNA control",cell line: HEK293 | sirna: control | treatment: Cycloheximide
6515,GSM4331577,HEK293,HEK293,585,HEK293,NA,11434,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"HEK293, siRNA control",cell line: HEK293 | sirna: control | treatment: Cycloheximide
6516,GSM4331578,HEK293,HEK293,585,HEK293,NA,11435,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"HEK293, siRNA eif5A",cell line: HEK293 | sirna: eif5A | treatment: Cycloheximide
6517,GSM4331579,HEK293,HEK293,585,HEK293,NA,11436,585,NA,GSE145723,Homo sapiens,HEK293,hek293,HEK293,"HEK293, siRNA eif5A",cell line: HEK293 | sirna: eif5A | treatment: Cycloheximide
6552,GSM4378947,HAP1,HAP-1,834,HAP-1,NA,15883,834,NA,GSE146364,Homo sapiens,HAP-1,hap-1,HAP-1,haploid cells,cell line: HAP1 cells | genotype: Wild type
6553,GSM4378948,HAP1,HAP-1,834,HAP-1,NA,15884,834,NA,GSE146364,Homo sapiens,HAP-1,hap-1,HAP-1,haploid cells,cell line: HAP1 cells | genotype: Wild type
6554,GSM4378949,HAP1,HAP-1,834,HAP-1,NA,15885,834,NA,GSE146364,Homo sapiens,HAP-1,hap-1,HAP-1,haploid cells,cell line: HAP1 cells | genotype: METTL18 knockout
6555,GSM4378950,HAP1,HAP-1,834,HAP-1,NA,15886,834,NA,GSE146364,Homo sapiens,HAP-1,hap-1,HAP-1,haploid cells,cell line: HAP1 cells | genotype: METTL18 knockout
6556,GSM4378951,HAP1,HAP-1,834,HAP-1,NA,15887,834,NA,GSE146364,Homo sapiens,HAP-1,hap-1,HAP-1,haploid cells,cell line: HAP1 cells | genotype: METTL18 knockout
6575,GSM4407814,THP-1,THP-1,578,THP-1,NA,11333,578,11339,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: A5-KD
6576,GSM4407815,THP-1,THP-1,578,THP-1,NA,11334,578,11340,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: A5-KD
6577,GSM4407816,THP-1,THP-1,578,THP-1,NA,11335,578,11337,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: control
6578,GSM4407817,THP-1,THP-1,578,THP-1,NA,11336,578,11338,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: control
6579,GSM4407818,THP-1,THP-1,578,THP-1,NA,11337,578,11335,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: input
6580,GSM4407819,THP-1,THP-1,578,THP-1,NA,11338,578,11336,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: input
6581,GSM4407820,THP-1,THP-1,578,THP-1,NA,11339,578,11333,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: A5-KD
6582,GSM4407821,THP-1,THP-1,578,THP-1,NA,11340,578,11334,GSE146849,Homo sapiens,THP-1,thp-1,THP-1,THP-1,cell line: THP1 | genotype/variaton: A5-KD
6583,GSM4407914,HeLa cells,HeLa,559,HeLa,NA,10950,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,UPF1 KD 01 Ã¢Â€Â“ total RNA seq,cell line: HeLa cells | sirna: UPF1 knockdowns
6584,GSM4407915,HeLa cells,HeLa,559,HeLa,NA,10951,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,UPF1 KD 02 Ã¢Â€Â“ total RNA seq,cell line: HeLa cells | sirna: UPF1 knockdowns
6585,GSM4407916,HeLa cells,HeLa,559,HeLa,NA,10952,559,NA,GSE143301,Homo sapiens,HeLa,hela,HeLa,UPF1 KD 03 Ã¢Â€Â“ total RNA seq,cell line: HeLa cells | sirna: UPF1 knockdowns
6586,GSM4425990,HEK293T,HEK293T,616,HEK293T,NA,11742,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: none | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: after ligation | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6587,GSM4425991,HEK293T,HEK293T,616,HEK293T,NA,11743,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: legacy riboZero gold | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6588,GSM4425992,HEK293T,HEK293T,616,HEK293T,NA,11744,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: riboCop | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6589,GSM4425993,HEK293T,HEK293T,616,HEK293T,NA,11745,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: NEBNExt | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6590,GSM4425994,HEK293T,HEK293T,616,HEK293T,NA,11746,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: none | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6591,GSM4425995,HEK293T,HEK293T,616,HEK293T,NA,11747,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: legacy riboZero gold | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6592,GSM4425996,HEK293T,HEK293T,616,HEK293T,NA,11748,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: riboCop | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6593,GSM4425997,HEK293T,HEK293T,616,HEK293T,NA,11749,616,NA,GSE147324,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,cell line: HEK293T | depletion strategy: NEBNExt | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6594,GSM4425998,K562,K562,616,K562,NA,11750,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: NEBNExt | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6595,GSM4425999,K562,K562,616,K562,NA,11751,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: NEBNExt | sizes selected (nt): 20-60 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6596,GSM4426000,K562,K562,616,K562,NA,11752,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: NEBNExt | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6597,GSM4426001,K562,K562,616,K562,NA,11753,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: NEBNExt | sizes selected (nt): 20-60 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6598,GSM4426002,K562,K562,616,K562,NA,11754,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: qiagen fastselect | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6599,GSM4426003,K562,K562,616,K562,NA,11755,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: qiagen fastselect | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6600,GSM4426004,K562,K562,616,K562,NA,11756,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: ribopools | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6601,GSM4426005,K562,K562,616,K562,NA,11757,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: ribopools | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6602,GSM4426006,K562,K562,616,K562,NA,11758,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,"cell line: K562 | depletion strategy: ribopools, cold elution | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)"
6603,GSM4426007,K562,K562,616,K562,NA,11759,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,"cell line: K562 | depletion strategy: ribopools, cold elution | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)"
6604,GSM4426008,K562,K562,616,K562,NA,11760,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: ribo-zero plus | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6605,GSM4426009,K562,K562,616,K562,NA,11761,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,"cell line: K562 | depletion strategy: ribo-zero plus, formaldehyde | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)"
6606,GSM4426010,K562,K562,616,K562,NA,11762,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,"cell line: K562 | depletion strategy: ribo-zero plus, oligos | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)"
6607,GSM4426011,K562,K562,616,K562,NA,11763,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,"cell line: K562 | depletion strategy: ribo-zero plus, oligos, formaldehyde | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)"
6608,GSM4426012,K562,K562,616,K562,NA,11764,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: undepleted | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6609,GSM4426013,K562,K562,616,K562,NA,11765,616,NA,GSE147324,Homo sapiens,K562,k562,K562,K562 cells,cell line: K562 | depletion strategy: undepleted | sizes selected (nt): 20-34 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6610,GSM4426014,HEK293FT,HEK293FT,616,HEK293FT,NA,11766,616,NA,GSE147324,Homo sapiens,HEK293FT,hek293ft,HEK293FT,HEK293FT cells,cell line: HEK293FT | depletion strategy: custom oligos | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6611,GSM4426015,HEK293FT,HEK293FT,616,HEK293FT,NA,11767,616,NA,GSE147324,Homo sapiens,HEK293FT,hek293ft,HEK293FT,HEK293FT cells,cell line: HEK293FT | depletion strategy: undepleted | sizes selected (nt): 15-35 | adapter: NNNNNNCACTCGGGCACCAAGGAC | depletion step: NNNNNNCACTCGGGCACCAAGGAC | molecule subtype: Ribosome Protected mRNA (15-35 nt)
6690,GSM4458510,A549,A549,583,A549,NA,11397,583,NA,GSE148245,Homo sapiens,A549,a549,A549,A549,innoculum: A/Puerto Rico/8/1934 (H1N1) | treatment: harringtonine
6691,GSM4458511,A549,A549,583,A549,NA,11398,583,NA,GSE148245,Homo sapiens,A549,a549,A549,A549,innoculum: A/Puerto Rico/8/1934 (H1N1) | treatment: harringtonine
6692,GSM4458512,A549,A549,583,A549,NA,11399,583,NA,GSE148245,Homo sapiens,A549,a549,A549,A549,innoculum: A/Puerto Rico/8/1934 (H1N1) | treatment: dmso
6693,GSM4458513,A549,A549,583,A549,NA,11400,583,NA,GSE148245,Homo sapiens,A549,a549,A549,A549,innoculum: A/Puerto Rico/8/1934 (H1N1) | treatment: dmso
6706,GSM4475936,NCI-H1650,NCI-H1650,491,NCI-H1650,NA,9177,491,NA,GSE148636,Homo sapiens,NCI-H1650,nci-h1650,NCI-H1650,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: NCI-H1650
6707,GSM4475937,NCI-H1650,NCI-H1650,491,NCI-H1650,NA,9178,491,NA,GSE148636,Homo sapiens,NCI-H1650,nci-h1650,NCI-H1650,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: NCI-H1650
6708,GSM4475938,NCI-H520,NCI-H520,491,NCI-H520,NA,9179,491,NA,GSE148636,Homo sapiens,NCI-H520,nci-h520,NCI-H520,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: NCI-H520
6709,GSM4475939,NCI-H521,NCI-H521,491,NCI-H521,NA,9180,491,NA,GSE148636,Homo sapiens,NCI-H521,nci-h521,NCI-H521,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: NCI-H521
6710,GSM4475940,Hs 936.T,Hs 936.T,491,Hs 936.T,NA,9181,491,NA,GSE148636,Homo sapiens,Hs 936.T,hs 936.t,Hs 936.T,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: Hs 936.T
6711,GSM4475941,Hs 936.T,Hs 936.T,491,Hs 936.T,NA,9182,491,NA,GSE148636,Homo sapiens,Hs 936.T,hs 936.t,Hs 936.T,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: Hs 936.T
6712,GSM4475942,A375,A375,491,A375,NA,9183,491,NA,GSE148636,Homo sapiens,A375,a375,A375,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: A375
6713,GSM4475943,A375,A375,491,A375,NA,9184,491,NA,GSE148636,Homo sapiens,A375,a375,A375,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: DMSO | genetic background: WT | cell line: A375
6714,GSM4475944,NCI-H1650,NCI-H1650,491,NCI-H1650,NA,9185,491,NA,GSE148636,Homo sapiens,NCI-H1650,nci-h1650,NCI-H1650,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 0.3 microM | genetic background: WT | cell line: NCI-H1650
6715,GSM4475945,NCI-H1650,NCI-H1650,491,NCI-H1650,NA,9186,491,NA,GSE148636,Homo sapiens,NCI-H1650,nci-h1650,NCI-H1650,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 3 microM | genetic background: WT | cell line: NCI-H1650
6716,GSM4475946,NCI-H520,NCI-H520,491,NCI-H520,NA,9187,491,NA,GSE148636,Homo sapiens,NCI-H520,nci-h520,NCI-H520,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 0.3 microM | genetic background: WT | cell line: NCI-H520
6717,GSM4475947,NCI-H521,NCI-H521,491,NCI-H521,NA,9188,491,NA,GSE148636,Homo sapiens,NCI-H521,nci-h521,NCI-H521,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 3 microM | genetic background: WT | cell line: NCI-H521
6718,GSM4475948,Hs 936.T,Hs 936.T,491,Hs 936.T,NA,9189,491,NA,GSE148636,Homo sapiens,Hs 936.T,hs 936.t,Hs 936.T,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 0.3 microM | genetic background: WT | cell line: Hs 936.T
6719,GSM4475949,Hs 936.T,Hs 936.T,491,Hs 936.T,NA,9190,491,NA,GSE148636,Homo sapiens,Hs 936.T,hs 936.t,Hs 936.T,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 3 microM | genetic background: WT | cell line: Hs 936.T
6720,GSM4475950,A375,A375,491,A375,NA,9191,491,NA,GSE148636,Homo sapiens,A375,a375,A375,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 0.3 microM | genetic background: WT | cell line: A375
6721,GSM4475951,A375,A375,491,A375,NA,9192,491,NA,GSE148636,Homo sapiens,A375,a375,A375,"Rnase I footprinting, ribosome pelleting, RNA extraction",treatment: RocA 3 microM | genetic background: WT | cell line: A375
6722,GSM4478779,Hela,HeLa,551,HeLa,NA,10781,551,NA,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: WT | cell line: Hela | library preparation kit: Takara/Clonentech | rrna depletion: - | index sequence: ATTACTCG
6723,GSM4478780,Hela,HeLa,551,HeLa,NA,10782,551,NA,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Takara/Clonentech | rrna depletion: - | index sequence: TCCGGAGA
6724,GSM4478781,Hela,HeLa,551,HeLa,NA,10783,551,NA,GSE140084,Homo sapiens,HeLa,hela,HeLa,Hela Cells,genotype: DENR KO | cell line: Hela | library preparation kit: Takara/Clonentech | rrna depletion: - | index sequence: CGCTCATT
6725,GSM4483514,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11507,596,11508,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6726,GSM4483515,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11508,596,11507,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6727,GSM4483516,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11509,596,11510,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6728,GSM4483517,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11510,596,11509,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6729,GSM4483518,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11511,596,11512,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6730,GSM4483519,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11512,596,11511,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6731,GSM4483520,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11513,596,NA,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6732,GSM4483521,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11514,596,11515,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6733,GSM4483522,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11515,596,11514,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6734,GSM4483523,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11516,596,11517,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6735,GSM4483524,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11517,596,11516,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6736,GSM4483525,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11518,596,11519,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6737,GSM4483526,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11519,596,11518,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6738,GSM4483527,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11520,596,NA,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6739,GSM4483528,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11521,596,11522,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6740,GSM4483529,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11522,596,11521,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6741,GSM4483530,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11523,596,11524,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6742,GSM4483531,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11524,596,11523,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6743,GSM4483532,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11525,596,11526,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6744,GSM4483533,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11526,596,11525,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6745,GSM4483534,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11527,596,NA,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6746,GSM4483535,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11528,596,11529,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6747,GSM4483536,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11529,596,11528,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6748,GSM4483537,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11530,596,11531,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6749,GSM4483538,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11531,596,11530,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6750,GSM4483539,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11532,596,11533,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6751,GSM4483540,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11533,596,11532,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: Ribosome protected mRNA
6752,GSM4483541,SH-SY5Y,SH-SY5Y,596,SH-SY5Y,NA,11534,596,NA,GSE148827,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,Neuronally differentiated SH-SY5Y,cell type: Neuronally differentiated SH-SY5Y | passages: 11 | molecule subtype: poly(A) mRNA
6753,GSM4485596,HeLa,HeLa,526,HeLa,NA,10388,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,HelaUnt,cell line: HeLa | plasmid(s): ZAK-FLAG | treatment: untreated | sample type: Isolated monosomes | molecule subtype: Ribosome Protected mRNA (15-34 nt)
6754,GSM4485597,HeLa,HeLa,526,HeLa,NA,10389,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,HelaUnt,cell line: HeLa | plasmid(s): ZAK-FLAG | treatment: untreated | sample type: Isolated monosomes | molecule subtype: Ribosome Protected mRNA (15-34 nt)
6755,GSM4485598,HeLa,HeLa,526,HeLa,NA,10390,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,HelaUV,cell line: HeLa | plasmid(s): ZAK-FLAG | treatment: UV-irradiated | sample type: Isolated monosomes | molecule subtype: Ribosome Protected mRNA (15-34 nt)
6756,GSM4485599,HeLa,HeLa,526,HeLa,NA,10391,526,NA,GSE141459,Homo sapiens,HeLa,hela,HeLa,HelaUV,cell line: HeLa | plasmid(s): ZAK-FLAG | treatment: UV-irradiated | sample type: Isolated monosomes | molecule subtype: Ribosome Protected mRNA (15-34 nt)
6757,GSM4495441,HEK293T,HEK293T,513,HEK293T,NA,9920,513,9924,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: wild type
6758,GSM4495442,HEK293T,HEK293T,513,HEK293T,NA,9921,513,9925,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: wild type
6759,GSM4495443,HEK293T,HEK293T,513,HEK293T,NA,9922,513,9926,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: ZNF598-null
6760,GSM4495444,HEK293T,HEK293T,513,HEK293T,NA,9923,513,9927,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: ZNF598-null
6761,GSM4495445,HEK293T,HEK293T,513,HEK293T,NA,9924,513,9920,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: wild type
6762,GSM4495446,HEK293T,HEK293T,513,HEK293T,NA,9925,513,9921,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: wild type
6763,GSM4495447,HEK293T,HEK293T,513,HEK293T,NA,9926,513,9922,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: ZNF598-null
6764,GSM4495448,HEK293T,HEK293T,513,HEK293T,NA,9927,513,9923,GSE149279,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genotype: ZNF598-null
6765,GSM4504137,PDX,PDX,826,PDX,NA,15749,826,15751,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6766,GSM4504138,PDX,PDX,826,PDX,NA,15750,826,15752,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6767,GSM4504139,PDX,PDX,826,PDX,NA,15751,826,15749,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6768,GSM4504140,PDX,PDX,826,PDX,NA,15752,826,15750,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6769,GSM4504141,PDX,PDX,826,PDX,NA,15753,826,15755,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6770,GSM4504142,PDX,PDX,826,PDX,NA,15754,826,15756,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6771,GSM4504143,PDX,PDX,826,PDX,NA,15755,826,15753,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6772,GSM4504144,PDX,PDX,826,PDX,NA,15756,826,15754,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6773,GSM4504145,PDX,PDX,826,PDX,NA,15757,826,15759,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6774,GSM4504146,PDX,PDX,826,PDX,NA,15758,826,15760,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6775,GSM4504147,PDX,PDX,826,PDX,NA,15759,826,15757,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6776,GSM4504148,PDX,PDX,826,PDX,NA,15760,826,15758,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6777,GSM4504149,PDX,PDX,826,PDX,NA,15761,826,15763,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6778,GSM4504150,PDX,PDX,826,PDX,NA,15762,826,15764,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6779,GSM4504151,PDX,PDX,826,PDX,NA,15763,826,15761,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6780,GSM4504152,PDX,PDX,826,PDX,NA,15764,826,15762,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
6975,GSM4519099,Vero 6,Vero 6,584,Vero 6,NA,11401,584,11403,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,mrna_05hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6976,GSM4519100,Vero 6,Vero 6,584,Vero 6,NA,11402,584,11404,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,mrna_05hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6977,GSM4519101,Vero 6,Vero 6,584,Vero 6,NA,11403,584,11401,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_chx_05hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6978,GSM4519102,Vero 6,Vero 6,584,Vero 6,NA,11404,584,11402,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_chx_05hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6979,GSM4519103,Vero 6,Vero 6,584,Vero 6,NA,11405,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_ltm_05hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6980,GSM4519104,Vero 6,Vero 6,584,Vero 6,NA,11406,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_ltm_05hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6981,GSM4519105,Vero 6,Vero 6,584,Vero 6,NA,11407,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_harr_05hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6982,GSM4519106,Vero 6,Vero 6,584,Vero 6,NA,11408,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_harr_05hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 5"
6983,GSM4519107,Vero 6,Vero 6,584,Vero 6,NA,11409,584,11411,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,mrna_24hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6984,GSM4519108,Vero 6,Vero 6,584,Vero 6,NA,11410,584,11412,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,mrna_24hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6985,GSM4519109,Vero 6,Vero 6,584,Vero 6,NA,11411,584,11409,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_chx_24hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6986,GSM4519110,Vero 6,Vero 6,584,Vero 6,NA,11412,584,11410,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_chx_24hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6987,GSM4519111,Vero 6,Vero 6,584,Vero 6,NA,11413,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_ltm_24hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6988,GSM4519112,Vero 6,Vero 6,584,Vero 6,NA,11414,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_ltm_24hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6989,GSM4519113,Vero 6,Vero 6,584,Vero 6,NA,11415,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_harr_24hr_1,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6990,GSM4519114,Vero 6,Vero 6,584,Vero 6,NA,11416,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,fp_harr_24hr_2,"virus strain: BetaCoV/Germany/BavPat1/2020 EPI_ISL_406862 | cell line: Vero cells, ATCC, CCL-81 | hours post infection: 24"
6991,GSM4550615,HEK293T,HEK293T,523,HEK293T,NA,10250,523,NA,GSE150439,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
6992,GSM4550616,HEK293T,HEK293T,523,HEK293T,NA,10251,523,NA,GSE150439,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: WT | cell line: HEK293T
6993,GSM4550617,HEK293T,HEK293T,523,HEK293T,NA,10252,523,NA,GSE150439,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: QTRT2 KO | cell line: HEK293T
6994,GSM4550618,HEK293T,HEK293T,523,HEK293T,NA,10253,523,NA,GSE150439,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,genetic background: QTRT2 KO | cell line: HEK293T
7003,GSM4588291,HAP1,HAP-1,536,HAP-1,NA,10485,536,10491,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7004,GSM4588292,HAP1,HAP-1,536,HAP-1,NA,10486,536,10492,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7005,GSM4588293,HAP1,HAP-1,536,HAP-1,NA,10487,536,10493,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7006,GSM4588294,HAP1,HAP-1,536,HAP-1,NA,10488,536,10494,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7007,GSM4588295,HAP1,HAP-1,536,HAP-1,NA,10489,536,10495,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7008,GSM4588296,HAP1,HAP-1,536,HAP-1,NA,10490,536,10496,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7009,GSM4588297,HAP1,HAP-1,536,HAP-1,NA,10491,536,10485,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7010,GSM4588298,HAP1,HAP-1,536,HAP-1,NA,10492,536,10486,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7011,GSM4588299,HAP1,HAP-1,536,HAP-1,NA,10493,536,10487,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: DMSO
7012,GSM4588300,HAP1,HAP-1,536,HAP-1,NA,10494,536,10488,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7013,GSM4588301,HAP1,HAP-1,536,HAP-1,NA,10495,536,10489,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7014,GSM4588302,HAP1,HAP-1,536,HAP-1,NA,10496,536,10490,GSE151687,Homo sapiens,HAP-1,hap-1,HAP-1,HAP1 cells,cell type: HAP1 cells | treatment: Hippuristanol 50 nM
7048,GSM4618168,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15849,830,15854,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 46 years | age group: middle-aged | gender: Male | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7049,GSM4618169,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15850,830,15855,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 43 years | age group: middle-aged | gender: Female | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7050,GSM4618170,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15851,830,15856,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 41 years | age group: middle-aged | gender: Female | ethnicity: African_American | tissue: skeletal muscle | health status: healthy
7051,GSM4618171,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15852,830,15857,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 85 years | age group: old (O) | gender: Male | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7052,GSM4618172,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15853,830,15858,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 83 years | age group: old (O) | gender: Female | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7053,GSM4618177,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15854,830,15849,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 46 years | age group: middle-aged (MA) | gender: Male | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7054,GSM4618178,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15855,830,15850,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 43 years | age group: middle-aged (MA) | gender: Female | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7055,GSM4618179,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15856,830,15851,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 41 years | age group: middle-aged (MA) | gender: Female | ethnicity: African_American | tissue: skeletal muscle | health status: healthy
7056,GSM4618180,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15857,830,15852,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 85 years | age group: old (O) | gender: Male | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7057,GSM4618181,skeletal muscle,skeletal muscle,830,skeletal muscle,NA,15858,830,15853,GSE152558,Homo sapiens,skeletal muscle,skeletal muscle,skeletal muscle,Vastus_ lateralis_muscle_biopsy,age: 83 years | age group: old (O) | gender: Female | ethnicity: Caucasian | tissue: skeletal muscle | health status: healthy
7058,GSM4647797,K562,K562,558,K562,NA,10918,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgEIF4E2 | sgrna target: EIF4E2 | replicate: r1
7059,GSM4647798,K562,K562,558,K562,NA,10919,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgEIF4E2 | sgrna target: EIF4E2 | replicate: r2
7060,GSM4647799,K562,K562,558,K562,NA,10920,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgGal4 | sgrna target: non-targeting | replicate: r1
7061,GSM4647800,K562,K562,558,K562,NA,10921,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgGal4 | sgrna target: non-targeting | replicate: r2
7062,GSM4647801,K562,K562,558,K562,NA,10922,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgGIGYF2 | sgrna target: GIGYF2 | replicate: r1
7063,GSM4647802,K562,K562,558,K562,NA,10923,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgGIGYF2 | sgrna target: GIGYF2 | replicate: r2
7064,GSM4647803,K562,K562,558,K562,NA,10924,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells,sgrna: none | sgrna target: n/a | replicate: r1
7065,GSM4647804,K562,K562,558,K562,NA,10925,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells,sgrna: none | sgrna target: n/a | replicate: r2
7066,GSM4647805,K562,K562,558,K562,NA,10926,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgNEMF | sgrna target: NEMF | replicate: r1
7067,GSM4647806,K562,K562,558,K562,NA,10927,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgNEMF | sgrna target: NEMF | replicate: r2
7068,GSM4647807,K562,K562,558,K562,NA,10928,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgZNF598 | sgrna target: ZNF598 | replicate: r1
7069,GSM4647808,K562,K562,558,K562,NA,10929,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: sgZNF598 | sgrna target: ZNF598 | replicate: r2
7070,GSM4647809,K562,K562,558,K562,NA,10930,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: mixed | sgrna target: mixed | replicate: r1
7071,GSM4647810,K562,K562,558,K562,NA,10931,558,NA,GSE153597,Homo sapiens,K562,k562,K562,K562-dCas9 cells with GFP non-stop reporter,sgrna: mixed | sgrna target: mixed | replicate: r2
7080,GSM4670758,Vero 6,Vero 6,584,Vero 6,NA,11417,584,NA,GSE149973,Homo sapiens,Vero 6,vero 6,Vero 6,virus,virus strain: BavPat1/2020 EPI_ISL_406862
7081,GSM4670759,Calu 3,Calu 3,584,Calu 3,NA,11418,584,NA,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,virus,virus strain: BavPat1/2020 Ref-SKU: 026V-03883
7082,GSM4670760,Calu 3,Calu 3,584,Calu 3,NA,11419,584,11421,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7083,GSM4670761,Calu 3,Calu 3,584,Calu 3,NA,11420,584,11422,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7084,GSM4670762,Calu 3,Calu 3,584,Calu 3,NA,11421,584,11419,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7085,GSM4670763,Calu 3,Calu 3,584,Calu 3,NA,11422,584,11420,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7086,GSM4670764,Calu 3,Calu 3,584,Calu 3,NA,11423,584,NA,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7087,GSM4670765,Calu 3,Calu 3,584,Calu 3,NA,11424,584,NA,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7088,GSM4670766,Calu 3,Calu 3,584,Calu 3,NA,11425,584,NA,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7089,GSM4670767,Calu 3,Calu 3,584,Calu 3,NA,11426,584,NA,GSE149973,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","virus strain: BavPat1/2020 Ref-SKU: 026V-03883 | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: 7"
7168,GSM4711285,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10214,522,10215,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: Poly(A) mRNA
7169,GSM4711286,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10215,522,10214,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: ribosome-protected mRNA
7170,GSM4711288,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10217,522,10218,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: Poly(A) mRNA
7171,GSM4711289,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10218,522,10217,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: ribosome-protected mRNA
7172,GSM4711291,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10220,522,10221,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: Poly(A) mRNA
7173,GSM4711292,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10221,522,10220,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: ribosome-protected mRNA
7174,GSM4711294,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10223,522,10224,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: Poly(A) mRNA
7175,GSM4711295,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10224,522,10223,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,resting,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: No | molecule subtype: ribosome-protected mRNA
7176,GSM4711297,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10226,522,10227,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 1,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7177,GSM4711298,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10227,522,10226,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 1,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7178,GSM4711300,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10229,522,10230,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 2,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7179,GSM4711301,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10230,522,10229,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 2,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7180,GSM4711303,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10232,522,10233,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 3,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7181,GSM4711304,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10233,522,10232,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 3,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7182,GSM4711306,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10235,522,10236,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 4,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7183,GSM4711307,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10236,522,10235,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 0 hours 4,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7184,GSM4711309,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10238,522,10239,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 1,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7185,GSM4711310,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10239,522,10238,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 1,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7186,GSM4711312,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10241,522,10242,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 2,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7187,GSM4711313,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10242,522,10241,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 2,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7188,GSM4711315,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10244,522,10245,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 3,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7189,GSM4711316,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10245,522,10244,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 3,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7190,GSM4711318,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10247,522,10248,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 4,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: Poly(A) mRNA
7191,GSM4711319,SH-SY5Y,SH-SY5Y,522,SH-SY5Y,NA,10248,522,10247,GSE155727,Homo sapiens,SH-SY5Y,sh-sy5y,SH-SY5Y,depol 2 hours 4,cell type: Neuronally differentiated SH-SY5Y | passages: 7 | depolarised: Yes | molecule subtype: ribosome-protected mRNA
7192,GSM4715688,Multiple Myeloma,Multiple Myeloma,819,Multiple Myeloma,NA,15575,819,NA,GSE155917,Homo sapiens,Multiple Myeloma,multiple myeloma,Multiple Myeloma,CAG WT,cell type: Mutiple Myeloma | genotype/variation: Wildtype
7193,GSM4715689,Multiple Myeloma,Multiple Myeloma,819,Multiple Myeloma,NA,15576,819,NA,GSE155917,Homo sapiens,Multiple Myeloma,multiple myeloma,Multiple Myeloma,CAG NAT10 OE,cell type: Mutiple Myeloma | genotype/variation: NAT10 overexpression
7222,GSM4736503,hESC,hESC,524,hESC,NA,10285,524,NA,GSE156671,Homo sapiens,hESC,hesc,hESC,hESCs,tissue: hESCs | batch: batch3 | development stage: Day0 | library type: RNAseq | treatment: --
7223,GSM4736504,hESC,hESC,524,hESC,NA,10286,524,NA,GSE156671,Homo sapiens,hESC,hesc,hESC,hESCs,tissue: hESCs | batch: batch3 | development stage: Day0 | library type: RNAseq | treatment: --
7224,GSM4736505,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10287,524,NA,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch3 | development stage: Day7 | library type: RNAseq | treatment: --
7225,GSM4736506,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10288,524,NA,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch3 | development stage: Day7 | library type: RNAseq | treatment: --
7226,GSM4736507,early neurons,early neurons,524,early neurons,NA,10289,524,NA,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,early neurons,tissue: early neurons | batch: batch3 | development stage: Day8 | library type: RNAseq | treatment: --
7227,GSM4736508,early neurons,early neurons,524,early neurons,NA,10290,524,NA,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,early neurons,tissue: early neurons | batch: batch3 | development stage: Day8 | library type: RNAseq | treatment: --
7228,GSM4736509,neurons,neurons,524,neurons,NA,10291,524,NA,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch3 | development stage: Day14 | library type: RNAseq | treatment: --
7229,GSM4736510,neurons,neurons,524,neurons,NA,10292,524,NA,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch3 | development stage: Day14 | library type: RNAseq | treatment: --
7230,GSM4736511,hESC,hESC,524,hESC,NA,10293,524,10294,GSE156671,Homo sapiens,hESC,hesc,hESC,hESCs,tissue: hESCs | batch: batch4 | development stage: Day0 | library type: Ribosomal Profiling | treatment: mRNA
7231,GSM4736512,hESC,hESC,524,hESC,NA,10294,524,10293,GSE156671,Homo sapiens,hESC,hesc,hESC,hESCs,tissue: hESCs | batch: batch4 | development stage: Day0 | library type: Ribosomal Profiling | treatment: Footprint
7232,GSM4736513,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10295,524,10296,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch4 | development stage: Day7 | library type: Ribosomal Profiling | treatment: mRNA
7233,GSM4736514,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10296,524,10295,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch4 | development stage: Day7 | library type: Ribosomal Profiling | treatment: Footprint
7234,GSM4736515,early neurons,early neurons,524,early neurons,NA,10297,524,10298,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,early neurons,tissue: early neurons | batch: batch4 | development stage: Day8 | library type: Ribosomal Profiling | treatment: mRNA
7235,GSM4736516,early neurons,early neurons,524,early neurons,NA,10298,524,10297,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,early neurons,tissue: early neurons | batch: batch4 | development stage: Day8 | library type: Ribosomal Profiling | treatment: Footprint
7236,GSM4736517,neurons,neurons,524,neurons,NA,10299,524,10300,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch4 | development stage: Day14 | library type: Ribosomal Profiling | treatment: mRNA
7237,GSM4736518,neurons,neurons,524,neurons,NA,10300,524,10299,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch4 | development stage: Day14 | library type: Ribosomal Profiling | treatment: Footprint
7238,GSM4736519,hESC,hESC,524,hESC,NA,10301,524,10305,GSE156671,Homo sapiens,hESC,hesc,hESC,hESCs,tissue: hESCs | batch: batch5 | development stage: Day0 | library type: Ribosomal Profiling | treatment: mRNA
7239,GSM4736520,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10302,524,10306,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,hESCs,tissue: hESCs | batch: batch5 | development stage: Day7 | library type: Ribosomal Profiling | treatment: mRNA
7240,GSM4736521,early neurons,early neurons,524,early neurons,NA,10303,524,10304,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch5 | development stage: Day8 | library type: Ribosomal Profiling | treatment: mRNA
7241,GSM4736522,early neurons,early neurons,524,early neurons,NA,10304,524,10303,GSE156671,Homo sapiens,early neurons,early neurons,early neurons,neuronal precursor cells,tissue: neuronal precursor cells | batch: batch5 | development stage: Day8 | library type: Ribosomal Profiling | treatment: Footprint
7242,GSM4736523,hESC,hESC,524,hESC,NA,10305,524,10301,GSE156671,Homo sapiens,hESC,hesc,hESC,early neurons,tissue: early neurons | batch: batch5 | development stage: Day0 | library type: Ribosomal Profiling | treatment: Footprint
7243,GSM4736524,neuronal precursor cells,neuronal precursor cells,524,neuronal precursor cells,NA,10306,524,10302,GSE156671,Homo sapiens,neuronal precursor cells,neuronal precursor cells,neuronal precursor cells,early neurons,tissue: early neurons | batch: batch5 | development stage: Day7 | library type: Ribosomal Profiling | treatment: Footprint
7244,GSM4736525,neurons,neurons,524,neurons,NA,10307,524,10308,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch5 | development stage: Day14 | library type: Ribosomal Profiling | treatment: mRNA
7245,GSM4736526,neurons,neurons,524,neurons,NA,10308,524,10307,GSE156671,Homo sapiens,neurons,neurons,neurons,neurons,tissue: neurons | batch: batch5 | development stage: Day14 | library type: Ribosomal Profiling | treatment: Footprint
7258,GSM4744693,HEK293T,HEK293T,809,HEK293T,NA,15407,809,15408,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: Input RNA | guide rna: Negative control sgRNA
7259,GSM4744694,HEK293T,HEK293T,809,HEK293T,NA,15408,809,15407,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: ribosome footprint RNA | guide rna: Negative control sgRNA
7260,GSM4744695,HEK293T,HEK293T,809,HEK293T,NA,15409,809,15410,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: Input RNA | guide rna: sgMETTL16
7261,GSM4744696,HEK293T,HEK293T,809,HEK293T,NA,15410,809,15409,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: ribosome footprint RNA | guide rna: sgMETTL16
7262,GSM4744697,HEK293T,HEK293T,809,HEK293T,NA,15411,809,15412,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: Input RNA | guide rna: sgMETTL16
7263,GSM4744698,HEK293T,HEK293T,809,HEK293T,NA,15412,809,15411,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: ribosome footprint RNA | guide rna: sgMETTL16
7264,GSM4744699,HEK293T,HEK293T,809,HEK293T,NA,15413,809,15414,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: Input RNA | guide rna: sgMETTL16
7265,GSM4744700,HEK293T,HEK293T,809,HEK293T,NA,15414,809,15413,GSE156796,Homo sapiens,HEK293T,hek293t,HEK293T,embryonic kidney,cell line: HEK293T | rna fragment: ribosome footprint RNA | guide rna: sgMETTL16
7278,GSM4751855,HCT-116,HCT-116,520,HCT-116,NA,10008,520,10018,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, DMSO treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: DMSO | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7279,GSM4751856,HCT-116,HCT-116,520,HCT-116,NA,10009,520,10019,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, DMSO treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: DMSO | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7280,GSM4751857,HCT-116,HCT-116,520,HCT-116,NA,10010,520,10020,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7281,GSM4751858,HCT-116,HCT-116,520,HCT-116,NA,10011,520,10021,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7282,GSM4751859,HCT-116,HCT-116,520,HCT-116,NA,10012,520,10022,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X WT transfected, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X WT transfected | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7283,GSM4751860,HCT-116,HCT-116,520,HCT-116,NA,10013,520,10023,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X WT transfected, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X WT transfected | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7284,GSM4751861,HCT-116,HCT-116,520,HCT-116,NA,10014,520,10024,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X R326H transfected, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X R326H transfected | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7285,GSM4751862,HCT-116,HCT-116,520,HCT-116,NA,10015,520,10025,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X R326H transfected, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X R326H transfected | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
7286,GSM4751863,HCT-116,HCT-116,520,HCT-116,NA,10016,520,10026,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,,
7287,GSM4751864,HCT-116,HCT-116,520,HCT-116,NA,10017,520,10027,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,,
7288,GSM4751865,HCT-116,HCT-116,520,HCT-116,NA,10018,520,10008,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, DMSO treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: DMSO | rna isolation: Total RNA
7289,GSM4751866,HCT-116,HCT-116,520,HCT-116,NA,10019,520,10009,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, DMSO treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: DMSO | rna isolation: Total RNA
7290,GSM4751867,HCT-116,HCT-116,520,HCT-116,NA,10020,520,10010,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | rna isolation: Total RNA
7291,GSM4751868,HCT-116,HCT-116,520,HCT-116,NA,10021,520,10011,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | rna isolation: Total RNA
7292,GSM4751869,HCT-116,HCT-116,520,HCT-116,NA,10022,520,10012,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X WT transfected, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X WT transfected | rna isolation: Total RNA
7293,GSM4751870,HCT-116,HCT-116,520,HCT-116,NA,10023,520,10013,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X WT transfected, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X WT transfected | rna isolation: Total RNA
7294,GSM4751871,HCT-116,HCT-116,520,HCT-116,NA,10024,520,10014,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X R326H transfected, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X R326H transfected | rna isolation: Total RNA
7295,GSM4751872,HCT-116,HCT-116,520,HCT-116,NA,10025,520,10015,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,"HCT-116 with DDX3X degron, auxin treated, DDX3X R326H transfected, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID | treatment: 500 micromolar IAA | treatment: DDX3X R326H transfected | rna isolation: Total RNA
7296,GSM4751873,HCT-116,HCT-116,520,HCT-116,NA,10026,520,10016,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,,
7297,GSM4751874,HCT-116,HCT-116,520,HCT-116,NA,10027,520,10017,GSE157063,Homo sapiens,HCT-116,hct-116,HCT-116,,
7368,GSM4787156,Hap1,HAP-1,475,HAP-1,NA,8893,475,NA,GSE158044,Homo sapiens,HAP-1,hap-1,HAP-1,whole cell,cell line: Hap1 | treatment: untreated | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7369,GSM4787157,Hap1,HAP-1,475,HAP-1,NA,8894,475,NA,GSE158044,Homo sapiens,HAP-1,hap-1,HAP-1,whole cell,"cell line: Hap1 | treatment: 10 Ã‚ÂµM 2-5A treated, 3 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7370,GSM4787158,HeLa,HeLa,475,HeLa,NA,8895,475,NA,GSE158044,Homo sapiens,HeLa,hela,HeLa,whole cell,cell line: HeLa | treatment: untreated | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7371,GSM4787159,HeLa,HeLa,475,HeLa,NA,8896,475,NA,GSE158044,Homo sapiens,HeLa,hela,HeLa,whole cell,"cell line: HeLa | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7372,GSM4787160,HeLa,HeLa,475,HeLa,NA,8897,475,NA,GSE158044,Homo sapiens,HeLa,hela,HeLa,whole cell,cell line: HeLa | treatment: 1 Ã‚ÂµM tetramer 2-5A. 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7373,GSM4787161,HeLa,HeLa,475,HeLa,NA,8898,475,NA,GSE158044,Homo sapiens,HeLa,hela,HeLa,whole cell,"cell line: HeLa | treatment: 10 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7374,GSM4787162,HeLa,HeLa,475,HeLa,NA,8899,475,NA,GSE158044,Homo sapiens,HeLa,hela,HeLa,whole cell,"cell line: HeLa | treatment: 10 Ã‚ÂµM tetramer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7375,GSM4787163,A549,A549,475,A549,NA,8900,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,cell line: A549 | treatment: untreated | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7376,GSM4787164,A549,A549,475,A549,NA,8901,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,cell line: A549 | treatment: untreated | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7377,GSM4787165,A549,A549,475,A549,NA,8902,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7378,GSM4787166,A549,A549,475,A549,NA,8903,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7379,GSM4787167,A549,A549,475,A549,NA,8904,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7380,GSM4787168,A549,A549,475,A549,NA,8905,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 10 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7381,GSM4787169,A549,A549,475,A549,NA,8906,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7382,GSM4787170,A549,A549,475,A549,NA,8907,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 2.25 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7383,GSM4787171,A549,A549,475,A549,NA,8908,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,cell line: A549 | treatment: untreated | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7384,GSM4787172,A549,A549,475,A549,NA,8909,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,cell line: A549 | treatment: 1 Ã‚ÂµM dimer 2-5A | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7385,GSM4787173,A549,A549,475,A549,NA,8910,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,cell line: A549 | treatment: untreated | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)
7386,GSM4787174,A549,A549,475,A549,NA,8911,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7387,GSM4787175,A549,A549,475,A549,NA,8912,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7388,GSM4787176,A549,A549,475,A549,NA,8913,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7389,GSM4787177,A549,A549,475,A549,NA,8914,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7390,GSM4787178,A549,A549,475,A549,NA,8915,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: untreated | genotype: RNASEL KO, wild type RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7391,GSM4787179,A549,A549,475,A549,NA,8916,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: untreated | genotype: RNASEL KO, H672N RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7392,GSM4787180,A549,A549,475,A549,NA,8917,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: RNASEL KO,H672N RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7393,GSM4787181,A549,A549,475,A549,NA,8918,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: RNASEL KO,H672N RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7394,GSM4787182,A549,A549,475,A549,NA,8919,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: RNASEL KO,wild type RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7395,GSM4787183,A549,A549,475,A549,NA,8920,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: RNASEL KO,wild type RNAse L transently transfected | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7396,GSM4787184,A549,A549,475,A549,NA,8921,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 1 Ã‚ÂµM trimer 2-5A, 4.5 h | genotype: wild type | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7397,GSM4787185,A549,A549,475,A549,NA,8922,475,NA,GSE158044,Homo sapiens,A549,a549,A549,whole cell,"cell line: A549 | treatment: 0.25 Ã‚Âµg/ml poly I:C, 4.5 h | genotype: RNASEL KO | molecule subtype: 80S ribosome protected RNA (25-34 nt)"
7406,GSM4793171,HEK293,HEK293,813,HEK293,NA,15468,813,15471,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7407,GSM4793172,HEK293,HEK293,813,HEK293,NA,15469,813,15472,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7408,GSM4793173,HEK293,HEK293,813,HEK293,NA,15470,813,15473,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7409,GSM4793174,HEK293,HEK293,813,HEK293,NA,15471,813,15468,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7410,GSM4793175,HEK293,HEK293,813,HEK293,NA,15472,813,15469,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7411,GSM4793176,HEK293,HEK293,813,HEK293,NA,15473,813,15470,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: CNOT1 siRNA | cell line: HEK293
7412,GSM4793179,HEK293,HEK293,813,HEK293,NA,15474,813,15477,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7413,GSM4793180,HEK293,HEK293,813,HEK293,NA,15475,813,15478,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7414,GSM4793181,HEK293,HEK293,813,HEK293,NA,15476,813,15479,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7415,GSM4793182,HEK293,HEK293,813,HEK293,NA,15477,813,15474,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7416,GSM4793183,HEK293,HEK293,813,HEK293,NA,15478,813,15475,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7417,GSM4793184,HEK293,HEK293,813,HEK293,NA,15479,813,15476,GSE158141,Homo sapiens,HEK293,hek293,HEK293,HEK293 cells,sirna: Control siRNA | cell line: HEK293
7430,GSM4798519,HEK293,HEK293,518,HEK293,NA,9982,518,9991,GSE158374,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7431,GSM4798520,HEK293,HEK293,518,HEK293,NA,9983,518,9992,GSE158375,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7432,GSM4798521,HEK293,HEK293,518,HEK293,NA,9984,518,9993,GSE158376,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7433,GSM4798522,HEK293,HEK293,518,HEK293,NA,9985,518,9994,GSE158377,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7434,GSM4798523,HEK293,HEK293,518,HEK293,NA,9986,518,9995,GSE158378,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7435,GSM4798524,HEK293,HEK293,518,HEK293,NA,9987,518,9996,GSE158379,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: RNA from ribosome footprint
7436,GSM4798525,HEK293,HEK293,518,HEK293,NA,9988,518,9997,GSE158380,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: RNA from ribosome footprint
7437,GSM4798526,HEK293,HEK293,518,HEK293,NA,9989,518,9998,GSE158381,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: RNA from ribosome footprint
7438,GSM4798527,HEK293,HEK293,518,HEK293,NA,9990,518,9999,GSE158382,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: RNA from ribosome footprint
7439,GSM4798528,HEK293,HEK293,518,HEK293,NA,9991,518,9982,GSE158383,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: Total RNA
7440,GSM4798529,HEK293,HEK293,518,HEK293,NA,9992,518,9983,GSE158384,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: Total RNA
7441,GSM4798530,HEK293,HEK293,518,HEK293,NA,9993,518,9984,GSE158385,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP1 expressing | cell line: HEK293 | rna population: Total RNA
7442,GSM4798531,HEK293,HEK293,518,HEK293,NA,9994,518,9985,GSE158386,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: Total RNA
7443,GSM4798532,HEK293,HEK293,518,HEK293,NA,9995,518,9986,GSE158387,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: Total RNA
7444,GSM4798533,HEK293,HEK293,518,HEK293,NA,9996,518,9987,GSE158388,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: NSP2 expressing | cell line: HEK293 | rna population: Total RNA
7445,GSM4798534,HEK293,HEK293,518,HEK293,NA,9997,518,9988,GSE158389,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: Total RNA
7446,GSM4798535,HEK293,HEK293,518,HEK293,NA,9998,518,9989,GSE158390,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: Total RNA
7447,GSM4798536,HEK293,HEK293,518,HEK293,NA,9999,518,9990,GSE158391,Homo sapiens,HEK293,hek293,HEK293,HEK293,treatment: no treatment | cell line: HEK293 | rna population: Total RNA
7479,GSM4815960,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9571,497,9579,GSE158930,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: mock-lowMOI
7480,GSM4815961,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9572,497,9580,GSE158931,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 6hpi
7481,GSM4815962,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9573,497,9581,GSE158932,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 24hpi
7482,GSM4815963,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9574,497,9582,GSE158933,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 48hpi
7483,GSM4815964,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9575,497,9583,GSE158934,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 72hpi
7484,GSM4815965,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9576,497,9584,GSE158935,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 6hpi
7485,GSM4815966,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9577,497,9585,GSE158936,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 24hpi
7486,GSM4815967,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9578,497,9586,GSE158937,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 48hpi
7487,GSM4815968,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9579,497,9571,GSE158938,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: mock-lowMOI
7488,GSM4815969,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9580,497,9572,GSE158939,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 6hpi
7489,GSM4815970,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9581,497,9573,GSE158940,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 24hpi
7490,GSM4815971,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9582,497,9574,GSE158941,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 48hpi
7491,GSM4815972,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9583,497,9575,GSE158942,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-lowMOI | time point: 72hpi
7492,GSM4815973,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9584,497,9576,GSE158943,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 6hpi
7493,GSM4815974,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9585,497,9577,GSE158944,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 24hpi
7494,GSM4815975,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,497,Primary human bronchial epithelial cells,NA,9586,497,9578,GSE158945,Homo sapiens,Primary human bronchial epithelial cells,primary human bronchial epithelial cells,Primary human bronchial epithelial cells,Primary human bronchial epithelial cells,treatment: Cycloheximide | agent: SARS2-highMOI | time point: 48hpi
7495,GSM4815976,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9587,497,9591,GSE158946,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: mock
7496,GSM4815977,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9588,497,9592,GSE158947,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: mock
7497,GSM4815978,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9589,497,9593,GSE158948,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: HIV
7498,GSM4815979,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9590,497,9594,GSE158949,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: HIV
7499,GSM4815980,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9591,497,9587,GSE158950,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: mock
7500,GSM4815981,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9592,497,9588,GSE158951,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: mock
7501,GSM4815982,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9593,497,9589,GSE158952,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: HIV
7502,GSM4815983,Primary CD4+ T-cells,Primary CD4+ T-cells,497,Primary CD4+ T-cells,NA,9594,497,9590,GSE158953,Homo sapiens,Primary CD4+ T-cells,primary cd4+ t-cells,Primary CD4+ T-cells,Primary CD4+ T-cells,treatment: Cycloheximide | agent: HIV
7503,GSM4822815,HEK293,HEK293,482,HEK293,NA,9024,482,9056,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7504,GSM4822816,HEK293,HEK293,482,HEK293,NA,9025,482,9057,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7505,GSM4822819,HEK293,HEK293,482,HEK293,NA,9028,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7506,GSM4822820,HEK293,HEK293,482,HEK293,NA,9029,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7507,GSM4822823,HEK293,HEK293,482,HEK293,NA,9032,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7508,GSM4822824,HEK293,HEK293,482,HEK293,NA,9033,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7509,GSM4822827,HEK293,HEK293,482,HEK293,NA,9036,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7510,GSM4822828,HEK293,HEK293,482,HEK293,NA,9037,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7511,GSM4822831,HEK293,HEK293,482,HEK293,NA,9040,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7512,GSM4822832,HEK293,HEK293,482,HEK293,NA,9041,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7513,GSM4822835,HEK293,HEK293,482,HEK293,NA,9044,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7514,GSM4822836,HEK293,HEK293,482,HEK293,NA,9045,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7515,GSM4822839,HEK293,HEK293,482,HEK293,NA,9048,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7516,GSM4822840,HEK293,HEK293,482,HEK293,NA,9049,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK293
7517,GSM4822843,HEK293,HEK293,482,HEK293,NA,9052,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7518,GSM4822844,HEK293,HEK293,482,HEK293,NA,9053,482,NA,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7519,GSM4822847,HEK293,HEK293,482,HEK293,NA,9056,482,9024,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7520,GSM4822848,HEK293,HEK293,482,HEK293,NA,9057,482,9025,GSE158930,Homo sapiens,HEK293,hek293,HEK293,Human embryonic kidney cells,cell type: HEK-TtH cells stably expressing fused ER:HRasG12V
7521,GSM4826365,C4-2,C4-2,488,C4-2,NA,9142,488,NA,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shCTRL_rep3_Ribo_seq,genotype: shCTRL | cell line: C4-2
7522,GSM4826366,C4-2,C4-2,488,C4-2,NA,9143,488,NA,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shEZH2_rep3_Ribo_seq,genotype: shEZH2 | cell line: C4-2
7523,GSM4826367,C4-2,C4-2,488,C4-2,NA,9144,488,NA,GSE143975,Homo sapiens,C4-2,c4-2,C4-2,shFBL_rep3_Ribo_seq,genotype: shFBL | cell line: C4-2
7524,GSM4832647,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15859,832,15865,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7525,GSM4832648,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15860,832,15866,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7526,GSM4832649,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15861,832,15867,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7527,GSM4832650,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15862,832,15868,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7528,GSM4832651,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15863,832,15869,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7529,GSM4832652,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15864,832,15870,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7530,GSM4832653,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15865,832,15859,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7531,GSM4832654,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15866,832,15860,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7532,GSM4832655,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15867,832,15861,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7533,GSM4832656,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15868,832,15862,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7534,GSM4832657,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15869,832,15863,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 negative megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 negative megakaryocytes
7535,GSM4832658,megakaryocytes,megakaryocytes,832,megakaryocytes,NA,15870,832,15864,GSE159579,Homo sapiens,megakaryocytes,megakaryocytes,megakaryocytes,CD42 positive megakaryocytes,cell type: Cultured human cord blood-derived CD34+ cells | cell subtype: CD42 positive megakaryocytes
7548,GSM4879484,OSCC,OSCC,504,OSCC,NA,9746,504,9748,GSE160803,Homo sapiens,OSCC,oscc,OSCC,OSCC cell line,cell type: Patient-derived oral squamous cell carcinoma (OSCC) | gender: Female | treatment: Transfection of siC
7549,GSM4879485,OSCC,OSCC,504,OSCC,NA,9747,504,9749,GSE160803,Homo sapiens,OSCC,oscc,OSCC,OSCC cell line,cell type: Patient-derived oral squamous cell carcinoma (OSCC) | gender: Female | treatment: Transfection of siD
7550,GSM4879486,OSCC,OSCC,504,OSCC,NA,9748,504,9746,GSE160803,Homo sapiens,OSCC,oscc,OSCC,OSCC cell line,cell type: Patient-derived oral squamous cell carcinoma (OSCC) | gender: Female | treatment: Transfection of siC
7551,GSM4879487,OSCC,OSCC,504,OSCC,NA,9749,504,9747,GSE160803,Homo sapiens,OSCC,oscc,OSCC,OSCC cell line,cell type: Patient-derived oral squamous cell carcinoma (OSCC) | gender: Female | treatment: Transfection of siD
7558,GSM4886540,HEK293T,HEK293T,481,HEK293T,NA,9016,481,9020,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: WT
7559,GSM4886541,HEK293T,HEK293T,481,HEK293T,NA,9017,481,9021,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: WT
7560,GSM4886542,HEK293T,HEK293T,481,HEK293T,NA,9018,481,9022,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: DROSHA KO
7561,GSM4886543,HEK293T,HEK293T,481,HEK293T,NA,9019,481,9023,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: DROSHA KO
7562,GSM4886544,HEK293T,HEK293T,481,HEK293T,NA,9020,481,9016,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: WT
7563,GSM4886545,HEK293T,HEK293T,481,HEK293T,NA,9021,481,9017,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: WT
7564,GSM4886546,HEK293T,HEK293T,481,HEK293T,NA,9022,481,9018,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: DROSHA KO
7565,GSM4886547,HEK293T,HEK293T,481,HEK293T,NA,9023,481,9019,GSE160917,Homo sapiens,HEK293T,hek293t,HEK293T,293T,genotype/variation: DROSHA KO
7566,GSM4904490,LNCaP,LNCaP,823,LNCaP,NA,15695,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: untreated
7567,GSM4904491,LNCaP,LNCaP,823,LNCaP,NA,15696,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: untreated
7568,GSM4904492,LNCaP,LNCaP,823,LNCaP,NA,15697,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: untreated
7569,GSM4904493,LNCaP,LNCaP,823,LNCaP,NA,15698,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: 200 ng/ml doxycycline 96 hours
7570,GSM4904494,LNCaP,LNCaP,823,LNCaP,NA,15699,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: 200 ng/ml doxycycline 96 hours
7571,GSM4904495,LNCaP,LNCaP,823,LNCaP,NA,15700,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: Non-targeting | treatment: 200 ng/ml doxycycline 96 hours
7572,GSM4904496,LNCaP,LNCaP,823,LNCaP,NA,15701,823,15717,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7573,GSM4904497,LNCaP,LNCaP,823,LNCaP,NA,15702,823,15718,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7574,GSM4904498,LNCaP,LNCaP,823,LNCaP,NA,15703,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7575,GSM4904499,LNCaP,LNCaP,823,LNCaP,NA,15704,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7576,GSM4904500,LNCaP,LNCaP,823,LNCaP,NA,15705,823,15719,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7577,GSM4904501,LNCaP,LNCaP,823,LNCaP,NA,15706,823,15720,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7578,GSM4904502,LNCaP,LNCaP,823,LNCaP,NA,15707,823,15721,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7579,GSM4904503,LNCaP,LNCaP,823,LNCaP,NA,15708,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7580,GSM4904504,LNCaP,LNCaP,823,LNCaP,NA,15709,823,15722,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7581,GSM4904505,LNCaP,LNCaP,823,LNCaP,NA,15710,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7582,GSM4904506,LNCaP,LNCaP,823,LNCaP,NA,15711,823,15723,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7583,GSM4904507,LNCaP,LNCaP,823,LNCaP,NA,15712,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7584,GSM4904508,LNCaP,LNCaP,823,LNCaP,NA,15713,823,15724,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7585,GSM4904509,LNCaP,LNCaP,823,LNCaP,NA,15714,823,15725,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7586,GSM4904510,LNCaP,LNCaP,823,LNCaP,NA,15715,823,15726,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7587,GSM4904511,LNCaP,LNCaP,823,LNCaP,NA,15716,823,NA,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7588,GSM4904512,LNCaP,LNCaP,823,LNCaP,NA,15717,823,15701,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7589,GSM4904513,LNCaP,LNCaP,823,LNCaP,NA,15718,823,15702,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: untreated
7590,GSM4904514,LNCaP,LNCaP,823,LNCaP,NA,15719,823,15705,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7591,GSM4904515,LNCaP,LNCaP,823,LNCaP,NA,15720,823,15706,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7592,GSM4904516,LNCaP,LNCaP,823,LNCaP,NA,15721,823,15707,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 1 | treatment: 200 ng/ml doxycycline 96 hours
7593,GSM4904517,LNCaP,LNCaP,823,LNCaP,NA,15722,823,15709,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7594,GSM4904518,LNCaP,LNCaP,823,LNCaP,NA,15723,823,15711,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: untreated
7595,GSM4904519,LNCaP,LNCaP,823,LNCaP,NA,15724,823,15713,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7596,GSM4904520,LNCaP,LNCaP,823,LNCaP,NA,15725,823,15714,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7597,GSM4904521,LNCaP,LNCaP,823,LNCaP,NA,15726,823,15715,GSE161301,Homo sapiens,LNCaP,lncap,LNCaP,LNCaP cell line,shRNA: METTL3 shRNA 2 | treatment: 200 ng/ml doxycycline 96 hours
7598,GSM4949718,Calu 3,Calu 3,828,Calu 3,NA,15801,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7599,GSM4949719,Calu 3,Calu 3,828,Calu 3,NA,15802,828,NA,GSE162324,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7600,GSM4949724,Calu 3,Calu 3,828,Calu 3,NA,15807,828,15813,GSE162325,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7601,GSM4949725,Calu 3,Calu 3,828,Calu 3,NA,15808,828,15814,GSE162326,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7602,GSM4949730,Calu 3,Calu 3,828,Calu 3,NA,15813,828,15807,GSE162327,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7603,GSM4949731,Calu 3,Calu 3,828,Calu 3,NA,15814,828,15808,GSE162328,Homo sapiens,Calu 3,calu 3,Calu 3,Homo Sapiens,"virus strain: -- | cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7645,GSM4958135,muscle tissue,muscle tissue,492,muscle tissue,NA,9193,492,9199,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7646,GSM4958136,muscle tissue,muscle tissue,492,muscle tissue,NA,9194,492,9200,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7647,GSM4958137,muscle tissue,muscle tissue,492,muscle tissue,NA,9195,492,9201,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7648,GSM4958138,muscle tissue,muscle tissue,492,muscle tissue,NA,9196,492,9202,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7649,GSM4958139,muscle tissue,muscle tissue,492,muscle tissue,NA,9197,492,9203,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7650,GSM4958140,muscle tissue,muscle tissue,492,muscle tissue,NA,9198,492,9204,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7651,GSM4958141,muscle tissue,muscle tissue,492,muscle tissue,NA,9199,492,9193,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7652,GSM4958142,muscle tissue,muscle tissue,492,muscle tissue,NA,9200,492,9194,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7653,GSM4958143,muscle tissue,muscle tissue,492,muscle tissue,NA,9201,492,9195,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7654,GSM4958144,muscle tissue,muscle tissue,492,muscle tissue,NA,9202,492,9196,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7655,GSM4958145,muscle tissue,muscle tissue,492,muscle tissue,NA,9203,492,9197,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7656,GSM4958146,muscle tissue,muscle tissue,492,muscle tissue,NA,9204,492,9198,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 17,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7657,GSM4958147,muscle tissue,muscle tissue,492,muscle tissue,NA,9205,492,9211,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7658,GSM4958148,muscle tissue,muscle tissue,492,muscle tissue,NA,9206,492,9212,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7659,GSM4958149,muscle tissue,muscle tissue,492,muscle tissue,NA,9207,492,9213,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7660,GSM4958150,muscle tissue,muscle tissue,492,muscle tissue,NA,9208,492,9214,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7661,GSM4958151,muscle tissue,muscle tissue,492,muscle tissue,NA,9209,492,9215,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7662,GSM4958152,muscle tissue,muscle tissue,492,muscle tissue,NA,9210,492,9216,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7663,GSM4958153,muscle tissue,muscle tissue,492,muscle tissue,NA,9211,492,9205,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7664,GSM4958154,muscle tissue,muscle tissue,492,muscle tissue,NA,9212,492,9206,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7665,GSM4958155,muscle tissue,muscle tissue,492,muscle tissue,NA,9213,492,9207,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7666,GSM4958156,muscle tissue,muscle tissue,492,muscle tissue,NA,9214,492,9208,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7667,GSM4958157,muscle tissue,muscle tissue,492,muscle tissue,NA,9215,492,9209,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7668,GSM4958158,muscle tissue,muscle tissue,492,muscle tissue,NA,9216,492,9210,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 18,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7669,GSM4958159,muscle tissue,muscle tissue,492,muscle tissue,NA,9217,492,9223,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7670,GSM4958160,muscle tissue,muscle tissue,492,muscle tissue,NA,9218,492,9224,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7671,GSM4958161,muscle tissue,muscle tissue,492,muscle tissue,NA,9219,492,9225,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7672,GSM4958162,muscle tissue,muscle tissue,492,muscle tissue,NA,9220,492,9226,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7673,GSM4958163,muscle tissue,muscle tissue,492,muscle tissue,NA,9221,492,9227,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7674,GSM4958164,muscle tissue,muscle tissue,492,muscle tissue,NA,9222,492,9228,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7675,GSM4958165,muscle tissue,muscle tissue,492,muscle tissue,NA,9223,492,9217,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7676,GSM4958166,muscle tissue,muscle tissue,492,muscle tissue,NA,9224,492,9218,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7677,GSM4958167,muscle tissue,muscle tissue,492,muscle tissue,NA,9225,492,9219,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7678,GSM4958168,muscle tissue,muscle tissue,492,muscle tissue,NA,9226,492,9220,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7679,GSM4958169,muscle tissue,muscle tissue,492,muscle tissue,NA,9227,492,9221,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7680,GSM4958170,muscle tissue,muscle tissue,492,muscle tissue,NA,9228,492,9222,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 19,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7681,GSM4958171,muscle tissue,muscle tissue,492,muscle tissue,NA,9229,492,9235,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7682,GSM4958172,muscle tissue,muscle tissue,492,muscle tissue,NA,9230,492,9236,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7683,GSM4958173,muscle tissue,muscle tissue,492,muscle tissue,NA,9231,492,9237,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7684,GSM4958174,muscle tissue,muscle tissue,492,muscle tissue,NA,9232,492,9238,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7685,GSM4958175,muscle tissue,muscle tissue,492,muscle tissue,NA,9233,492,9239,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7686,GSM4958176,muscle tissue,muscle tissue,492,muscle tissue,NA,9234,492,9240,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7687,GSM4958177,muscle tissue,muscle tissue,492,muscle tissue,NA,9235,492,9229,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7688,GSM4958178,muscle tissue,muscle tissue,492,muscle tissue,NA,9236,492,9230,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7689,GSM4958179,muscle tissue,muscle tissue,492,muscle tissue,NA,9237,492,9231,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7690,GSM4958180,muscle tissue,muscle tissue,492,muscle tissue,NA,9238,492,9232,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7691,GSM4958181,muscle tissue,muscle tissue,492,muscle tissue,NA,9239,492,9233,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7692,GSM4958182,muscle tissue,muscle tissue,492,muscle tissue,NA,9240,492,9234,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 20,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7693,GSM4958183,muscle tissue,muscle tissue,492,muscle tissue,NA,9241,492,9247,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7694,GSM4958184,muscle tissue,muscle tissue,492,muscle tissue,NA,9242,492,9248,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7695,GSM4958185,muscle tissue,muscle tissue,492,muscle tissue,NA,9243,492,9249,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7696,GSM4958186,muscle tissue,muscle tissue,492,muscle tissue,NA,9244,492,9250,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7697,GSM4958187,muscle tissue,muscle tissue,492,muscle tissue,NA,9245,492,9251,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7698,GSM4958188,muscle tissue,muscle tissue,492,muscle tissue,NA,9246,492,9252,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7699,GSM4958189,muscle tissue,muscle tissue,492,muscle tissue,NA,9247,492,9241,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7700,GSM4958190,muscle tissue,muscle tissue,492,muscle tissue,NA,9248,492,9242,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7701,GSM4958191,muscle tissue,muscle tissue,492,muscle tissue,NA,9249,492,9243,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7702,GSM4958192,muscle tissue,muscle tissue,492,muscle tissue,NA,9250,492,9244,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7703,GSM4958193,muscle tissue,muscle tissue,492,muscle tissue,NA,9251,492,9245,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7704,GSM4958194,muscle tissue,muscle tissue,492,muscle tissue,NA,9252,492,9246,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 21,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7705,GSM4958195,muscle tissue,muscle tissue,492,muscle tissue,NA,9253,492,9259,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7706,GSM4958196,muscle tissue,muscle tissue,492,muscle tissue,NA,9254,492,9260,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7707,GSM4958197,muscle tissue,muscle tissue,492,muscle tissue,NA,9255,492,9261,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7708,GSM4958198,muscle tissue,muscle tissue,492,muscle tissue,NA,9256,492,9262,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7709,GSM4958199,muscle tissue,muscle tissue,492,muscle tissue,NA,9257,492,9263,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7710,GSM4958200,muscle tissue,muscle tissue,492,muscle tissue,NA,9258,492,9264,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7711,GSM4958201,muscle tissue,muscle tissue,492,muscle tissue,NA,9259,492,9253,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7712,GSM4958202,muscle tissue,muscle tissue,492,muscle tissue,NA,9260,492,9254,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7713,GSM4958203,muscle tissue,muscle tissue,492,muscle tissue,NA,9261,492,9255,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7714,GSM4958204,muscle tissue,muscle tissue,492,muscle tissue,NA,9262,492,9256,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7715,GSM4958205,muscle tissue,muscle tissue,492,muscle tissue,NA,9263,492,9257,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7716,GSM4958206,muscle tissue,muscle tissue,492,muscle tissue,NA,9264,492,9258,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 23,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7717,GSM4958207,muscle tissue,muscle tissue,492,muscle tissue,NA,9265,492,9271,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7718,GSM4958208,muscle tissue,muscle tissue,492,muscle tissue,NA,9266,492,9272,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7719,GSM4958209,muscle tissue,muscle tissue,492,muscle tissue,NA,9267,492,9273,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7720,GSM4958210,muscle tissue,muscle tissue,492,muscle tissue,NA,9268,492,9274,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7721,GSM4958211,muscle tissue,muscle tissue,492,muscle tissue,NA,9269,492,9275,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7722,GSM4958212,muscle tissue,muscle tissue,492,muscle tissue,NA,9270,492,9276,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7723,GSM4958213,muscle tissue,muscle tissue,492,muscle tissue,NA,9271,492,9265,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7724,GSM4958214,muscle tissue,muscle tissue,492,muscle tissue,NA,9272,492,9266,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7725,GSM4958215,muscle tissue,muscle tissue,492,muscle tissue,NA,9273,492,9267,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7726,GSM4958216,muscle tissue,muscle tissue,492,muscle tissue,NA,9274,492,9268,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7727,GSM4958217,muscle tissue,muscle tissue,492,muscle tissue,NA,9275,492,9269,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7728,GSM4958218,muscle tissue,muscle tissue,492,muscle tissue,NA,9276,492,9270,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 25,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7729,GSM4958219,muscle tissue,muscle tissue,492,muscle tissue,NA,9277,492,9283,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7730,GSM4958220,muscle tissue,muscle tissue,492,muscle tissue,NA,9278,492,9284,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7731,GSM4958221,muscle tissue,muscle tissue,492,muscle tissue,NA,9279,492,9285,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7732,GSM4958222,muscle tissue,muscle tissue,492,muscle tissue,NA,9280,492,9286,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7733,GSM4958223,muscle tissue,muscle tissue,492,muscle tissue,NA,9281,492,9287,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7734,GSM4958224,muscle tissue,muscle tissue,492,muscle tissue,NA,9282,492,9288,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7735,GSM4958225,muscle tissue,muscle tissue,492,muscle tissue,NA,9283,492,9277,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 0 baseline
7736,GSM4958226,muscle tissue,muscle tissue,492,muscle tissue,NA,9284,492,9278,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 60 min after Leucine
7737,GSM4958227,muscle tissue,muscle tissue,492,muscle tissue,NA,9285,492,9279,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Pre reduced activity 180 min after Leucine
7738,GSM4958228,muscle tissue,muscle tissue,492,muscle tissue,NA,9286,492,9280,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 0 baseline
7739,GSM4958229,muscle tissue,muscle tissue,492,muscle tissue,NA,9287,492,9281,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 60 min after Leucine
7740,GSM4958230,muscle tissue,muscle tissue,492,muscle tissue,NA,9288,492,9282,GSE162730,Homo sapiens,muscle tissue,muscle tissue,muscle tissue,Patient 26,tissue: muscle biopsy | time point: Post reduced activity 180 min after Leucine
7773,GSM5049233,Calu 3,Calu 3,828,Calu 3,NA,15831,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7774,GSM5049234,Calu 3,Calu 3,828,Calu 3,NA,15832,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7775,GSM5049235,Calu 3,Calu 3,828,Calu 3,NA,15833,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7776,GSM5049236,Calu 3,Calu 3,828,Calu 3,NA,15834,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7777,GSM5049237,Calu 3,Calu 3,828,Calu 3,NA,15835,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7778,GSM5049238,Calu 3,Calu 3,828,Calu 3,NA,15836,828,NA,GSE162323,Homo sapiens,Calu 3,calu 3,Calu 3,"Calu 3 cells, ATCC HTB-55","cell line: Calu 3 cells, ATCC HTB-55 | hours post infection: uninfected"
7779,GSM5066043,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15541,817,15553,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
7780,GSM5066044,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15542,817,15554,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
7781,GSM5066045,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15543,817,15555,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
7782,GSM5066049,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15547,817,15556,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
7783,GSM5066050,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15548,817,15557,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
7784,GSM5066051,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15549,817,15558,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
7785,GSM5099830,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15888,835,15898,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7786,GSM5099831,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15889,835,15894,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7787,GSM5099832,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15890,835,15895,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7788,GSM5099833,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15891,835,15899,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7789,GSM5099834,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15892,835,15896,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7790,GSM5099835,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15893,835,15897,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | treatment 2: Harringtonine+Cyclohexamide | library: Ribosome profiling | molecule subtype: Footprint mRNA
7791,GSM5099836,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15894,835,15889,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7792,GSM5099837,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15895,835,15890,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7793,GSM5099838,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15896,835,15892,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7794,GSM5099839,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15897,835,15893,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7795,GSM5099840,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15898,835,15888,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: IFNÃŽÂ³ +IL1ÃŽÂ² | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7796,GSM5099841,EndoC-BH1,EndoC-BH1,835,EndoC-BH1,NA,15899,835,15891,GSE167223,Homo sapiens,EndoC-BH1,endoc-bh1,EndoC-BH1,Human fetal pancreatic bulbs,cell type: EndoC-{beta}H1 | treatment 1: untreated | library: Long-RNA sequencing | molecule subtype: poly-A mRNA
7884,GSM5229605,A549,A549,806,A549,NA,15361,806,NA,GSE171640,Homo sapiens,A549,a549,A549,lung cancer cells,cell line: A549 | cell type: human lung cancer cells | genotype: RBMS1 knockdown ctrl
7885,GSM5229606,A549,A549,806,A549,NA,15362,806,NA,GSE171640,Homo sapiens,A549,a549,A549,lung cancer cells,cell line: A549 | cell type: human lung cancer cells | genotype: RBMS1 knockdown
7886,GSM5229607,A549,A549,806,A549,NA,15363,806,NA,GSE171640,Homo sapiens,A549,a549,A549,lung cancer cells,cell line: A549 | cell type: human lung cancer cells | genotype: RBMS1 knockdown
7887,GSM5229608,A549,A549,806,A549,NA,15364,806,NA,GSE171640,Homo sapiens,A549,a549,A549,lung cancer cells,cell line: A549 | cell type: human lung cancer cells | genotype: RBMS1 overexpress ctrl
7888,GSM5229609,A549,A549,806,A549,NA,15365,806,NA,GSE171640,Homo sapiens,A549,a549,A549,lung cancer cells,cell line: A549 | cell type: human lung cancer cells | genotype: RBMS1 overexpress
7901,GSM5234100,IMR90,IMR90,827,IMR90,NA,15775,827,NA,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblast IMR90,cell line: IMR90 | isolate: I90-10 | sirna: Non-targeting control (NTC)
7902,GSM5234101,IMR90,IMR90,827,IMR90,NA,15776,827,NA,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblast IMR90,cell line: IMR90 | isolate: I90-79 | sirna: Non-targeting control (NTC)
7903,GSM5234102,IMR90,IMR90,827,IMR90,NA,15777,827,NA,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblast IMR90,cell line: IMR90 | isolate: I90-10 | sirna: siHMGB1 knock-down
7904,GSM5234103,IMR90,IMR90,827,IMR90,NA,15778,827,NA,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblast IMR90,cell line: IMR90 | isolate: I90-79 | sirna: siHMGB1 knock-down
7905,GSM5234104,IMR90,IMR90,827,IMR90,NA,15779,827,15785,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7906,GSM5234105,IMR90,IMR90,827,IMR90,NA,15780,827,15786,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7907,GSM5234106,IMR90,IMR90,827,IMR90,NA,15781,827,15787,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7908,GSM5234107,IMR90,IMR90,827,IMR90,NA,15782,827,15788,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7909,GSM5234108,IMR90,IMR90,827,IMR90,NA,15783,827,15789,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7910,GSM5234109,IMR90,IMR90,827,IMR90,NA,15784,827,15790,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7911,GSM5234110,IMR90,IMR90,827,IMR90,NA,15785,827,15779,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7912,GSM5234111,IMR90,IMR90,827,IMR90,NA,15786,827,15780,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7913,GSM5234112,IMR90,IMR90,827,IMR90,NA,15787,827,15781,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Proliferating
7914,GSM5234113,IMR90,IMR90,827,IMR90,NA,15788,827,15782,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7915,GSM5234114,IMR90,IMR90,827,IMR90,NA,15789,827,15783,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7916,GSM5234115,IMR90,IMR90,827,IMR90,NA,15790,827,15784,GSE171782,Homo sapiens,IMR90,imr90,IMR90,Normal lung fibroblasts IMR90,cell line: IMR90 | condition: Senescent
7917,GSM5291027,HeLa,HeLa,820,HeLa,NA,15577,820,15583,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: total RNA
7918,GSM5291028,HeLa,HeLa,820,HeLa,NA,15578,820,15584,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: total RNA
7919,GSM5291029,HeLa,HeLa,820,HeLa,NA,15579,820,15585,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: total RNA
7920,GSM5291030,HeLa,HeLa,820,HeLa,NA,15580,820,15586,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: total RNA
7921,GSM5291031,HeLa,HeLa,820,HeLa,NA,15581,820,15587,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: total RNA
7922,GSM5291032,HeLa,HeLa,820,HeLa,NA,15582,820,15588,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: total RNA
7923,GSM5291033,HeLa,HeLa,820,HeLa,NA,15583,820,15577,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: ribosome protected fragment RNA
7924,GSM5291034,HeLa,HeLa,820,HeLa,NA,15584,820,15578,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: ribosome protected fragment RNA
7925,GSM5291035,HeLa,HeLa,820,HeLa,NA,15585,820,15579,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 cells,cell type: HelaS3 | genotype/variation: wild type | molecule: ribosome protected fragment RNA
7926,GSM5291036,HeLa,HeLa,820,HeLa,NA,15586,820,15580,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: ribosome protected fragment RNA
7927,GSM5291037,HeLa,HeLa,820,HeLa,NA,15587,820,15581,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: ribosome protected fragment RNA
7928,GSM5291038,HeLa,HeLa,820,HeLa,NA,15588,820,15582,GSE148965,Homo sapiens,HeLa,hela,HeLa,HelaS3 SNORD45C knockout cells,cell type: HelaS3 | genotype/variation: HelaS3-SNORD45C-KO | molecule: ribosome protected fragment RNA
7929,GSM5291864,HEK293T,HEK293T,821,HEK293T,NA,15595,821,NA,GSE174329,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF3D-V5 KI | treatment: none
7930,GSM5291865,HEK293T,HEK293T,821,HEK293T,NA,15596,821,NA,GSE174330,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF3D-V5 KI | treatment: none
7931,GSM5291866,HEK293T,HEK293T,821,HEK293T,NA,15597,821,15599,GSE174331,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7932,GSM5291867,HEK293T,HEK293T,821,HEK293T,NA,15598,821,15600,GSE174332,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7933,GSM5291868,HEK293T,HEK293T,821,HEK293T,NA,15599,821,15597,GSE174333,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: none
7934,GSM5291869,HEK293T,HEK293T,821,HEK293T,NA,15600,821,15598,GSE174334,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: none
7935,GSM5291870,HEK293T,HEK293T,821,HEK293T,NA,15601,821,NA,GSE174335,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: lactimidomycin
7936,GSM5291871,HEK293T,HEK293T,821,HEK293T,NA,15602,821,NA,GSE174336,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: lactimidomycin
7937,GSM5291872,HEK293T,HEK293T,821,HEK293T,NA,15603,821,15605,GSE174337,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7938,GSM5291873,HEK293T,HEK293T,821,HEK293T,NA,15604,821,15606,GSE174338,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7939,GSM5291874,HEK293T,HEK293T,821,HEK293T,NA,15605,821,15603,GSE174339,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7940,GSM5291875,HEK293T,HEK293T,821,HEK293T,NA,15606,821,15604,GSE174340,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: none
7941,GSM5291876,HEK293T,HEK293T,821,HEK293T,NA,15607,821,15609,GSE174341,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: none
7942,GSM5291877,HEK293T,HEK293T,821,HEK293T,NA,15608,821,15610,GSE174342,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: none
7943,GSM5291878,HEK293T,HEK293T,821,HEK293T,NA,15609,821,15607,GSE174343,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: none
7944,GSM5291879,HEK293T,HEK293T,821,HEK293T,NA,15610,821,15608,GSE174344,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: none
7945,GSM5291880,HEK293T,HEK293T,821,HEK293T,NA,15611,821,15613,GSE174345,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: none
7946,GSM5291881,HEK293T,HEK293T,821,HEK293T,NA,15612,821,15614,GSE174346,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: none
7947,GSM5291882,HEK293T,HEK293T,821,HEK293T,NA,15613,821,15611,GSE174347,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: none
7948,GSM5291883,HEK293T,HEK293T,821,HEK293T,NA,15614,821,15612,GSE174348,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: none
7949,GSM5291884,HEK293T,HEK293T,821,HEK293T,NA,15615,821,15617,GSE174349,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: none
7950,GSM5291885,HEK293T,HEK293T,821,HEK293T,NA,15616,821,15618,GSE174350,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: none
7951,GSM5291886,HEK293T,HEK293T,821,HEK293T,NA,15617,821,15615,GSE174351,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: none
7952,GSM5291887,HEK293T,HEK293T,821,HEK293T,NA,15618,821,15616,GSE174352,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: none
7953,GSM5291888,HEK293T,HEK293T,821,HEK293T,NA,15619,821,15621,GSE174353,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: none
7954,GSM5291889,HEK293T,HEK293T,821,HEK293T,NA,15620,821,15622,GSE174354,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: none
7955,GSM5291890,HEK293T,HEK293T,821,HEK293T,NA,15621,821,15619,GSE174355,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: none
7956,GSM5291891,HEK293T,HEK293T,821,HEK293T,NA,15622,821,15620,GSE174356,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: none
7957,GSM5291892,HEK293T,HEK293T,821,HEK293T,NA,15623,821,15625,GSE174357,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7958,GSM5291893,HEK293T,HEK293T,821,HEK293T,NA,15624,821,15626,GSE174358,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7959,GSM5291894,HEK293T,HEK293T,821,HEK293T,NA,15625,821,15623,GSE174359,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7960,GSM5291895,HEK293T,HEK293T,821,HEK293T,NA,15626,821,15624,GSE174360,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7961,GSM5291896,HEK293T,HEK293T,821,HEK293T,NA,15627,821,15629,GSE174361,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7962,GSM5291897,HEK293T,HEK293T,821,HEK293T,NA,15628,821,15630,GSE174362,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7963,GSM5291898,HEK293T,HEK293T,821,HEK293T,NA,15629,821,15627,GSE174363,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7964,GSM5291899,HEK293T,HEK293T,821,HEK293T,NA,15630,821,15628,GSE174364,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: none"
7965,GSM5291900,HEK293T,HEK293T,821,HEK293T,NA,15631,821,15633,GSE174365,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: arsenite
7966,GSM5291901,HEK293T,HEK293T,821,HEK293T,NA,15632,821,15634,GSE174366,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: WT | treatment: arsenite
7967,GSM5291902,HEK293T,HEK293T,821,HEK293T,NA,15633,821,15631,GSE174367,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: arsenite
7968,GSM5291903,HEK293T,HEK293T,821,HEK293T,NA,15634,821,15632,GSE174368,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: WT | treatment: arsenite
7969,GSM5291904,HEK293T,HEK293T,821,HEK293T,NA,15635,821,15637,GSE174369,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: arsenite
7970,GSM5291905,HEK293T,HEK293T,821,HEK293T,NA,15636,821,15638,GSE174370,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: arsenite
7971,GSM5291906,HEK293T,HEK293T,821,HEK293T,NA,15637,821,15635,GSE174371,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: arsenite
7972,GSM5291907,HEK293T,HEK293T,821,HEK293T,NA,15638,821,15636,GSE174372,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: arsenite
7973,GSM5291908,HEK293T,HEK293T,821,HEK293T,NA,15639,821,15641,GSE174373,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: arsenite
7974,GSM5291909,HEK293T,HEK293T,821,HEK293T,NA,15640,821,15642,GSE174374,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2A KO | treatment: arsenite
7975,GSM5291910,HEK293T,HEK293T,821,HEK293T,NA,15641,821,15639,GSE174375,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: arsenite
7976,GSM5291911,HEK293T,HEK293T,821,HEK293T,NA,15642,821,15640,GSE174376,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2A KO | treatment: arsenite
7977,GSM5291912,HEK293T,HEK293T,821,HEK293T,NA,15643,821,15645,GSE174377,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: arsenite
7978,GSM5291913,HEK293T,HEK293T,821,HEK293T,NA,15644,821,15646,GSE174378,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: arsenite
7979,GSM5291914,HEK293T,HEK293T,821,HEK293T,NA,15645,821,15643,GSE174379,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: arsenite
7980,GSM5291915,HEK293T,HEK293T,821,HEK293T,NA,15646,821,15644,GSE174380,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: arsenite
7981,GSM5291916,HEK293T,HEK293T,821,HEK293T,NA,15647,821,15649,GSE174381,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: arsenite
7982,GSM5291917,HEK293T,HEK293T,821,HEK293T,NA,15648,821,15650,GSE174382,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: eIF2D KO | treatment: arsenite
7983,GSM5291918,HEK293T,HEK293T,821,HEK293T,NA,15649,821,15647,GSE174383,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: arsenite
7984,GSM5291919,HEK293T,HEK293T,821,HEK293T,NA,15650,821,15648,GSE174384,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: eIF2D KO | treatment: arsenite
7985,GSM5291920,HEK293T,HEK293T,821,HEK293T,NA,15651,821,15653,GSE174385,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7986,GSM5291921,HEK293T,HEK293T,821,HEK293T,NA,15652,821,15654,GSE174386,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7987,GSM5291922,HEK293T,HEK293T,821,HEK293T,NA,15653,821,15651,GSE174387,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7988,GSM5291923,HEK293T,HEK293T,821,HEK293T,NA,15654,821,15652,GSE174388,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7989,GSM5291924,HEK293T,HEK293T,821,HEK293T,NA,15655,821,15657,GSE174389,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7990,GSM5291925,HEK293T,HEK293T,821,HEK293T,NA,15656,821,15658,GSE174390,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: Ribo-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7991,GSM5291926,HEK293T,HEK293T,821,HEK293T,NA,15657,821,15655,GSE174391,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7992,GSM5291927,HEK293T,HEK293T,821,HEK293T,NA,15658,821,15656,GSE174392,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,"protocol: RNA-seq | genotype: eIF2A, eIF2D DKO | treatment: arsenite"
7993,GSM5291928,HEK293T,HEK293T,821,HEK293T,NA,15659,821,15665,GSE174393,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si control | treatment: none
7994,GSM5291929,HEK293T,HEK293T,821,HEK293T,NA,15660,821,15666,GSE174394,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si control | treatment: none
7995,GSM5291930,HEK293T,HEK293T,821,HEK293T,NA,15661,821,15667,GSE174395,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si eIF2alpha | treatment: none
7996,GSM5291931,HEK293T,HEK293T,821,HEK293T,NA,15662,821,15668,GSE174396,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si eIF2alpha | treatment: none
7997,GSM5291932,HEK293T,HEK293T,821,HEK293T,NA,15663,821,15669,GSE174397,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si eIF2alpha | treatment: none
7998,GSM5291933,HEK293T,HEK293T,821,HEK293T,NA,15664,821,15670,GSE174398,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: Ribo-seq | genotype: si eIF2alpha | treatment: none
7999,GSM5291934,HEK293T,HEK293T,821,HEK293T,NA,15665,821,15659,GSE174399,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si control | treatment: none
8000,GSM5291935,HEK293T,HEK293T,821,HEK293T,NA,15666,821,15660,GSE174400,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si control | treatment: none
8001,GSM5291936,HEK293T,HEK293T,821,HEK293T,NA,15667,821,15661,GSE174401,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si eIF2alpha | treatment: none
8002,GSM5291937,HEK293T,HEK293T,821,HEK293T,NA,15668,821,15662,GSE174402,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si eIF2alpha | treatment: none
8003,GSM5291938,HEK293T,HEK293T,821,HEK293T,NA,15669,821,15663,GSE174403,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si eIF2alpha | treatment: none
8004,GSM5291939,HEK293T,HEK293T,821,HEK293T,NA,15670,821,15664,GSE174404,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T cells,protocol: RNA-seq | genotype: si eIF2alpha | treatment: none
8005,GSM5310244,HepG2,HepG2,825,HepG2,NA,15731,825,15735,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: WT | treatment: cycloheximide (CHX) | condition: input
8006,GSM5310245,HepG2,HepG2,825,HepG2,NA,15732,825,15736,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: WT | treatment: cycloheximide (CHX) | condition: input
8007,GSM5310246,HepG2,HepG2,825,HepG2,NA,15733,825,15737,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,METTL5 KO HepG2,cell line: HepG2 | genotype: METTL5 KO | treatment: cycloheximide (CHX) | condition: input
8008,GSM5310247,HepG2,HepG2,825,HepG2,NA,15734,825,15738,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,METTL5 KO HepG2,cell line: HepG2 | genotype: METTL5 KO | treatment: cycloheximide (CHX) | condition: input
8009,GSM5310248,HepG2,HepG2,825,HepG2,NA,15735,825,15731,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: WT | treatment: cycloheximide (CHX) | condition: ribosome-protected-fragments (RPFs)
8010,GSM5310249,HepG2,HepG2,825,HepG2,NA,15736,825,15732,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,HepG2,cell line: HepG2 | genotype: WT | treatment: cycloheximide (CHX) | condition: ribosome-protected-fragments (RPFs)
8011,GSM5310250,HepG2,HepG2,825,HepG2,NA,15737,825,15733,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,METTL5 KO HepG2,cell line: HepG2 | genotype: METTL5 KO | treatment: cycloheximide (CHX) | condition: ribosome-protected-fragments (RPFs)
8012,GSM5310251,HepG2,HepG2,825,HepG2,NA,15738,825,15734,GSE174419,Homo sapiens,HepG2,hepg2,HepG2,METTL5 KO HepG2,cell line: HepG2 | genotype: METTL5 KO | treatment: cycloheximide (CHX) | condition: ribosome-protected-fragments (RPFs)
8013,GSM5321286,PDX,PDX,826,PDX,NA,15765,826,15767,GSE130465,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
8014,GSM5321287,PDX,PDX,826,PDX,NA,15766,826,15768,GSE130466,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
8015,GSM5321288,PDX,PDX,826,PDX,NA,15767,826,15765,GSE130467,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
8016,GSM5321289,PDX,PDX,826,PDX,NA,15768,826,15766,GSE130468,Homo sapiens,PDX,pdx,PDX,Prostate cancer tissue,tissue: tumor sample
8035,GSM5326922,HEK293,HEK293,808,HEK293,NA,15383,808,15395,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: DMSO
8036,GSM5326923,HEK293,HEK293,808,HEK293,NA,15384,808,15396,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: DMSO
8037,GSM5326924,HEK293,HEK293,808,HEK293,NA,15385,808,15397,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: Thapsigargin 50 nM
8038,GSM5326925,HEK293,HEK293,808,HEK293,NA,15386,808,15398,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: Thapsigargin 500 nM
8039,GSM5326926,HEK293,HEK293,808,HEK293,NA,15387,808,15399,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: DMSO
8040,GSM5326927,HEK293,HEK293,808,HEK293,NA,15388,808,15400,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: DMSO
8041,GSM5326928,HEK293,HEK293,808,HEK293,NA,15389,808,15401,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: Thapsigargin 50 nM
8042,GSM5326929,HEK293,HEK293,808,HEK293,NA,15390,808,15402,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: Thapsigargin 500 nM
8043,GSM5326930,HEK293,HEK293,808,HEK293,NA,15391,808,15403,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: DMSO
8044,GSM5326931,HEK293,HEK293,808,HEK293,NA,15392,808,15404,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: DMSO
8045,GSM5326932,HEK293,HEK293,808,HEK293,NA,15393,808,15405,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: Thapsigargin 50 nM
8046,GSM5326933,HEK293,HEK293,808,HEK293,NA,15394,808,15406,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: Thapsigargin 500 nM
8047,GSM5326934,HEK293,HEK293,808,HEK293,NA,15395,808,15383,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: DMSO
8048,GSM5326935,HEK293,HEK293,808,HEK293,NA,15396,808,15384,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: DMSO
8049,GSM5326936,HEK293,HEK293,808,HEK293,NA,15397,808,15385,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: Thapsigargin 50 nM
8050,GSM5326937,HEK293,HEK293,808,HEK293,NA,15398,808,15386,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-3xFLAG | treatment: Thapsigargin 500 nM
8051,GSM5326938,HEK293,HEK293,808,HEK293,NA,15399,808,15387,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: DMSO
8052,GSM5326939,HEK293,HEK293,808,HEK293,NA,15400,808,15388,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: DMSO
8053,GSM5326940,HEK293,HEK293,808,HEK293,NA,15401,808,15389,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: Thapsigargin 50 nM
8054,GSM5326941,HEK293,HEK293,808,HEK293,NA,15402,808,15390,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-3xFLAG | treatment: Thapsigargin 500 nM
8055,GSM5326942,HEK293,HEK293,808,HEK293,NA,15403,808,15391,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: DMSO
8056,GSM5326943,HEK293,HEK293,808,HEK293,NA,15404,808,15392,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: DMSO
8057,GSM5326944,HEK293,HEK293,808,HEK293,NA,15405,808,15393,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: Thapsigargin 50 nM
8058,GSM5326945,HEK293,HEK293,808,HEK293,NA,15406,808,15394,GSE174764,Homo sapiens,HEK293,hek293,HEK293,HEK293 T-REx,cell line: HEK293 T-REx | cell type: naive | plasmid: pI.18-SFSVNSs-c1+2-Ala-mut-3xFLAG | treatment: Thapsigargin 500 nM
8059,GSM5348507,HepG2,HepG2,824,HepG2,NA,15727,824,NA,GSE175827,Homo sapiens,HepG2,hepg2,HepG2,Hepatocellular carcinoma HepG2 cells,genotype: Wild type
8060,GSM5348508,HepG2,HepG2,824,HepG2,NA,15728,824,NA,GSE175827,Homo sapiens,HepG2,hepg2,HepG2,Hepatocellular carcinoma HepG2 cells,genotype: Wild type
8061,GSM5348509,HepG2,HepG2,824,HepG2,NA,15729,824,NA,GSE175827,Homo sapiens,HepG2,hepg2,HepG2,Hepatocellular carcinoma HepG2 cells,genotype: METTL5 knockout
8062,GSM5348510,HepG2,HepG2,824,HepG2,NA,15730,824,NA,GSE175827,Homo sapiens,HepG2,hepg2,HepG2,Hepatocellular carcinoma HepG2 cells,genotype: METTL5 knockout
8071,GSM5363896,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15553,817,15541,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
8072,GSM5363897,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15554,817,15542,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
8073,GSM5363898,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15555,817,15543,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Control (DMSO)
8074,GSM5363899,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15556,817,15547,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
8075,GSM5363900,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15557,817,15548,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
8076,GSM5363901,SH-SH5Y,SH-SH5Y,817,SH-SH5Y,NA,15558,817,15549,GSE166214,Homo sapiens,SH-SH5Y,sh-sh5y,SH-SH5Y,human neuroblastoma,cell type: SH-SY5Y | treatment: Retinoic acid (final conc. 30ÃŽÂ¼M)
8077,GSM5386896,ICC,ICC,815,ICC,NA,15496,815,15505,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8078,GSM5386897,ICC,ICC,815,ICC,NA,15497,815,15500,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8079,GSM5386898,ICC,ICC,815,ICC,NA,15498,815,15506,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8080,GSM5386899,ICC,ICC,815,ICC,NA,15499,815,15503,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8081,GSM5386900,ICC,ICC,815,ICC,NA,15500,815,15497,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8082,GSM5386901,ICC,ICC,815,ICC,NA,15501,815,NA,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8083,GSM5386902,ICC,ICC,815,ICC,NA,15502,815,NA,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8084,GSM5386903,ICC,ICC,815,ICC,NA,15503,815,15499,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8085,GSM5386904,ICC,ICC,815,ICC,NA,15504,815,NA,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8086,GSM5386905,ICC,ICC,815,ICC,NA,15505,815,15496,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: wild type
8087,GSM5386906,ICC,ICC,815,ICC,NA,15506,815,15498,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8088,GSM5386907,ICC,ICC,815,ICC,NA,15507,815,NA,GSE161319,Homo sapiens,ICC,icc,ICC,intrahepatic cholangiocarcinoma cell line,cell type: Mettl1 knockdown
8089,GSM5397153,MB135,MB135,822,MB135,NA,15671,822,15683,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8090,GSM5397154,MB135,MB135,822,MB135,NA,15672,822,15684,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8091,GSM5397155,MB135,MB135,822,MB135,NA,15673,822,15685,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8092,GSM5397156,MB135,MB135,822,MB135,NA,15674,822,15686,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8093,GSM5397157,MB135,MB135,822,MB135,NA,15675,822,15687,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8094,GSM5397158,MB135,MB135,822,MB135,NA,15676,822,15688,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8095,GSM5397159,MB135,MB135,822,MB135,NA,15677,822,15689,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8096,GSM5397160,MB135,MB135,822,MB135,NA,15678,822,15690,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8097,GSM5397161,MB135,MB135,822,MB135,NA,15679,822,15691,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8098,GSM5397162,MB135,MB135,822,MB135,NA,15680,822,15692,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8099,GSM5397163,MB135,MB135,822,MB135,NA,15681,822,15693,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8100,GSM5397164,MB135,MB135,822,MB135,NA,15682,822,15694,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8101,GSM5397165,MB135,MB135,822,MB135,NA,15683,822,15671,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8102,GSM5397166,MB135,MB135,822,MB135,NA,15684,822,15672,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8103,GSM5397167,MB135,MB135,822,MB135,NA,15685,822,15673,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: untreated
8104,GSM5397168,MB135,MB135,822,MB135,NA,15686,822,15674,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8105,GSM5397169,MB135,MB135,822,MB135,NA,15687,822,15675,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8106,GSM5397170,MB135,MB135,822,MB135,NA,15688,822,15676,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 4 h
8107,GSM5397171,MB135,MB135,822,MB135,NA,15689,822,15677,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8108,GSM5397172,MB135,MB135,822,MB135,NA,15690,822,15678,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8109,GSM5397173,MB135,MB135,822,MB135,NA,15691,822,15679,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 8 h
8110,GSM5397174,MB135,MB135,822,MB135,NA,15692,822,15680,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8111,GSM5397175,MB135,MB135,822,MB135,NA,15693,822,15681,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8112,GSM5397176,MB135,MB135,822,MB135,NA,15694,822,15682,GSE178761,Homo sapiens,MB135,mb135,MB135,MB135iDUX4 myoblasts,cell type: skeletal muscle myoblast | cell line: MB135iDUX4 | treatment: treated with doxycycline for 14 h
8113,GSM5412810,PFB,PFB,818,PFB,NA,15559,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: untreat
8114,GSM5412811,PFB,PFB,818,PFB,NA,15560,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: untreat
8115,GSM5412812,PFB,PFB,818,PFB,NA,15561,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: 0.1mg/mL G418, 24 hours"
8116,GSM5412813,PFB,PFB,818,PFB,NA,15562,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: 0.1mg/mL G418, 24 hours"
8117,GSM5412814,PFB,PFB,818,PFB,NA,15563,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: 0.5mg/mL G418, 24 hours"
8118,GSM5412815,PFB,PFB,818,PFB,NA,15564,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: 0.5mg/mL G418, 24 hours"
8119,GSM5412816,PFB,PFB,818,PFB,NA,15565,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: Lentivirus_EGFP, MOI200"
8120,GSM5412817,PFB,PFB,818,PFB,NA,15566,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: Lentivirus_EGFP, MOI200"
8121,GSM5412818,PFB,PFB,818,PFB,NA,15567,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: Lentivirus_rAAV9.2xsup-tRNATyr, MOI200"
8122,GSM5412819,PFB,PFB,818,PFB,NA,15568,818,NA,GSE179274,Homo sapiens,PFB,pfb,PFB,PatientÃ‚Â fibroblasts (PFB),"strain: PatientÃ‚Â fibroblasts cell line | genotype: Idua-W402X/W402X | treat: Lentivirus_rAAV9.2xsup-tRNATyr, MOI200"
8129,GSM5467434,HCT116,HCT116,804,HCT116,NA,15323,804,15324,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, DMSO treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: DMSO | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8130,GSM5467435,HCT116,HCT116,804,HCT116,NA,15324,804,15323,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, DMSO treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: DMSO | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8131,GSM5467436,HCT116,HCT116,804,HCT116,NA,15325,804,15326,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, DMSO treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: DMSO | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8132,GSM5467437,HCT116,HCT116,804,HCT116,NA,15326,804,15325,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, DMSO treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: DMSO | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8133,GSM5467438,HCT116,HCT116,804,HCT116,NA,15327,804,15328,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8134,GSM5467439,HCT116,HCT116,804,HCT116,NA,15328,804,15327,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8135,GSM5467440,HCT116,HCT116,804,HCT116,NA,15329,804,15330,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8136,GSM5467441,HCT116,HCT116,804,HCT116,NA,15330,804,15329,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiCTRL, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiCTRL | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8137,GSM5467442,HCT116,HCT116,804,HCT116,NA,15331,804,15332,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3X, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3X | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8138,GSM5467443,HCT116,HCT116,804,HCT116,NA,15332,804,15331,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3X, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3X | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8139,GSM5467444,HCT116,HCT116,804,HCT116,NA,15333,804,15334,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3X, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3X | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8140,GSM5467445,HCT116,HCT116,804,HCT116,NA,15334,804,15333,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3X, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3X | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8141,GSM5467446,HCT116,HCT116,804,HCT116,NA,15335,804,15336,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3Y, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3Y | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8142,GSM5467447,HCT116,HCT116,804,HCT116,NA,15336,804,15335,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3Y, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3Y | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8143,GSM5467448,HCT116,HCT116,804,HCT116,NA,15337,804,15338,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3Y, auxin treated, ribosome profiling",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3Y | treatment: 500 micromolar IAA | rna isolation: ribosome profiling | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8144,GSM5467449,HCT116,HCT116,804,HCT116,NA,15338,804,15337,GSE180669,Homo sapiens,HCT116,hct116,HCT116,"HCT-116 with DDX3X degron, lentiDDX3Y, auxin treated, stranded rRNA depleted RNA seq",cell line background: HCT-116 | genotype/variation: HCT-116 pCMV-OsTIR1 DDX3X-mAID lentiDDX3Y | treatment: 500 micromolar IAA | rna isolation: Total RNA | adapter sequence: TAGACAGATCGGAAGAGCACACGTCTGAACTCCAGTCAC
8180,GSM5511478,Molm13,MOLM-13,814,MOLM-13,NA,15480,814,15484,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: sh-NC | sample type: Ribosome profiling RNA
8181,GSM5511479,Molm13,MOLM-13,814,MOLM-13,NA,15481,814,15485,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: sh-NC | sample type: Ribosome profiling RNA
8182,GSM5511480,Molm13,MOLM-13,814,MOLM-13,NA,15482,814,15486,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: Sh-Speptide | sample type: Ribosome profiling RNA
8183,GSM5511481,Molm13,MOLM-13,814,MOLM-13,NA,15483,814,15487,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: Sh-Speptide | sample type: Ribosome profiling RNA
8184,GSM5511482,Molm13,MOLM-13,814,MOLM-13,NA,15484,814,15480,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: sh-NC | sample type: RNA-seq
8185,GSM5511483,Molm13,MOLM-13,814,MOLM-13,NA,15485,814,15481,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: sh-NC | sample type: RNA-seq
8186,GSM5511484,Molm13,MOLM-13,814,MOLM-13,NA,15486,814,15482,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: Sh-Speptide | sample type: RNA-seq
8187,GSM5511485,Molm13,MOLM-13,814,MOLM-13,NA,15487,814,15483,GSE181795,Homo sapiens,MOLM-13,molm-13,MOLM-13,acute myeloid leukemia cells,cell line: Molm13 | treatment: Sh-Speptide | sample type: RNA-seq
8310,GSM5591840,HEK293T,HEK293T,811,HEK293T,NA,15422,811,NA,GSE184519,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,tissue: kidney | developmental stage: embryonic | treatment: C13-benzamidyl cycloheximide
8311,GSM5591841,HEK293T,HEK293T,811,HEK293T,NA,15423,811,NA,GSE184519,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,tissue: kidney | developmental stage: embryonic | treatment: C13-benzamidyl cycloheximide
8312,GSM5591842,HEK293T,HEK293T,811,HEK293T,NA,15424,811,NA,GSE184519,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,tissue: kidney | developmental stage: embryonic | treatment: cycloheximide
8313,GSM5591843,HEK293T,HEK293T,811,HEK293T,NA,15425,811,NA,GSE184519,Homo sapiens,HEK293T,hek293t,HEK293T,HEK293T,tissue: kidney | developmental stage: embryonic | treatment: cycloheximide
8316,GSM5598098,THP-1,THP-1,810,THP-1,NA,15418,810,15420,GSE184842,Homo sapiens,THP-1,thp-1,THP-1,Peripheral blood,tissue: Peripheral blood | treatment: untreated | antibody: none
8317,GSM5598099,THP-1,THP-1,810,THP-1,NA,15419,810,15421,GSE184842,Homo sapiens,THP-1,thp-1,THP-1,Peripheral blood,tissue: Peripheral blood | treatment: YTHDF1 knockdown | antibody: none
8318,GSM5598100,THP-1,THP-1,810,THP-1,NA,15420,810,15418,GSE184842,Homo sapiens,THP-1,thp-1,THP-1,Peripheral blood,tissue: Peripheral blood | treatment: untreated | antibody: none
8319,GSM5598101,THP-1,THP-1,810,THP-1,NA,15421,810,15419,GSE184842,Homo sapiens,THP-1,thp-1,THP-1,Peripheral blood,tissue: Peripheral blood | treatment: YTHDF1 knockdown | antibody: none
8407,GSM782786,HEK293,HEK293,7,HEK293,NA,63,7,62,GSE31539,Homo sapiens,HEK293,hek293,HEK293,HEK293_ER_footprints,cell line: HEK293 | sample fraction: Purified endoplasmic reticulum
8408,GSM782787,HEK293,HEK293,7,HEK293,NA,64,7,65,GSE31539,Homo sapiens,HEK293,hek293,HEK293,HEK293_Cyt_mRNA,cell line: HEK293 | sample fraction: Purified cytoplasm
